2020 ANNUAL REPORT
Stock Code: 603605 Short Name: Proya
Proya Cosmetics Co., Ltd.
2020 ANNUAL REPORT
1 / 323
2020 ANNUAL REPORT
Important Notice
I The Board of Directors, Board of Supervisors, directors, supervisors and senior
management of the Company warrant that the contents of the annual report are true,
accurate and complete, without any misrepresentation, misleading statements or
material omissions, and will severally and jointly bear the legal responsibilities
thereof.
II All directors of the Company attended the Board meeting.
III Pan-China Certified Public Accountants LLP has issued the audit report with
standard unqualified opinions to the Company.
IV Hou Juncheng, Chairman of the Company, Wang Li, CFO of the Company and Wang
Li, head of the public accountant (person in charge of accounting) warrant the
truthfulness, accuracy and completeness of the financial report in this annual report.
V Profit distribution plan or capitalization plan from capital reserve to share capital
approved by the Board of Directors during the Reporting Period
The Company shall distribute cash dividend of RMB 7.20 (tax inclusive) per 10 shares
to all shareholders registered on the equity registration date based on the total share
capital registered as at the registration date of dividend-paying equity, with the
distributed cash dividend totaling RMB 144,804,186.00 (tax inclusive), but without bonus
shares and capitalization from capital reserve to share capital. In case of a change in
the total share capital of the Company before the equity registration date of interest
distribution, the distribution ratio of each share will remain unchanged. The total amount
of distribution shall be adjusted accordingly, and the specific adjustment shall be
further announced.
VI Risks statement of the forward-looking statements
√ Applicable□ Not applicable
Forward-looking statements including future plans and development strategies
involved in this annual report do not constitute the Company’s substantive commitments
to investors. The investors are advised to pay attention to investment risks.
VII Is there any non-operating misappropriation of funds of the Company by any
controlling shareholders and their related parties
No
2 / 323
2020 ANNUAL REPORT
VIII Has the Company provided any external guarantees in violation of the
decision-making procedures
No
IX Whether more than half of the directors cannot guarantee the truthfulness, accuracy
and completeness of the annual report disclosed by the Company
No
X Warning on significant risks
The Company has illustrated the risks in detail in this report. Please refer to
“Potential Challenges and Risks” in the discussion and analysis on future development
of the Company set out in “Section IV Discussion and Analysis of Operation”.
XI Others
□ Applicable√ Not applicable
3 / 323
2020 ANNUAL REPORT
Contents
Section I Definition ............................................................................................................................ 5
Section II Company Profile and Key Financial Indicators .................................................................. 7
Section III Business Overview ............................................................................................................ 12
Section IV Discussion and Analysis of Operation............................................................................... 14
Section V Major Events ..................................................................................................................... 44
Section VI Changes in Ordinary Shares and Shareholders ............................................................... 104
Section VII Preferred Shares .............................................................................................................. 116
Section VIII Directors, Supervisors, Senior Management and Employees ......................................... 117
Section IX Corporate Governance..................................................................................................... 129
Section X Corporate Bonds.............................................................................................................. 132
Section XI Financial Report .............................................................................................................. 133
Section XII Directory of Documents for Future Reference ................................................................ 323
4 / 323
2020 ANNUAL REPORT
Section I Definition
I Definition
In this report, unless the content requires otherwise, the following terms shall have
the following meanings:
Definition of common terms
Proya, Proya Co., Proya Cosmetics Co., Ltd.
Ltd., the Company,
Company
Huzhou Branch Huzhou Branch of Proya Cosmetics Co., Ltd., a subsidiary of
the Company
Proya Trade Hangzhou Proya Trade Co., Ltd., a wholly-owned subsidiary of
the Company
Korea Hanna Hanna Cosmetics Co., Ltd., a wholly-owned subsidiary of the
Company
Huzhou Anya Anya (Huzhou) Cosmetics Co., Ltd., a wholly-owned subsidiary
of Korea Hanna
Yueqing Laiya Yueqing Laiya Trading Co., Ltd., a wholly-owned subsidiary
of the Company
Huzhou UZERO Huzhou UZERO Trading Co., Ltd., a wholly-owned subsidiary of
the Company
Mijing Siyu Mijing Siyu (Hangzhou) Cosmetics Co., Ltd., a wholly-owned
(Hangzhou) subsidiary of the Company
Meiligu Zhejiang Meiligu Electronic Commerce Co., Ltd., a
wholly-owned subsidiary of the Company
Chuangdai Huzhou Chuangdai E-commerce Co., Ltd., a wholly-owned
E-commerce subsidiary of Meiligu
Hapsode (Hangzhou) Hapsode (Hangzhou) Cosmetics Co., Ltd., a wholly-owned
subsidiary of the Company
Korea Hapsode Hapsode Co., Ltd., a wholly-owned subsidiary of Hapsode
(Hangzhou)
Huzhou Hapsode Huzhou Hapsode Trading Co., Ltd., a wholly-owned subsidiary
of Hapsode (Hangzhou)
Shanghai Tiyu Shanghai Tiyu Cosmetics Co., Ltd., a wholly-owned subsidiary
of Hapsode (Hangzhou)
Danyang Hapsode Danyang Hapsode Cosmetics Trading Co., Ltd., a wholly-owned
subsidiary of Hapsode (Hangzhou)
Proya Commercial Hangzhou Proya Commercial Management Co., Ltd., a
wholly-owned subsidiary of the Company
Tiedingxian Hangzhou Tiedingxian Catering Management Co., Ltd., a
holding subsidiary of Proya Commercial
Tielexin Aini Hangzhou Tielexin Aini Catering Management Co., Ltd., a
wholly-owned subsidiary of Proya Commercial
Xiake Bar Hangzhou Xiake Bar Catering Management Co., Ltd., a
wholly-owned subsidiary of Proya Commercial
Snail Fitness Hangzhou Proya Snail Fitness Co., Ltd., a wholly-owned
subsidiary of Proya Commercial
HONGKONG KESHI HONGKONG KESHI TRADING LIMITED, a holding subsidiary of the
5 / 323
2020 ANNUAL REPORT
Company
Hong Kong Xinghuo Hong Kong Xinghuo Industry Limited, a wholly-owned
subsidiary of the Company
Hong Kong Zhongwen Hong Kong Zhongwen Electronic Commerce Co., Limited, a
holding subsidiary of Hong Kong Xinghuo
Hong Kong Xuchen Hong Kong Xuchen Trading Limited, a wholly-owned subsidiary
of Hong Kong Xinghuo
Proya Luxembourg Proya Europe SARL, a wholly-owned subsidiary of Hong Kong
Xinghuo
Shanghai Zhongwen Shanghai Zhongwen Electronic Commerce Co., Ltd., a holding
subsidiary of the Company
Huzhou Niuke Huzhou Niuke Technology Co., Ltd., a holding subsidiary of
the Company
Hangzhou Wanyan Hangzhou Wanyan Culture Media Co., Ltd., a holding subsidiary
of Huzhou Niuke
Hong Kong Wanyan Hong Kong Wanyan Electronic Commerce Co., Limited, a holding
subsidiary of Huzhou Niuke
Huzhou Younimi Huzhou Younimi Cosmetics Co., Ltd., a holding subsidiary of
the Company
Korea Younimi Korea Younimi Cosmetics Co., Ltd., a holding subsidiary of
the Company
Ningbo TIMAGE Ningbo TIMAGE Cosmetics Co., Ltd., a holding subsidiary of
the Company
Ningbo Keshi Ningbo Keshi Trading Limited, a holding subsidiary of the
Company
Zhejiang Biyouti Zhejiang Biyouti Cosmetics Co., Ltd., a holding subsidiary
of the Company
Ningbo Proya Ningbo Proya Enterprise Consulting Management Co., Ltd., a
wholly-owned subsidiary of the Company
Zhejiang Qingya Zhejiang Qingya Culture Art Communication Co., Ltd., a
holding subsidiary of the Company
BOYA (Hong Kong) BOYA (Hong Kong) Investment Management Co., Limited, a
wholly-owned subsidiary of the Company
Japan OR P.R.O CO., LTD., a holding subsidiary of BOYA (Hong Kong)
Hangzhou Weiluoke Hangzhou Weiluoke Cosmetics Co., Ltd., a holding subsidiary
of the Company
Hangzhou Yizhuo Hangzhou Yizhuo Culture Media Co., Ltd., a wholly-owned
subsidiary of the Company
Hangzhou Oumisi Hangzhou Oumisi Trading Co., Ltd., a wholly-owned subsidiary
of the Company
Huzhou Poyun Huzhou Poyun Electronic Commerce Co., Ltd., a holding
subsidiary of the Company
Guangzhou Qianxi Guangzhou Qianxi Network Technology Co., Ltd., a
wholly-owned subsidiary of the Company
Shanghai Healthlong Shanghai Healthlong Biochemical Technology Co., Ltd., a
holding subsidiary of the Company
Weifang Zhengyi Weifang Zhengyi Network Technology Partnership (Limited
Partnership)
China Securities China Securities Regulatory Commission
6 / 323
2020 ANNUAL REPORT
Regulatory
Commission/CSRC
Shanghai Stock Shanghai Stock Exchange
Exchange
Pan-China Certified Pan-China Certified Public Accountants LLP
Public Accountants,
audit institution
Company Law Company Law of the People's Republic of China
Securities Law Securities Law of the People's Republic of China
Articles of Articles of Association of Proya Cosmetics Co., Ltd.
Association
RMB/RMB 0’000 RMB/RMB 10,000
Reporting period 1 January 2020 to 31 December 2020
Section II Company Profile and Key Financial Indicators
I Company Information
Chinese name of the Company 珀莱雅化妆品股份有限公司
Short name of the Company in Chinese 珀莱雅
English name of the Company Proya Cosmetics Co., Ltd.
Abbreviation of English name of the Proya
Company
Legal representative of the Company Hou Juncheng
II Contact Information
Board Secretary Securities Affairs Representative
Name Zhang Yefeng Wang Xiaoyan
Office address 9/F, Proya Building, No.588 Xixi 9/F, Proya Building, No.588 Xixi
Road, Xihu District, Hangzhou City, Road, Xihu District, Hangzhou
Zhejiang Province City, Zhejiang Province
Telephone 0571-87352850 0571-87352850
Fax 0571-87352813 0571-87352813
E-mail proyazq@proya.com proyazq@proya.com
III Introduction to General Information
Registered address No.588 Xixi Road, Liuxia Street, Xihu District,
Hangzhou City, Zhejiang Province
Postal code of registered address 310023
Office address Proya Building, No.588 Xixi Road, Xihu District,
Hangzhou City, Zhejiang Province
Postal code of office address 310023
Website of the Company http://www.proya-group.com
E-mail proyazq@proya.com
IV Information Disclosure and Place for Obtaining the Report
Media for the Company’s information Shanghai Securities News, Securities Times
disclosure
7 / 323
2020 ANNUAL REPORT
CSRC's designated website for the http://www.sse.com.cn
Company’s Annual Report disclosure
The Company’s Annual Report may be Board of Director’s Office, Proya Building,
obtained at No.588 Xixi Road, Xihu District, Hangzhou City,
Zhejiang Province
V Stock Information
Stock Information
Share class Exchanges on Stock short name Stock code Stock short name
which the stocks before change
are listed
A share Shanghai Stock Proya 603605 None
Exchange
VI Other Relevant Information
Name Pan-China Certified Public Accountants
LLP
Office address Block B, China Resources Building,
Auditor of the Company No.1366 Qianjiang Road, Jianggan
(domestic) District, Hangzhou City
Name of the Yin Zhibin, Wang Xiaokang
signing
accountant
VII Major Accounting Data and Financial Indicators for the Past Three Years
（I） Major accounting data
Unit: Yuan Currency: RMB
Major Year-on-year
2020 2019 2018
accounting data change (%)
Revenue 3,752,386,849.02 3,123,520,211.77 20.13 2,361,248,766.72
Net profits 476,009,298.41 392,681,976.58 21.22 287,188,727.12
attributable to
shareholders of
the listed
company
Net profit 469,935,904.22 386,170,257.02 21.69 277,682,743.63
attributable to
shareholders of
the listed
companies, net
of
non-recurring
gains and
losses
Net cash flow 331,550,109.14 235,961,328.34 40.51 512,918,568.86
generated from
operating
activities
8 / 323
2020 ANNUAL REPORT
Year-on-year
Major End of 2020 End of 2019 End of 2018
change (%)
accounting data
Net assets 2,391,535,435.94 2,029,687,883.68 17.83 1,694,310,463.85
attributable to
shareholders of
the listed
company
Total assets 3,636,882,185.29 2,979,365,076.82 22.07 2,860,042,557.71
（II） Key financial indicators
Year-on-year
Key financial indicators 2020 2019 2018
change (%)
Basic earnings per share 2.37 1.96 20.92 1.44
(Yuan/share)
Diluted earnings per share 2.37 1.96 20.92 1.43
(Yuan/share)
Basic earnings per share， net 2.34 1.93 21.24 1.39
of non-recurring gains and
losses (Yuan/share)
Weighted average ROE (%) 21.82 21.24 Increase by 18.28
0.58
percentage
points
Weighted average ROE, net of 21.54 20.89 Increase by 17.67
non-recurring gains and 0.65
losses (%) percentage
points
Explanation of major accounting data and financial indicators for the past three years
by the end of the Reporting Period
□ Applicable√ Not applicable
VIII Accounting data difference between PRC GAAP and Overseas Accounting
Standards
（I） Differences in net profit and net asset attributable to shareholders of the listed company in
financial reports disclosed under International Accounting Standards and PRC GAAP
□ Applicable√ Not applicable
（II） Differences in net profit and net assets attributable to shareholders of the listed company
in financial reports disclosed under overseas accounting standards and PRC GAAP
□ Applicable√ Not applicable
（III） Explanation on the differences between PRC GAAP and Overseas Accounting Standards:
□ Applicable√ Not applicable
IX Key Financial Data for the Year of 2020 by Quarter
Unit: Yuan Currency: RMB
Key financial 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter
indicators （Jan-Mar） （Apr-Jun） （Jul-Sept） （Oct-Dec）
9 / 323
2020 ANNUAL REPORT
Revenue 608,193,650.94 776,130,197.94 906,747,098.59 1,461,315,901.55
Net profit
attributable to
77,728,276.22 101,038,744.54 106,232,700.41 191,009,577.24
shareholders of
the listed company
Net profit
attributable to
shareholders of
the listed company 83,469,428.49 98,996,965.70 105,814,578.25 181,654,931.78
after
non-recurring
profit or loss
Net cash flow
generated from
-134,873,267.48 171,437,646.36 170,331,901.76 124,653,828.50
operating
activities
Note: Main reasons for quarterly fluctuation of operating revenue and net profit
attributable to shareholders of the listed companies: The quarterly sales fluctuated in
cosmetics industry owing to the vulnerability to seasonal factors and holiday activities.
For example, Q4 gathered the peak sales such as National Day, “Double Eleven” and
“Double Twelve” shopping festivals. Therefore, the operating revenue and net profit
of Q4 were higher than other quarters.
Explanation on difference between information by quarter and information disclosed in periodical
reports
□ Applicable√ Not applicable
X Items and Amounts of Non-recurring Gains or Losses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Items of Non-recurring Amounts in Notes (if Amounts in Amounts in
Gains or Losses 2020 applicable) 2019 2018
Gains or losses on disposal of 150,560.30 43,245.67 22,987.42
non-current assets
Tax returns and exemption with 8,167.37
approval exceeding one's
authority or without formal
approval document, or on an
accidental basis
Government grants included in 12,198,410.18 7,913,746.66 9,805,967.39
profits and losses for the
current period, excluding those
closely related to the normal
business and of fixed amount
or fixed quantity granted on an
on-going basis in accordance
with certain standards and in
compliance with the State
policies
Fund possession cost from 27,000.00
non-financial business included
10 / 323
2020 ANNUAL REPORT
in current profit or loss
Gains arising from investment
costs for acquisition of
subsidiaries, associates and
joint ventures less than the fair
values of attributable
identifiable net assets of the
invested entity at the time of
acquisition
Profit and loss from exchange
of non-currency assets
Gains or losses on entrusted 401,621.91
investment or asset
management
Provision for asset impairment
due to force majeure factors,
such as natural disaster
Profit and loss from
restructuring of debts
Enterprise restructuring charge,
such as expenditure on staffing,
integration cost
Profit and loss of the part
exceeding fair value generated
from transaction with
unreasonable transaction price
Net current profit and loss of
subsidiary generated from
enterprise merger under
common control from the
beginning of the period to the
date of merger
Profit and loss generated from
contingencies unrelated to
normal business of company
Investment income arising from 2,266,301.37 Investment 4,653,362.83
changes in fair values income from
held-for-trading financial disposal of
assets, derivative financial financial
assets, held-for-trading asset
financial liabilities and designated
derivative financial liabilities,
as at fair
and investment gains on the
value
disposal of held-for-trading
through
financial assets, derivative
financial assets, profit or
held-for-trading financial loss
liabilities, derivative financial
liabilities and other debt
investment, except the
Company normal operations
related to effective hedging
business
11 / 323
2020 ANNUAL REPORT
Reversal of provision for 744,899.00
impairment of receivables and
contract assets which are
individually tested for
impairment
Profit and loss obtained from
entrusted loans
Profit and loss generated from
fair value change of investment
real estate whose subsequent
measurement is conducted
with fair value model
Influences on current profit and
loss of one-time adjustment to
current profit or loss pursuant
to the laws and regulations on
tax and accounting
Trustee fee income obtained
from entrusted operation
Other net non-operating -6,810,805.57 -5,128,895.30 398,144.30
income and expenses, other
than the above items
Other profit and loss items
conforming to the definition of
non-recurring gains and losses
Effect of minority equity -688,969.45 187,247.54 2,301.47
Effect of income tax -1,042,102.64 -1,192,155.21 -1,869,938.00
Total 6,073,394.19 6,511,719.56 9,505,983.49
XI Items Measured at Fair Values
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Opening Closing Changes in the Effect on profit
Items
balance balance Period for the Period
Wealth management 71,450,000.00 0.00 -71,450,000.00 0.00
products
Receivables 2,150,000.00 5,531,997.32 3,381,997.32 0.00
financing
Total 73,600,000.00 5,531,997.32 -68,068,002.68 0.00
XII Others
□ Applicable√ Not applicable
Section III Business Overview
I Description of the Company’s principal business, operation model and industry
condition during the Reporting Period
(I) Principal business
The Company is committed to building a new domestic beauty industry platform, mainly
engaged in the research and development, production and sales of beauty and personal care
12 / 323
2020 ANNUAL REPORT
products. It mainly owns "Proya", "Hapsode", "TIMAGE", "INSBAHA", and "CORRECTORS" brands.
At present, the Company's brands have covered the beauty fields such as popular exquisite
skin care, make-up and high-efficacy skin care products:
1. Popular exquisite skin care brand
(1) Proya, focusing on technology skin care for young white-collar women. The main
price range is RMB 100-300. This brand is sold both online and offline.
(2) Hapsode, specially tailored for young skin, is aimed at students and young women
in small towns. The main price range is RMB 50-100. This brand is sold mainly online.
2. Make-up brand
(1) TIMAGE is a professional make-up brand for new Chinoiserie dressers. The main
price range is RMB 150-200. This brand is sold online.
(2) INSBAHA is a punk style make-up brand for the minority. The main price range is
RMB 50-150. This brand is sold online.
3. High-efficacy skin care brand
CORRECTORS is a high-efficiency skin care brand. The main price range is RMB 260-600.
This brand is sold online.
(II) Main operation model
1. Sales mode
The main sales channel is online sales, with offline sales as the auxiliary channel.
Online channels mainly include direct sales and distribution. Direct sales focus on
platforms such as Tmall and JD.COM, while expanding emerging platforms such as TikTok
shops, and distribution focuses on platforms such as Taobao, JD.COM, Vipshop and
Pinduoduo.
Off-line channels are mainly operated by dealers. Channels include cosmetics
specialty stores, malls and supermarkets, and single brand stores.
2. Production/R&D mode
The Company is mainly engaged in independent production, supplemented by OEM
outsourcing factories. It operates self-built skin care/personal care factories and
make-up factories.
The Company takes independent research and development as the main R&D mode, supplemented
by the industry-university-research cooperation mode. It maintains R&D cooperation
relations with leading raw material suppliers in the world, such as BASF China, Ashland
China and LIPOTRUE S.L. in Spain.
(III) Explanation on the industry
In accordance with the Guidelines for the Industry Classification of Listed Companies
issued by the China Securities Regulatory Commission, the industry to which the Company
belongs is chemical raw materials and chemical products manufacturing (classification
code: C26); in accordance with the China National Economic Industry Classification and
Code (GB/T 4754-2011), the Company belongs to the industry of daily chemical products
manufacturing (C268), and the subdivided industry is cosmetics manufacturing (C2682).
According to the statistics of the National Bureau of Statistics, the total retail
sales of social consumer goods was RMB 39,198.1 billion in 2020, with a year-on-year
decrease of 3.9%, of which the total amount of cosmetics was RMB 340 billion, up 9.5%
year on year (retail sales of unit consumer goods above quota).
II Explanation on significant change in major assets of the Company during the Reporting
Period
□ Applicable√ Not applicable
13 / 323
2020 ANNUAL REPORT
III Analysis on core competitiveness during the Reporting Period
√ Applicable□ Not applicable
The Company's core competitiveness is mainly reflected in: building a self-driven
organization with high efficiency and collaboration in front, middle and back grounds
with "products, contents and operations" as the main line, and constructing a consistent
operation management system of "culture-strategy-mechanism-talents" from top to bottom,
with culture as the traction, strategy as the guidance, mechanism and talents as the two
wings, so as to fully implement the strategy.
Section IV Discussion and Analysis of Operation
I Discussion and Analysis of Operation
1. Year-on-year increase of operating revenue
The operating revenue was RMB 3.752 billion, with a year-on-year increase of 20.13%.
Where: The principal business income was RMB 3.748 billion, with a year-on-year
increase of 20.26%.
Other business income was RMB 4,462,200.
Principal business income:
(1) By channel
Year-on- Year-on- Year-on-
Amoun
year year year
t (in Percent Percent Percent
increase increase increase
RMB age in age in age in
Sub-channel or or or
100 2020 2019 2018
decrease decrease decrease
milli (%) (%) (%)
in 2020 in 2019 in 2018
on)
(%) (%) (%)
Direct
79.63 88.25 90.19 60.63 53.53 45.77
sales 15.91
Onlin Distribu
10.33 34.36 37.95 40.97 39.37 46.47 54.23
e tion
Sub-tota
26.24 58.59 60.97 59.91 70.01 53.09 43.57
l
Cosmetic
8.45 -19.28 4.42 7.45 75.22 71.64 75.35
s stores
Offli
Others 2.79 -32.81 26.33 59.72 24.78 28.36 24.65
ne
Sub-tota
11.24 -23.12 9.82 16.88 29.99 46.91 56.43
l
Total 37.48 20.26 32.11 32.41 100.00 100.00 100.00
Note: The proportion of online and offline subtotal refers to the proportion of principal
business revenue.
(2) By brand
Amoun Year-on- Year-on- Year-on-
t (in year year year Percent Percent Percent
RMB increase increase increase age in age in age in
Sub-brand
100 or or or 2020 2019 2018
milli decrease decrease decrease (%) (%) (%)
on) in 2020 in 2019 in 2018
14 / 323
2020 ANNUAL REPORT
(%) (%) (%)
Proya 29.86 12.43 26.81 32.38 84.32 89.33 88.77
Self-ow Other
5.55 75.08 19.74 32.65 15.68 10.67 11.23
ned brands
brand Sub-tota
35.41 19.11 26.02 32.41 94.48 95.39 100.00
l
Cross-bo
Agent rder
2.07 44.09 - - 5.52 4.61 -
brand agency
Brand
Total 37.48 20.26 32.11 32.41 100.00 100.00 100.00
Note: Among them, TIMAGE records revenue of RMB 121 million.
(3) By category
Amount Year-on-year Year-on-year Year-on-year
(in RMB increase or increase or increase or Percentage Percentage Percentage
Category
100 decrease in decrease in decrease in in 2020 (%) in 2019 (%) in 2018 (%)
million) 2020 (%) 2019 (%) 2018 (%)
Skin care
(including 32.42 11.38 24.89 32.29 86.50 93.40 98.80
cleansing)
Make-up 4.65 181.91 482.43 42.59 12.41 5.29 1.20
Others 0.41 0.47 - - 1.09 1.31 -
Total 37.48 20.26 32.11 32.41 100.00 100.00 100.00
2. Year-on-year increase of net profit
The net profit attributable to shareholders of the listed companies was RMB 476
million, with a year-on-year increase of 21.22%.
The net profit attributable to shareholders of the listed companies, net of
non-recurring gains and losses, was RMB 470 million, with a year-on-year increase of
21.69%.
Index 2020 2019 2018 Description
1. Net profit margin 12.04% 11.73% 12.14%
Due to the implementation of new revenue
standards, the freight charge of RMB 118
million was listed in the principal business
2. Gross profit margin 63.55% 63.96% 64.03%
cost in the current period, and the gross
profit margin excluding freight charge on
comparable basis was 66.70% in 2020
1. The online revenue occupied an increased
proportion, and the investment for image
publicity and brand promotion of the Company
increased RMB 387 million compared with the
3. Ratio of expenses to
39.90% 39.16% 37.52% prior year, with year-on-year growth of
sales
46.17%; 2. Due to the implementation of new
revenue standards, the freight charge of RMB
118 million was listed in the principal
business cost in the current period (freight
15 / 323
2020 ANNUAL REPORT
charge of RMB 76.25 million was included in
the selling expense in the same period in
2019).
Where: Image promotion
32.68% 26.86% 21.19%
expense
4. Administrative expense
5.44% 6.25% 7.26%
ratio
The R&D expense was essentially on par with
5. R&D expense ratio 1.92% 2.39% 2.17%
the previous year.
Main reasons in the current period: (1) The
growth rate of accounts receivable from
online platform business (such as JD.COM and
6. Turnover rate of Vipshop) exceeded that of operating revenue,
accounts receivable 15.53 21.74 36.04 which affected the turnover rate; (2) Dealers
(times) were offered greater credit support to
stabilize offline sales, and the balance of
accounts receivable increased; (3) The
impact of new brand business
7. Turnover days of
accounts receivable 23.18 16.56 9.99
(days)
8. Inventory turnover Mainly due to the overstock for live
3.50 4.12 4.04
rate (times) streaming in Q4 of the current period
9. Inventory turnover
102.86 87.38 89.11
days (days)
II Financial Performance during the Reporting Period
During the Reporting Period, the Company’s operations focused on three aspects: product
drive, brand building and organizational reform.
1. Product drive
During the Reporting Period, the channel-driven strategy was rapidly upgraded to a
product-driven strategy. Digital product management was implemented. The digital
management was realized in the whole life cycle from insight into consumer market and
product development to product listing. In addition, the strategy of popular single
products was implemented. Star single products with brand mind and representativeness
were created, so as to improve the per customer transaction and re-purchase rate and
enhance brand loyalty. For example, Ruby Essence, Double Anti-aging Essence, Double
Anti-aging Nightlight Eye Cream, TIMAGE Shading Powder and other popular single products
were developed.
2. Brand building
Proya brand continued to upgrade, with the upgrading of the product system as the
core, continuously enhancing the brand's sense of technology and youth, conveying the
brand's spirit of discovery, and closely binding with the younger generation of consumers
from material to spirit. Consumers can intuitively feel that "Proya is really different".
In marketing activities, brand content was continuously and uniformly exported
throughout the year around positioning, and the brand deeply interacts with consumers
through original theme content, official announcement of new spokesperson,
cross-border/IP and other forms, to continuously make innovation. Such activities include
#Young Dreamers# in January; # Young People Fear Nothing# + official announcement of Sun
16 / 323
2020 ANNUAL REPORT
Li in March; official announcement of Cai Xukun in April; #Take on adventure for love
when you are young# in May; Proya * Nayuku, #Realize your dream while you are young# in
June; Nightlight * Tmall Black Box in July; PROYA* Young Artist Jiang Yueyin in September;
PROYA* Eastsea Festival in October; and TIMELAB press conference +PROYA* Bu Kewen and
#Just do it while you are young in November.
3. Organizational reform
Organizational level: Focused on building a digitalmiddle platform: the product
middle platform deepened the strategy of popular single products and hot products; the
accurate promotion ROI strategies of the middle platform were launched. The virtual
project organization form with products and delivery as the main line was adopted to create
an end-to-end, efficient and self-driven process organization.
Talent: The Company continued to further promote the talent supply chain mechanism
that matches the business, selected talents accurately, identified talents quickly and
employed talents efficiently, so as to gradually build a young team with strong fighting
capacity, learning ability, self-driven ability and entrepreneurial passion.
Mechanism: The Company advocated the “three-high" performance culture of "high
investment, high performance and high return", and established a performance management
system of "setting goals, focusing on processes and getting results"; around the business
strategy, the Company made every effort to build a short (quarterly performance, project
incentives), medium (annual excess dividends) and long-term (equity incentives, partners)
diversified business incentive system.
(I) Analysis of principal business
1. Analysis of change in certain items in income statement and cash flow statement
Unit: Yuan Currency: RMB
Item Amount in the
Amount in the Change in the
same period last
current period proportion (%)
year
Revenue 3,752,386,849.02 3,123,520,211.77 20.13
Cost of sales 1,367,561,949.78 1,125,573,226.23 21.50
Selling expenses 1,497,058,943.34 1,223,031,824.07 22.41
Administrative expenses 204,279,378.68 195,259,927.02 4.62
R&D expenses 72,200,028.77 74,602,606.55 -3.22
Financial expenses -13,607,115.53 -9,494,812.30 Not applicable
Net cash flow generated from 331,550,109.14 235,961,328.34 40.51
operating activities
Net cash flow generated from 14,534,157.08 -54,596,265.69 Not applicable
investing activities
Net cash flow from financing -43,382,734.32 -209,256,879.22 Not applicable
activities
2. Analysis of revenue and cost
√ Applicable□ Not applicable
Explanation on the reason for change in operating revenue: Mainly due to the growth of
revenue from online channels.
Explanation on the reason for change in operating cost:
17 / 323
2020 ANNUAL REPORT
The year-on-year increase achieved RMB 242 million, up 21.50%. The main reasons are as
follows:
1. The operating revenue increased and the operating cost increased correspondingly;
2. Due to the implementation of new revenue standards, the freight charge of RMB 118
million was listed in the principal business cost in the current period.
Explanation on the reason for change in selling expense:
The selling expense was RMB 1.497 billion in 2020, accounting for 39.90% of the operating
revenue (39.16% in the same period last year). The year-on-year increase of selling
expense achieved RMB 274 million, up 22.41%. The main reasons are as follows:
1. The online revenue occupied an increased proportion, and the investment for image
publicity and brand promotion of the Company increased RMB 387 million compared with the
prior year, with year-on-year growth of 46.17%;
2. Due to the implementation of new revenue standards, the freight charge of RMB 118
million was listed in the principal business cost in the current period (freight charge
of RMB 76.25 million was included in the selling expense in the same period in 2019).
Explanation on the reason for change in administrative expense:
The administrative expense was RMB 204 million in 2020, accounting for 5.44% of the
operating revenue (6.25% in the same period last year). The administrative expense,
increased RMB 9.02 million on year-on-year basis, up 4.62%, was essentially on par with
the previous year.
Explanation on the reason for change in R&D expenses:
The R&D expense was RMB 72.2 million in 2020, accounting for 1.92% of the operating revenue
(2.39% in the same period last year). It was essentially on par with the previous year.
The R&D expense of the parent company was 3.96% in 2020 (4.51% in the same period last
year).
Explanation on the reason for change in financial expense: Mainly due to the increase
of interest income.
Explanation on the reason for change in net cash flow generated from operating
activities:
The year-on-year net flow increased RMB 95.59 million, mainly due to the followings:
1. Increase of cash: The year-on-year increase of sales outstanding achieved RMB 728
million;
2. Decrease of cash: The goods payment increased RMB 171 million on year-on-year basis,
and the cash paid for other operating activities increased RMB 484 million.
Explanation on the reason for change in net cash flow generated from investing
activities:
The year-on-year net flow increased by RMB 69.13 million, mainly due to the followings:
1. Increase of cash: Increase of net redemption of wealth management products and increase
of monetary capital for new consolidated subsidiary, i.e., acquisition of “Shanghai
Healthlong”;
18 / 323
2020 ANNUAL REPORT
2. Decrease of cash: The year-on-year increase for investment on associate and other
equity as well as expenditure for the acquisition of fixed assets and construction in
progress in the current period.
Explanation on the reason for change in net cash flow generated from financing
activities:
The year-on-year net flow increased by RMB 166 million, mainly due to the followings:
1. The short-term borrowings from banks had a year-on-year net increase of RMB 170 million,
and the outlay for debt payment had a year-on-year net decrease of RMB 46 million. For
these two items, the net cash inflows increased by RMB 216 million;
2. The interest expenditure for dividend distribution increased by RMB 30 million on
year-on-year basis.
(1). Result of principal business by industry, product and region
Unit: Yuan Currency: RMB
Result of principal business by industry
Change
Change
in
Gross in cost Change in gross
By revenue
Revenue Cost of sales margin from profit margin from
industry from
(%) last last year (%)
last
year (%)
year (%)
Beauty and 3,747,924,600.60 1,363,486,774.26 63.62 20.26 21.71 Decrease by 0.43
personal percentage points
care
industry
Result of principal business by product
Change
Change
in
Gross in cost Change in gross
revenue
By product Revenue Cost of sales margin from profit margin from
from
(%) last last year (%)
last
year (%)
year (%)
Skin care 3,242,093,549.02 1,139,865,475.50 64.84 11.38 11.02 Increase by 0.11
(including percentage points
cleansing)
Make-up 464,967,347.81 197,578,914.36 57.51 181.91 213.38 Decrease by 4.26
percentage points
Other 40,863,703.77 26,042,384.40 36.27 0.47 -14.60 Increase by 11.25
categories percentage points
Total 3,747,924,600.60 1,363,486,774.26 63.62 20.26 21.71 Decrease by 0.43
percentage points
Result of principal business by region
Change Change
Gross in in cost Change in gross
By
Revenue Cost of sales margin revenue from profit margin from
geography
(%) from last last year (%)
last year (%)
19 / 323
2020 ANNUAL REPORT
year (%)
Northeast 44,304,893.79 15,645,677.45 64.69 -30.34 -32.65 Increase by 1.21
China percentage points
North 111,815,638.32 45,042,729.22 59.72 -35.95 -32.60 Decrease by 2.00
China percentage points
East China 805,871,057.44 277,383,905.03 65.58 41.83 32.09 Increase by 2.54
percentage points
South 78,086,349.46 31,545,110.66 59.60 -56.84 -54.37 Decrease by 2.19
China percentage points
Central 209,350,223.42 82,846,339.82 60.43 -46.97 -43.57 Decrease by 2.39
China percentage points
Northwest 72,627,248.27 24,751,079.45 65.92 -31.79 -30.69 Decrease by 0.54
China percentage points
Southwest 143,373,945.60 51,533,131.56 64.06 -7.33 -2.99 Decrease by 1.61
China percentage points
Hong Kong, 127,445,152.37 110,143,260.74 13.58 -13.85 -14.30 Increase by 0.46
China and percentage points
overseas
Others 2,155,050,091.93 724,595,540.33 66.38 62.61 87.25 Decrease by 4.42
(some percentage points
e-commerce
channels)
Total 3,747,924,600.60 1,363,486,774.26 63.62 20.26 21.71 Decrease by 0.43
percentage points
Explanation on result of principal business by industry, product and geography
(1) Due to the implementation of new revenue standards, the freight charge of RMB 118
million was listed in the principal business cost in the current period, and the gross
profit margin of principal business excluding freight charge on comparable basis was 66.80%
in 2020, increased by 2.75 percentage points over the previous year.
(2) Increase in beauty and personal careindustry: The increase of principal business
income in the current year was mainly from the online sales of RMB 2.624 billion, with
year-on-year growth of 58.59%.
(3) Increase in make-up: The main reason lies in the development of new make-up products
in the Reporting Period (including in-house and OEM products). For example, “TIMAGE”,
the new make-up brand in the Reporting Period, witnessed revenue of RMB 121 million.
(4) Increase by regions: The increase in East China is mainly due to the increase of online
distribution; the revenue of others (part of the E-commerce) presented a year-on-year
growth of 62.61%; the revenue of other regions except E-commerce and East China decreased
to varying degrees: mainly due to the year-on-year decrease of online revenue.
(2). Analysis of production and sales volume
√ Applicable□ Not applicable
Change in Chang Change in
Major
productio e in inventor
product Unit Production Sales Inventory
n from sales y from
s
last year from last year
20 / 323
2020 ANNUAL REPORT
(%) last (%)
year
(%)
Beauty Piec 194,003,30 180,825,86 47,873,37 15.29 10.00 37.98
and e 0 6 2
persona
l care
product
Explanation on production and sales volume
Both in-house and OEM products are included in the above table, but excluding the quantity
for products like cross-border agent brand.
(3). Analysis of cost
Unit: Yuan
By industry
Percentage
change in
Percentage the amount
Percentage
of total for the
of total
Amount in the costs for current
By Amount in the costs for Explan
Cost item same period last the same period as
industry current period the ation
year period compared
current
last year to the same
period (%)
(%) period
last year
(%)
Beauty Raw 851,018,281.40 62.42 799,853,363.25 71.39 6.40
and materials
personal Labor and 82,914,903.34 6.08 78,047,754.49 6.97 6.24
care manufactu
industry ring costs
Purchases 311,700,853.56 22.86 242,407,770.07 21.64 28.59
Freight 117,852,735.96 8.64
charge
Sub-total 1,363,486,774.26 100.00 1,120,308,887.81 100.00 21.71
By product
Percentage
change in
Percentage the amount
Percentage
of total for the
of total
Amount in the costs for current
By Amount in the costs for Explan
Cost item same period last the same period as
product current period the ation
year period compared
current
last year to the same
period (%)
(%) period
last year
(%)
Skin care Raw 798,070,230.37 70.02 769,807,079.06 74.97 3.67
(including materials
21 / 323
2020 ANNUAL REPORT
cleansing) Labor and 76,267,474.56 6.69 74,427,379.74 7.25 2.47
manufactu
ring costs
Purchases 164,300,108.50 14.41 182,531,687.96 17.78 -9.99
Freight 101,227,662.07 8.88
Sub-total 1,139,865,475.50 100.00 1,026,766,146.76 100.00 11.02
Make-up Raw 52,948,051.03 26.80 30,046,284.19 47.66 76.22 Sales
materials increas
e of
new
make-u
p
product
s
Labor and 6,647,428.78 3.36 3,620,374.75 5.74 83.61 Sales
manufactu increas
ring costs e of
new
make-u
p
product
s
Purchases 121,703,172.90 61.60 29,381,356.62 46.60 314.22 Mainly
due to
the
sales of
new
brand
TIMAGE
Freight 16,280,261.65 8.24
Sub-total 197,578,914.36 100.00 63,048,015.56 100.00 213.38
Other Raw
categories materials
Labor and
manufactu
ring costs
Purchases 25,697,572.16 98.68 30,494,725.49 100.00 -15.73
Freight 344,812.24 1.32
Sub-total 26,042,384.40 100.00 30,494,725.49 100.00 -14.60
Total 1,363,486,774.26 1,120,308,887.81 21.71
Explanation on other situations of cost analysis
None
(4). Major customers and suppliers
√ Applicable□ Not applicable
Sales of the top 5 customers amounted to RMB 565,284,600, accounting for 15.08% of the
total annual sales. Of the sales of the top 5 customers, sales of related parties amounted
to RMB0.00, accounting for 0.00% of the total annual sales.
22 / 323
2020 ANNUAL REPORT
Procurement of the top 5 suppliers amounted to RMB261,040,300, accounting for 19.65% of
the total annual procurement. Of the procurement of the top 5 suppliers, procurement of
related parties amounted to RMB0.00, accounting for 0.00% of the total annual procurement.
Other particulars
None
3. Expense
√ Applicable□ Not applicable
Unit: Yuan
Increase or
Item 2020 2019 decrease of the Growth rate
current period
Selling
1,497,058,943.34 1,223,031,824.07 274,027,119.27 22.41%
expenses
Administrative
204,279,378.68 195,259,927.02 9,019,451.66 4.62%
expenses
R&D expenses 72,200,028.77 74,602,606.55 -2,402,577.78 -3.22%
Financial Not
-13,607,115.53 -9,494,812.30 -4,112,303.23
expenses applicable
4. R&D investment
(1). Table of R&D investment
√ Applicable□ Not applicable
Unit: Yuan
Expensed R&D investment in the 72,200,028.77
current period
Capitalized R&D investment in the
current period
Total R&D investment 72,200,028.77
Proportion of total R&D investment 1.92
to operating revenue (%)
Number of the Company’s R&D staff 196
Percentage of the number of R&D staff 6.76
to the Company’s total number of
employees (%)
Percentage of capitalized R&D
investment (%)
(2). Explanation
□ Applicable√ Not applicable
5. Cash flow
√ Applicable□ Not applicable
Item Amount in the Amount in the Growth Explanation
current period same period last rate (%)
year
23 / 323
2020 ANNUAL REPORT
Net cash flow 331,550,109.14 235,961,328.34 40.51 The year-on-year net flow
generated from increased by RMB 95.59 million,
operating mainly due to the followings: 1.
activities Cash inflow: The year-on-year
increase of cash received from
sales of goods achieved RMB 728
million; 2. Cash outflow: The
cash paid for goods and services
increased by RMB 171 million on
year-on-year basis, and the cash
paid for other operating
activities increased by RMB 484
million
Net cash flow 14,534,157.08 -54,596,265.69 Not The year-on-year net flow
generated from applicabl increased by RMB 69.13 million,
investing e mainly due to the followings: 1.
activities Increase of cash: (1) The net
redemption of wealth management
products was RMB 213 million in
the current period (RMB 110
million in the same period last
year), with year-on-year net flow
increase of RMB 103 million; (2)
The cash balance of “Shanghai
Healthlong of RMB 66.05 million
at the acquisition; 2. Decrease
of cash: (1) The year-on-year
increase for investment on
associate and other equity was
RMB 76.29 million in the current
period; (2) The year-on-year
increase for the acquisition of
fixed assets and construction in
progress was RMB 20.32 million.
Net cash flow from -43,382,734.32 -209,256,879.22 Not The year-on-year net flow
financing applicabl increased by RMB 166 million,
activities e mainly due to the followings: 1.
The short-term borrowings from
banks had a year-on-year net
increase of RMB 170 million, and
the outlay for debt payment had a
year-on-year net decrease of RMB
46 million. For these two items,
the net cash inflows increased by
RMB 216 million; 2. The interest
expenditure for dividend
distribution increased by RMB 30
million on year-on-year basis
Other cash 81,739,953.02 27,439,741.01 197.89 Mainly due to amount from the
received from newly consolidated subsidiary in
24 / 323
2020 ANNUAL REPORT
operating the current period
activities
Cash paid for 1,422,965,037.76 939,446,827.05 51.47 The main reason lies in the
other operating year-on-year increase of image
activities promotion expense of RMB 434
million in the current period,
including: 1. increase for new
consolidated subsidiary; 2.
increase of image promotion
expense for new incubation brands
and investment brands
Cash received from 213,200,000.00 380,000,000.00 -43.89 Mainly due to the year-on-year
disposal of decrease of wealth management
investments product redemption
Cash received from 2,266,301.37 4,653,362.83 -51.30 Mainly due to the earnings change
returns on from wealth management products
investments
Other cash 66,052,759.40 2,500,000.00 2,542.11 The cash balance of “Shanghai
received relating Healthlong” at the acquisition;
to investing repayment of the loan principal
activities of RMB 2.5 million was made by
Beijing Mitangpai Cosmetics Co.,
Ltd. in the same period last year
Cash paid for 81,930,000.00 275,588,295.00 -70.27 Main reasons: 1. The investment
investment on associate and other equity
totaled RMB 66.58 million, and
the equity transfer fund of RMB
15.35 million was paid to
minority shareholders in the
current period; 2. Cash of RMB
269.95 million was paid for
purchase of wealth management
products, and the equity transfer
fund of RMB 5.64 million was paid
to minority stockholders in the
same period last year
Other cash paid 1,035,148.02 2,500,000.00 -58.59 Net cash paid for disposal of
relating to Huzhou Tizhi Cosmetics Co., Ltd.
investing in the current period; loan of RMB
activities 2.5 million to Beijing Mitangpai
Cosmetics Co., Ltd. in the same
period last year
Proceeds received 2,266,300.00 21,085,273.44 -89.25 The main reason lies in the
from financing decrease of equity investment by
activities minority shareholders of the
consolidated holding subsidiary
in 2020 as compared with 2019
Cash received from 299,000,000.00 128,939,749.33 131.89 Mainly due to the year-on-year
borrowings increase of short-term
borrowings from bank
25 / 323
2020 ANNUAL REPORT
Dividends paid, 127,734,055.29 97,824,202.19 30.58 Mainly due to the year-on-year
profit increase of cash dividend
distributed or distribution of RMB 32.2 million
interest paid
Other cash paid 2,684,110.55 1,657,699.80 61.92 Mainly due to the year-on-year
for increase of equity repurchase
financing-related payment in 2020
activities
(II) Explanation on significant change of profit caused by non-principal business
□ Applicable√ Not applicable
(III) Analysis of assets and liabilities
√ Applicable□ Not applicable
1. Assets and liabilities
Unit: Yuan
Change in
Amount as Percentage Percentage
Amount as percentage
at the of total of total
at the for the
end of assets at assets at
Items end of current Explanation
the the end of the end of
last period over
current current last
period the last
period period (%) period (%)
period (%)
Held-for-trad 71,450,0 2.40 -100.00 Mainly due to
ing financial 00.00 redemption on
assets maturity of wealth
management
products purchased
at the beginning of
the period in the
current period
Accounts 284,878, 7.83 198,409, 6.66 43.58 Main reasons: 1.
receivable 419.58 249.19 The accounts
receivable from
online platform
business
increased; for
example, the
accounts
receivable of
JD.COM and Vipshop
increased by RMB
29.59 million; 2.
Dealers were
offered greater
credit support to
stabilize offline
sales, and the
balance of accounts
26 / 323
2020 ANNUAL REPORT
receivable
increased; 3. the
accounts
receivable was
increased due to
new brand business,
etc.
Receivables 5,531,99 0.15 2,150,00 0.07 157.30 Mainly due to the
financing 7.32 0.00 increase in the
balance of bank
acceptance bill at
the end of the
period
Prepayment 82,742,8 2.28 53,313,9 1.79 55.20 Mainly due to the
15.92 63.76 increase of advance
payment and expense
of the new
consolidated
subsidiary in the
current period
Other 48,733,5 1.34 15,269,9 0.51 219.15 Main reasons: 1.
receivables 27.35 49.97 The deposit
receivable of the
new consolidated
subsidiary
increased in the
current period; 2.
Epidemic
prevention and
control supplies
were proposed to be
purchased from
abroad during the
outbreak of
COVID-19, but no
consensus was
reached as to the
return policy, and
further
negotiation was
required
Inventories 468,641, 12.89 313,649, 10.53 49.42 Main reasons: 1.
017.75 003.07 Overstock for live
streaming in Q4; 2.
Increase of ending
inventory of the
new consolidated
subsidiary in the
current period
Other current 35,235,8 0.97 11,723,2 0.39 200.56 Main reasons: 1.
27 / 323
2020 ANNUAL REPORT
assets 11.27 68.59 According to the
new revenue
standards, it was
expected that the
net return of RMB
5.76 million at the
end of the period
should be included
in “estimated
liabilities”, but
it was actually
reflected as
“estimated
liabilities of RMB
10.19 million” and
“other current
assets of RMB 4.43
million” based on
the amount that
affects the revenue
and cost; 2. The
input tax of excess
VAT paid was
reclassified as
“other current
assets”, and the
balance was
increased
Long-term 58,220,0 1.60 14,728,0 0.49 295.30 Mainly due to the
equity 59.60 03.68 new equity
investments investment of RMB
46 million on the
associate - Jiaxing
Woyong
Investments in 20,580,0 0.57 Not Mainly due to the
other equity 00.00 applicable equity investment
instruments of RMB 20.58
million on Hangzhou
Regenovo
Biotechnology.,
Ltd.
Construction 47,324,5 1.30 31,894,6 1.07 48.38 Mainly due to the
in progress 23.36 58.49 new investment on
make-up line in the
current period
Goodwill 31,034,1 0.85 Not Main reason: The
61.20 applicable portion of the
investment of the
new consolidated
subsidiary
28 / 323
2020 ANNUAL REPORT
“Shanghai
Healthlong” that
exceeded the fair
value of its net
identifiable
assets calculated
according to the
shareholding ratio
was recognized as
goodwill in the
current period
Long-term 50,576,7 1.39 26,378,5 0.89 91.73 Main reasons: 1.
prepaid 93.53 64.50 Increase in the
expenses balance of
endorsement fee to
be amortized; 2.
The increase of RMB
13.03 million for
renovation of
make-up factory
Deferred 46,660,5 1.28 27,975,2 0.94 66.79 Mainly due to the
income tax 50.76 58.51 increase in the
assets balance of deferred
income tax assets
calculated based on
the amortized
share-based
payment
Other 87,322,7 2.40 15,006,1 0.50 481.91 Main reasons: 1.
non-current 80.03 46.49 RMB 81.6 million
assets was paid for the
land in Longwu,
Hangzhou, but the
corresponding land
delivery procedure
has not been
completed as at 31
December 2020; 2.
The purchase amount
of long-term assets
originally prepaid
for the new
building has been
partially
transferred into
fixed assets.
Short-term 299,280, 8.23 129,047, 4.33 131.92 Mainly due to the
borrowings 435.09 396.51 new bank loans in
the current period
Bills payable 64,580,0 1.78 41,830,9 1.40 54.38 Mainly due to the
29 / 323
2020 ANNUAL REPORT
00.00 48.53 increase of bank
acceptance
Accounts 515,832, 14.18 347,316, 11.66 48.52 Mainly due to
payable 031.27 843.39 overstock for live
streaming in Q4 and
the payment day yet
to come
Accounts 40,913,4 1.37 -100.00 Mainly due to the
received in 90.55 adjustment from the
advance original
“accounts
received in
advance” to
“contract
liabilities” and
“other current
liabilities”
owing to the
implementation of
new revenue
standards
Contract 30,618,7 0.84 Not Mainly due to the
liabilities 78.99 applicable implementation of
new revenue
standards: 1. The
unredeemed member
points originally
included in the
“deferred
income” were
adjusted to
“contract
liabilities”; 2.
The original
“accounts
received in
advance” were
adjusted to
“contract
liabilities” and
“other current
liabilities”
Non-current 85,258,2 2.86 -100.00 Mainly due to the
liabilities 47.69 repayment of
due within one long-term
year borrowings due
within one year in
the current period
Other current 1,439,26 0.04 Not Mainly due to the
liabilities 2.02 applicable adjustment from the
30 / 323
2020 ANNUAL REPORT
original
“accounts
received in
advance” to
“contract
liabilities” and
“other current
liabilities”
owing to the
implementation of
new revenue
standards
Deferred 8,495,35 0.23 19,743,0 0.66 -56.97 The unredeemed
income 3.33 36.56 member points
originally
included in the
“deferred
income” was
adjusted to
“contract
liabilities” due
to the
implementation of
new revenue
standards, while
the balance at the
beginning of the
period included
unredeemed member
points of RMB 11.25
million
Deferred 6,874,10 0.19 5,132,01 0.17 33.95 Mainly due to the
income tax 5.45 1.38 increase of taxable
liabilities temporary
differences
recognized by
one-time deduction
of depreciation of
fixed assets
Undistributed 1,265,67 34.80 908,411, 30.49 39.33 Mainly due to the
profit 1,865.63 607.62 increase of net
profit in the
current period
Minority 90,326,8 2.48 40,370,1 1.35 123.75 Main reason was due
equity 30.19 59.89 to the
consolidation of
“ Shanghai
Healthlong”
happened in the
current period
31 / 323
2020 ANNUAL REPORT
Other particulars
None
2. Major restricted assets as at the end of the Reporting Period
√ Applicable□ Not applicable
Item Carrying value at the end of the Reason for restriction
period
Land construction deposit,
Cash and equivalents 14,803,886.05 transformer deposit, L/C
deposit, Tmall deposit,
Alipay deposit, etc.
Total 14,803,886.05
3. Other particulars
□ Applicable√ Not applicable
(IV) Analysis on industry operating information
√ Applicable□ Not applicable
See the content below for details.
32 / 323
2020 ANNUAL REPORT
Analysis on operating information of the chemical business
1 Basic information of the industry
(1).Industry policy and its changes
□ Applicable√ Not applicable
(2).Basic information of main subdivided industries and company position in the industry
√ Applicable□ Not applicable
Refer to the related description in “(I) Industry pattern and trend” in “III.
Discussion and analysis on future development of the Company” of “Section IV Discussion
and Analysis of Operation”.
Company position in the industry:
Based on the analysis of various industry data, the Company occupies a certain market
share in the Chinese cosmetics market.
2 Products and production
(1).Main operation model
√ Applicable□ Not applicable
Please refer to the description of the operation model in the “I. Description of
the Company’s Principle Business, Operation Model and Industry Condition During the
Reporting Period” of “Section III Business Overview of the Company”.
Main information on adjustment of operation model during the Reporting Period
□ Applicable√ Not applicable
(2).Information on major products
√ Applicable□ Not applicable
Main downstream
Subdivided Main upstream raw Main influencing
Product application
industry materials factors of price
fields
Skin care Skin care Moisturizer, Skin care and Personal income,
(cleansing) active cleansing skin type,
substance, lifestyle and
grease wax, brand preference
emulsifier,
surfactant,
essence and
packaging
Make-up Make-up Grease wax, Make-up, beauty Personal income,
emulsifier, and shading lifestyle and
toner, essence brand preference
and packaging
33 / 323
2020 ANNUAL REPORT
(3).R&D innovation
√ Applicable□ Not applicable
The Company's main operations for continuous innovation in scientific research during
the Reporting Period were as follows:
1. A total of 9 new national invention patents were awarded in 2020, and meanwhile,
new applications for 10 invention patents, 3 utility model patents and 27 design patents
were filed. As at the end of the Reporting Period, the Company has 75 national invention
patents, 30 utility model patent and 80 design patents, totaling 185 patents.
2. Industry-university-research cooperation: Developed cooperation on the
“utilization of deep-sea microbial resources and development of active substances” with
the Institute of Microbiology, Chinese Academy of Sciences. Signed the agreement on
industry-university-research cooperation with the International School of Cosmetics,
Shanghai Institute of Technology, for the purpose of comprehensive cooperation in terms
of talent cultivation, scientific research, scientific and technological innovation, and
personnel training.
3. Strategic technology cooperation: Achieved strategic technical cooperation with
BASF China, etc.; built a joint laboratory center for high-throughput 3D printing of Asian
skin models together with Hangzhou Regenovo Biotechnology., Ltd.;
4. The project named Key Technology and Standardization for Testing of Prohibited
Substances in Cosmetics, jointly carried out by the Company and Hangzhou Institute for
Food and Drug Control, National Center for Quality Supervision and Inspection of Daily
Commodities, Hangzhou Institute of Test and Calibration for Quality and Technical
Supervision, was granted the third prize of Zhejiang Provincial Science and Technology
Progress Award;
5. Proya won the honorary title of “Excellent R&D Team” in the Science and Technology
th
Conference of China Fragrance, Flavour and Cosmetics Industry in 2020 and the 13 Academic
Symposium.
6. Participated in the formulation of group standards of animal substitute test for
cosmetics, three of which have been approved and issued by Zhejiang Health Products and
Cosmetic Industry Association, and implemented from 20 February 2020; participated in
two scientific research projects of the key laboratory for animal substitute test for
cosmetics in National Medical Products Administration.
(4).Production process and work flow
√ Applicable□ Not applicable
The Company's products are mainly divided into skin care(cleansing)and make-up. The
production process is shown in the figure below:
1. Production process of skin care products
34 / 323
2020 ANNUAL REPORT
Basic raw material
Active ingredient
Semi-finished
Heating and dissolving
Homogeneous Heat-preservati Cooling Filtering
product
inspection
Warehousing Packing Packaging Filling Storage
Finished product
2. Production process of cleansing products
Basic raw
Active ingredient
Dissolving Homogeneous Heat-preservatio Cooling Filtering Semi-finished
product
inspection
Warehousing Packing Packaging Filling Storage
Finished product
3. Production process of make-up
(1) Make-up pressed powder:
35 / 323
2020 ANNUAL REPORT
Raw material Active ingredient Semi-finished product
Crushing and sieving
Mixing evenly Color correction Discharging Powder storage
Warehousing Packing Packaging Press forming Filling
Aluminum plate
Finished product Appearance inspection
(2) Lipstick and lip gloss:
Basic raw material Active ingredient
Semi-
Heating and dissolving Heat-preservation Color correction Defoaming Filtering
finis
hed
produ
Warehousing Packing Packaging Die forming Storage
ct
inspe
Finished product Appearance inspection
(3) Eyelashes and eyeliner:
Basic raw material Active ingredient
Semi-
Heating and dissolving
Homogeneous Heat-preservation Cooling Discharging
finis
hed
Warehousing Packing Packaging Filling Storage produ
ct
Finished product
(5). Capacity and commencement
√ Applicable□ Not applicable
36 / 323
2020 ANNUAL REPORT
Unit: RMB 0’000 Currency: RMB
Estimated
Investment
Main completion
amount of
plant Capacity time of
Designed Capacity under capacity
area or utilizatio capacity
capacity construction under
projec n rate (%) under
constructio
t constructio
n
n
Huzhou 200,000,00 84.48 0.00 0.00 None
Factor 0 pcs.
y
Increase or decrease in production capacity
□ Applicable√ Not applicable
Adjustment of product line and capacity structure optimization
□ Applicable√ Not applicable
Abnormal shutdown
□ Applicable√ Not applicable
3 Raw material purchase
(1).Basic information of main raw materials
√ Applicable□ Not applicable
Year-on-yea
Purchas
Settlemen r price Consumptio
Main raw materials Purchasing mode e
t method change n
volume
ratio (%)
Dominated by In
competitive accordanc About
About 1.03
procurement, e with the 1.05
Packaging material 0.91 billion
except for some contract billion
pcs.
strategic provision pcs.
suppliers s
Dominated by In
competitive accordanc
procurement; e with the
establish contract About
Raw About
long-term provision -16.68 1,640
material_moisturizer 1,600 tons
strategic s tons
cooperation
with supplier
with advantages
37 / 323
2020 ANNUAL REPORT
Mainly purchase In
via price accordanc
comparison; try e with the
About
Raw material_active to empower contract About 477
74.17 487
substance diversified provision tons
tons
feature for s
single-source
suppliers
Mainly Subject
competitive to
procurement; contract
establish provision About
Raw material_grease About 707
long-term s -48.71 738
wax tons
strategic tons
cooperation
with supplier
with advantages
Mainly Subject
competitive to
procurement; contract
About
Raw cooperate with provision About 125
5.36 135
material_emulsifier industry-leadi s tons
tons
ng suppliers
for some raw
materials
Mainly Subject
competitive to
procurement; contract
Raw establish provision
About About 58
material_sun-screeni long-term s -1.56
55 tons tons
ng agent strategic
cooperation
with supplier
with advantages
The impact of price changes of main raw materials on the Company's operating costs:
Compared with the same period in 2019, the price of packaging materials rose slightly,
and the operating cost registered a small rise; the overall price of raw materials
decreased by 7.06% from 2019, which lowered the operating cost.
(2).Basic information of major energy sources
√ Applicable□ Not applicable
Year-on-year
Major energy Purchasing Settlement Purchase
price change Consumption
sources mode method volume
ratio (%)
38 / 323
2020 ANNUAL REPORT
Pay in
Sign fixed advance on a
agreement monthly
Water with local basis or pay 0.00 156,273 tons 156,273 tons
water supply on demand as
company per local
requirements
Pay in
Sign fixed advance on a
agreement monthly
8.43 million 8.43 million
Electricity with local basis or pay 6.73
KWH KWH
power supply on demand as
company per local
requirements
Pay in
advance on a
Sign fixed
monthly
agreement 3 3
Gas basis or pay -15.83 306,164 m 306,164 m
with local
on demand as
gas company
per local
requirements
The impact of price changes of main energy sources on the Company's operating costs: The
operating cost increased slightly due to the low proportion of energy amount consumed
in the production process of the Company in the production cost; in addition, the
electricity price in 2020 rose by 6.73% year on year, the price of gas decreased by 15.83%,
and electricity is the main energy for consumption.
(3).Measures to deal with raw material price fluctuation risks
Main situation of holding financial products such as derivatives
□ Applicable√ Not applicable
(4).Basic situation of adopting other methods such as phased reserve
□ Applicable√ Not applicable
4 Product sales
(1).Basic information of the Company's principal business by subdivided industry
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Change Gross
Subdivi Change in Change in
Gross in margin of
ded Cost of revenue cost from
Revenue margin gross products in
industr sales from last last year
(%) profit the same
y year (%) (%)
margin industry
39 / 323
2020 ANNUAL REPORT
from and field
last
year
(%)
Skin No
care public
Increas
(includ informat
324,209.35 113,986.55 64.84 11.38 11.02 e by
ing ion
0.11%
cleansi availabl
ng) e
No public
Decreas
Make-up 46,496.73 19,757.89 57.51 181.91 213.38 information
e by
available
4.27%
Other Increas No public
categor 4,086.37 2,604.24 36.27 0.47 -14.60 e by information
ies 11.25% available
(2).Basic information of the Company's principal business by sales channel
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Change in revenue from last
Sales channel Revenue
year (%)
Online 262,402.07 58.59
Offline 112,390.39 -23.12
The sales model integrates offline and online channels.
Online channels mainly include direct sales and distribution. Such channels mainly
include Tmall, Taobao, JD.COM, Vipshop, and Pinduoduo.
Off-line channels are mainly operated by dealers. Such channels mainly include malls
and supermarkets, cosmetics specialty stores, and single brand stores.
Statement of accounting policy
□ Applicable√ Not applicable
5 Environmental protection and safety
(1).Basic information of major work safety accidents of the Company during the Reporting Period
□ Applicable√ Not applicable
(2).Major environmental violations
□ Applicable√ Not applicable
(V) Analysis of investment
1、 Overall analysis of external equity investment
√ Applicable□ Not applicable
40 / 323
2020 ANNUAL REPORT
Unit: Yuan
Closing balance Opening balance
Item Carrying Impairment Carrying Impairment
Carrying value Carrying value
balance provisions balance provisions
Investment
on joint 3,306,630.57 3,306,630.57 3,314,489.57 3,314,489.57
ventures
Investment
on 54,913,429.03 54,913,429.03 15,490,224.94 4,076,710.83 11,413,514.11
associates
Total 58,220,059.60 58,220,059.60 18,804,714.51 4,076,710.83 14,728,003.68
Refer to “VII. 17. Long-term equity investment” in “Section XI Financial Report”
herein for details.
(1) Significant equity investment
□ Applicable√ Not applicable
(2) Significant non-equity investment
□ Applicable√ Not applicable
(3) Financial assets measured at fair value
□ Applicable√ Not applicable
(VI) Sale of major assets and equities
□ Applicable√ Not applicable
(VII) Analysis of major controlled companies and shareholding companies
√ Applicable□ Not applicable
Unit: RMB 00’000
Major Nature Major Registere Total Net Net Controlled
subsidiarie of the products d capital asset assets profit or
s business and shareholdin
services g company
Hangzhou Cosmetic Cosmetic 5,000.00 48,620.4 13,043.03 2,015.43 Controlled
Proya Trade s sales s 6
Co., Ltd.
Hapsode Cosmetic Cosmetic 5,000.00 10,913.1 -19,848.8 -3,317.4 Controlled
(Hangzhou) s sales s 1 6 8
Cosmetics
Co., Ltd.
41 / 323
2020 ANNUAL REPORT
Note: The loss of Hapsode (Hangzhou) Cosmetics Co., Ltd. amounted to RMB 33,174,800, in
which the loss of Hapsode brand amounted to RMB 15,546,000.
(VIII) Structured entities controlled by the Company
□ Applicable√ Not applicable
III Discussion and analysis on future development of the Company
(I) Industry pattern and trend
√ Applicable□ Not applicable
According to the statistics of the National Bureau of Statistics, the total retail
sales of social consumer goods was RMB 39,198.1 billion in 2020, with a year-on-year
decrease of 3.9%, of which the total amount of cosmetics was RMB 340 billion, up 9.5%
year on year (retail sales of unit consumer goods above quota).
(II) Development strategy of the Company
√ Applicable□ Not applicable
Adhering to the corporate values of "diligence and pragmatism, passion and initiative,
honesty and gratitude", the Company is committed to becoming a world-class beauty makeup
enterprise, and building a new Chinese cosmetics industry platform. Focus on the "6 *
N" strategy in the future:
"6" refers to new consumption, new marketing, new organization, new mechanism, new
technology and new intelligent creation, and "N" refers to creating N brands
(1) New consumption: It refers to meeting the needs of more consumers and providing
consumers with innovation services with high value;
(2) New marketing: It refers to marketing digitalization, omni-channel refined
operation as well as accurate and advanced insight into consumers;
(3) New organization: It refers to an efficient organization with flat,
platform-based and self-driven coordination;
(4) New mechanism: It refers to the establishment of a flexible, diversified and
business-oriented incentive mechanism;
(5) New technology: It refers to paying attention to basic scientific research in
the field of research and development, in order to create R&D technology competitiveness
that is difficult to replicate; and focusing on the Company's transformation of
informatization and digitization, to build an intelligent operation management system;
(6) New intelligent creation: It refers to building an agile and flexible supply chain
to adapt to the current fast-paced production and sales;
——The core connotation of "6 * N" refers to the creation, empowerment and incubation
of "different" brands that meet the "different" needs of "different" consumers based on
the above six capabilities.
(III) Business plan
√ Applicable□ Not applicable
42 / 323
2020 ANNUAL REPORT
In 2021, we will focus on the following aspects:
1. Strengthen brand building: gradually implement the blueprint of the self-owned
brand matrix, plan new brands and reshape old brands.
(1) Main brand: Complete the Proya brand upgrade plan and shape it into a new high-tech,
youth-centric and proactive brand. Attract more first-and second-tier young consumers,
and gradually upgrade the consumer level. In addition, maintain the steady growth of the
main brand.
(2) Potential brands: Complete the leap from incubation period to high-speed growth
period of TIMAGE, and complete the brand reshaping of Hapsode.
(3) Other brands: Incubate more new brands.
2. Product upgrading strategy: Establish product planning and marketing capabilities
ahead of the market to improve product success rate.
(1) Proya: Plan, create and reserve a variety of popular single products and new
products. Try to launch products priced above RMB 300, and increase the unit price
gradually.
(2) TIMAGE, Hapsode, CORRECTORS: Plan and create a variety of popular single products
and hot products.
3. Refined operation channels:
(1) Online channels: Maintain the rapid growth of online channels as a whole, focus
on refined operation of direct channels, and keep emerging channels such as TikTok stores
growing rapidly.
(2) Offline channels: Maintain the steady and healthy development of CS channels,
and continue expanding mall and supermarket channels.
(IV) Potential risks
√ Applicable□ Not applicable
1. Industry competition risk
(1) Competition among brands in the industry becomes increasingly fierce. The
Company's brand upgrading strategy and popular single product strategy may fail to meet
expectations;
(2) Competition in marketing becomes increasingly fierce. The digital and refined
cost control may fail to meet expectations.
2. Project incubation risk
(1) New brand incubation risk: The marketing investment is large and the performance
fails to meet expectations;
(2) New category cultivation risk: The operation modes of different categories are
quite different; the team fails to meet the requirements and the performance fails to
meet the expectations.
3. Uncertain impact of COVID-19 on business operation
(V) Others
□ Applicable√ Not applicable
43 / 323
2020 ANNUAL REPORT
IV Explanation on the failure to disclose as per rules due to inapplicability or special
reasons such as state secrets and business secrets
□ Applicable√ Not applicable
Section V Major Events
I Proposal for profit distribution of ordinary shares or capitalization of capital reserve
(I) Formulation, implementation or adjustment of the cash dividend policy
√ Applicable□ Not applicable
Pursuant to the relevant requirements of Regulatory Guidance No.3 of Listed Companies
— Cash Dividend Distribution of Listed Companies issued by the China Securities
Regulatory Commission and Guidelines of Shanghai Stock Exchange Guidelines for Cash
Dividends of Listed Companies, combined with the actual situation of the Company, the
Company held the eighth meeting of the first session of the Board of Directors and the
second extraordinary general shareholders’ meeting in 2016 on 12 April 2016 and 5 May
2016 respectively, and deliberated and approved the Proposal on Formulating the
Shareholder Dividend Distribution Plan in Three Years after the Listing of the Company
and the Proposal on Formulating the Applicable after
the Listing of the Company as below:
I. Considerations for Formulating Shareholder Dividend Distribution Plan
With a view to long-term and sustainable development, on the basis of comprehensive
analysis of enterprise development strategy, shareholders' requirements and wishes,
social capital cost, external financing environment and other factors, the Company
solicits and listens to the requirements and wishes of shareholders, especially small
and medium shareholders, fully considers the Company's current and future profit scale,
cash flow status, development stage, project investment fund demand, bank credit, etc.,
balances the short-term and long-term interests of shareholders, and makes institutional
arrangements for profit distribution, so as to establish a sustained, stable and
scientific dividend return mechanism for investors to ensure the continuity and stability
of the Company's profit distribution policy.
II. Principles for Formulating Shareholder Dividend Distribution Plan
Implement a sustained and stable profit distribution policy, attach importance to
the reasonable return on investment to investors and take into account the sustainable
development of the Company, and establish a sustained and stable return mechanism for
investors in combination with the Company's profitability and the actual needs of the
development strategy for the future business. The Company shall formulate the profit
distribution plan in accordance with the Articles of Association. The opinions of
independent directors, supervisors and public investors shall be fully considered in the
decision-making and demonstration of profit distribution policies by the Board of
Directors, Board of Supervisors and general shareholders’ meeting of the Company.
III. Shareholder Dividend Distribution Plan
1. The Company shall implement a sustained and stable profit distribution policy.
The Company's profit distribution shall pay attention to the reasonable return on
44 / 323
2020 ANNUAL REPORT
investment to investors and take into account the actual operation and sustainable
development of the Company in the current year.
2. The Company can distribute profits in cash or stock, or a combination of cash and
stock or other methods permitted by laws and regulations. The profit distribution shall
not exceed the range of accumulated distributable profits or affect the Company’s ability
to continue as a going concern. Under the condition of meeting cash dividends, the Company
shall give priority to profit distribution by means of cash dividends.
Under the condition of meeting the cash dividend conditions stipulated in the Articles
of Association of the Company, the Company shall distribute profits in cash. In principle,
cash dividends shall be paid once a year. The Board of Directors of the Company can propose
the Company to pay medium-term cash dividends according to the Company's profit and
capital demand.
The Company shall maintain the continuity and stability of the profit distribution policy.
The annual profit distributed in cash shall not be less than 20% of the distributable
profit realized in the current year. The Board of Directors of the Company shall
comprehensively consider factors such as the characteristics of the industry, the stage
of development, its operation model, profitability and significant capital expenditure
arrangement, and put forward differentiated cash dividend policies pursuant to the
procedures set out in the Articles of Association of the Company.
3. Adjustment of profit distribution plan and relevant decision-making mechanism
(1) The Company shall evaluate the implementation of the implemented shareholder
dividend distribution plan at least once every three years.
According to relevant laws and regulations as well as the Company's operating conditions,
the opinions of shareholders (especially small and medium-sized investors) and
independent directors, the Company's profit distribution policy in implementation shall
be revised accordingly when necessary, and a new shareholder dividend distribution plan
shall be formulated. After the adjustment of the shareholder dividend distribution plan,
it must be deliberated and approved at the general shareholders’ meeting by voting.
(2) The Board of Directors of the Company shall scientifically formulate the annual
distribution plan or the medium-term profit distribution plan according to the needs of
operation and development by fully considering the Company's profit, cash flow status,
development fund demand, financing cost, external financing environment and other factors,
and implement it upon the approval at the general shareholders’ meeting of the Company
by voting.
th nd
At the 8 meeting of the first session of the Board of Directors and the 2
extraordinary general shareholders’ meeting in 2016, the Company deliberated and
approved the Proposal on Distribution of Accumulated Profits before the Public Offering
of Shares and Listing of the Company: if the Company's initial public offering of shares
is successfully completed, the undistributed profits accumulated before this public
offering shall be shared by the new and old shareholders after the initial public offering
according to their shareholding ratio.
th
On 12 October 2020 and 28 October 2020 respectively, the Company held the 16 meeting
rd
of the second session of the Board of Directors and the 3 extraordinary general
45 / 323
2020 ANNUAL REPORT
shareholders’ meeting in 2020, and deliberated and approved the Proposal on Shareholder
Dividend Distribution Plan for the Next Three Years (2020-2022) as below:
I. Considerations for Formulating Shareholder Dividend Distribution Plan
With a view to long-term and sustainable development, on the basis of comprehensive
analysis of enterprise development strategy, shareholders' requirements and wishes,
social capital cost, external financing environment and other factors, the Company
solicits and listens to the requirements and wishes of shareholders, especially small
and medium shareholders, fully considers the Company's current and future profit scale,
cash flow status, development stage, project investment fund demand, bank credit, etc.,
balances the short-term and long-term interests of shareholders, and makes institutional
arrangements for profit distribution, so as to establish a sustained, stable and
scientific dividend return mechanism for investors to ensure the continuity and stability
of the Company's profit distribution policy.
II.Principles for Formulating Shareholder Dividend Distribution Plan
Implement a sustained and stable profit distribution policy, attach importance to
the reasonable return on investment to investors and take into account the sustainable
development of the Company, and establish a sustained and stable return mechanism for
investors in combination with the Company's profitability and the actual needs of the
development strategy for the future business. The Company shall formulate the profit
distribution plan in accordance with the Articles of Association. The opinions of
independent directors, supervisors and public investors shall be fully considered in the
decision-making and demonstration of profit distribution policies by the Board of
Directors, Board of Supervisors and general shareholders’ meeting of the Company.
III. Shareholder Dividend Distribution Plan (2020-2022)
1. The Company shall implement a sustained and stable profit distribution policy.
The Company's profit distribution shall pay attention to the reasonable return on
investment to investors and take into account the actual operation and sustainable
development of the Company in the current year.
2. The Company can distribute profits in cash or stock, or a combination of cash and
stock or other methods permitted by laws and regulations. The profit distribution shall
not exceed the range of accumulated distributable profits or affect the Company’s ability
to continue as a going concern. Under the condition of meeting cash dividends, the Company
shall give priority to profit distribution by means of cash dividends.
Under the condition of meeting the cash dividend conditions stipulated in the Articles
of Association of the Company, the Company shall distribute profits in cash. In principle,
cash dividends shall be paid once a year. The Board of Directors of the Company can propose
the Company to pay medium-term cash dividends according to the Company's profit and
capital demand. The Company shall maintain the continuity and stability of the profit
distribution policy, and the annual profit distributed in cash shall not be less than
20% of the distributable profit realized in the current year. The Board of Directors of
the Company shall comprehensively consider factors such as the characteristics of the
industry, the stage of development, its operation model, profitability and significant
capital expenditure arrangement, and put forward differentiated cash dividend policies
pursuant to the procedures set out in the Articles of Association of the Company.
46 / 323
2020 ANNUAL REPORT
3. Adjustment of profit distribution plan and relevant decision-making mechanism
(1) The Company shall evaluate the implementation of the implemented shareholder
dividend distribution plan at least once every three years. According to relevant laws
and regulations as well as the Company's operating conditions, the opinions of
shareholders (especially small and medium-sized investors) and independent directors,
the Company's profit distribution policy in implementation shall be revised accordingly
when necessary, and a new shareholder dividend distribution plan shall be formulated.
After the adjustment of the shareholder dividend distribution plan, it must be deliberated
and approved at the general shareholders’ meeting by voting.
(2) The Board of Directors of the Company shall scientifically formulate the annual
distribution plan or the medium-term profit distribution plan according to the needs of
operation and development by fully considering the Company's profit, cash flow status,
development fund demand, financing cost, external financing environment and other factors,
and implement it upon the approval at the general shareholders’ meeting of the Company
by voting.
During the Reporting Period, the 2019 annual general meeting of the Company
deliberated and approved the 2019 annual profit distribution plan: the Company shall
distribute cash dividend of RMB 5.90 (tax inclusive) per 10 shares to all shareholders
registered on the equity registration date based on the total share capital registered
as at the registration date of dividend-paying equity, with the distributed cash dividend
totaling RMB 118,749,040.40 (tax inclusive). The above dividend distribution plan was
implemented on 13 May 2020.
(II) Ordinary shares dividend distribution scheme or plan, and capitalization scheme or plan
from capital reserve to share capital of the Company in recent three years (including the
Reporting Period)
Unit: Yuan Currency: RMB
Percentage
Net profit of the net
attributable profit
to the attributab
Number Amount of ordinary le to the
of dividends Number of shareholders ordinary
Amount of
Year for bonus distribut shares of the listed shareholde
cash
dividend shares ed per 10 transferr company in rs of the
dividends
distributi per 10 shares ed per 10 the listed
(inclusive
on shares (Yuan) shares consolidated company in
of tax)
(shares (inclusiv (shares) financial the
) e of tax) statements consolidat
for the ed
distribution financial
year statements
(%)
47 / 323
2020 ANNUAL REPORT
2020 0 7.20 0 144,804,186. 476,009,298. 30.42
00 41
2019 0 5.90 0 118,749,040. 392,681,976. 30.24
40 58
2018 0 4.30 0 86,552,894.0 287,188,727. 30.14
0 12
(III) The inclusion of shares repurchased through cash offer in cash dividend
□ Applicable√ Not applicable
(IV) If the Company recorded positive profit distributable to ordinary shareholders of the parent
company during the Reporting Period, but there was no proposal for cash dividend, the
Company shall disclose the reasons, the usage and the utilization plan of the undistributed
profits in detail
□ Applicable√ Not applicable
48 / 323
2020 ANNUAL REPORT
II Performance of undertakings
(I) Undertakings by the Company’s beneficial controllers, shareholders, related parties, acquirers, the Company and other related parties during or
subsisted in the Reporting Period
√ Applicable□ Not applicable
If not
Whether If not
Whether performed
strictly performed
Background Time and term there is in time,
Type of Undertaking performed in time,
of Content of undertakings of the deadline describe
undertakings party in a describe
undertakings undertaking for the
timely plans in
performance specific
manner next steps
reasons
Restriction Controlling (1) Within 36 months from the Time of the Yes Yes Not Not
on sale of shareholders date of listing of the undertaking: applicable applicable
shares and Company's shares, I will not 15 November
beneficial transfer or entrust others 2017, period
controllers: to manage the Company's of validity:
Undertakings
Hou Juncheng shares directly or 15 November
related to
and Fang Aiqin indirectly held by me, nor 2017 to 14
initial
will the Company repurchase November
public
the shares; (2) If the 2020
offering
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
49 / 323
2020 ANNUAL REPORT
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; (3) If
I sell the Company's shares
held by within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
the issue price. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
months.
Restriction Fang Yuyou, (1) Within 36 months from the Time of the Yes Yes Not Not
on sale of Director & date of listing of the undertaking: applicable applicable
shares General Company's shares, I will not 15 November
Manager transfer or entrust others 2017, period
to manage the Company's of validity:
50 / 323
2020 ANNUAL REPORT
shares directly or 15 November
indirectly held by me, nor 2017 to 14
will the Company repurchase November
the shares; (2) If the 2020
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; (3) If
I sell the Company's shares
held by within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
the issue price. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
51 / 323
2020 ANNUAL REPORT
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
months.
Restriction 12 natural (1) Within 36 months from the Time of the Yes Yes Not Not
on sale of person date of listing of the undertaking: applicable applicable
shares shareholders, Company's shares, I will not 15 November
i.e., Li transfer or entrust others 2017, period
Xiaolin, Xu to manage the Company's of validity:
Junqing, Fang shares directly or 15 November
Aifen, Ye indirectly held by me, nor 2017 to 14
Caifu, Li will the Company repurchase November
Jianqing, the shares; (2) If the 2020
Chen closing price of the
Dongfang, Li Company's shares has been
Wenqing, Xu lower than the issue price
Dongkui, Bao for 20 consecutive trading
Qingfang, days within 6 months after
Fang Jiaqin, the listing of the Company,
Fang Shanming or the closing price is lower
and Ye Hong than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
52 / 323
2020 ANNUAL REPORT
extended for 6 months; (3) If
I sell the Company's shares
held by within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
the issue price. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
months.
Restriction Directors and (1) During my tenure as Time of the No Yes Not Not
on sale of senior director/senior management undertaking: applicable applicable
shares management: of the Company, the shares 15 November
Hou Juncheng, transferred each year shall 2017, period
Fang Yuyou and not exceed 25% of the total of validity:
Cao Liangguo number of the Company's 15 November
shares directly or 2017 to long
indirectly held by me; term
within half a year after my
demission, I will not
transfer the Company's
shares directly or
53 / 323
2020 ANNUAL REPORT
indirectly held by me; (2) If
I sell the Company's shares
held by me within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
the issue price; if the
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; and it
will not be terminated due to
my job change, demission and
other reasons. (3) If I/the
partnership violates the
above-mentioned share
locking commitment, the
54 / 323
2020 ANNUAL REPORT
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
months.
Restriction Senior (1) Within 12 months from the Time of the No Yes Not Not
on sale of management: date of listing of the undertaking: applicable applicable
shares Zhang Yefeng Company's shares, I will not 15 November
and Zhang transfer or entrust others 2017, period
Minhua to manage the Company's of validity:
shares directly or 15 November
indirectly held by me, nor 2017 to long
will the Company buy back the term
shares; (2) During my tenure
as senior management of the
Company, the shares
transferred each year shall
not exceed 25% of the total
number of the Company's
shares directly or
indirectly held by me;
within half a year after my
demission, I will not
transfer the Company's
shares directly or
indirectly held by me; (3) If
I sell the Company's shares
55 / 323
2020 ANNUAL REPORT
held by me within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
the issue price; if the
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; and it
will not be terminated due to
my job change, demission and
other reasons. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
lockup period of the
Company's shares held by
56 / 323
2020 ANNUAL REPORT
me/the partnership will be
automatically extended for 6
months.
Restriction Senior (1) Within 12 months from the Time of the No Yes Not Not
on sale of management: date of listing of the undertaking: applicable applicable
shares Jin Yanhua Company's shares, I will not 16 April
transfer or entrust others 2018, period
to manage the Company's of validity:
shares directly or 16 April 2018
indirectly held by me, nor to long term
will the Company buy back the
shares; (2) During my tenure
as senior management of the
Company, the shares
transferred each year shall
not exceed 25% of the total
number of the Company's
shares directly or
indirectly held by me;
within half a year after my
demission, I will not
transfer the Company's
shares directly or
indirectly held by me; (3) If
I sell the Company's shares
held by me within two years
after the expiration of the
57 / 323
2020 ANNUAL REPORT
lockup period, the selling
price shall not be lower than
the issue price; if the
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; and it
will not be terminated due to
my job change, demission and
other reasons. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
58 / 323
2020 ANNUAL REPORT
months.
Restriction Senior (1) Within 12 months from the Time of the No Yes Not Not
on sale of management: date of listing of the undertaking: applicable applicable
shares Wang Li Company's shares, I will not 3 September
transfer or entrust others 2018, period
to manage the Company's of validity:
shares directly or 3 September
indirectly held by me, nor 2018 to long
will the Company buy back the term
shares; (2) During my tenure
as senior management of the
Company, the shares
transferred each year shall
not exceed 25% of the total
number of the Company's
shares directly or
indirectly held by me;
within half a year after my
demission, I will not
transfer the Company's
shares directly or
indirectly held by me; (3) If
I sell the Company's shares
held by me within two years
after the expiration of the
lockup period, the selling
price shall not be lower than
59 / 323
2020 ANNUAL REPORT
the issue price; if the
closing price of the
Company's shares has been
lower than the issue price
for 20 consecutive trading
days within 6 months after
the listing of the Company,
or the closing price is lower
than the issue price as at
the end of the six-month
period upon the listing, the
lockup period of the
Company's shares held by me
will be automatically
extended for 6 months; and it
will not be terminated due to
my job change, demission and
other reasons. (4) If I/the
partnership violates the
above-mentioned share
locking commitment, the
lockup period of the
Company's shares held by
me/the partnership will be
automatically extended for 6
months.
Restriction Controlling (1) If I intend to reduce my Time of the No Yes Not Not
60 / 323
2020 ANNUAL REPORT
on sale of shareholders shares within 24 months undertaking: applicable applicable
shares and after the expiration of the 15 November
beneficial lockup period, the number of 2017, period
controllers: issuer shares directly or of validity:
Hou Juncheng indirectly reduced shall not 15 November
and Fang Aiqin exceed 6% of the total number 2017 to long
of issuer shares before this term
issuance; (2) The reduction
of the Company's shares
shall comply with the
provisions of relevant laws,
regulations and rules; the
specific methods include but
are not limited to
centralized bidding in the
exchange, block trading, and
agreement transfer; (3)
Before selling the Company's
shares, I shall make a public
announcement three trading
days in advance and perform
the obligation of
information disclosure in a
timely and accurate manner
in accordance with the rules
of the stock exchange,
except for the case when I
61 / 323
2020 ANNUAL REPORT
hold less than 5% of the
Company's shares; (4) If I
fail to fulfill the above
reduction intention, I will
publicly explain the
specific reasons for the
failure in the general
shareholders’ meeting of
the Company and the
disclosure media designated
by China Securities
Regulatory Commission and
apologize to the
shareholders of the Company
and public investors.
Restriction Shareholders (1) If I intend to reduce my Time of the No Yes Not Not
on sale of directly shares after the expiration undertaking: applicable applicable
shares holding more of the lockup period, I will 15 November
than 5% earnestly abide by the 2017, period
shares: Fang relevant regulations of the of validity:
Yuyou, Li China Securities Regulatory 15 November
Xiaolin Commission and the Exchange 2017 to long
on the reduction of shares of term
shareholders, prudently
formulate a share reduction
plan in combination with the
Company's needs of
62 / 323
2020 ANNUAL REPORT
stabilizing the stock price,
carrying out operation and
capital operation, and
gradually reduce my shares
after the expiration of the
lockup period; (2) The
reduction of the Company's
shares shall comply with the
provisions of relevant laws,
regulations and rules; the
specific methods include but
are not limited to
centralized bidding in the
exchange, block trading, and
agreement transfer; (3)
Before reducing the
Company's shares, I shall
make a public announcement
three trading days in
advance and perform the
obligation of information
disclosure in a timely and
accurate manner in
accordance with the rules of
the stock exchange, except
for the case when I hold less
than 5% of the Company's
63 / 323
2020 ANNUAL REPORT
shares; (4) If I fail to
fulfill the above reduction
intention, I will publicly
explain the specific reasons
for the failure in the
general shareholders’
meeting and the disclosure
media designated by China
Securities Regulatory
Commission and apologize to
the shareholders of the
Company and public
investors.
Others Company Before satisfying the Time of the No Yes Not Not
prerequisites for undertaking: applicable applicable
initiating stock price 15 November
stabilization plan, if the 2017, period
Company fails to take of validity:
measures for stock price 15 November
stabilization, the Company 2017 to long
will publicly explain the term
specific reasons for the
failure to take measures for
stock price stabilization in
the general shareholders’
meeting and the disclosure
media designated by China
64 / 323
2020 ANNUAL REPORT
Securities Regulatory
Commission and apologize to
the shareholders and public
investors. If the loss to the
investors is not due to the
force majeure, the Company
will bear the compensation
responsibility to the
investors pursuant to law,
and bear the corresponding
responsibility as required
by laws, regulations and
relevant regulatory
agencies; if the loss to the
investors is due to the force
majeure, the treatment
scheme to minimize the loss
to investors interests shall
be developed as soon as
possible and submitted to
the general shareholders’
meeting for deliberation, so
as to protect the interests
of investors of the Company
as much as possible. Within
three years from the date of
listing of the Company's
65 / 323
2020 ANNUAL REPORT
shares, if the Company
employs new directors and
senior management, the
Company will require such
new directors and senior
management to fulfill the
corresponding undertakings
made by the directors and
senior management at the
time of listing of the
Company.
Others Controlling Before satisfying the Time of the No Yes Not Not
shareholders prerequisites for undertaking: applicable applicable
and initiating stock price 15 November
beneficial stabilization plan, if I 2017, period
controllers fail to take measures to of validity:
stabilize the stock price 15 November
according to the stock price 2017 to long
stabilization plan, I will term
publicly explain the
specific reasons for the
failure to take the above
measures for stock price
stabilization in the general
shareholders’ meeting of
the issuer and the
disclosure media designated
66 / 323
2020 ANNUAL REPORT
by China Securities
Regulatory Commission and
apologize to the
shareholders of the issuer
and public investors; if I
fail to fulfill the above
commitment, I will stop
receiving shareholder
dividends from the issuer
within 5 working days from
the date of occurrence of the
aforesaid event, and
meanwhile the issuer share
held by me shall not be
transferred until I take
corresponding stock price
stabilization plan
according to the above plan
and complete such measures.
Others Director Before satisfying the Time of the No Yes Not Not
(excluding prerequisites for undertaking: applicable applicable
independent initiating stock price 15 November
director) and stabilization measures, if I 2017, period
senior fail to take measures to of validity:
management stabilize the stock price 15 November
according to the stock price 2017 to long
stabilization plan, I will term
67 / 323
2020 ANNUAL REPORT
publicly explain the
specific reasons for the
failure to take the above
measures for stock price
stabilization in the general
shareholders’ meeting of
the issuer and the
disclosure media designated
by China Securities
Regulatory Commission and
apologize to the
shareholders of the issuer
and public investors; if I
fail to fulfill the above
commitment, I will stop
receiving remuneration and
shareholder dividends (if
any) from the issuer within
5 working days from the date
of occurrence of the
aforesaid event, and
meanwhile the issuer share
held by me (if any) shall not
be transferred until I take
corresponding stock price
stabilization plan
according to the above plan
68 / 323
2020 ANNUAL REPORT
and complete such measures.
Others Company If false records, misleading Time of the No Yes Not Not
statements or major undertaking: applicable applicable
omissions in the prospectus 15 November
of the Company cause losses 2017, period
to investors in securities of validity:
trading, the investors will 15 November
be compensated for their 2017 to long
losses pursuant to law. term
After the identification of
such violations by China
Securities Regulatory
Commission, the stock
exchange where the Company
is located or the judicial
organs, we will reach an
amicable settlement with the
investors, and compensate
the investors for the direct
economic losses arising
therefrom through amicable
settlement between the third
party and the investors and
investor compensation fund
according to the measurable
economic losses directly
suffered by investors, in
69 / 323
2020 ANNUAL REPORT
the principle of simplified
procedure, active
negotiation, compensation
in advance and guarantee of
the interests of investors,
especially small and medium
investors. If the Company
violates the above
commitment, the Company will
disclose this in the general
shareholders’ meeting and
the disclosure media
designated by China
Securities Regulatory
Commission and apologize to
the shareholders and public
investors for the failure to
fulfill the above
compensation measures, and
compensate the investors
according to the actual loss
determined by China
Securities Regulatory
Commission and relevant
judicial organs.
Others Controlling If false records, misleading Time of the No Yes Not Not
shareholders statements or major undertaking: applicable applicable
70 / 323
2020 ANNUAL REPORT
and omissions in the prospectus 15 November
beneficial of the issuer cause losses to 2017, period
controllers investors in securities of validity:
of issuer trading, I will compensate 15 November
the investors for their 2017 to long
losses pursuant to law. term
After the identification of
such violations by China
Securities Regulatory
Commission, the stock
exchange where the Company
is located or the judicial
organs, we will reach an
amicable settlement with the
investors, and compensate
the investors for the direct
economic losses arising
therefrom through amicable
settlement between the third
party and the investors and
investor compensation fund
according to the measurable
economic losses directly
suffered by investors, in
the principle of simplified
procedure, active
negotiation, compensation
71 / 323
2020 ANNUAL REPORT
in advance and guarantee of
the interests of investors,
especially small and medium
investors. If the
controlling shareholders
and beneficial controllers
of the Company violate the
above commitment, the
controlling shareholders
and beneficial controllers
will disclose this in the
general shareholders’
meeting of the issuer and the
disclosure media designated
by China Securities
Regulatory Commission and
apologize to the
shareholders of the issuer
and public investors for the
failure to fulfill the above
compensation measures;
besides, the controlling
shareholders and beneficial
controllers will stop
receiving shareholder
dividends from the issuer
within 5 working days from
72 / 323
2020 ANNUAL REPORT
the date of breach of the
above commitments, and
meanwhile the issuer shares
held by them shall not be
transferred until they take
corresponding compensation
measures according to the
above commitments and
complete such measures.
Director, If false records, misleading Time of the No Yes Not Not
supervisor statements or major undertaking: applicable applicable
and senior omissions in the prospectus 15 November
management of the issuer cause losses to 2017, period
investors in securities of validity:
trading, I will compensate 15 November
the investors for their 2017 to long
losses pursuant to law. term
After the identification of
such violations by China
Securities Regulatory
Commission, the stock
exchange where the Company
is located or the judicial
organs, we will reach an
amicable settlement with the
investors, and compensate
the investors for the direct
73 / 323
2020 ANNUAL REPORT
economic losses arising
therefrom through amicable
settlement between the third
party and the investors and
investor compensation fund
according to the measurable
economic losses directly
suffered by investors, in
the principle of simplified
procedure, active
negotiation, compensation
in advance and guarantee of
the interests of investors,
especially small and medium
investors. If the director,
supervisor and senior
management of the Company
violate the above
commitment, the director,
supervisor and senior
management will disclose
this in the general
shareholders’ meeting of
the issuer and the
disclosure media designated
by China Securities
Regulatory Commission and
74 / 323
2020 ANNUAL REPORT
apologize to the
shareholders of the issuer
and public investors for the
failure to fulfill the above
compensation measures;
besides, the director,
supervisor and senior
management will stop
receiving remuneration (or
allowance) and shareholder
dividends (if any) from the
issuer within 5 working days
from the date of breach of
the above commitments, and
meanwhile the issuer shares
held by them (if any) shall
not be transferred until
they take corresponding
compensation measures
according to the above
commitments and complete
such measures.
Others Company To ensure effective Time of the No Yes Not Not
utilization of funds raised undertaking: applicable applicable
this time, effective 15 November
prevention against the risk 2017, period
that immediate return will of validity:
75 / 323
2020 ANNUAL REPORT
be diluted and improvement 15 November
of future ability to 2017 to long
generate returns, the term
Company is proposed to
improve the quality of
assets, enhance operating
revenue, increase future
income and realize
sustainable development by
strengthening operation
management and internal
control, speeding up the
construction progress of
investment projects and
strengthening the return
mechanism of investors, so
as to fill the diluted
immediate return. The
Company undertakes to
continue improving the
measures for filling the
diluted immediate return in
accordance with follow-up
implementation rules issued
by China Securities
Regulatory Commission and
Shanghai Stock Exchange. If
76 / 323
2020 ANNUAL REPORT
the Company violates the
aforesaid commitments, the
Company will announce the
facts and reasons of
violation in a timely
manner. Except for force
majeure or other reasons not
attributable to the Company,
it will apologize to the
shareholders and public
investors of the Company,
and make supplementary
commitment or alternative
commitment to the investors
for the purpose of
protecting the interests of
investors as much as
possible, and implement the
supplementary commitment or
alternative commitment upon
the deliberation and
approval by the general
shareholders’ meeting of
the Company.
Others Controlling I, as the controlling Time of the No Yes Not Not
shareholders shareholder and beneficial undertaking: applicable applicable
and controller of the Company, 15 November
77 / 323
2020 ANNUAL REPORT
beneficial make the following 2017, period
controllers: undertakings to ensure the of validity:
Hou Juncheng practical implementation of 15 November
and Fang Aiqin diluted immediate return 2017 to long
filling measures of the term
Company: (1) In any case, I
undertake neither to act
beyond the authority of
controlling shareholder and
beneficial controller to
intervene in operating
management activities of the
Company, nor to
misappropriate interests of
the Company; (2) After China
Securities Regulatory
Commission and Shanghai
Stock Exchange issues
relevant opinions and
implementation rules on
diluted immediate return
filling measures and
commitment separately, if
the relevant provisions of
the Company and my
commitment are inconsistent
with such provisions, I
78 / 323
2020 ANNUAL REPORT
undertake to issue a
supplementary commitment in
accordance with the
provisions of China
Securities Regulatory
Commission and Shanghai
Stock Exchange immediately,
and actively urge the
Company to make new
commitments or measures to
be in line with the
requirements of China
Securities Regulatory
Commission and Shanghai
Stock Exchange; (3) I
undertake to fully,
completely and timely
implement the measures
related to diluted immediate
return filling of the
Company and my commitment
about diluted immediate
return filling measures. If
I violate these commitments
and cause losses to the
Company or shareholders, I
am willing to: ① publicly
79 / 323
2020 ANNUAL REPORT
explain the specific reasons
in the general
shareholders’ meeting and
the disclosure media
designated by China
Securities Regulatory
Commission and make an
apology; ② assume the
liability of indemnity to
the Company and/or
shareholders pursuant to
law; ③ unconditionally
accept the punishment or
relevant regulatory
measures made by China
Securities Regulatory
Commission and/or Shanghai
Stock Exchange and other
securities regulatory
institutions in accordance
with their relevant
regulations and rules. The
diluted immediate return
filling measures above do
not guarantee the future
profit of the Company.
Others Director and I, as the director and senior Time of the No Yes Not Not
80 / 323
2020 ANNUAL REPORT
senior management of the Company, undertaking: applicable applicable
management make the following 15 November
undertakings to ensure the 2017, period
practical implementation of of validity:
diluted immediate return 15 November
filling measures of the 2017 to long
Company: (1) I undertake term
neither to transfer benefits
to other units or
individuals without
compensation or under unfair
conditions, nor to damage
the Company’s interests in
other ways; (2) I undertake
to strictly abide by the
budget management of the
Company, restrict my
position-related
consumption activities
within the scope necessary
for fulfilling my duty, and
strictly accept the
supervision and management
from the Company to avoid
waste or excessive
consumption; (3) I undertake
not to use the Company’s
81 / 323
2020 ANNUAL REPORT
assets for investment and
consumption activities not
related to execution of my
duties; (4) I undertake to
actively promote the
improvement of remuneration
system of the Company to
better fit the requirements
for filling the diluted
immediate return, support
that the remuneration system
developed, revised and
supplemented by the Board of
Directors or the
Compensation Committee of
the Company are linked with
execution of the Company’s
diluted immediate return
filling measures, and
undertakes that the vesting
conditions for the
Company’s equity incentive
to be released are linked
with execution of the
Company’s return filling
measures; (5) After China
Securities Regulatory
82 / 323
2020 ANNUAL REPORT
Commission and Shanghai
Stock Exchange issues
relevant opinions and
implementation rules on
diluted immediate return
filling measures and
commitment separately, if
the relevant provisions of
the Company and my
commitment are inconsistent
with such provisions, I
undertake to issue a
supplementary commitment in
accordance with the
provisions of China
Securities Regulatory
Commission and Shanghai
Stock Exchange immediately,
and actively urge the
Company to make new
commitments or measures to
be in line with the
requirements of China
Securities Regulatory
Commission and Shanghai
Stock Exchange; (6) I
undertake to fully and
83 / 323
2020 ANNUAL REPORT
completely implement the
measures related to diluted
immediate return filling of
the Company and my
commitment about diluted
immediate return filling
measures in a timely manner.
If I violate these
commitments and cause losses
to the Company or
shareholders, I am willing
to: ① publicly explain the
specific reasons in the
general shareholders’
meeting and the disclosure
media designated by China
Securities Regulatory
Commission and make an
apology; ② assume the
liability of indemnity to
the Company and/or
shareholders pursuant to
law; ③ unconditionally
accept the punishment or
relevant regulatory
measures made by China
Securities Regulatory
84 / 323
2020 ANNUAL REPORT
Commission and/or Shanghai
Stock Exchange and other
securities regulatory
institutions in accordance
with their relevant
regulations and rules. The
diluted immediate return
filling measures above do
not guarantee the future
profit of the issuer.
Address Controlling 1. I do not and will not Time of the No Yes Not Not
competition shareholders directly or indirectly undertaking: applicable applicable
between and engage in any activities 15 November
counterparts beneficial compete with the existing 2017, period
controllers: and future business of Proya of validity:
Hou Juncheng Co., Ltd. and its holding 15 November
and Fang Aiqin subsidiaries, including but 2017 to long
not limited to the R&D, term
production and sale of any
products that are the same or
similar to those of Proya
Co., Ltd. and its holding
subsidiaries, and I am
willing to compensate Proya
Co., Ltd. for the economic
loss caused due to violation
of the above commitment; 2.
85 / 323
2020 ANNUAL REPORT
For enterprises under my
control, I will fulfill the
obligations under this
commitment in these
enterprises through the
dispatched agencies and
personnel (including but not
limited to director and
manager), and I am willing to
compensate Proya Co., Ltd.
for the economic loss caused
due to violation of the above
commitment; 3. From the date
of signing this commitment
letter, if Proya Co., Ltd.
further expands its product
and business scope, I and the
enterprise under my control
will not compete with the
expanded product or business
of Proya Co., Ltd.; in case
of possible competition with
the expanded product or
business of Proya Co., Ltd.,
I and the enterprise under my
control will withdraw from
the competition with Proya
86 / 323
2020 ANNUAL REPORT
Co., Ltd. by the following
ways: (1) stop producing
competing or potentially
competing products; (2) stop
the operation of competing
or potentially competing
business; (3) incorporate
competing business into
Proya Co., Ltd. for
operation; (4) transfer the
competing business to
unrelated third parties. 4.
My shareholding
corporations, i.e.,
Hangzhou Huazhuang
Industrial Investment Co.,
Ltd., Huzhou Mogan Wangshu
Cosmetics Industry Phase I
Venture Capital Partnership
(Limited Partnership) and
its foreign investment
enterprises, are not engaged
in cosmetics business or
upstream and downstream
cosmetics business. If these
are engaged in cosmetics
business or upstream and
87 / 323
2020 ANNUAL REPORT
downstream cosmetics
business in the future, I
undertake to withdraw the
investment in these
enterprises by means of
equity transfer, and give
priority to Proya Cosmetics
Co., Ltd. for choosing
whether to invest in the
event of compliance with the
law and with the consent of
other shareholders of these
enterprises.
Others Controlling The following undertakings Time of the No Yes Not Not
shareholders are made in respect to undertaking: applicable applicable
and practical implementation of 12 October
beneficial immediate return filling 2020, period
controllers: measures of the Company: of validity:
Hou Juncheng 1. I undertake neither to act 12 October
Undertakings
and Fang Aiqin beyond the authority to 2020 to long
related to
intervene in operating term
refinancing
management activities of the
Company, nor to
misappropriate interests of
the Company;
2. From the issuance date of
this commitment to the
88 / 323
2020 ANNUAL REPORT
completion of this public
offering of A-share
convertible corporate
bonds, if China Securities
Regulatory Commission makes
other new regulatory
provisions on the return
filling measures and
commitment, and the above
commitment fails to meet the
requirements of China
Securities Regulatory
Commission, I undertake to
issue a supplementary
commitment in accordance
with the latest provisions
of China Securities
Regulatory Commission at
that time;
3. I undertake to
practically implement the
Company’s return filling
measures and fulfill any
undertakings I make thereto
in connection with return
filling measures. In case of
breach of my undertakings
89 / 323
2020 ANNUAL REPORT
with losses to the Company or
investors, I hereby agree to
assume liability of
indemnity to the Company or
investors.
If I, as one of the
responsible subjects of
return filling measures,
violate the above commitment
or refuse to fulfill the
above commitment, I will
accept punishment or
relevant regulatory
measures in accordance with
the relevant regulations and
rules of China Securities
Regulatory Commission and
Shanghai Stock Exchange and
other securities regulatory
institutions.
Others Director and The following undertakings Time of the No Yes Not Not
senior are made in respect to undertaking: applicable applicable
management practical implementation of 12 October
immediate return filling 2020, period
measures of the Company: of validity:
1. I undertake neither to 12 October
transfer benefits to other 2020 to long
90 / 323
2020 ANNUAL REPORT
units or individuals without term
compensation or under unfair
conditions, nor to damage
the Company’s interests in
other ways;
2. I undertake to restrict my
position-related
consumption activities;
3. I undertake not to use the
Company’s assets for
investment and consumption
activities not related to
execution of my duties;
4. I undertake that the
remuneration system
developed by the Board of
Directors or the
Remuneration and Appraisal
Committee are linked with
execution of the Company’s
return filling measures;
5. If equity incentive is
carried out in the Company in
the future, I undertake that
the vesting conditions for
the Company’s equity
incentive to be released are
91 / 323
2020 ANNUAL REPORT
linked with execution of the
Company’s return filling
measures;
6. From the issuance date of
this commitment to the
completion of this public
offering of A-share
convertible corporate bonds
of the Company, if China
Securities Regulatory
Commission makes other new
regulatory provisions on the
return filling measures and
commitment, and the above
commitment fails to meet the
requirements of China
Securities Regulatory
Commission, I undertake to
issue a supplementary
commitment in accordance
with the latest provisions
of China Securities
Regulatory Commission at
that time.
If I, as one of the
responsible subjects of
return filling measures,
92 / 323
2020 ANNUAL REPORT
violate the above commitment
or refuse to fulfill the
above commitment, I will
accept punishment or
relevant regulatory
measures in accordance with
the relevant regulations and
rules of China Securities
Regulatory Commission and
Shanghai Stock Exchange and
other securities regulatory
institutions.
93 / 323
2020 ANNUAL REPORT
(II) Where the Company has profit forecasts on assets or projects, and the Reporting Period was
within the term of profit forecasts, the Company has to state whether such profit forecasts on
assets or projects are fulfilled and the reasons therefor
□ Fulfilled□ Unfulfilled√ Not applicable
(III) Execution of the performance undertakings and impact on the goodwill impairment
testing
□ Applicable√ Not applicable
III Occupation of funds and repayment of debts during the Reporting Period
□ Applicable√ Not applicable
IV Explanation of the Company on the “non-standard opinions audit report” from
accounting firm
□ Applicable√ Not applicable
V Analysis and explanation from the Company on the reasons and impact of the
change of accounting policies, accounting estimates or correction on significant
accounting errors
(I) Analysis and explanation from the Company on the reasons and impact of the change of
accounting policies or accounting estimates
√ Applicable□ Not applicable
Refer to “44. Changes in significant accounting policies and accounting estimates” in
“V. Significant accounting policies and accounting estimates” of “Section XI Financial
Report” herein.
(II)Analysis and explanation from the Company on the reasons and impact of the correction on
significant accounting errors
□ Applicable√ Not applicable
(III) Communication with the previous accounting firm
□ Applicable√ Not applicable
(IV)Other particulars
□ Applicable√ Not applicable
VI Appointment and dismissal of the accounting firm
Unit: Yuan Currency: RMB
Current accounting firm
94 / 323
2020 ANNUAL REPORT
Name of domestic accounting firm Pan-China Certified Public Accountants LLP
Remuneration of domestic accounting firm 1,200,000
Term of office of domestic accounting firm 10 years
Name Remuneration
Internal control audit Pan-China Certified Public 200,000
accounting firm Accountants LLP
Explanation on appointment and dismissal of the accounting firm
□ Applicable√ Not applicable
Explanation on the change of accounting firm during the auditing period
□ Applicable√ Not applicable
VII Risk of suspension of listing
（I） Causes of suspension of listing
□ Applicable√ Not applicable
（II） Measures to be taken by the Company
□ Applicable√ Not applicable
VIII Situation and causes for termination of listing
□ Applicable√ Not applicable
IX Matters related to bankruptcy and reorganization
□ Applicable√ Not applicable
X Material litigation and arbitration
□ The Company had material litigation and arbitration during the year
√ The Company did not have material litigation and arbitration during the year
XI Punishment and rectification to the listed Company, its directors, supervisors,
senior management, controlling shareholders, beneficial controllers and acquirers
□ Applicable√ Not applicable
XII Explanation on credibility status of the Company, its controlling shareholders and
beneficial controllers during the Reporting Period
√ Applicable□ Not applicable
The Company, its controlling shareholders and beneficial controllers held reliable
creditability during the Reporting Period.
95 / 323
2020 ANNUAL REPORT
XIII Equity incentive plan, employee shareholding plan or other employee incentive
measures of the Company and their impacts
（I） Incentive matters disclosed in temporary announcements and without further progress or
change in subsequent implementation
√ Applicable□ Not applicable
Item Query index
Announcement on Adjusting the Website of Shanghai Stock Exchange on 20 June 2020, China
Performance Evaluation Securities Journal, Shanghai Securities News,
Indicators at the Company Securities Times and Securities Daily
Level in 2020 in the 2018
Restricted Share Incentive
Plan and Related Documents
Announcement on Adjusting the Website of Shanghai Stock Exchange website on 26 August
Repurchase Price of 2020, China Securities Journal, Shanghai Securities
Restricted Share Incentive News, Securities Times and Securities Daily
Plan in 2018
Announcement on Repurchase Website of Shanghai Stock Exchange website on 26 August
and Cancellation of Some 2020, China Securities Journal, Shanghai Securities
Restricted Shares for Equity News, Securities Times and Securities Daily
Incentive
Announcement on Capital Website of Shanghai Stock Exchange website on 26 August
Reduction of Repurchase and 2020, China Securities Journal, Shanghai Securities
Cancellation of Some News, Securities Times and Securities Daily
Restricted Shares
Announcement on the Website of Shanghai Stock Exchange website on 28 October
Implementation of Repurchase 2020, China Securities Journal, Shanghai Securities
and Cancellation of News, Securities Times and Securities Daily
Restricted Share for Equity
Incentive
（II） Incentive matters not disclosed in temporary announcements or with further progress
Equity incentive
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
Employee shareholding plan
□ Applicable√ Not applicable
Other incentive measures
□ Applicable√ Not applicable
96 / 323
2020 ANNUAL REPORT
XIV Major related transactions
（I） Related transactions in relation to daily operation
1 Events disclosed in temporary announcements and without further progress or change
in subsequent implementation
□ Applicable√ Not applicable
2 Events disclosed in temporary announcements and with further progress or change in
subsequent implementation
√ Applicable□ Not applicable
th
The 12 meeting of the second session of the Board of Directors and 2019 annual general
meeting of the Company reviewed and passed the Proposal on Expected Daily Related
Transaction Quota in 2019 on 31 March 2020 and 22 April 2020 respectively. Refer to the
Announcement for Expected Daily Related Transaction Quota in 2020 disclosed by the Company
on the website of Shanghai Stock Exchange on 2 April 2020 (announcement No.: 2020-019)
for details. In 2020, the daily related transactions of the Company did not exceed the
expected amount at the beginning of the year.
The expected and actual daily related transactions of 2020 are as follows:
Type of
Actual amount in
related Related party Estimated amount in 2020
2020
transactions
Related
Zhejiang Yueqing Rural No more than RMB 150
party's bank
Commercial Bank million for daily maximum RMB 143,907,700
account
Company Limited limit
deposit
Particulars Huzhou Meizhuang Town
on Science and Technology
RMB 1.8 million RMB 652,600
related-party Incubation Park Co.,
leases Ltd.
Note: The "actual amount in 2020” of Zhejiang Yueqing Rural Commercial Bank Company
Limited is the account balance as at 31 December 2020. In 2020, the Company obtained
deposit interest of RMB 5,939,700 from Zhejiang Yueqing Rural Commercial Bank Company
Limited.
3 Events not disclosed in temporary announcements
□ Applicable√ Not applicable
（II） Related transactions as a result of acquisition and disposal of assets or equity
1 Events disclosed in temporary announcements and without further progress or change
in subsequent implementation
□ Applicable√ Not applicable
97 / 323
2020 ANNUAL REPORT
2 Events disclosed in temporary announcements and with further progress or change in
subsequent implementation
□ Applicable√ Not applicable
3 Events not disclosed in temporary announcements
□ Applicable√ Not applicable
4 Disclosable performance achievements during the Reporting Period when involved with
agreed-upon performance
□ Applicable√ Not applicable
（III） Major related transactions in joint external investment
1 Events disclosed in temporary announcements and without further progress or change
in subsequent implementation
□ Applicable√ Not applicable
2 Events disclosed in temporary announcements and with further progress or change in
subsequent implementation
□ Applicable√ Not applicable
3 Events not disclosed in temporary announcements
□ Applicable√ Not applicable
（IV） Creditor’s rights and debts with related parties
1、 Events disclosed in temporary announcements and without further progress or change
in subsequent implementation
□ Applicable√ Not applicable
2、 Events disclosed in temporary announcements and with further progress or change in
subsequent implementation
□ Applicable√ Not applicable
3、 Events not disclosed in temporary announcements
□ Applicable√ Not applicable
（V） Others
□ Applicable√ Not applicable
98 / 323
2020 ANNUAL REPORT
XV Material contracts and their performance
（I） Trusteeship, contracting and leasing matters
（II） Trusteeship
□ Applicable√ Not applicable
1 Contracting
□ Applicable√ Not applicable
2 Leasing
□ Applicable√ Not applicable
（III） Guarantees
√ Applicable□ Not applicable
Unit: RMB 00’000 Currency: RMB
Company's external guarantees (excluding guarantees for subsidiaries)
Relati Whet Wheth
Date
onship her Whet er it
of Over
betwee the her is
Amou guara Type due
n the guar the Whether guara Relate
Guar Guara nt of ntee Star Matu of amou
guaran ante guar there is a nteed d
anto nteed guar (agre ting rity guar nt of
tor and e has ante counter-g by relati
r Party ante ement date date ante guar
the been e is uarantee the onship
e signi e ante
listed perf over relat
ng e
compan orme due ed
date)
y d party
Total amount of guarantee incurred 0
during the Reporting Period
(excluding guarantee for
subsidiaries)
Total balance of guarantee at the end 0
of the Reporting Period (A)
(excluding guarantees for
subsidiaries)
The guarantee of the Company and its subsidiaries for the subsidiaries
Total amount of guarantee for 23,141.25
subsidiaries during the Reporting
Period
Total balance of guarantee for 9,900
subsidiaries at the end of the
Reporting Period (B)
Total amount of the Company guarantee (including guarantee for subsidiaries)
99 / 323
2020 ANNUAL REPORT
Total amount of guarantee (A + B) 9,900
Proportion of total guarantee 4.14
amount to the Company’s net assets
(%)
Where:
Amount of guarantee for
shareholders, beneficial
controllers and related parties
thereof (C)
Amount of debt guarantees directly
or indirectly provided for
guaranteed objects with
asset-liability ratio exceeding 70%
(D)
Total amount of guarantee exceeding
50% of the net assets (E)
Sum of the above three guarantees
(C+D+E)
Description on the possible joint
liability for satisfaction of
unexpired guarantee
Description on guarantees
（IV） Entrusting others to manage cash assets
1. Entrusted wealth management
(1) Overall condition of entrusted wealth management
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Amount Overdue uncollected
Types Source of fund Undue balance
incurred amount
Bank wealth Self-owned 17,000 3,000 0
management capital
products
Trust wealth Self-owned 7,000 0 0
management capital
products
Others
□ Applicable√ Not applicable
100 / 323
2020 ANNUAL REPORT
(2) Individual entrusted wealth management
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Whe Amo
the unt
Whe r of
Beg the the pro
Term
Amo inn r it re vis
Typ inat U
unt ing has is a ion
e of ion s Ann Exp
of dat Met gon fut for
ent date a ual ect Act
ent e of Sou hod e ure the
rus of g ize ed ual Act
rus ent rce to thr ent imp
Tru ted entr e d ret gai ual
ted rus of det oug rus air
ste wea uste o rat urn ns rec
wea ted fun erm h a ted men
e lth d f e of (if or ove
lth wea d ine leg wea t
man weal f ret any los ry
man lth ret al lth (if
age th u urn ) ses
age man urn pro man any
men mana n
men age ced age )
t geme d
t men ure men
nt
t or t
not pla
n or
not
Chi Pri 14, 201 2020 Sel 1.5 187 Rec Yes No
na nci 000 9/9 /3/3 f-o 5% .78 ove
Mer pal /3 wne or red
cha gua d 2.6
nts ran cap 9%
Ban tee ita or
k d l 2.8
Xix wit 9%
ing h
Bra flo
nch ati
ng
ret
urn
s
Others
□ Applicable√ Not applicable
101 / 323
2020 ANNUAL REPORT
(3) Provision for the impairment of entrusted wealth management
□ Applicable√ Not applicable
2. Entrusted loans
(1) Overall condition of entrusted loans
□ Applicable√ Not applicable
Others
□ Applicable√ Not applicable
(2) Individual entrusted loans
□ Applicable√ Not applicable
Others
□ Applicable√ Not applicable
(3) Provision for the impairment of entrusted loans
□ Applicable√ Not applicable
3. Others
□ Applicable√ Not applicable
（V） Other material contracts
□ Applicable√ Not applicable
XVI Explanation on other material matters
□ Applicable√ Not applicable
XVII Active fulfillment of social responsibilities
（I） Poverty alleviation by the listed company
□ Applicable√ Not applicable
（II） Overview of social responsibility
√ Applicable□ Not applicable
See Sustainable Development Report of Proya Cosmetics Co., Ltd. 2020 on the website of
Shanghai Stock Exchange (www.sse.com.cn) disclosed on the same day
102 / 323
2020 ANNUAL REPORT
（III） Environmental information
1. Explanation on environmental protection of the company and its major subsidiaries
falling into the category of key pollutant discharging units designated by the
environmental protection authorities
□ Applicable√ Not applicable
2. Explanation on environmental protection of companies other than key pollutant
discharging units
√ Applicable□ Not applicable
1. During the Reporting Period, the wastewater discharge was guaranteed to meet Class
A standard by packing replacement in cooling tower, cleaning of boiler furnace, overall
assessment of monthly production schedule, reduction of wire and boiler change, decrease
of wastewater discharge, and 24h online monitoring of COD content in the treated water.
2. The concept of resource-saving and environment-friendly green factory was continued
during the Reporting Period. The wastewater discharge at the production base was
guaranteed to meet Class A standard by new investment of 120t water storage tank, premature
cooling of process cooling water by peak-valley electricity, improvement of manufacturing
efficiency, reduction of energy consumption input; addition of 4t ultra-low nitrogen gas
fired boiler, active support of “actions on new standards for NOx atmospheric emission
from boilers” issued by the Department of Environmental Protection, improvement of
ambient air quality; intelligent evaluation of monthly production schedule by scheduling
software, and decrease of wastewater discharge; and 24h online monitoring of COD content
in the treated water.
3. Each department continued to perform the garbage sorting, pure water filtration and
recycling of bottle washer, and rationalization proposals on energy conservation and
consumption reduction. While providing customers with high-quality products and services,
the factory has been committed to protecting the natural environment and sparing no effort
to build a resource-saving and environment-friendly green factory.
3. Explanation on environment information of companies other than key pollutant
discharging units not disclosed
□ Applicable√ Not applicable
4. Explanation on further progress or changes of environmental information disclosed
during the Reporting Period
□ Applicable√ Not applicable
（IV） Other particulars
□ Applicable√ Not applicable
XVIII Convertible corporate bonds
□ Applicable√ Not applicable
103 / 323
2020 ANNUAL REPORT
Section VI Changes in Ordinary Shares and Shareholders
I Changes in share capital of ordinary shares
（I） Changes in ordinary shares
1 Changes in ordinary shares
Unit: 0’000 shares
Before the After the
Increase/decrease of the change (+, -)
change change
Capita
Issue
Bon l
Percent of Percent
Numbe us reserv Numbe
age new Others Sub-total age
r sha e-conv r
(%) share (%)
res erted
s
shares
I. 13,917 69.149 -13,843 -13,843. 74.742 0.3716
Restricted .7760 9 .0335 0335 5
shares
1.
State-owned
shares
2. Shares
held by
state-owned
legal
person
3. Other 13,917 69.149 -13,843 -13,843. 74.742 0.3716
domestic .7760 9 .0335 0335 5
shares
Where:
Shares held
by domestic
non-state-o
wned legal
person
Share 13,917 69.149 -13,843 -13,843. 74.742 0.3716
s held by .7760 9 .0335 0335 5
domestic
natural
person
4. Overseas
104 / 323
2020 ANNUAL REPORT
shares
Where:
Shares held
by overseas
legal
person
Share
s held by
overseas
natural
person
II. 6,209. 30.850 +13,827 +13,827. 20,036 99.628
Non-restric 18 1 .7700 7700 .9500 4
ted
circulating
shares
1. Ordinary 6,209. 30.850 +13,827 +13,827. 20,036 99.628
RMB shares 18 1 .7700 7700 .9500 4
2.
Domesticall
y listed
foreign
shares
3. Overseas
listed
foreign
shares
4. Others
III. Total 20,126 100.00 -15.263 -15.2635 20,111 100.00
ordinary .9560 5 .6925
shares
2 Explanation on changes in ordinary shares
√ Applicable□ Not applicable
th
On 30 December 2019, the 10 meeting of the second session of the Board of Directors
th
and the 10 meeting of the second session of the Board of Supervisors of the Company
reviewed and passed the Proposal on Achievements of Lifting Selling Restrictions in the
First Selling Restrictions Lifting Date for the First Grant and Reserved Grant of
Restricted Share Incentive Plan in 2018, and agreed to handle the matters about lifting
the selling restrictions in a unified form for the incentive objects in line with the
conditions for lifting selling restrictions, totaling 369,500 restricted shares lifted.
The listing and circulation date of such lifted shares is 6 January 2020. The
non-restricted circulating shares of the Company increased from 62,091,800 shares before
105 / 323
2020 ANNUAL REPORT
this listing to 62,461,300 shares; the restricted circulating shares decreased from
139,177,760 shares before this listing to 138,808,260 shares.
On 30 October 2020, the Company received the Certificate of Securities Change
Registration issued by Shanghai Branch of China Securities Depository and Clearing
Corporation Limited, and completed the repurchase and cancellation of 152,635 restricted
shares that were authorized but not yet unlocked of incentive objects not meeting the
incentive conditions. The total non-restricted shares of the Company decreased from
201,269,560 shares before this repurchase to 201,116,925 shares, in which the
non-restricted circulating shares are 62,461,300 shares and the restricted circulating
shares are 138,655,625 shares.
The Company carried out initial public offering of some restricted shares on 16
November 2020, and the number of restricted shares for listing and circulation is
137,908,200 shares this time. The total shares of the Company remains unchanged, in which
the non-restricted circulating shares increased from 62,461,300 shares before this
listing to 200,369,500 share; the restricted circulating shares decreased from
138,655,625 shares before this listing to 747,425 shares.
3 Impact of changes in ordinary shares on the earnings per share, net asset value per
share and other financial indicators in the last year and period (if any)
□ Applicable√ Not applicable
4 Other contents that the Company deems necessary and the securities regulatory
authorities require disclosing
□ Applicable√ Not applicable
（II） Changes in restricted shares
√ Applicable□ Not applicable
Unit: Share
Increase
Number of Number of Number of
in number Date of
restricted restricted restrict
Name of of Reason for removal of
shares at shares ed shares
sharehol restrict selling selling
the removed at the
der ed shares restrictions restrictio
beginning during the end of
during ns
of the year year the year
the year
Hou 72,640,500 72,640,500 0 0 Initial 16
Juncheng public November
offering 2020
Fang 48,858,000 48,858,000 0 0 Initial 16
Yuyou public November
offering 2020
Li 7,589,400 7,589,400 0 0 Initial 16
Xiaolin public November
offering 2020
106 / 323
2020 ANNUAL REPORT
Xu 7,419,900 7,419,900 0 0 Initial 16
Junqing public November
offering 2020
Fang 390,900 390,900 0 0 Initial 16
Aifen public November
offering 2020
Ye Caifu 216,300 216,300 0 0 Initial 16
public November
offering 2020
Li 199,050 199,050 0 0 Initial 16
Jianqing public November
offering 2020
Chen 183,300 183,300 0 0 Initial 16
Dongfang public November
offering 2020
Li 159,150 159,150 0 0 Initial 16
Wenqing public November
offering 2020
Xu 68,100 68,100 0 0 Initial 16
Dongkui public November
offering 2020
Bao 65,400 65,400 0 0 Initial 16
Qingfang public November
offering 2020
Fang 49,950 49,950 0 0 Initial 16
Jiaqin public November
offering 2020
Fang 49,950 49,950 0 0 Initial 16
Shanming public November
offering 2020
Ye Hong 18,300 18,300 0 0 Initial 16
public November
offering 2020
Jin 97,481 28,671 0 68,810 First grant -
Yanhua of the
restricted
share
incentive
plan in 2018
Zhang 47,770 13,750 0 34,020 First grant -
Yefeng of the
restricted
share
incentive
107 / 323
2020 ANNUAL REPORT
plan in 2018
Wang Li 58,900 17,670 0 41,230 First grant -
of the
restricted
share
incentive
plan in 2018
25 865,023 254,063 -149,315 461,645 First grant -
grantees of the
(first restricted
grant of share
the incentive
restrict plan in 2018
ed share
incentiv
e plan in
2018)
10 200,386 55,346 -3,320 141,720 Reserved -
grantees grant of the
(reserve restricted
d grant share
of the incentive
restrict plan in 2018
ed share
incentiv
e plan in
2018)
Total 139,177,760 138,277,700 -152,635 747,425 / /
Note: The negative “increase in number of restricted shares during the year” is due to
the repurchase of restricted shares for equity incentive.
II Issuance and listing of securities
（I） Issuance of securities as at the Reporting Period
□ Applicable√ Not applicable
Explanation on issuance of securities as at the Reporting Period (please provide separate
explanation on the bonds with different interest rates during their duration):
□ Applicable√ Not applicable
（II） Changes in the total number of ordinary shares and shareholder structure of the Company
and changes in the structure of assets and liabilities of the Company
√ Applicable□ Not applicable
The total number of ordinary shares of the Company was 201,269,560 at the beginning
of the Reporting Period and 201,116,925 at the end of the Reporting Period.
108 / 323
2020 ANNUAL REPORT
At the beginning of the Reporting Period, the total assets were RMB 2,979,365,076.82,
total liabilities were RMB 909,307,033.25, and the asset-liability ratio was 30.52%. At
the end of the Reporting Period, the total assets were RMB 3,636,882,185.29, total
liabilities were RMB 1,155,019,919.16, and the asset-liability ratio was 31.76%.
（III） Existing internal employee shares
□ Applicable√ Not applicable
III Shareholders and beneficial controllers
（I） Total number of shareholders
Total number of shareholders of ordinary shares as at the 16,869
end of the Reporting Period
Total number of shareholders of ordinary shares at the end 20,423
of last month prior to the disclosure date of this annual
report
Total number of shareholders of preferred shares whose 0
voting rights have been restored as at the end of the
Reporting Period
Total number of shareholders of preferred shares whose 0
voting rights have been restored at the end of last month
prior to the disclosure date of this annual report
（II） Table of shareholdings of the top ten shareholders and the top ten shareholders of shares
in circulation (or shareholders not subject to selling restrictions) as at the end of the Reporting
Period
Unit: Share
Shareholdings of the top ten shareholders
Number of Pledged or frozen
shares
Number of
Change held
Name of shares Percen Shar Nature of
during the subject
shareholder held as at tage e sharehol
Reporting to Number
(full name) the end of (%) stat der
Period selling
the period us
restrict
ions
Domestic
Hou
72,640,500 36.12 0 None natural
Juncheng
person
Domestic
Pled
Fang Yuyou -4,038,882 44,819,118 22.29 0 23,120,000 natural
ge
person
109 / 323
2020 ANNUAL REPORT
Hong Kong
Securities
Clearing 16,309,444 16,759,683 8.33 0 None Others
Company
Limited
Domestic
Li Xiaolin -1,345,178 6,244,222 3.10 0 None natural
person
Domestic
Xu Junqing -1,476,099 5,943,801 2.96 0 None natural
person
Domestic
Cao
-1,373,912 4,124,938 2.05 0 None natural
Liangguo
person
China
Constructio
n Bank
Corporation
- Yinhua
Fuyu Theme
Hybrid
Securities 1,209,437 3,649,293 1.81 0 None Others
Investment
Fund（中国建
设银行股份
有限公司－
银华富裕主
题混合型证
券投资基金）
110 / 323
2020 ANNUAL REPORT
Industrial
and
Commercial
Bank of
China
Limited-Inv
esco Great
Wall
Emerging
Mature and
2,499,766 2,499,766 1.24 0 None Others
Hybrid
Equity
Investment
Funds（中国
工商银行股
份有限公司
－景顺长城
新兴成长混
合型证券投
资基金）
China Citic
Bank
Corporation
Limited -
China
ABC-CA
Strategy
Selected
Hybrid 221,096 1,028,941 0.51 0 None Others
Securities
Investment
Fund（中信银
行股份有限
公司－农银
汇理策略精
选混合型证
券投资基金）
Abu Dhabi
Investment -142,311 997,598 0.50 0 None Others
Authority
Shareholdings of the top ten shareholders of non-restricted circulating shares
Name of shareholder Number of Type and number of shares
111 / 323
2020 ANNUAL REPORT
non-restricted
circulating Type Number
shares held
Hou Juncheng 72,640,500 Ordinary RMB 72,640,500
Shares
Fang Yuyou 44,819,118 Ordinary RMB 44,819,118
Shares
Hong Kong Securities Clearing Company 16,759,683 Ordinary RMB 16,759,683
Limited Shares
Li Xiaolin 6,244,222 Ordinary RMB 6,244,222
Shares
Xu Junqing 5,943,801 Ordinary RMB 5,943,801
Shares
Cao Liangguo 4,124,938 Ordinary RMB 4,124,938
Shares
China Construction Bank Corporation - 3,649,293 Ordinary RMB 3,649,293
Yinhua Fuyu Theme Hybrid Securities Shares
Investment Fund（中国建设银行股份有限公
司－银华富裕主题混合型证券投资基金）
Industrial and Commercial Bank of China 2,499,766 Ordinary RMB 2,499,766
Limited-Invesco Great Wall Emerging Shares
Mature and Hybrid Equity Investment Funds
（中国工商银行股份有限公司－景顺长城新
兴成长混合型证券投资基金）
China Citic Bank Corporation Limited - 1,028,941 Ordinary RMB 1,028,941
China ABC-CA Strategy Selected Hybrid Shares
Securities Investment Fund（中信银行股份
有限公司－农银汇理策略精选混合型证券投
资基金）
Abu Dhabi Investment Authority 997,598 Ordinary RMB 997,598
Shares
Explanation on the related relationship Fang Yuyou is the younger brother of Hou
or parties acting in concert among the Juncheng's spouse Fang Aiqin, so Hou Juncheng
above shareholders and Fang Yuyou are related.
Explanation on the preference None
shareholders with voting rights restored
and their shareholdings
Shareholdings of the top ten shareholders subject to trading moratorium and the condition
of trading moratorium
√ Applicable□ Not applicable
Unit: Share
112 / 323
2020 ANNUAL REPORT
Listed transactions of
restricted shares
Number of Trading Selling
Numb Name of restricted
restricted time Number of new restrict
er shareholder
shares availabl tradable ions
e for shares
listing
1 Equity incentive object 747,425 See
“note”
for
details
Explanation on the related None
relationship or parties acting in
concert among the above
shareholders
Note: The restricted shares held by the equity incentive object is those from the first
grant and reserved grant of restricted share incentive plan of the Company in 2018. The
restricted period of first-grant shares is 24 months and 36 months from the completion
of the registration of first-grant restricted share in Shanghai Branch of China Securities
Depository and Clearing Corporation Limited (10 September 2018); the restricted period
of reserved-grant shares is 25 months and 37 months from the completion of the registration
of reserved-grant restricted share in Shanghai Branch of China Securities Depository and
Clearing Corporation Limited (10 September 2018).
（III） Strategic investors or general legal persons becoming the top ten shareholders because of
placing of new shares
□ Applicable√ Not applicable
IV Controlling shareholders and beneficial controllers
（I） Controlling shareholder
1 Legal person
□ Applicable√ Not applicable
2 Natural person
√ Applicable□ Not applicable
Name Hou Juncheng, Fang Aiqin
Nationality China
Acquire right of residence in No
other countries or regions or
not
Main job and title Hou Juncheng and Fang Aiqin are husband and wife. Hou
Juncheng was the Chairman of the Company, and Fang Aiqin
was the Senior Purchasing Consultant of the Company.
113 / 323
2020 ANNUAL REPORT
3 Special explanation on the Company not having controlling shareholders
□ Applicable√ Not applicable
4 Index and date of changes in controlling shareholders during the Reporting Period
□ Applicable√ Not applicable
5 Diagram of the ownership and controlling relationship between the Company and its
controlling shareholders
√ Applicable□ Not applicable
夫妇 Couple
侯军呈 Hou Juncheng
方爱琴 Fang Aiqin
潍坊正益 Weifang Zhengyi
珀莱雅化妆品股份有限公司 Proya Cosmetics Co., Ltd.
Note: The shareholding ratio in the above diagram is the data as at the end of the Reporting
Period.
（II） Beneficial controllers
1 Legal person
□ Applicable√ Not applicable
2 Natural person
√ Applicable□ Not applicable
Name Hou Juncheng, Fang Aiqin
Nationality China
Acquire right of residence in No
other countries or regions or
not
Main job and title Hou Juncheng and Fang Aiqin are husband and wife. Hou
Juncheng was the Chairman of the Company, and Fang Aiqin
114 / 323
2020 ANNUAL REPORT
was the Senior Purchasing Consultant of the Company.
Shareholdings in other domestic None
or overseas listed companies
over the past 10 years
3 Special explanation on the Company not having beneficial controllers
□ Applicable√ Not applicable
4 Index and date of changes in beneficial controllers during the Reporting Period
□ Applicable√ Not applicable
5 Diagram of the ownership and controlling relationship between the Company and its
beneficial controllers
√ Applicable□ Not applicable
夫妇 Couple
侯军呈 Hou Juncheng
方爱琴 Fang Aiqin
潍坊正益 Weifang Zhengyi
珀莱雅化妆品股份有限公司 Proya Cosmetics Co., Ltd.
Note: The shareholding ratio in the above diagram is the data as at the end of the Reporting
Period.
6 Control of the Company by beneficial controllers by way of trust or other means of
asset management
□ Applicable√ Not applicable
（III） Other explanation regarding the controlling shareholders and the beneficial controllers
□ Applicable√ Not applicable
115 / 323
2020 ANNUAL REPORT
V Other legal person shareholders with more than 10% shareholdings
□ Applicable√ Not applicable
VI Explanation on limitation on reduction of shareholding
□ Applicable√ Not applicable
Section VII Preferred Shares
□ Applicable√ Not applicable
116 / 323
2020 ANNUAL REPORT
Section VIII Directors, Supervisors, Senior Management and Employees
I Shareholding change and remuneration
（I） Shareholding change and remuneration of directors, supervisors and senior management currently employed and retired during the Reporting Period
√ Applicable□ Not applicable
Unit: Share
Total pre-tax Whether
remuneration to get
Number of from the remunera
Number of
shares held Change in Reasons Company during tion
Position Gend shares held
Name Age From To at the share of for the Reporting from
(note) er at the end
beginning the year change Period (RMB related
of the year
of the year 0’000) parties
of the
Company
Hou Chairman Male 57 2015.7.30 2021.9.2 72,640,500 72,640,500 0 162.51 No
Junchen
g
Fang Director, Male 52 2015.7.30 2021.9.2 48,858,000 44,819,118 -4,038,882 Decrease 162.51 No
Yuyou General in
Manager sharehol
ding due
to
personal
capital
needs
Cao Director, Male 49 2015.7.30 2021.9.2 5,498,850 4,124,938 -1,373,912 Decrease 125.61 No
Lianggu Deputy in
o General sharehol
Manager ding due
to
117 / 323
2020 ANNUAL REPORT
personal
capital
needs
Chu Independent Male 57 2015.7.30 2021.9.2 0 0 0 9.52 No
Xiuqi Director
Chen Independent Male 49 2017.8.1 2021.9.2 0 0 0 9.52 No
Yan Director
Ye Nana Chairman of Fema 37 2018.9.3 2021.9.2 0 0 0 21.21 No
the Board of le
Supervisors
Fang Supervisor Fema 31 2018.5.8 2021.9.2 0 0 0 21.26 No
Qin le
Hou Supervisor Fema 32 2018.5.2 2021.9.2 0 0 0 17.66 No
Luting le
Jin Deputy Male 59 2018.4.16 2021.9.2 97,481 73,181 -24,300 Decrease 62.31 No
Yanhua General in
Manager sharehol
ding due
to
personal
capital
needs
Wang Li Financial Fema 43 2018.9.3 2021.9.2 58,900 44,200 -14,700 Decrease 82.77 No
Leader le in
sharehol
ding due
to
personal
capital
needs
Zhang Deputy Fema 46 2015.7.30 2021.9.2 47,770 35,870 -11,900 Decrease 59.99 No
Yefeng General le in
118 / 323
2020 ANNUAL REPORT
Manager, sharehol
Board ding due
Secretary to
personal
capital
needs
Total / / / / / 127,201,501 121,737,807 -5,463,694 / 734.87 /
Name Main working experience
Hou Hou Juncheng worked in Yiwu Liaoyuan Daily Chemical Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd. and Hangzhou Proya Holding
Juncheng Co., Ltd. Since 2007, Hou Juncheng has been working in the Company and its predecessor. He has served as the Executive Director
of the Company since September 2007, and Chairman of the Company and its predecessor since August 2012. As at the end of the
Reporting Period, Hou Juncheng concurrently served as Executive Director and General Manager of Hangzhou Proya Trade Co., Ltd.,
Executive Director of Zhejiang Meiligu Electronic Commerce Co., Ltd., Executive Director of Huzhou Chuangdai E-commerce Co.,
Ltd., Executive Director of Yueqing Laiya Trading Co., Ltd., Internal Director and Representative Director of Hanna Cosmetics
Co., Ltd., Korea, Executive Director and General Manager of Hapsode (Hangzhou) Cosmetics Co., Ltd., Executive Director and General
Manager of Huzhou Hapsode, Executive Director and General Manager of Danyang Hapsode, Executive Director and General Manager
of Mijing Siyu (Hangzhou) Cosmetics Co., Ltd., Chairman and General Manager of Hangzhou Kunyi Industrial Co., Ltd., Chairman
of Cosmetics Industry (Huzhou) Investment Development Co., Ltd., Executive Director and General Manager of Huzhou Meizhuang
Town Science and Technology Incubation Park Co., Ltd., Chairman of Huzhou Younimi Cosmetics Co., Ltd., and Director of Xinjiang
Huanyu New Silk Road Investment Development Co., Ltd.
Fang Fang Yuyou worked in Shijiazhuang Liaoyuan Cosmetics Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd. and Hangzhou Proya Holding
Yuyou Co., Ltd. Since 2007, Fang Yuyou has been working in the Company and its predecessor. Fang Yuyou has served as the Director
and General Manager of the Company and its predecessor since August 2012. As at the end of the Reporting Period, Fang Yuyou
concurrently served as General Manager of Zhejiang Meiligu Electronic Commerce Co., Ltd., General Manager of Yueqing Laiya Trading
Co., Ltd., Internal Director of Hanna Cosmetics Co., Ltd., Korea, Director of Hangzhou Kunyi Industrial Co., Ltd., Director
of Hangzhou Tairentang Biotechnology Co., Ltd., Executive Director and Manager of Hangzhou Fangxiake Investment Co., Ltd.,
Director of Huzhou Younimi Cosmetics Co., Ltd. and Director of Hong Kong Xinghuo Industry Limited.
Cao Cao Liangguo worked in Leshan Chengbei Electric Appliance Factory, Hainan International United Cosmetics Co., Ltd., Chongqing
119 / 323
2020 ANNUAL REPORT
Liangguo Xielida Cosmetics Co., Ltd., Chongqing Dongyin Technology Industry Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd. and Hangzhou
Proya Holding Co., Ltd. Since 2007, Cao Liangguo has been working in the Company and its predecessor. Cao Liangguo has served
as the Director and Deputy General Manager of the Company and its predecessor since August 2012. As at the end of the Reporting
Period, he concurrently serves as Supervisor of Hanna Cosmetics Co., Ltd., Korea, Director of Hangzhou Kunyi Industrial Co.,
Ltd., Director of Hangzhou Tairentang Biotechnology Co., Ltd., Internal Director and General Manager of Hapsode Co., Ltd., Korea,
Director of Huzhou Younimi Cosmetics Co., Ltd., Director of HONGKONG KESHI TRADING LIMITED, Director of Ningbo Keshi Trading
Limited, Director of Hong Kong Zhongwen Electronic Commerce Co., Limited, Director of Hong Kong Wanyan Electronic Commerce Co.,
Limited, and Director of Japan OR.
Chu Chu Xiuqi once served as Deputy Director of the Department Store Bureau of the Ministry of Commerce of the People's Republic
Xiuqi of China, Deputy General Manager of China National General Merchandise and Textile CO., Ltd., and Executive Vice President and
Secretary General of China Commerce Association for General Merchandise. As at the end of the Reporting Period, Chu Xiuqi
concurrently served as Honorary President of China Commerce Association for General Merchandise, Vice Chairman of China Sporting
Goods Federation, President of Trade Fair Economy Magazine, Vice Chairman of Reed Huabai Exhibitions (Beijing) Co., Ltd.,
Independent Director of Tianjin Yishang Friendly Co., Ltd., Independent Director of Zhejiang Aokang Shoes Co., Ltd. and
Independent Director of Proya Cosmetics Co., Ltd.
Chen Yan Chen Yan once served as Accountant of Huzhou Textile Import and Export Co., Ltd., Project Director of Zhejiang Omex Environmental
Engineering Co., Ltd., Vice Chairman, Chief Financial Officer and Board Secretary and Deputy General Manager of Zhejiang Unifull
Industrial Fibre Co., Ltd, and Investment Director of Huzhou Youchuang Investment Management Partnership (Limited Partnership).
As at the end of the Reporting Period, Chen Yan concurrently served as Executive Partner of Huzhou Haoyu Investment Management
Partnership (Limited Partnership), Executive Partner of Huzhou Haorui Enterprise Management Consulting Partnership (Limited
Partnership), Executive Partner of Huzhou Juzhi Equity Investment Partnership (Limited Partnership), Supervisor of Hangzhou
Quanzhimai Electronic Commerce Co., Ltd., Supervisor of Huzhou Jingrui Human Resources Management Co., Ltd., Supervisor of
Shanghai Beikebo Technology Co., Ltd., Executive Director and General Manager of Huzhou Shengshun Trading Co., Ltd., and
Independent Director of Proya Cosmetics Co., Ltd.
Ye Nana Ye Nana worked in Zhejiang Dahua Technology Co., Ltd. and Hangzhou Gankun Industrial Co., Ltd. From 2010 to the end of the Reporting
Period, Ye Nana served as Senior Administrative Manager in the Company and its predecessor, and has served as Supervisor of
Huzhou Younimi Cosmetics Co., Ltd. since March 2019.
Fang Qin From November 2008 to January 2018, Fang Qin served as Head of the Planning Department of the Company and its predecessor, and
from January 2018 to the end of the Reporting Period, Fang Qin served as Planning Strategy Manager of the Company.
Hou From July 2013 to January 2014, Hou Luting served as Expatriate Financial Specialist in Zhonghui Certified Public Accountants,
Luting and from February 2014 to June 2017, Hou Luting served as Packaging Material Purchasing Specialist in the Purchasing Department
of the Company; from June 2017 to October 2019, Hou Luting served as Raw Material Purchasing Specialist in the Purchasing Department
120 / 323
2020 ANNUAL REPORT
of the Company; since October 2019, Hou Luting has served as Raw Material Evaluation Engineer in the Price Evaluation Department
of the Company.
Jin Jin Yanhua worked in Zhejiang Sanmen Chemical Fertilizer Plant, Zhejiang InBev Yandance Beer Co., Ltd., Zhejiang InBev Jinhua
Yanhua Beer Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd. and Hangzhou Proya Holding Co., Ltd. From 2007 to August 2012, Jin Yanhua
served as General Manager of Huzhou Factory of the Company and its predecessor. Since August 2012, Jin Yanhua has served the
General Manager of Supply Chain Management Center of the Company; since April 2018, Jin Yanhua has served as Deputy General
Manager of the Company. As at the end of the Reporting Period, Jin Yanhua concurrently served as Executive Director of Anya
(Huzhou) Cosmetics Co., Ltd., Executive Director of Huzhou UZERO Trading Co., Ltd., Manager of Huzhou Chuangdai E-commerce Co.,
Ltd., Executive Director and General Manager of Hangzhou Proya Commercial Management Co., Ltd., Executive Director and General
Manager of Huzhou Niuke Technology Co., Ltd., Executive Director and General Manager of Huzhou Tizhi Cosmetics Co., Ltd., Director
of Hong Kong Wanyan Electronic Commerce Co., Limited, Executive Director and General Manager of Hangzhou Wanyan Culture Media
Co., Ltd., Executive Director and General Manager of Zhejiang Biyouti Cosmetics Co., Ltd., Director of Hong Kong Zhongwen
Electronic Commerce Co., Limited, Chairman of Shanghai Zhongwen Electronic Commerce Co., Ltd., Executive Director and General
Manager of Ningbo Proya Enterprise Consulting Management Co., Ltd., Chairman of HONGKONG KESHI TRADING LIMITED, Chairman of
Ningbo Keshi Trading Limited, Chairman of Ningbo TIMAGE Cosmetics Co., Ltd., Director of Ningbo Segu Brand Management Co., Ltd.
and Executive Partner of Weifang Zhengyi. In addition, Jin Yanhua served as Executive Director of Zhejiang Qingya Culture Art
Communication Co., Ltd., Executive Director of Hangzhou Proya Snail Fitness Co., Ltd., Executive Director and General Manager
of Hangzhou Yizhuo Culture Media Co., Ltd., Executive Director and General Manager of Hangzhou Weiluoke Cosmetics Co., Ltd.,
Executive Director and General Manager of Hangzhou Oumisi Trading Co., Ltd., Director of Japan OR, Executive Director and General
Manager of Guangzhou Qianxi Network Technology Co., Ltd., Director of Ningbo Xiyou Mutual Entertainment Cultural Media Co.,
Ltd., Director of Shanghai Healthlong Biochemical Technology Co., Ltd., Executive Director and General Manager of Huzhou Poyun
Electronic Commerce Co., Ltd., Executive Director of Xuzhou Proya Information Technology Co., Ltd., Director of Shanghai Weiman
Cosmetics Co., Ltd., and Executive Director and General Manager of Ningbo Weiman Cosmetics Co., Ltd.
Wang Li Wang Li worked in Nanjing Branch of Guangzhou Yingtai Digital Power Technology Co., Ltd., CELLSTAR of the United States, Nanjing
Branch of Shanghai Ruili Sports Co., Ltd., Nanjing Biancheng Sports Co., Ltd., Vgrass Fashion Co., Ltd., Zhuoshang Clothing
(Hangzhou) Co., Ltd. and Nanjing Rituo Photovoltaic Co., Ltd. Since May 2018, Wang Li has served the Chief Financial Officer
of the Company.
Zhang Zhang Yefeng worked in Zhejiang Modern Industry and Trade Group Co., Ltd., Guangdong Robust Group Co., Ltd., Hangzhou Aupu Electric
Yefeng Appliance Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd. and Hangzhou Proya Holding Co., Ltd. Since 2007, Zhang Yefeng has been
working in the Company and its predecessor; since August 2012, Zhang Yefeng has served as the Board Secretary and Director of
Public Relations Management Department of the Company and its predecessor; since December 2015, Zhang Yefeng has served as the
Deputy General Manager of the Company. As at the end of the Reporting Period, she concurrently serves as Internal Director of
121 / 323
2020 ANNUAL REPORT
Hapsode (Korea).
Particulars on other information
□ Applicable√ Not applicable
（II） Equity incentives granted to directors and senior management during the Reporting Period
□ Applicable√ Not applicable
√ Applicable□ Not applicable
Unit: Share
Number of
Number of Market price
new Number of the
restricted at the end of
restricted Granted price of restricted
shares at Locked the
Name Position shares the restricted Locked shares shares at the
the shares Reporting
during the shares (RMB) end of the
beginning Period
Reporting period
of the year (Yuan)
Period
Jin Deputy General 97,481 0 17.95 28,671 68,810 68,810 12,248,180.0
Yanhua Manager 0
Wang Li Financial Leader 58,900 0 17.95 17,670 41,230 41,230 7,338,940.00
Zhang Deputy General 47,770 0 17.95 13,750 34,020 34,020 6,055,560.00
Yefeng Manager, Board
Secretary
/ 204,151 0 / 60,091 144,060 144,060 25,642,680.0
Total
0
II Employment of directors, supervisors and senior management currently employed and retired during the Reporting Period
（I） Employment in shareholders’ companies
√ Applicable□ Not applicable
Position held in
Name of person employed Name of shareholder’s company From To
shareholder’s company
122 / 323
2020 ANNUAL REPORT
Jin Yanhua Weifang Zhengyi Executive Partner August 2019
Particulars on employment None
in shareholders’
companies
（II） Employment in other companies
√ Applicable□ Not applicable
Name of
Position held in other
person Name of other companies From To
companies
employed
Hou Juncheng Proya Trade Executive Director and June 2011
General Manager
Meiligu Executive Director November 2012
Chuangdai E-commerce Executive Director December 2016
Yueqing Laiya Executive Director September 2015
Korea Hanna Internal Director and November 2011
Representative Director
Hapsode (Hangzhou) Executive Director and February 2018
General Manager
Huzhou Hapsode Executive Director and May 2016
General Manager
Danyang Hapsode Executive Director and December 2016
General Manager
Mijing Siyu (Hangzhou) Executive Director and February 2018
General Manager
Hangzhou Kunyi Industrial Co., Ltd. Chairman and General April 2014
Manager
Huzhou Meizhuang Town Science and Technology Executive Director and January 2019
Incubation Park Co., Ltd. General Manager
Huzhou Younimi Chairman March 2019
123 / 323
2020 ANNUAL REPORT
Cosmetics Industry (Huzhou) Investment Chairman December 2018
Development Co., Ltd.
Xinjiang Huanyu New Silk Road Investment Director March 2021
Development Co., Ltd.
Fang Yuyou Meiligu General Manager November 2012
Yueqing Laiya General Manager September 2015
Korea Hanna Internal Director November 2011
Hangzhou Kunyi Industrial Co., Ltd. Director April 2014
Hangzhou Tairentang Biotechnology Co., Ltd. Director December 2014
Hangzhou Fangxiake Investment Co., Ltd. Executive Director and May 2018
General Manager
Huzhou Younimi Director March 2019
Hong Kong Xinghuo Director March 2019
Cao Liangguo Korea Hanna Supervisor November 2011
Hangzhou Kunyi Industrial Co., Ltd. Director February 2013
Hangzhou Tairentang Biotechnology Co., Ltd. Director December 2014
Korea Hapsode, Internal Director and August 2017
General Manager
Shanghai Zhongwen Director April 2019 January 2021
Huzhou Younimi Director March 2019
HONGKONG KESHI Director March 2019
Ningbo Keshi Director September 2019
Ningbo Segu Brand Management Co., Ltd. Director June 2019 January 2021
Hong Kong Zhongwen Director July 2019
Hong Kong Wanyan Director October 2019
Japan OR Director August 2020
Chu Xiuqi Zhejiang Aokang Shoes Co., Ltd. Independent Director July 2015
Tianjin Yishang Friendly Co., Ltd. Independent Director October 2011
Reed Huabai Exhibitions (Beijing) Co., Ltd. Vice Chairman July 2018
Chen Yan Huzhou Haoyu Investment Management Partnership Executive Partner March 2018
(Limited Partnership)
124 / 323
2020 ANNUAL REPORT
ZhongWang Fabric. Co., Ltd. Independent Director November 2017 June 2020
Hangzhou Quanzhimai Electronic Commerce Co., Supervisor March 2018
Ltd.
Huzhou Jingrui Management Consulting Co., Ltd. Supervisor November 2019
Huzhou Haorui Enterprise Management Consulting Executive Partner August 2019
Partnership (Limited Partnership)
Shanghai Beikebo Technology Co., Ltd. Supervisor April 2019
Huzhou Shengshun Trading Co., Ltd. Executive Director and March 2020
General Manager
Jin Yanhua Anya (Hangzhou) Executive Director December 2016
Huzhou UZERO Executive Director January 2018
Chuangdai E-commerce Manager February 2018
Proya Commercial Executive Director and September 2018
General Manager
Huzhou Niuke Executive Director and December 2018
General Manager
Huzhou Tizhi Executive Director and September 2018
General Manager
Hangzhou Wanyan Executive Director and January 2019
General Manager
Hong Kong Wanyan Director October 2019
Zhejiang Biyouti Executive Director and March 2019
General Manager
Shanghai Zhongwen Chairman April 2019
Hong Kong Zhongwen Director July 2019
Ningbo Segu Brand Management Co., Ltd. Director June 2019
HONGKONG KESHI Chairman March 2019
Ningbo Keshi Chairman September 2019
Ningbo TIMAGE Chairman July 2019
Weifang Zhengyi Executive Partner August 2019
Zhejiang Qingya Executive Director May 2020
125 / 323
2020 ANNUAL REPORT
Snail Fitness Executive Director August 2020
Hangzhou Yizhuo Executive Director and July 2020
General Manager
Hangzhou Weiluoke Executive Director and July 2020
General Manager
Hangzhou Oumisi Executive Director and August 2020
General Manager
Hangzhou Qingyan Cosmetics Co., Ltd. Chairman August 2020 December 2020
Japan OR Director August 2020
Guangzhou Qianxi Executive Director and October 2020
General Manager
Ningbo Xiyou Mutual Entertainment Cultural Director September 2020
Media Co., Ltd.
Shanghai Healthlong Director November 2020
Huzhou Poyun Executive Director and September 2020
General Manager
Xuzhou Proya Information Technology Co., Ltd. Executive Director January 2021
Shanghai Weiman Cosmetics Co., Ltd. Director August 2020
Ningbo Weiman Cosmetics Co., Ltd. Executive Director and February 2021
General Manager
Zhang Yefeng Hapsode (Korea) Internal Director August 2017
Ye Nana Huzhou Younimi Supervisor March 2019
Particulars None
on
employment
in other
companies
III Remuneration of directors, supervisors and senior management
√ Applicable□ Not applicable
126 / 323
2020 ANNUAL REPORT
Decision-making procedures for the The remuneration of directors and supervisors of the Company shall be submitted to the general
remuneration of directors, supervisors shareholders’ meeting for approval after passing the review by the Remuneration and Appraisal
and senior management Committee of the Board of Directors, the Board of Directors and the Board of Supervisors; the
remuneration of senior management shall be subject to the review by the Board of Directors and
the Remuneration and Appraisal Committee of the Board of Directors.
Determination basis for the remuneration The annual remuneration of directors, supervisors and senior management of the Company shall
of directors, supervisors and senior be based on the basic remuneration and performance appraisal.
management
Actual payment of the remuneration of Already paid
directors, supervisors and senior
management
Total remuneration actually received by The total amount of remuneration received by all directors, supervisors and senior management
all directors, supervisors and senior of the Company during the Reporting Period was RMB 7,348,700.
management at the end of the Reporting
Period
IV Changes in directors, supervisors and senior management of the Company
□ Applicable√ Not applicable
V Particulars on punishments by securities regulatory authorities in the past three years
□ Applicable√ Not applicable
127 / 323
2020 ANNUAL REPORT
VI Employees of the parent company and major subsidiaries
（I） Employees
Number of employees in the parent company 948
Number of employees in major subsidiaries 1,950
Number of employees 2,898
Number of retirees of whom the parent company and 6
major subsidiaries are responsible for the expenses
Professional structure
Category Number
Production personnel 239
Sales personnel 2,002
Management personnel 461
R&D personnel 196
Total 2,898
Education background
Category Number (person)
Undergraduate and above 799
Junior college 616
High school and below 1,483
Total 2,898
（II） Remuneration policy
√ Applicable□ Not applicable
Value creation is the basis of the Company's remuneration distribution, and
performance is the intuitive embodiment of value. Based on a comprehensive and objective
performance evaluation system, the remuneration distribution and performance evaluation
of employees are combined to comprehensively guide and motivate employees create greater
value.
（III） Training plan
√ Applicable□ Not applicable
To gather elite talents and develop outstanding talents in the industry, the Company
has always taken the learning and growth of employees as its primary task, to continuously
innovate and optimize training research, training topics, training forms, training
implementation, training evaluation and improvement, teacher management, etc. The
Company has provided offline teaching and online platform learning as well as sharing
to enhance participation of employees, thus enabling employees to learn more pertinently
and autonomously.
（IV） Labor outsourcing
√ Applicable□ Not applicable Unit:Yuan Currency:RMB
Total working hours of labor outsourcing
Total remuneration paid for labor 26,126,382.48
outsourcing
Huzhou Branch of Proya Cosmetics Co., Ltd. signed the Service Project Contract
Agreement with Jiangxi Zhilian Outsourcing Service Co., Ltd. in January 2017. Huzhou
128 / 323
2020 ANNUAL REPORT
Branch outsourced auxiliary services such as canteen, greening, cleaning, goods handling,
loading and unloading and packaging to Jiangxi Zhilian Outsourcing Service Co., Ltd. and
paid remuneration according to the agreed business volume. As the Company adjusted its
sales strategy, the number of urgent orders increased. In October 2019, in order to ensure
timely shipment and other purposes, Huzhou Branch signed the Service Project Contract
Agreement with Yancheng Dafeng Xinxinyuan Enterprise Management Co., Ltd. Huzhou Branch
outsourced some work such as goods handling, loading and unloading, packaging and facial
mask folding to Yancheng Dafeng Xinxinyuan Enterprise Management Co., Ltd. and paid
remuneration according to the agreed business volume.
VII Others
□ Applicable√ Not applicable
Section IX Corporate Governance
I Particulars on corporate governance
√ Applicable□ Not applicable
During the Reporting Period, the Company continuously improved its standard operation
level and corporate governance structure based on the actual situation in accordance with
the provisions of the Company Law, Securities Law, Share Listing Rules of Shanghai Stock
Exchange, Code of Corporate Governance for Listed Companies and other applicable laws
and regulations as well as the Articles of Association. The Company has set up the general
shareholders’ meeting, Board of Directors, Board of Supervisors and special committees
under the Board of Directors as required, and developed the corresponding rules of
procedure. It defines the duties and authorities, procedures and obligations of the
institutions at all levels in terms of decision-making, supervision and implementation,
so as to form a scientific and effective governance structure featuring clear rights and
responsibilities, mutual checks and balances and mutual coordination. During the
Reporting Period, the Company consciously fulfilled the obligation of information
disclosure and managed investor relationship to continuously improve the standard
operation level. The corporate governance of the Company conforms to the normative
documents published by China Securities Regulatory Commission in connection with
governance of the listed company.
Whether there are significant differences between corporate governance and the
requirements of the relevant regulations of the China Securities Regulatory Commission;
if there are significant differences, the reasons should be explained
□ Applicable√ Not applicable
II Brief introduction to general shareholders’ meetings
Query index of the
Disclosure date
designated website on
Session number Convening date when the resolution
which the resolution
is published
is published
First extraordinary 20 March 2020 No. 2020-010 21 March 2020
general Announcement on the
shareholders’ website of Shanghai
meeting in 2020 Stock Exchange
(www.sse.com.cn)
2019 annual general 22 April 2020 No. 2020-024 23 April 2020
129 / 323
2020 ANNUAL REPORT
meeting Announcement on the
website of Shanghai
Stock Exchange
(www.sse.com.cn)
Second extraordinary 6 July 2020 No. 2020-035 7 July 2020
general Announcement on the
shareholders’ website of Shanghai
meeting in 2020 Stock Exchange
(www.sse.com.cn)
Third extraordinary 28 October 2020 No. 2020-055 29 October 2020
general Announcement on the
shareholders’ website of Shanghai
meeting in 2020 Stock Exchange
(www.sse.com.cn)
Particulars on general shareholders’ meetings
□ Applicable√ Not applicable
III Performance of functions and duties by directors
（I） Attendance of directors at board meetings and general shareholders’ meetings
Attendance
at general
Attendance at board meetings shareholde
rs’
Name Indepen
meetings
of dent
Number Two Number of
direc directo Number Number of Number
of Numbe consecu attendance
tor r of attendanc of
attenda r of tive at general
attenda e by attenda
nce absen absence shareholde
nce in communica nce by
require ce s in rs’
person tion proxy
d person meetings
Hou No 7 7 0 0 0 No 4
Junch
eng
Fang No 7 7 1 0 0 No 4
Yuyou
Cao No 7 7 0 0 0 No 4
Liang
guo
Chu Yes 7 7 7 0 0 No 4
Xiuqi
Chen Yes 7 7 7 0 0 No 4
Yan
Particulars on two consecutive absences in person from board meetings
□ Applicable√ Not applicable
Number of board meetings held during the 7
year
130 / 323
2020 ANNUAL REPORT
Where: Number of on-site meeting 0
by communication 0
on site and by communication 7
（II） Independent directors' objections to the Company's related matters
□ Applicable√ Not applicable
（III） Others
□ Applicable√ Not applicable
IV If there is any objection to important opinions and suggestions put forward by the
special committees under the Board of Directors in performing its functions and
duties during the Reporting Period, the specific situation should be disclosed
□ Applicable√ Not applicable
V Particulars on risks in the Company identified by the Board of Supervisors
□ Applicable√ Not applicable
VI Particulars on the situations that the Company and its controlling shareholders
cannot guarantee independence and cannot maintain self-operation ability in the
aspects of business, personnel, assets, organization and finance
□ Applicable√ Not applicable
The corresponding solutions, work progress and follow-up work plan of the Company in case
of horizontal competition
□ Applicable√ Not applicable
VII Establishment and implementation of appraisal mechanism and the incentive
mechanism for senior management during the Reporting Period
√ Applicable□ Not applicable
During the Reporting Period, the appraisal of General Manager and other senior
management of the Company was conducted based on the performance indicator requirements,
and the annual performance remuneration was submitted, by Remuneration and Appraisal
Committee of the Board of Directors, to the Board of Directors for review.
VIII Whether to disclose the self-appraisal report on internal control
√ Applicable□ Not applicable
See 2020 Appraisal Report on Internal Control disclosed by the Company on the website
of Shanghai Stock Exchange (www.sse.com.cn) on the same day for details
Particulars on major defects in the internal control during the Reporting Period
□ Applicable√ Not applicable
IX Particulars on the audit report on internal control
√ Applicable□ Not applicable
During the Reporting Period, Pan-China Certified Public Accountants LLP, the internal
control audit organization of the Company, issued the Audit Report on Internal Control
(TJS [2021] No.[3599]), and believed that the Company maintained effective internal
131 / 323
2020 ANNUAL REPORT
control related to financial reports in all major aspects in accordance with the General
Guidelines on Enterprise Internal Control System and relevant provisions on 31 December
2020.
Whether to disclose the Audit Report on Internal Control: Yes
Opinion types of the Audit Report on Internal Control: Standard and unqualified opinions
X Others
□ Applicable√ Not applicable
Section X Corporate Bonds
□ Applicable√ Not applicable
132 / 323
2020 ANNUAL REPORT
Section XI Financial Report
I Auditor’s Report
√ Applicable□ Not applicable
Auditor’s Report
TJS [2021] No. 3598
To the shareholders of Proya Cosmetics Co., Ltd.:
I. Audits’ opinion
We have audited the accompanying financial statements of Proya Cosmetics Co., Ltd.
(hereinafter referred to as “Proya”), which comprise the consolidated and parent
company’s balance sheets as at 31 December 2020, the consolidated and parent company’s
income statements, the consolidated and parent company’s cash flow statements, and the
consolidated and parent company’s statements of changes in owners’ equity for the year
of 2020, as well as notes to financial statements.
In our opinion, the attached financial statements are prepared in accordance with
the provisions of the Accounting Standards for Business Enterprises in all major aspects,
and fairly reflect Proya's consolidated and parent company's financial position as at
31 December 2020, as well as the consolidated and parent company's operating results and
cash flows in 2020.
II. Basis of auditors’ opinion
We have conducted our audit in accordance with the Chinese Auditing Standards for
Certified Public Accountants. The “Responsibilities of Certified Public Accountants for
Auditing of Financial Statements” in the auditor’s report further illustrate our
responsibilities under those standards. In accordance with the Code of Professional
Ethics of Chinese Certified Public Accountants, we are independent of Proya and have
performed other responsibilities in respect of professional ethics. We believe that the
audit evidence we have obtained is sufficient and appropriate to provide a basis for our
opinion.
III. Key audit matters
Key audit matters are those matters that, in our professional judgment, were of most
significance in our audit of the financial statements for the current period. These
133 / 323
2020 ANNUAL REPORT
matters were addressed in the context of our audit of the financial statements as a whole
and, in forming our opinion thereon, we do not provide a separate opinion on these matters.
(I) Revenue recognition
1. Item description
Refer to V.38, VII.61 and XVI.6 in “Section XI Financial Report” herein for relevant
information disclosure.
The operating revenue of Proya mainly came from the sale of cosmetics. According to
the financial statements, the operating revenue of Proya was RMB 3,752,386,800 in 2020.
Pursuant to the sales contract between Proya and its customer, under the distribution
mode, Proya recognizes the sales revenue after the its product delivery to the purchaser
and acceptance by the purchaser; under the proxy mode, Proya delivers the products to
the trustee and recognizes the sales revenue when the trustee achieves sales and issues
the proxy list; under the direct sales mode, Proya delivers the products to the consumer
and recognizes the sales revenue after the consumer confirms the receipt and makes the
payment.
Operating revenue is one of the key performance indicators of Proya, so there is an
inherent risk that the management of Proya (hereinafter referred to as the “management”)
achieves specific goals or expectations through inappropriate revenue recognition.
Therefore, we identify the revenue recognition as a key audit matter.
2. Audit response
Our main audit procedures for revenue recognition include the followings:
(1) Understand the key internal controls related to the revenue recognition, evaluate
the design of these controls, determine the feasibility, and test the effectiveness of
the relevant internal controls;
(2) Send letter to the main customers to confirm the sales volume in 2020 and the
balance of accounts receivable at the end of 2020;
(3) Perform the test of details, carry out spot check over the supporting documents
for revenue recognition (including sales contract, delivery document, receipt, proxy list,
sales invoice, etc.), in order to understand major contract terms or conditions, evaluate
whether the revenue recognition method is appropriate, and check the recovery of accounts
receivable;
(4) Implement analysis procedures, including monthly income fluctuation analysis in
2020 and sales revenue change analysis of main customers;
134 / 323
2020 ANNUAL REPORT
(5) Obtain the rebate and subsidy policy, rebate and subsidy calculation sheet and
other information to check whether the withholding amount of rebate and subsidy at the
end of 2020 was sufficient; and meanwhile, analyze whether the amount of rebate and subsidy
and the withholding amount were reasonable based on the rebate and subsidy policy as well
as the income in 2020; check the settlement after rebate and subsidy withholding period
at the end of 2020;
(6) Obtain the return and exchange policy, estimated balance sheet and other
information, and check whether the estimated future return and exchange rate was
reasonable; check the return and exchange situation after the period, and compare with
the estimated return and exchange data;
(7) Understand the inventory and stock age of the dealer at the end of 2020, and check
whether the inventory amount and structure of the deal were reasonable;
(8) Analyze the sales data of main online direct stores, calculate the consumption
per capita, consumption per time, purchase times and repurchase information of customers
of direct online stores to compare with the selling price and normal consumption of Proya
products, judge the rationality of the above data in combination with normal consumption
habits, and analyze the authenticity and rationality of the income of direct online
stores;
(9) Compare the background transaction data, Alipay receipts data and sales revenue
data on financial accounts of direct online stores, analyze the matching attribute of
data, and check the authenticity of sales from the direct online stores.
(II) Inventory falling price reserve
1. Item description
Refer to V.15 and VII.9 in “Section XI Financial Report” herein for relevant
information disclosure.
As at 31 December 2020, the book balance of inventory of Proya amounted to RMB
494,268,000, inventory falling price reserve amounted to RMB 25,627,000, and the carrying
value of inventory amounted to RMB 468,641,000. Proya measures inventories on the basis
of the lower one between the cost and net realizable value, and the inventory falling
price reserve is withdrawn in accordance with the difference between the single inventory
cost and the net realizable value. The management needs to estimate the net realizable
value of inventories and make provision for inventory falling price reserve. Therefore,
we identify this item as a key audit matter.
2. Audit response
135 / 323
2020 ANNUAL REPORT
Our main audit procedures for inventory falling price reserve include the followings:
(1) Understand the key internal controls related to the provision for inventory
falling price reserve, evaluate the design of these controls, determine the feasibility,
and test the effectiveness of the relevant internal controls;
(2) Obtain the provision policy for inventory falling price reserve and calculation
process prepared by Proya, and recheck the calculation process;
(3) Obtain the inventory stock age sheet, and check whether provision for inventory
falling price reserve was sufficient in combination with the inventory stock age, shelf
life and post-period inventory sales;
(4) Obtain a list of products that are no longer for sale, make statistics about the
inventory of offline products and the corresponding raw materials, and pay attention to
whether this part of the inventory made provision for inventory falling price reserve;
(5) Monitor the inventory, check the quantity and condition of the inventory, and
pay attention to whether the inventory with signs of impairment made provision for falling
price reserve.
IV. Other information
The management is responsible for the other information, which comprises all the
information covered in the Annual Report other than the financial statements and this
auditor’s report.
Our audit opinion on the financial statements does not cover the other information
and we do not express any form of assurance conclusion thereon.
In conjunction with our audit to the financial statements, our responsibility is to
read the other information. During the process, we considered whether there is material
inconsistency or there is likely material misstatement between the other information and
the financial statements or the information we obtained during the audit.
As we have performed the work on the other information obtained before the date of
our auditor’s report, we shall report if we confirmed there was a material misstatement
among the other information. We have nothing needed to be reported on this case.
V. Responsibilities of the management and governing bodies for the financial statements
The management shall be responsible for the preparation of financial statements in
accordance with the Accounting Standards for Business Enterprises to enable them to be
fairly reflected, and to design, implement and maintain the necessary internal controls
136 / 323
2020 ANNUAL REPORT
so that there is no material misstatement due to fraud or error in the financial
statements.
In the preparation of the financial statements, the management is responsible for
assessing Proya’s continuous operating capacity, disclosing matters relating to
continuous operations (if applicable), and applying the continuing operating assumptions
unless the management plans to perform liquidation, cease operation or otherwise has no
realistic choice.
The governing bodies of Proya (hereinafter referred to as “governing bodies”) are
responsible for overseeing the financial reporting process of Proya.
VI. Responsibilities of CPA for the audit of the financial statements
Our objective is to obtain reasonable assurance of the financial statements as a whole
whether there is a material misstatement due to fraud or error and to issue an auditor’s
report containing audit opinion. Reasonable assurance is a high level of assurance, but
is not a guarantee that an audit conducted in accordance with China Standards on Auditing
will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in the aggregate, they
could reasonably be expected to influence the economic decisions of users taken on the
basis of these financial statements.
As part of an audit in accordance with the auditing standards, we exercised
professional judgment and maintained professional skepticism throughout the audit. We
also performed the following works:
(I) to identify and assess the risks of material misstatement of the financial
statements, whether due to fraud or error; design and perform audit procedures responsive
to those risks; and obtain audit evidence that is sufficient and appropriate to provide
a basis for our opinion. The risk of not detecting a material misstatement resulting from
fraud is higher than for one resulting from error, as fraud may involve collusion, forgery,
intentional omissions, misrepresentations, or the override of internal control.
(II) to understand the internal control related to the audit to design the appropriate
audit procedures.
(III) to evaluate the appropriateness of accounting policies used and the
reasonableness of accounting estimates and related disclosures made by the management.
(IV) to draw a conclusion on the appropriateness of the management’s use of the going
concern basis of accounting, and, based on the audit evidence obtained, whether a material
uncertainty exists related to events or conditions that may cast significant doubt on
137 / 323
2020 ANNUAL REPORT
the ability of Proya to continue as a going concern. If we conclude that a material
uncertainty exists, we are required to draw attention in our auditor’s report to the
related disclosures in the financial statements or, if such disclosures are inadequate,
to modify our opinion. Our conclusions are based on the audit evidence obtained up to
the date of our auditor’s report. However, future events or conditions may cause Proya
to cease to continue as a going concern.
(V) to evaluate the overall presentation, structure and content of the financial
statements, and to assess whether the financial statements reflect the related
transactions and events fairly.
(VI) to obtain sufficient and appropriate audit evidence of the financial information
of the entity or business activity of the Proya in order to express an opinion on the
financial statements. We are responsible for directing, supervising and performing group
audits. We take full responsibility for the audit opinion.
We communicated with the governing bodies regarding, among other matters, the planned
scope and timing of the audit and significant audit findings, including any significant
deficiencies in internal control that we identify during the audit.
We also provided a statement to management on compliance with ethical requirements
related to independence, and communicated with governing bodies about all relationships
and other matters that may be reasonably considered to affect our independence, as well
as related precautions (if applicable).
From the matters we had discussed with the governing bodies, we confirmed which
matters were most important to the audit of the financial statements for the current period
and thus constituted the key audit matters. We set out these matters in the auditor’s
report. Unless the disclosure of these matters are forbidden by the laws and regulations,
or, in rare cases, if it is reasonably expected that the negative impacts caused by
discussing certain matters in the auditor’s report would be larger than the benefits
for public interest, we shall not disclose the matters in the auditor’s report under
such circumstances.
Pan-China Certified Public Accountants LLP Certified Public Accountant:
(Project Partner)
Hangzhou, China Certified Public Accountant:
21 April 2021
138 / 323
2020 ANNUAL REPORT
II Financial Statements
Consolidated Balance Sheet
31 December 2020
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB
Item Notes 31 December 2020 31 December 2019
Current assets:
Cash and equivalents VII. 1 1,416,654,640.93 1,246,901,218.99
Transaction settlement
funds
Lending funds
Held-for-trading VII. 2 71,450,000.00
financial assets
Derivative financial
assets
Bills receivable
Accounts receivable VII. 5 284,878,419.58 198,409,249.19
Receivables financing VII. 6 5,531,997.32 2,150,000.00
Prepayment VII. 7 82,742,815.92 53,313,963.76
Premium receivable
Reinsurance premium
receivable
Reserves for reinsurance
contract receivable
Other receivables VII. 8 48,733,527.35 15,269,949.97
Where: Interest
receivable
Dividend
receivable
Financial assets
purchased under agreements
to resell
Inventories VII. 9 468,641,017.75 313,649,003.07
Contract assets
Held for sale assets
Non-current assets due
within one year
Other current assets VII. 13 35,235,811.27 11,723,268.59
Total current assets 2,342,418,230.12 1,912,866,653.57
Non-current assets:
Loans and advances to
customers
Debt investment
Other debt investment
Long-term receivables
Long-term equity VII. 17 58,220,059.60 14,728,003.68
investments
139 / 323
2020 ANNUAL REPORT
Investments in other VII. 18 20,580,000.00
equity instruments
Other non-current
financial assets
Investment real estate VII. 20 72,237,610.10 71,622,083.18
Fixed assets VII. 21 565,864,152.62 550,329,145.07
Construction in progress VII. 22 47,324,523.36 31,894,658.49
Productive biological
assets
Oil and gas assets
Right-of-use assets
Intangible assets VII. 26 314,643,323.97 328,564,563.33
Development expenses
Goodwill VII. 28 31,034,161.20
Long-term prepaid VII. 29 50,576,793.53 26,378,564.50
expenses
Deferred income tax VII. 30 46,660,550.76 27,975,258.51
assets
Other non-current assets VII. 31 87,322,780.03 15,006,146.49
Total non-current 1,294,463,955.17 1,066,498,423.25
assets
Total assets 3,636,882,185.29 2,979,365,076.82
Current liabilities:
Short-term borrowings VII. 32 299,280,435.09 129,047,396.51
Borrowings from central
bank
Placements from banks and
other financial
institutions
Held-for-trading
financial liabilities
Derivative financial
liabilities
Bills payable VII. 35 64,580,000.00 41,830,948.53
Accounts payable VII. 36 515,832,031.27 347,316,843.39
Accounts received in VII. 37 40,913,490.55
advance
Contract liabilities VII. 38 30,618,778.99
Financial assets sold
under repurchase
agreements
Deposits from customers
and other banks
Brokerage for trading
securities
Brokerage for
underwriting securities
Employee benefits VII. 39 70,828,239.70 66,684,151.98
payable
140 / 323
2020 ANNUAL REPORT
Taxes payable VII. 40 71,335,290.77 71,833,700.61
Other payables VII. 41 75,546,323.32 91,444,673.31
Where: Interest payable
Dividend payable
Fees and commissions
payable
Reinsured accounts
payable
Held-for-sale
liabilities
Non-current liabilities VII. 43 85,258,247.69
due within one year
Other current VII. 44 1,439,262.02
liabilities
Total current 1,129,460,361.16 874,329,452.57
liabilities
Non-current liabilities:
Reserves for insurance
contracts
Long-term borrowings
Bonds payable
Where: Preference shares
Perpetual bonds
Lease liabilities
Long-term payables
Long-term employee
benefits payable
Estimated liabilities VII. 50 10,190,099.22 10,102,532.74
Deferred income VII. 51 8,495,353.33 19,743,036.56
Deferred income tax VII. 30 6,874,105.45 5,132,011.38
liabilities
Other non-current
liabilities
Total non-current 25,559,558.00 34,977,580.68
liabilities
Total liabilities 1,155,019,919.16 909,307,033.25
Owner’s equity (or
shareholders’ equity):
Share capital VII. 53 201,116,925.00 201,269,560.00
Other equity instruments
Where: Preference shares
Perpetual bonds
Capital reserve VII. 55 837,034,836.69 835,353,615.48
Less: Treasury shares VII. 56 12,653,905.25 15,769,051.20
Other comprehensive VII. 57 -269,066.13 -212,628.22
income
Special reserve
Surplus reserve VII. 59 100,634,780.00 100,634,780.00
141 / 323
2020 ANNUAL REPORT
General risk provision
Undistributed profit VII. 60 1,265,671,865.63 908,411,607.62
Total equity 2,391,535,435.94 2,029,687,883.68
attributable to the owners
of the parent company
Minority equity 90,326,830.19 40,370,159.89
Total owners’ equity 2,481,862,266.13 2,070,058,043.57
(or shareholders’ equity)
Total liabilities 3,636,882,185.29 2,979,365,076.82
and owner's equity (or
shareholders’ equity)
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
Balance Sheet of Parent Company
31 December 2020
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB
Item Notes 31 December 2020 31 December 2019
Current assets:
Cash and equivalents 498,358,108.55 403,072,398.35
Held-for-trading 70,000,000.00
financial assets
Derivative financial
assets
Bills receivable
Accounts receivable XVII. 1 565,037,411.15 614,081,454.90
Receivables financing
Prepayment 9,389,481.27 13,257,712.52
Other receivables XVII. 2 236,585,409.48 31,800,093.90
Where: Interest
receivable
Dividend
receivable
Inventories 227,126,018.70 157,614,679.78
Contract assets
Held for sale assets
Non-current assets due
within one year
Other current assets 15,543,206.01
Total current assets 1,552,039,635.16 1,289,826,339.45
Non-current assets:
Debt investment
Other debt investment
Long-term receivables
Long-term equity XVII. 3 347,372,956.06 159,882,467.38
142 / 323
2020 ANNUAL REPORT
investments
Investments in other 20,580,000.00
equity instruments
Other non-current
financial assets
Investment real estate 339,018,465.70 336,462,349.68
Fixed assets 291,193,420.67 283,156,520.47
Construction in progress 46,993,562.96 31,877,256.59
Productive biological
assets
Oil and gas assets
Right-of-use assets
Intangible assets 308,401,627.24 318,477,880.56
Development expenses
Goodwill
Long-term prepaid 34,817,495.54 1,177,831.47
expenses
Deferred income tax 15,889,636.90 18,414,499.56
assets
Other non-current assets 87,545,799.42 15,006,146.49
Total non-current 1,491,812,964.49 1,164,454,952.20
assets
Total assets 3,043,852,599.65 2,454,281,291.65
Current liabilities:
Short-term borrowings 200,163,972.59
Held-for-trading
financial liabilities
Derivative financial
liabilities
Bills payable 64,580,000.00 41,830,948.53
Accounts payable 403,605,887.84 300,820,130.33
Accounts received in 13,628,235.50
advance
Contract liabilities 10,212,194.96
Employee benefits 29,624,549.78 23,436,531.67
payable
Taxes payable 34,953,057.88 49,102,562.13
Other payables 24,771,086.23 27,706,157.37
Where: Interest payable
Dividend payable
Held-for-sale
liabilities
Non-current liabilities 85,258,247.69
due within one year
Other current
liabilities
Total current 767,910,749.28 541,782,813.22
liabilities
143 / 323
2020 ANNUAL REPORT
Non-current liabilities:
Long-term borrowings
Bonds payable
Where: Preference shares
Perpetual bonds
Lease liabilities
Long-term payables
Long-term employee
benefits payable
Estimated liabilities
Deferred income 8,495,353.33 8,491,110.00
Deferred income tax 6,283,428.68 4,986,605.71
liabilities
Other non-current
liabilities
Total non-current 14,778,782.01 13,477,715.71
liabilities
Total liabilities 782,689,531.29 555,260,528.93
Owner’s equity (or
shareholders’ equity):
Share capital 201,116,925.00 201,269,560.00
Other equity instruments
Where: Preference shares
Perpetual bonds
Capital reserve 837,075,425.32 834,592,133.74
Less: Treasury shares 12,653,905.25 15,769,051.20
Other comprehensive
income
Special reserve
Surplus reserve 100,634,780.00 100,634,780.00
Undistributed profit 1,134,989,843.29 778,293,340.18
Total owners’ equity 2,261,163,068.36 1,899,020,762.72
(or shareholders’ equity)
Total liabilities 3,043,852,599.65 2,454,281,291.65
and owner's equity (or
shareholders’ equity)
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
Consolidated Income Statement
January - December 2020
Unit: Yuan Currency: RMB
Item Notes 2020 2019
I. Total operating income 3,752,386,849.02 3,123,520,211.77
Where: Revenue VII. 61 3,752,386,849.02 3,123,520,211.77
Interest income
144 / 323
2020 ANNUAL REPORT
Premium received
Handling fee and
commission income
II. Total operating costs 3,160,438,371.03 2,636,811,936.85
Where: Cost of sales VII. 61 1,367,561,949.78 1,125,573,226.23
Interest expenses
Handling fee and
commission expenses
Payment on surrenders
Net compensation expenses
Net provision drawn for
insurance contract
Policy dividend expenses
Reinsurance expenses
Taxes and surcharges VII. 62 32,945,185.99 27,839,165.28
Selling expenses VII. 63 1,497,058,943.34 1,223,031,824.07
Administrative expenses VII. 64 204,279,378.68 195,259,927.02
R&D expenses VII. 65 72,200,028.77 74,602,606.55
Financial expenses VII. 66 -13,607,115.53 -9,494,812.30
Where: Interest expense 9,190,674.26 8,565,736.81
Interest income 20,740,463.77 18,108,947.26
Add: Other income VII. 67 13,491,509.72 8,415,457.68
Income from investment VII. 68 1,769,391.50 2,123,024.87
(“-” refers to loss)
Where: Investment income -646,615.60 -2,530,337.96
from associates and joint
ventures
Derecognition of
income from financial assets at
amortized cost
Exchange gains (“-”
refers to loss)
Net gain on exposure
hedging (“-” refers to loss)
Gain on change in fair
value (“-” refers to loss)
Losses on credit VII. 71 -23,908,722.39 -8,542,539.16
impairment (“-” refers to loss)
Losses on assets VII. 72 -28,234,605.50 -27,139,408.88
impairment (“-” refers to loss)
Gains from asset disposal VII. 73 854.57 43,245.67
(“-” refers to loss)
III. Operating profits (“-” 555,066,905.89 461,608,055.10
refers to loss)
Add: Non-operating profits VII. 74 1,542,594.25 778,978.15
Less: Non-operating expenses VII. 75 9,037,929.71 6,144,076.84
IV. Total profits (“-” refers 547,571,570.43 456,242,956.41
to total loss)
Less: Income tax expenses VII. 76 95,962,016.20 89,874,756.94
145 / 323
2020 ANNUAL REPORT
V. Net profits (“-” refers to 451,609,554.23 366,368,199.47
net loss)
(I) Classified by operation continuity
1. Net profits from 451,609,554.23 366,368,199.47
continuing activities (“-”
refers to net loss)
2. Net profits from
discontinuing activities (“-”
refers to net loss)
(II) Classified by ownership
1. Net profits attributable 476,009,298.41 392,681,976.58
to shareholders of the parent
company (“-” refers to net
loss)
2. Profit or loss -24,399,744.18 -26,313,777.11
attributable to minority
shareholders (“-” refers to net
loss)
VI. Net amount of other VII. 77 -56,437.91 117,952.25
comprehensive income after tax
(I) Net amount of other -56,437.91 117,952.25
comprehensive income after tax
attributable to owners of the
parent company
1. Other comprehensive
income not to be reclassified
into profit or loss
(1) Change in re-measurement of
defined benefit plans
(2) Other comprehensive income
that may not be reclassified to
profit or loss under equity
method
(3) Change in fair value of
investments in other equity
instruments
(4) Change in fair value of
enterprise's own credit risk
2. Other comprehensive -56,437.91 117,952.25
income to be reclassified into
profit or loss
(1) Other comprehensive income
that may be reclassified to
profit or loss under equity
method
(2) Change in fair value of
other debt investments
(3) Amount included in other
comprehensive income on
reclassification of financial
146 / 323
2020 ANNUAL REPORT
assets
(4) Credit impairment
provisions of other debt
investments
(5) Cash flow hedging reserve
(6) Exchange differences from -56,437.91 117,952.25
translation of financial
statements
(7) Others
(II) Net amount of other
comprehensive income after tax
attributable to minority
shareholders
VII. Total comprehensive income 451,553,116.32 366,486,151.72
(I) Total comprehensive income 475,952,860.50 392,799,928.83
attributable to owners of the
parent company
(II) Total comprehensive -24,399,744.18 -26,313,777.11
income attributable to minority
shareholders
VIII. Earnings per share:
(I) Basic earnings per share 2.37 1.96
(Yuan/share)
(II) Diluted earnings per share 2.37 1.96
(Yuan/share)
In case of business merger under common control, net profit realized by the acquiree before
the merger in the current period was: RMB 0; net profit realized by the acquiree in the
prior period was: RMB 0.
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
Income Statement of Parent Company
January - December 2020
Unit: Yuan Currency: RMB
Item Notes 2020 2019
I. Revenue XVII. 4 1,950,969,218.93 1,770,795,873.74
Less: Cost of sales XVII. 4 918,617,344.96 870,410,762.03
Taxes and surcharges 17,071,963.70 17,659,284.56
Selling expenses 208,262,239.67 190,509,676.67
Administrative expenses 144,076,974.98 145,490,559.40
R&D expenses 77,218,796.44 79,845,015.25
Financial expenses -7,606,803.28 -3,225,179.42
Where: Interest expense 5,563,830.24 7,093,653.17
Interest income 19,588,179.32 10,371,466.14
Add: Other income 9,703,059.04 7,156,047.42
Income from investment XVII. 5 1,039,199.20 1,784,206.96
(“-” refers to loss)
147 / 323
2020 ANNUAL REPORT
Where: Investment income -1,112,228.47 -2,869,155.87
from associates and joint
ventures
Derecognition of
income from financial assets at
amortized cost
Net gain on exposure
hedging (“-” refers to loss)
Gain on change in fair
value (“-” refers to loss)
Losses on credit -30,085,608.30 -56,884,503.83
impairment (“-” refers to loss)
Losses on assets -11,111,698.11 -12,656,887.41
impairment (“-” refers to loss)
Gains from asset disposal -3,727.50 43,245.67
(“-” refers to loss)
II. Operating profits (“-” 562,869,926.79 409,547,864.06
refers to loss)
Add: Non-operating profits 783,184.91 29,722.00
Less: Non-operating expenses 8,378,795.22 4,974,545.09
III. Total profits (“-” refers 555,274,316.48 404,603,040.97
to total loss)
Less: Income tax expenses 79,828,772.97 61,812,795.82
IV. Net profits (“-” refers to 475,445,543.51 342,790,245.15
net loss)
(I) Net profits from continuing 475,445,543.51 342,790,245.15
activities (“-” refers to net
loss)
(II) Net profits from
discontinuing activities (“-”
refers to net loss)
V. Net amount of other
comprehensive income after tax
(I) Other comprehensive income
not to be reclassified into
profit or loss
1. Change in re-measurement
of defined benefit plans
2. Other comprehensive
income that may not be
reclassified to profit or loss
under equity method
3. Change in fair value of
investments in other equity
instruments
4. Change in fair value of
enterprise's own credit risk
(II) Other comprehensive
income to be reclassified into
profit or loss
148 / 323
2020 ANNUAL REPORT
1. Other comprehensive
income that may be reclassified
to profit or loss under equity
method
2. Change in fair value of
other debt investments
3. Amount included in other
comprehensive income on
reclassification of financial
assets
4. Credit impairment
provisions of other debt
investments
5. Cash flow hedging reserve
6. Exchange differences from
translation of financial
statements
7. Others
VI. Total comprehensive income 475,445,543.51 342,790,245.15
VII. Earnings per share:
(I) Basic earnings per share
(Yuan/share)
(II) Diluted earnings per
share (Yuan/share)
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
Consolidated Cash Flow Statement
January - December 2020
Unit: Yuan Currency: RMB
Item Notes 2020 2019
I. Cash flow from operating
activities:
Cash received from sales of 3,884,361,008.59 3,156,670,977.79
goods or rendering of
services
Net increase in customer
and interbank deposits
Net increase in borrowings
from central bank
Net increase in placements
from banks and other
financial institutions
Cash received from premiums
under original insurance
contract
Net cash received from
reinsurance business
Net increase in deposits of
149 / 323
2020 ANNUAL REPORT
policy holders and
investments
Cash received from
interest, fees and
commissions
Net increase in borrowings
Net increase in repurchase
business capital
Net cash received from
securities trading agency
services
Tax rebates 1,344,632.09 1,215,639.09
Other cash received from VII. 78(1) 81,739,953.02 27,439,741.01
operating activities
Sub-total of cash inflows 3,967,445,593.70 3,185,326,357.89
from operating activities
Cash paid for goods and 1,455,030,507.05 1,283,742,313.97
services
Net increase in customer
loans and advances
Net increase in deposits
with PBOC and interbank
deposits
Cash paid for compensation
payments under original
insurance contract
Net increase in funds for
lending
Cash paid for interests,
handling charges and
commissions
Cash paid for policy
dividends
Cash paid to and on behalf 376,790,463.82 366,291,357.36
of employees
Taxes and fees paid 381,109,475.93 359,884,531.17
Cash paid for other VII. 78(2) 1,422,965,037.76 939,446,827.05
operating activities
Sub-total of cash 3,635,895,484.56 2,949,365,029.55
outflows from operating
activities
Net cash flow generated 331,550,109.14 235,961,328.34
from operating activities
II. Cash flow from investing
activities:
Cash received from disposal 213,200,000.00 380,000,000.00
of investments
Cash received from returns 2,266,301.37 4,653,362.83
on investments
Net cash received from 37,500.00 72,000.00
150 / 323
2020 ANNUAL REPORT
disposal of fixed assets,
intangible assets and other
long-term assets
Net cash received from
disposal of subsidiaries and
other operating entities
Other cash received VII. 78(3) 66,052,759.40 2,500,000.00
relating to investing
activities
Sub-total of cash inflows 281,556,560.77 387,225,362.83
from investing activities
Cash paid for purchase and 184,057,255.67 163,733,333.52
construction of fixed assets,
intangible assets and other
long-term assets
Cash paid for investment 81,930,000.00 275,588,295.00
Net increase in pledged
loans
Net cash paid for acquiring
subsidiaries and other
operating entities
Other cash paid relating to VII. 78(4) 1,035,148.02 2,500,000.00
investing activities
Sub-total of cash 267,022,403.69 441,821,628.52
outflows from investing
activities
Net cash flow generated 14,534,157.08 -54,596,265.69
from investing activities
III. Cash flow from financing
activities:
Proceeds received from 2,266,300.00 21,085,273.44
financing activities
Where: Cash received by 2,266,300.00 21,085,273.44
subsidiaries from minority
shareholders’ investment
Cash received from 299,000,000.00 128,939,749.33
borrowings
Other cash received from
financing-related activities
Sub-total of cash inflows 301,266,300.00 150,025,022.77
from financing activities
Cash repayments of 214,230,868.48 259,800,000.00
borrowings
Dividends paid, profit 127,734,055.29 97,824,202.19
distributed or interest paid
Where: Dividend and profit
paid by subsidiaries to
minority shareholders
Other cash paid for VII. 78(6) 2,684,110.55 1,657,699.80
financing-related activities
151 / 323
2020 ANNUAL REPORT
Sub-total of cash 344,649,034.32 359,281,901.99
outflows from financing
activities
Net cash flow from -43,382,734.32 -209,256,879.22
financing activities
IV. Effects of exchange rate 56,437.91 117,952.25
fluctuations on cash and cash
equivalents
V. Net increase in cash and 302,757,969.81 -27,773,864.32
cash equivalents
Add: Cash and cash 1,099,092,785.07 1,126,866,649.39
equivalents at the beginning
of the period
VI. Cash and cash equivalents 1,401,850,754.88 1,099,092,785.07
at the end of the period
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
Cash Flow Statement of Parent Company
January - December 2020
Unit: Yuan Currency: RMB
Item Notes 2020 2019
I. Cash flow from operating
activities:
Cash received from sales of 2,223,396,958.25 1,818,365,238.11
goods or rendering of
services
Tax rebates 8,126.42
Other cash received from 20,551,684.95 10,032,566.19
operating activities
Sub-total of cash inflows 2,243,948,643.20 1,828,405,930.72
from operating activities
Cash paid for goods and 922,769,531.45 900,766,094.66
services
Cash paid to and on behalf 142,663,372.92 116,744,546.33
of employees
Taxes and fees paid 226,100,654.30 215,181,333.30
Cash paid for other 332,949,353.49 280,174,037.91
operating activities
Sub-total of cash 1,624,482,912.16 1,512,866,012.20
outflows from operating
activities
Net cash flow generated 619,465,731.04 315,539,918.52
from operating activities
II. Cash flow from investing
activities:
Cash received from disposal 211,750,000.00 230,000,000.00
of investments
152 / 323
2020 ANNUAL REPORT
Cash received from returns 2,266,301.37 4,653,362.83
on investments
Net cash received from 5,000.00 72,000.00
disposal of fixed assets,
intangible assets and other
long-term assets
Net cash received from
disposal of subsidiaries and
other operating entities
Other cash received 1,000,000.00 2,500,000.00
relating to investing
activities
Sub-total of cash inflows 215,021,301.37 237,225,362.83
from investing activities
Cash paid for purchase and 174,825,452.05 139,077,372.86
construction of fixed assets,
intangible assets and other
long-term assets
Cash paid for investment 200,190,000.00 353,787,528.61
Net cash paid for acquiring
subsidiaries and other
operating entities
Other cash paid relating to 219,330,066.00 9,500,000.00
investing activities
Sub-total of cash 594,345,518.05 502,364,901.47
outflows from investing
activities
Net cash flow generated -379,324,216.68 -265,139,538.64
from investing activities
III. Cash flow from financing
activities:
Proceeds received from
financing activities
Cash received from 200,000,000.00
borrowings
Other cash received from
financing-related activities
Sub-total of cash inflows 200,000,000.00
from financing activities
Cash repayments of 85,130,289.87 199,800,000.00
borrowings
Dividends paid, profit 124,276,855.87 96,380,324.63
distributed or interest paid
Other cash paid for 2,584,110.55 1,657,699.80
financing-related activities
Sub-total of cash 211,991,256.29 297,838,024.43
outflows from financing
activities
Net cash flow from -11,991,256.29 -297,838,024.43
financing activities
153 / 323
2020 ANNUAL REPORT
IV. Effects of exchange rate
fluctuations on cash and cash
equivalents
V. Net increase in cash and 228,150,258.07 -247,437,644.55
cash equivalents
Add: Cash and cash 255,868,964.43 503,306,608.98
equivalents at the beginning
of the period
VI. Cash and cash equivalents 484,019,222.50 255,868,964.43
at the end of the period
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public
accountant: Wang Li
154 / 323
2020 ANNUAL REPORT
Consolidated Statements of Changes in Owners’ Equity
January - December 2020
Unit: Yuan Currency: RMB
2020
Equity attributable to owners of the parent company
Other equity
Paid-up Total equity
Item instruments Gener Minority
capital Other Spec attributable
Pref Per Less: al Undistrib equity
(or Capital comprehen ial Surplus to owners
eren pet Treasury risk uted Others Sub-total
share Oth reserve sive rese reserve
ce ual shares provi profit
capital ers income rve
shar bon sion
)
es ds
I. 201,269 835,353 15,769,051 -212,628. 100,634, 908,411,6 2,029,687, 40,370,15 2,070,058,043
Balance ,560.00 ,615.48 .20 22 780.00 07.62 883.68 9.89 .57
at the
end of
last
year
Add:
Changes
in
account
ing
policie
s
Co
rrectio
n for
previou
s
errors
En
terpris
e
155 / 323
2020 ANNUAL REPORT
merger
under
the
same
control
Ot
hers
II. 201,269 835,353 15,769,051 -212,628. 100,634, 908,411,6 2,029,687, 40,370,15 2,070,058,043
Balance ,560.00 ,615.48 .20 22 780.00 07.62 883.68 9.89 .57
at the
beginni
ng of
the
year
III. -152,63 1,681,2 -3,115,145 -56,437.9 357,260,2 361,847,55 49,956,67 411,804,222.5
Increas 5.00 21.21 .95 1 58.01 2.26 0.30 6
e and
decreas
e for
the
period
(“-”
for
decreas
e)
(I) -56,437.9 476,009,2 475,952,86 -24,399,7 451,553,116.3
Total 1 98.41 0.50 44.18 2
compreh
ensive
income
(II) -152,63 1,761,8 -3,115,145 4,724,356. 2,266,300 6,990,656.27
Owner’ 5.00 45.32 .95 27 .00
s
contrib
ution
and
capital
156 / 323
2020 ANNUAL REPORT
reducti
on
1. -152,63 -2,431, -3,115,145 531,035.40 2,266,300 2,797,335.40
Ordinar 5.00 475.55 .95 .00
y
shares
contrib
uted by
the
owners
2.
Capital
contrib
utions
by
other
equity
instrum
ent
holders
3. 4,193,3 4,193,320. 4,193,320.87
Amount 20.87 87
of
share-b
ased
payment
s
credite
d to
owners
’
equity
4.
Others
(III) -118,749, -118,749,0 -118,749,040.
Profit 040.40 40.40 40
distrib
157 / 323
2020 ANNUAL REPORT
ution
1.
Withdra
wal of
surplus
reserve
2.
Withdra
wal of
general
risk
provisi
on
3. -118,749, -118,749,0 -118,749,040.
Distrib 040.40 40.40 40
ution
to
owners
(or
shareho
lders)
4.
Others
(IV)
Interna
l
carry-f
orward
of
owners
’
equity
1.
Transfe
r of
capital
reserve
158 / 323
2020 ANNUAL REPORT
to
capital
(or
share
capital
)
2.
Transfe
r of
surplus
reserve
to
capital
(or
share
capital
)
3.
Surplus
reserve
to
cover
loss
4.
Changes
in
defined
benefit
plan
carried
forward
to
retaine
d
earning
s
5.
159 / 323
2020 ANNUAL REPORT
Carry-f
orward
of
other
compreh
ensive
income
to
retaine
d
earning
s
6.
Others
(V)
Special
reserve
1.
Withdra
wal for
the
current
period
2.
Utiliza
tion
for the
current
period
(VI) -80,624 -80,624.11 72,090,11 72,009,490.37
Others .11 4.48
IV. 201,116 837,034 12,653,905 -269,066. 100,634, 1,265,671 2,391,535, 90,326,83 2,481,862,266
Balance ,925.00 ,836.69 .25 13 780.00 ,865.63 435.94 0.19 .13
at the
end of
the
period
160 / 323
2020 ANNUAL REPORT
2019
Equity attributable to owners of the parent company
Total
Other equity Gener equity
Item Paid-up Other Spec Minority
instruments Less: al Undistrib attributab
capital Capital comprehe ial Surplus Oth equity
Prefer Perpe Treasury risk uted Sub-total le to
(or share Oth reserve nsive rese reserve ers
ence tual shares provi profit owners
capital) ers income rve
shares bonds sion
I. 201,362, 814,814, 24,453,2 -330,580 68,469,0 634,448,2 1,694,310, 4,000,27 1,698,310,
Balance 300.00 724.28 85.00 .47 76.91 28.13 463.85 3.68 737.53
at the
end of
last
year
Add:
Changes
in
accounti
ng
policies
Cor
rection
for
previous
errors
Ent
erprise
merger
under
the same
control
Oth
ers
II. 201,362, 814,814, 24,453,2 -330,580 68,469,0 634,448,2 1,694,310, 4,000,27 1,698,310,
161 / 323
2020 ANNUAL REPORT
Balance 300.00 724.28 85.00 .47 76.91 28.13 463.85 3.68 737.53
at the
beginnin
g of the
year
III. -92,740. 20,538,8 -8,684,2 117,952. 32,165,7 273,963,3 335,377,41 36,369,8 371,747,30
Increase 00 91.20 33.80 25 03.09 79.49 9.83 86.21 6.04
and
decrease
for the
period
(“-”
for
decrease
)
(I) 117,952. 392,681,9 392,799,92 -26,313, 366,486,15
Total 25 76.58 8.83 777.11 1.72
comprehe
nsive
income
(II) -92,740. 15,299,1 -8,684,2 23,890,689 21,085,2 44,975,963
Owner’s 00 96.19 33.80 .99 73.44 .43
contribu
tion and
capital
reductio
n
1. -92,740. -1,564,9 -8,684,2 7,026,534. 21,085,2 28,111,807
Ordinary 00 59.80 33.80 00 73.44 .44
shares
contribu
ted by
the
owners
2.
Capital
contribu
162 / 323
2020 ANNUAL REPORT
tions by
other
equity
instrume
nt
holders
3. 16,864,1 16,864,155 16,864,155
Amount 55.99 .99 .99
of
share-ba
sed
payments
credited
to
owners’
equity
4.
Others
(III) 32,165,7 -118,718, -86,552,89 -86,552,89
Profit 03.09 597.09 4.00 4.00
distribu
tion
1. 32,165,7 -32,165,7
Withdraw 03.09 03.09
al of
surplus
reserve
2.
Withdraw
al of
general
risk
provisio
n
3. -86,552,8 -86,552,89 -86,552,89
Distribu 94.00 4.00 4.00
tion to
163 / 323
2020 ANNUAL REPORT
owners
(or
sharehol
ders)
4.
Others
(IV)
Internal
carry-fo
rward of
owners’
equity
1.
Transfer
of
capital
reserve
to
capital
(or
share
capital)
2.
Transfer
of
surplus
reserve
to
capital
(or
share
capital)
3.
Surplus
reserve
to cover
loss
164 / 323
2020 ANNUAL REPORT
4.
Changes
in
defined
benefit
plan
carried
forward
to
retained
earnings
5.
Carry-fo
rward of
other
comprehe
nsive
income
to
retained
earnings
6.
Others
(V)
Special
reserve
1.
Withdraw
al for
the
current
period
2.
Utilizat
ion for
the
current
165 / 323
2020 ANNUAL REPORT
period
(VI) 5,239,69 5,239,695. 41,598,3 46,838,084
Others 5.01 01 89.88 .89
IV. 201,269, 835,353, 15,769,0 -212,628 100,634, 908,411,6 2,029,687, 40,370,1 2,070,058,
Balance 560.00 615.48 51.20 .22 780.00 07.62 883.68 59.89 043.57
at the
end of
the
period
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public accountant: Wang Li
Statements of Changes in Owners’ Equity of Parent Company
January - December 2020
Unit: Yuan Currency: RMB
2020
Other equity instruments Total
Paid-up Other
Less: Undistri equity
Item capital Capital comprehe Special Surplus
Preferenc Perpetual Treasury buted attributa
(or share Others reserve nsive reserve reserve
e shares bonds shares profit ble to
capital) income
owners
I. Balance at the end of 201,269,5 834,592,1 15,769,05 100,634, 778,293, 1,899,020
last year 60.00 33.74 1.20 780.00 340.18 ,762.72
Add: Changes in accounting
policies
Correction for
previous errors
Others
II. Balance at the 201,269,5 834,592,1 15,769,05 100,634, 778,293, 1,899,020
beginning of the year 60.00 33.74 1.20 780.00 340.18 ,762.72
III. Increase and decrease -152,635. 2,483,291 -3,115,14 356,696, 362,142,3
for the period (“-” for 00 .58 5.95 503.11 05.64
decrease)
(I) Total comprehensive 475,445, 475,445,5
income 543.51 43.51
(II) Owner’s -152,635. -2,431,47 -3,115,14 531,035.4
166 / 323
2020 ANNUAL REPORT
contribution and capital 00 5.55 5.95 0
reduction
1. Ordinary shares -152,635. -2,431,47 -3,115,14 531,035.4
contributed by the owners 00 5.55 5.95 0
2. Capital contributions
by other equity instrument
holders
3. Amount of share-based
payments credited to
owners’ equity
4. Others
(III) Profit distribution -118,749 -118,749,
,040.40 040.40
1. Withdrawal of surplus
reserve
2. Distribution to owners -118,749 -118,749,
(or shareholders) ,040.40 040.40
3. Others
(IV) Internal
carry-forward of owners’
equity
1. Transfer of capital
reserve to capital (or
share capital)
2. Transfer of surplus
reserve to capital (or
share capital)
3. Surplus reserve to
cover loss
4. Changes in defined
benefit plan carried
forward to retained
earnings
5. Carry-forward of other
comprehensive income to
retained earnings
6. Others
167 / 323
2020 ANNUAL REPORT
(V) Special reserve
1. Withdrawal for the
current period
2. Utilization for the
current period
(VI) Others 4,914,767 4,914,767
.13 .13
IV. Balance at the end of 201,116,9 837,075,4 12,653,90 100,634, 1,134,98 2,261,163
the period 25.00 25.32 5.25 780.00 9,843.29 ,068.36
2019
Other equity instruments Total
Paid-up Other
Less: Undistri equity
Item capital Capital comprehe Special Surplus
Preferenc Perpetual Treasury buted attributa
(or share Others reserve nsive reserve reserve
e shares bonds shares profit ble to
capital) income
owners
I. Balance at the end of 201,362,3 814,053,2 24,453,28 68,469,0 554,221, 1,613,653
last year 00.00 42.54 5.00 76.91 692.12 ,026.57
Add: Changes in
accounting policies
Correction for
previous errors
Others
II. Balance at the 201,362,3 814,053,2 24,453,28 68,469,0 554,221, 1,613,653
beginning of the year 00.00 42.54 5.00 76.91 692.12 ,026.57
III. Increase and -92,740.0 20,538,89 -8,684,23 32,165,7 224,071, 285,367,7
decrease for the period 0 1.20 3.80 03.09 648.06 36.15
(“-” for decrease)
(I) Total comprehensive 342,790, 342,790,2
income 245.15 45.15
(II) Owner’s -92,740.0 15,299,19 -8,684,23 23,890,68
contribution and capital 0 6.19 3.80 9.99
reduction
1. Ordinary shares -92,740.0 -1,564,95 -8,684,23 7,026,534
contributed by the owners 0 9.80 3.80 .00
168 / 323
2020 ANNUAL REPORT
2. Capital contributions
by other equity
instrument holders
3. Amount of share-based 16,864,15 16,864,15
payments credited to 5.99 5.99
owners’ equity
4. Others
(III) Profit distribution 32,165,7 -118,718 -86,552,8
03.09 ,597.09 94.00
1. Withdrawal of surplus 32,165,7 -32,165,
reserve 03.09 703.09
2. Distribution to owners -86,552, -86,552,8
(or shareholders) 894.00 94.00
3. Others
(IV) Internal
carry-forward of owners’
equity
1. Transfer of capital
reserve to capital (or
share capital)
2. Transfer of surplus
reserve to capital (or
share capital)
3. Surplus reserve to
cover loss
4. Changes in defined
benefit plan carried
forward to retained
earnings
5. Carry-forward of other
comprehensive income to
retained earnings
6. Others
(V) Special reserve
1. Withdrawal for the
current period
169 / 323
2020 ANNUAL REPORT
2. Utilization for the
current period
(VI) Others 5,239,695 5,239,695
.01 .01
IV. Balance at the end of 201,269,5 834,592,1 15,769,05 100,634, 778,293, 1,899,020
the period 60.00 33.74 1.20 780.00 340.18 ,762.72
Legal Representative: Hou Juncheng CFO of the Company: Wang Li Head of the public accountant: Wang Li
170 / 323
2020 ANNUAL REPORT
III General Information about the Company
1. Company profile
√ Applicable□ Not applicable
Proya Cosmetics Co., Ltd. (hereinafter referred to as “Company” or “the Company”),
formerly known as Proya (Huzhou) Cosmetics Co., Ltd., was registered in Wuxing Branch
of Huzhou Municipal Administration for Industry and Commerce on 24 May 2006. The Company
is headquartered in Hangzhou, Zhejiang Province. At present, the Company holds a business
license with the unified social credit code of 91330100789665033F. The current registered
capital is RMB 201,116,900, and the number of shares totals 201,116,925 (with a par value
of RMB 1 per share). Among them, the number of restricted circulating shares is 747,425
(A-share), and the number of non-restricted circulating shares is 200,369,500 (A-share).
The Company was listed on Shanghai Stock Exchange on 15 November 2017.
The Company is an enterprise of the beauty and personal careindustry, mainly engaged
in the research and development, production and sales of cosmetics products. The main
product is: cosmetics.
th
The financial statements were approved for external disclosure by the 19 meeting
of the second session of the Board of Directors on 21 April 2021.
2. Scope of consolidated financial statements
√ Applicable□ Not applicable
The Company has incorporated 49 subsidiaries, including Hangzhou Proya Trade Co.,
Ltd., Anya (Huzhou) Cosmetics Co., Ltd., Zhejiang Meiligu Electronic Commerce Co., Ltd.,
Huzhou Chuangdai E-commerce Co., Ltd., Yueqing Laiya Trading Co., Ltd. and Hapsode
(Hangzhou) Cosmetics Co., Ltd., into the consolidated financial statements of the
Reporting Period. See “VIII. Change in Consolidation Scope” and “IX. Equity in Other
Entities” in “Section XI Financial Report” of this report for details.
IV Preparation basis of financial statements
1. Preparation basis
The financial statements of the Company are prepared based on going concern.
2. Going concern
√ Applicable□ Not applicable
There are no matters or situations that may cause a major doubt in respect of the
going-concern ability of the Company within 12 months since the end of the Reporting
Period.
171 / 323
2020 ANNUAL REPORT
V Significant accounting policies and accounting estimates
Notes to specific accounting policies and accounting estimates:
√ Applicable□ Not applicable
Refer to “44. Changes in significant accounting policies and accounting estimates” in
“V. Significant accounting policies and accounting estimates” of “Section XI Financial
Report”.
1. Statement of compliance of accounting standards for business enterprises
The financial statements have been prepared by the Company in conformity with the China
Accounting Standards for Business Enterprises, and present truly and completely the
Company’s financial position, operating results, changes in shareholders' equity and
cash flow and other related information.
2. Accounting period
The accounting period of the Company is from 1 January to 31 December of each calendar
year.
3. Operating cycle
√ Applicable□ Not applicable
The operating cycle of the Company’s businesses is short; the Company adopts 12 months
as the liquidity classification criteria for assets and liabilities.
4. Reporting currency
The reporting currency of the Company is RMB.
5. Accounting treatments for enterprise merger under or not under common control
√ Applicable□ Not applicable
1. Accounting treatments for enterprise merger under common control
The assets and liabilities acquired by the Company through enterprise merger are
measured at the carrying value of the acquiree in the consolidated financial statements
of the ultimate controlling party at the date of merger. The Company adjusts the capital
reserve in accordance with the difference between the carrying value of the owner's equity
of the acquiree in the final consolidated financial statements of the ultimate controlling
party and the carrying value of the consideration paid for the merger or the total nominal
value of the issued shares. If the capital reserve is insufficient to offset the difference,
the retained earnings shall be adjusted.
2. Accounting treatments for enterprise merger not under common control
Where the cost of merger is higher than the fair value proportion of the net
identifiable assets acquired from the acquiree in the merger on the acquisition date,
the Company recognizes such difference as goodwill. Where the combination cost is less
than the fair value of the net identifiable assets acquired from the acquiree in the merger,
172 / 323
2020 ANNUAL REPORT
the measurement of the obtained fair values of the acquiree’s identifiable assets,
liabilities or contingent liabilities, as well as the combination cost shall be checked
firstly; if the combination cost is still less than the fair value proportion of the net
identifiable assets acquired from the acquiree in the merger after the recheck, the
difference will be included in the current profit or loss.
6. Preparation of consolidated financial statements
√ Applicable□ Not applicable
The parent company incorporates all its subsidiaries under its control into the
consolidation scope of the consolidated financial statements. The consolidated financial
statements are based on the financial statements of the parent company and its
subsidiaries, and prepared by the parent company in accordance with the Accounting
Standards for Business Enterprises No. 33 - Consolidated Financial Statements.
7. Classification of joint venture arrangement and accounting treatment for joint operation
√ Applicable□ Not applicable
1. Jointly venture arrangement can be divided into joint operation and joint venture.
2. When the Company is a joint venture party of joint operation, the following items
that are related to the quantum of interest in joint operation are recognized:
(1) Assets held alone, and recognize the jointly owned assets according to the holding
shares;
(2) Liabilities undertaken alone, and jointly undertaken liabilities according to
the holding shares;
(3) Income incurred from selling the Company's output share of joint operation;
(4) Income of joint operation incurred from selling assets according to the Company's
share;
(5) Cost incurred alone; and cost incurred from joint operation according to the
Company's share;
8. Determination of cash and cash equivalents
The cash listed in the cash flow statement refers to the cash on hand and deposits
that are available for payment at any time. The cash equivalents refer to the short-term
and highly liquid investments that are readily convertible to known amounts of cash and
subject to an insignificant risk of change in value.
173 / 323
2020 ANNUAL REPORT
9. Foreign currency transactions and translation of foreign-currency statements
√ Applicable□ Not applicable
1. Translation of foreign currency transactions
Foreign currency transactions are translated into RMB at the approximate rate of spot
rate on the transaction date during initial recognition. On the balance sheet date, the
foreign currency monetary items are translated based on the spot rate on the balance sheet
date. The exchange difference arising from the different exchange rate is included in
the current profit or loss, except the exchange difference between the principal and
interest of the foreign currency borrowed for meeting the capitalization requirements;
the foreign currency non-monetary items measured at historical cost are also translated
based on the approximate rate of the spot rate on the transaction date, and the RMB amount
is not changed; the foreign currency non-monetary items measured at fair value are
translated based on the spot rate on the determination date of the fair value, and the
difference is included in the current profit or loss or other comprehensive income.
2. Translation of foreign-currency financial statements
Assets and liabilities items in the balance sheet are translated at the spot rates
prevailing at the balance sheet date. Owners’ equity items other than “undistributed
profit” are translated at the spot rates on the transaction dates. Income and expense
items in the income statement are translated at the approximate rates of the spot rates
on the transaction dates. Any balance incurred from the translation of foreign-currency
financial statements by the above method is included in other comprehensive income.
10. Financial instruments
√ Applicable□ Not applicable
1. Classification of financial assets and financial liabilities
The financial assets are classified into the following three categories during
initial recognition: (1) financial assets measured at amortized cost; (2) financial
assets measured at fair value through other comprehensive income; (3) financial assets
measured at fair value through current profit or loss.
The financial liabilities are classified into the following four categories during
initial recognition: (1) financial liabilities measured at fair value through current
profit or loss; (2) financial liabilities from failure of transfer of financial assets
to meet the derecognition conditions or continued involvement in transferred financial
assets; (3) loan commitments given at a rate lower than market interest rate, not belonging
to the financial guarantee contracts mentioned in (1) or (2) above and not in the case
174 / 323
2020 ANNUAL REPORT
described (1) above; (4) financial liabilities measured at amortized cost.
2. Recognition basis, measurement method and derecognition conditions for financial
assets and financial liabilities
(1) Recognition basis and initial measurement method for financial assets and
financial liabilities
One financial assets or financial liabilities are recognized when the Company becomes
one party of financial instrument contract. The financial assets and financial
liabilities are measured at the fair value during initial recognition. For financial
assets and financial liabilities measured at fair value through current profit or loss,
relevant transaction expenses are directly included into the current profit or loss: for
other kinds of financial assets or financial liabilities, relevant transaction expenses
are included into the amount of initial recognition. However, where the accounts
receivable initially recognized by the company do not include significant financing
components or the subsidiary does not take into account the financing components in the
contract for no more than one year, the initial measurement is made according to the
transaction price defined in the Accounting Standards for Business Enterprises No. 14
– Revenue.
(2) Subsequent measurement method for financial assets
1) Financial assets measured at amortized cost
Such financial assets are subsequently measured at amortized cost by adopting the
effective interest method. The gains and losses incurred by the financial assets measured
at amortized cost but not belonging to any hedging relationship are included in the current
profit or loss during derecognition, reclassification, amortization according to the
effective interest method or impairment recognition.
2) Debt instrument investment at fair value through other comprehensive income
The method of subsequent measurement with the fair value is adopted. The interest,
impairment losses or gains and exchange gains and losses based on effective interest
method are included in the current profit or loss, and other gains or losses are included
in other comprehensive income. When the recognition is terminated, the accumulated gains
or losses previously included in other comprehensive income are transferred from other
comprehensive income and included in the current profit or loss.
3) Equity instrument investment at fair value through other comprehensive income
The method of subsequent measurement with the fair value is adopted. The dividends
obtained (except for the part of investment cost recovery) shall be included in the current
175 / 323
2020 ANNUAL REPORT
profit or loss, and other gains or losses are included in other comprehensive income.
When the recognition is terminated, the accumulated gains or losses previously included
in other comprehensive income is transferred from other comprehensive income and included
in retained earnings.
4) Financial assets measured at fair value through current profit or loss
The method of subsequent measurement with the fair value is adopted. The generated
gains or losses (including interest and dividend income) are included in the current
profit or loss, unless the financial assets belong to part of the hedging relationship.
(3) Subsequent measurement method for financial liabilities
1) Financial liabilities measured at fair value through current profit or loss
Such financial liabilities include the trading financial liabilities (including
derivative instruments belonging to financial liabilities) and those designated as
financial liabilities measured at fair value through current profit or loss. As for such
financial liabilities, the method of subsequent measurement with the fair value is adopted.
The fair value changes of financial liabilities measured at fair value through current
profit or loss arising from the credit risk change of the Company are included into other
comprehensive income, unless the wrong accounting distribution in the profit or loss will
be caused or expanded by this. Other gains or losses (including interest, except the fair
value changes arising from the credit risk change of the Company) shall be included in
the current profit or loss, unless the financial liabilities belong to part of the hedging
relationship. When the recognition is terminated, the accumulated gains or losses
previously included in other comprehensive income is transferred from other comprehensive
income and included in retained earnings.
2) Financial liabilities from failure of transfer of financial assets to meet the
derecognition conditions or continued involvement in transferred financial assets
Measurement shall be performed in accordance with the Accounting Standards for
Business Enterprises No. 23 - Transfer of Financial Assets.
3) Loan commitments given at a rate lower than market interest rate, not belonging
to the financial guarantee contracts mentioned in 1) or 2) above and not in the case
described in 1) above.
The subsequent measurement is made by the higher of the following two amounts after
initial recognition: ① loss provisions determined according to regulations on impairment
of financial instruments; ② balance of the initially recognized amount after deducting
cumulative amortization recognized in accordance with the regulations set out in the
176 / 323
2020 ANNUAL REPORT
Accounting Standards for Business Enterprises No. 14 – Revenue.
4) Financial liabilities measured at amortized cost
The effective interest method is adopted to measure at amortized cost. The gains and
losses incurred by the financial liabilities measured at amortized cost but not belonging
to any hedging relationship are included in the current profit or loss during
derecognition, and amortization according to the effective interest method.
(4) Derecognition of financial assets and financial liabilities
1) Financial assets in conformity to one of the following conditions are derecognized:
① The contract right to collect cash flow for the financial asset has terminated;
② The financial assets have been transferred in accordance with the provisions for
derecognition of financial assets in the Accounting Standards for Business Enterprises
No. 23 - Transfer of Financial Assets.
2) When the present obligations under the financial liabilities (or part thereof)
are released, such financial liabilities (or that part thereof) are derecognized.
3. Recognition basis and measurement method for transfer of financial assets
If the Company has transferred almost all the risks and rewards related to the
ownership of financial assets, the financial assets are derecognized, and the rights and
obligations resulting from or retained in the transfer are separately recognized as the
assets or liabilities; and in case that almost all the risks and rewards related to the
ownership of the financial asset are retained, the recognition of the transferred
financial asset is continued. In case of neither transfer nor retaining of almost all
the risks and rewards related to the ownership of the financial asset, it will dealt with
according to the following situations respectively: (1) if the control over the financial
assets is not retained, the financial asset shall be derecognized, and the rights and
obligations resulting from or retained in the transfer are separately recognized as the
assets or liabilities; (2) if the control over the financial assets is retained, the
relevant financial assets are recognized according to the degree of continued involvement
in the transferred financial assets, and the relevant liabilities are recognized
accordingly.
If the transfer of an entire financial asset satisfies the conditions for
derecognition, the difference between the two amounts below shall be included in the
current profit or loss: (1) Carrying value of the transferred financial assets at the
date of derecognition; (2) The sum of consideration received for the transfer of financial
assets, plus the corresponding derecognized portion of accumulated change in fair value
177 / 323
2020 ANNUAL REPORT
previously included in other comprehensive income (in cases where the transferred
financial assets are debt instrument investment at fair value through other comprehensive
income). If partial transfer of financial assets is made and satisfies the conditions
for derecognition, the overall carrying value before the transfer of financial assets
is apportioned according to their respective relative fair value at the transfer date
between the portion of derecognized part and the remaining part, and the difference
between the two amounts below is included in the current profit or loss: (1) carrying
value of the derecognized part; (2) the sum of consideration for the derecognized part,
plus the corresponding derecognized part of accumulated change in fair value previously
included in other comprehensive income (in cases where the transferred financial assets
are debt instrument investment at fair value through other comprehensive income).
4. Method of determining the fair values of financial assets and financial liabilities
The Company adopts valuation techniques appropriate to the prevailing circumstances
with the support of sufficient data and other information available, to determine the
fair value of relevant financial assets and financial liabilities. The Company divides
the inputs used by the estimation technique into the following levels and uses them in
turn:
(1) The input value of the first level is the unadjusted quotation of the same assets
or liabilities that can be obtained on the measurement date in the active market;
(2) The input value of the second level is the directly or indirectly observable input
value of related assets or liabilities except the input value of the first level, including:
the quotation of similar assets or liabilities in an active market; the quotation of the
same or similar assets or liabilities in an inactive market; other observable input values
other than quotation, such as the interest rate and yield curves that can be observed
during the normal quotation intervals; and the input values for market validation;
(3) The third level input value is the unobservable input value of the related assets
or liabilities, including interest rate that cannot be observed directly or cannot be
verified according to observable market data, stock volatility, future cash flows of
retirement obligations borne during the business merger, and financial forecasts based
on its own data.
5. Impairment of financial instruments
(1) Impairment measurement and accounting treatment of financial instruments
Based on the expected credit loss, the Company carries out accounting treatment for
impairment and recognizes the loss provision for the financial assets measured at
178 / 323
2020 ANNUAL REPORT
amortized cost, the debt instrument investment measured at fair value through other
comprehensive income, contract assets, lease receivables, loan commitment other than
financial liabilities measured at fair value through current profit or loss, and the
financial guarantee contracts of financial liabilities not measured at fair value through
current profit or loss or financial liabilities not from failure of transfer of financial
assets to meet the derecognition conditions or continued involvement in transferred
financial assets.
Expected credit loss refers to the weighted average of credit losses of financial
instruments on the weight of default risk. Credit loss refers to the balance between all
contractual cash flows discounted according to the original effective interest rate and
receivable under the contract by the Company and all cash flows as expected, i.e. the
present value of all cash shortages. The purchased or underlying financial assets of the
Company with credit impairment incurred shall be discounted according to their effective
interest rate upon credit adjustment.
For the purchased or underlying financial assets with credit impairment incurred,
only the accumulative changes in the expected credit loss in the whole duration after
initial recognition shall be recognized by the Company as loss provision on the balance
sheet date.
For the receivables and contract assets from transactions in accordance with the
Accounting Standards for Business Enterprises No. 14 – Revenue, excluding significant
financing components or without consideration, by the Company, to the financing
components in the contract for no more than one year, the Company measures the loss
provision according to the amount equal to the expected credit loss in the whole duration
by applying simplified measurement method.
For the lease receivables as well as receivables and contract assets from transactions
in accordance with the Accounting Standards for Business Enterprises No. 14 – Revenue,
excluding significant financing components, the Company measures the loss provision
according to the amount equal to the expected credit loss in the whole duration by applying
simplified measurement method.
For financial assets other than above measurement methods, the Company shall, on each
balance sheet date, assess whether their credit risk has increased significantly since
initial recognition. If the credit risk has increased significantly since the initial
recognition, the Company will measure the loss provision based on the amount of expected
credit loss in the whole duration; if the credit risk has not significantly increased
179 / 323
2020 ANNUAL REPORT
since the initial recognition, the Company will measure the loss provision based on the
amount of expected credit loss for the financial instruments in the next 12 months.
The Company determines whether the credit risk of financial instruments has increased
significantly since initial recognition by utilizing the available, reasonable and
well-grounded information, including forward-looking information, and comparing the
default risks of the financial instruments on the balance sheet date and on the initial
recognition date.
If the Company determines that the financial instruments bear a low credit risk on
the balance sheet date, it assumes that the credit risk of the financial instruments has
not increased significantly since initial recognition.
The Company evaluates the expected credit risk and measures the expected credit loss
based on single financial instrument or portfolio of financial instruments. When based
on the portfolio of financial instruments, the Company divides financial instruments into
different portfolios on the basis of the common risk characteristics.
The Company re-measures the expected credit loss on each balance sheet date, and the
increased or reversed amount of the loss provision arising therefrom, as losses or gains
from impairment, shall be included in current profit or loss. For financial assets
measured at amortized cost, the loss provision deducts the carrying value of the financial
assets listed in the balance sheet; for the debt investment measured at fair value through
other comprehensive income, the Company recognizes its loss provision in other
comprehensive income without deducting the carrying value of the financial assets.
(2) Financial instruments for evaluating expected credit risk and measuring expected
credit loss by portfolio
Item Basis for determining the Method for measurement of
portfolio expected credit loss
Calculating the expected
credit loss by the default
risk exposure and the
expected credit loss rate
in next 12 months or in the
Other receivables - whole duration by
Account age
account age combination referring to historical
experience in credit loss
and according to the
current situation and the
forecast on future
economic conditions
(3) Receivables and contract assets with expected credit loss measured by portfolio
180 / 323
2020 ANNUAL REPORT
1) Portfolio details and method for measurement of expected credit loss
Item Basis for determining the Method for measurement of
portfolio expected credit loss
Calculating the expected
credit loss by the default
risk exposure and the
expected credit loss rate
Receivables financing - Bill type by referring to historical
bank acceptance experience in credit loss
and according to the
current situation and the
forecast on future
economic conditions
Calculating the expected
credit loss by preparing
the comparison table
between account age of
accounts receivable and
Accounts receivable - expected credit loss rate
Account age in the whole duration by
account age combination
referring to historical
experience in credit loss
and according to the
current situation and the
forecast on future
economic conditions
2) Accounts receivable - Comparison between account age of account age portfolio and
expected credit loss rate in the whole duration
Account age Accounts receivable
Expected credit loss rate (%)
Within 1 year (inclusive, same for
5
below)
1-2 years 30
2-3 years 50
Above 3 years 100
6. Offset of financial assets and financial liabilities
The financial assets and financial liabilities are listed in the balance sheet
respectively without offsetting. However, when the following conditions are met, the
financial assets and liabilities are presented at the net amount after mutual offset in
the balance sheet. (1) the Company has the legal right of offsetting the recognized amount
and such legal right is currently executable; (2) the Company plans to settle by net amount
181 / 323
2020 ANNUAL REPORT
or simultaneously realize the financial assets and clear off the financial liabilities.
When the financial assets that do not meet the derecognition conditions are
transferred, the Company does not offset the transferred financial assets with the
relevant liabilities.
11. Notes receivable
Determination and accounting treatment of the expected credit loss of notes receivable
□ Applicable√ Not applicable
12. Accounts receivable
Determination and accounting treatment of the expected credit loss of accounts
receivable
√ Applicable□ Not applicable
See IV “10. Financial instruments” in “Section XI Financial Report” of this report for
details
13. Receivables financing
√ Applicable□ Not applicable
See IV “10. Financial instruments” in “Section XI Financial Report” of this report
for details
14. Other receivables
Determination and accounting treatment of the expected credit loss of other receivables
√ Applicable□ Not applicable
See IV “10. Financial instruments” in “Section XI Financial Report” of this report
for details.
15. Inventories
√ Applicable□ Not applicable
1. Classification of inventories
Inventories include finished goods or commodities for sale in daily routines, goods
in process during the production, materials consumed during production or rendering of
service.
2. Valuation method for delivered inventories
Moving weighted average method is adopted for delivered inventories.
3. Basis for the determination of net realizable value of inventories
On the balance sheet date, the inventories shall be measured on the basis of the lower
one between the cost and net realizable value, and the inventory falling price reserve
shall be withdrawn in accordance with the difference between the single inventory cost
and the net realizable value. The net realizable value of inventories directly for sale
182 / 323
2020 ANNUAL REPORT
is determined by the amount of the estimated selling price after subtracting the estimated
selling expenses and relevant taxes during the normal production and operation; the net
realizable value of inventories required to be processed is determined by the amount of
the estimated selling price of the finished products after subtracting the estimated cost
by the end of processing, the estimated selling expenses and relevant taxes during the
normal production and operation. On the balance sheet date, the net realizable value is
determined separately for the two parts of the same inventory with or without contract
price, and is compared with the relevant costs to separately determine the amount
withdrawn or reversed for inventory falling price reserve.
4. Inventory system
The inventory system is the perpetual inventory system.
5. Amortization of low-value consumables and packaging materials
(1) Low-value consumables
Amortization is performed by the one-off write-off method.
(2) Packaging materials
Amortization is performed by the one-off write-off method.
16. Contract assets
(1).Recognition methods and standards of contract assets
√ Applicable□ Not applicable
The rights of the Company to collect consideration from the customer unconditionally
(i.e. only depending on time) are presented as receivables; the rights (depend on other
factors than time) to collect consideration for transferring goods to the customer are
presented as contract assets.
(2).Determination and accounting treatment of the expected credit loss of contract
assets
□ Applicable√ Not applicable
17. Held-for-sale assets
□ Applicable√ Not applicable
18. Debt investment
(1).Determination and accounting treatment of the expected credit loss of debt
investment
□ Applicable√ Not applicable
183 / 323
2020 ANNUAL REPORT
19. Other debt investments
(1).Determination and accounting treatment of the expected credit loss of other debt
investments
□ Applicable√ Not applicable
20. Long-term receivables
(1).Determination and accounting treatment of the expected credit loss of long-term
receivables
□ Applicable√ Not applicable
21. Long-term equity investment
√ Applicable□ Not applicable
1. Joint control or significant influence criterion
Joint control is the contractually agreed sharing of control of an arrangement, and
exists only when decisions about the relevant activities of the arrangement require the
unanimous consent of the parties sharing control. Significant influence refers to the
power to participate in the decision-making process on the financial and operating
policies of the investee, but not power to control or jointly control the formulation
of such policies with other parties.
2. Determination of investment cost
(1) For enterprise merger under common control: where the merging party pays cash,
transfers non-cash assets, bears debts or issues equity securities as consideration of
merger, the initial investment cost is the share with reference to the carrying value
of the owners’ equity of the acquiree in the consolidated financial statements of the
ultimate controlling party on the date of merger. The difference between the initial
investment cost of long-term equity investment and the carrying value of the consideration
paid for the merger or total nominal value of the issued shares is adjusted to capital
reserve. If the capital reserve is not sufficient to offset the difference, the retained
earnings are adjusted.
The Company judges whether the item is a "package deal” via long-term equity
investment formed by enterprise merger under common control through multiple transactions.
For “package deal”, multiple deals are subject to accounting treatment as
one deal that has acquired control right. For items that do not belong to the
“package deal”, the initial investment cost is determined on the basis of the share with
reference to the carrying value of the net asset of the acquiree in the consolidated
financial statements of the ultimate controlling party on the date of merger. The
difference between initial investment cost of long-term equity investment at the date
184 / 323
2020 ANNUAL REPORT
of merger and the carrying amount of long-term equity investment before merger and the
sum of carrying value of newly paid consideration for additional shares acquired on the
date of merger is to adjust capital reserve. If the balance of capital reserve is
insufficient to offset the difference, the retained earnings are adjusted.
(2) For the business merger not under common control, the fair value of consideration
paid for merger is regarded as the initial investment cost on the acquisition date.
For the long-term equity investment achieved by the Company via business merger not
under common control through several transactions, the relevant accounting treatment is
based on individual financial statement or consolidated financial statements:
1) In individual financial statements, the initial investment cost when changing to
the cost method is the sum of the carrying value of the equity investment originally held
and the newly increased investment cost.
2) In the consolidated financial statements, the item is determined whether it is
a “package deal”. For “package deal”, multiple deals are subject to accounting treatment
as one deal that has acquired control right. For items that do not belong to the “package
deal”, the equity of the acquiree held before the acquisition date is re-measured at
the fair value of this equity on the acquisition date, and the difference between the
fair value and its carrying value is included in the current investment income; if the
equity of the acquiree held before the acquisition date is related to other comprehensive
income under the equity method, the other related comprehensive income is converted into
the current income on the acquisition date, excluding the other comprehensive income
derived from changes of net liabilities or net assets due to re-measurement on defined
benefit plan by the investee.
(3) For cases other than business merger: If it is obtained through paying cash, the
initial investment cost shall be the actual payment; if it is obtained through issuing
equity securities, the initial investment cost is the fair value of the equity securities;
if it is obtained through debt restructuring, the initial investment cost is determined
based on the Accounting Standards for Business Enterprises No. 12 - Debt Restructuring;
if it is obtained through the exchange of non-monetary assets, the initial investment
cost is determined based on the Accounting Standards for Business Enterprises No. 7 -
Exchange of Non-monetary Assets.
3. Subsequent measurement and recognition of profit or loss
For long-term equity investment controlled by the investee, cost method is adopted
for accounting; for the long-term equity investment of associates and joint ventures,
185 / 323
2020 ANNUAL REPORT
equity method is adopted for accounting.
4. Treatment methods for loss of control upon a stepwise disposal of investment to
subsidiaries through multiple transactions
(1) Individual financial statements
For disposal of equity, the difference between the carrying value and the
consideration actually received is included in the current profit or loss. The accounting
of residual equity is completed by equity method in case of significant influence on the
investee or implementation of joint control with other parties; but in case of no control,
joint control or significant influence on the investee, the accounting of residual equity
must comply with the relevant provisions of the Accounting Standards for Business
Enterprises No.22 - Recognition and Measurement of Financial Instruments.
(2) Consolidated financial statements
1) Loss of control upon stepwise disposal of investment to subsidiaries through
multiple transactions, not belonging to “package deal”
Before losing the control, for the difference between the price of disposal and the
subsidiary’s net assets entitled from the disposal of long-term equity investment
cumulatively calculated from the acquisition date or the date of merger, the capital
reserve (capital premium) is adjusted. If the capital premium is insufficient to offset
the difference, the retained earnings are adjusted.
When control over the original subsidiary is lost, the remaining equity is remeasured
at fair value as at the date on which the control is lost. The difference between the
sum of the consideration received from equity disposal and the fair value of the remaining
equity and the net assets of the original subsidiary proportionate to the original
shareholding accumulated from the date of acquisition or merger is included in investment
gains of the period during which the control is lost, and meanwhile, the goodwill is offset.
Other comprehensive income related to the equity investment in the original subsidiary
is transferred to investment gains of the period during which the control is lost.
2) Loss of control upon stepwise disposal of investment to subsidiaries through
multiple transactions, belonging to “package deal”
All transactions are regarded as one transaction disposing the
subsidiaries and losing the control right for accounting treatment. However,
the difference between the amount received each time for disposal before
the control is lost and the net assets of such subsidiary corresponding
to the disposal of investment is recognized as other comprehensive income
in the consolidated financial statements, and is transferred to profit or
186 / 323
2020 ANNUAL REPORT
loss of the period during which the control is lost upon loss of control.
22. Investment real estate
(1).In case of cost measurement model:
Depreciation or amortization method
1. The investment real estate includes leased land use right, land use right held
for transfer upon appreciation, and rental building.
2. Cost method is employed for initial measurement of investment real estate, and
cost model for subsequent measurement; depreciation or amortization shall be withdrawn
using the same method as that for fixed assets and intangible assets.
23. Fixed assets
(1).Conditions for recognition
√ Applicable□ Not applicable
Fixed assets are tangible assets that are held for use in the production or supply
of goods or services, for rental to others, or for administrative purposes; and have a
useful life of more than one accounting year. The fixed assets are recognized when
following conditions are satisfied at the same time: the economic benefits are likely
to inflow to the Company; the costs of such fixed assets can be measured reliably.
(2).Method for depreciation
√ Applicable□ Not applicable
Useful lives of Annual
Method for
Category depreciation Residual value depreciation
depreciation
(year) rate
Property and Straight-line 10 or 30 5% 9.50% or 3.17%
buildings method
General Straight-line 3-10 5% 31.67%-9.50%
equipment method
Dedicated Straight-line 5-10 5% 19.00%-9.50%
equipment method
Means of Straight-line 5 5% 19.00%
transportation method
(3).Recognition basis, valuation and depreciation method of fixed assets under finance
lease
□ Applicable√ Not applicable
24. Construction in progress
√ Applicable□ Not applicable
1. The construction in progress is recognized when following conditions are satisfied
at the same time: the economic benefits are likely to inflow to the Company; the costs
187 / 323
2020 ANNUAL REPORT
of such construction in progress can be measured reliably. Construction in progress is
measured at the actual cost incurred to make the assets ready for their intended use.
2. Construction in progress is transferred to fixed assets at the actual cost when
it reaches the expected condition for service. When construction in progress has achieved
serviceable conditions but final settlement has not been finished yet, it is first
transferred to fixed assets as per estimated value. After final settlement is finished,
the estimated value is adjusted based on actual cost, but the depreciated amount will
not be adjusted.
25. Borrowing costs
√ Applicable□ Not applicable
1. Criteria for recognition of capitalized borrowing costs
For borrowing costs incurred by the Company that are directly attributable to the
acquisition and construction or production of assets qualified for capitalization, the
costs will be capitalized and included in the costs of the related assets. Other borrowing
costs shall be recognized as expense in the period in which they incur and are included
in the current profit or loss.
2. Capitalization period of borrowing costs
(1) Capitalization of borrowing costs begins when the following three conditions are
fully satisfied: 1) expenditures for the assets have been incurred; 2) borrowing costs
have been incurred; 3) acquisition and construction or production that are necessary to
enable the assets reach the intended usable or saleable conditions have commenced.
(2) Where abnormal interruption of the assets eligible for capitalization occurs
during the acquisition and construction or production process and such interruption has
lasted for more than 3 consecutive months, the capitalization of borrowing costs is
suspended; the borrowing costs during the interruption are recognized as current expenses
till resumption of purchasing or production of the assets.
(3) Capitalization of borrowing costs is suspended during periods in which the
qualifying asset under acquisition and construction or production is ready for the
intended use or sale.
3. Capitalization rate and amount of borrowing costs
In case of special borrowing for the acquisition and construction or production of
assets meeting the capitalization conditions, interest amount to be capitalized is
recognized after deducting the bank interests for the unused portion or the investment
income for temporary investment from the interest costs (including recognized
188 / 323
2020 ANNUAL REPORT
depreciation or amortization of premium under effective interest method) actually
incurred in the current period of specific borrowing; for general borrowing occupied for
the acquisition and construction or production of assets meeting the capitalization
conditions, the interest amount to be capitalized shall be determined by the result
obtained by multiplying the capitalization rate of occupied general borrowing with the
weighted average value of the asset expenditure for the accumulated expenditure exceeding
the specific borrowing portion.
26. Biological assets
□ Applicable√ Not applicable
27. Oil and gas assets
□ Applicable√ Not applicable
28. Right-of-use assets
□ Applicable√ Not applicable
29. Intangible assets
(1).Valuation method, useful life and impairment test
√ Applicable□ Not applicable
1. Intangible assets, including land use rights, patent rights and non-patented
technologies, are measured at the cost.
2. Amortization for the intangible assets with limited useful life is reasonably
performed in the expected realization pattern according to economic benefits related to
the intangible assets within its useful life; if the expected realization pattern cannot
be reliably determined, the straight-line method shall be adopted for amortization. The
specific year information are shown as below:
Item Amortization period
(year)
Land use rights 40 or 50
Unpatented 5
technology
Office software 3-10
Patent right 5
Customer resources 3
Trademark right 10
189 / 323
2020 ANNUAL REPORT
(2).Accounting policy regarding the expenditure on the internal research and development
√ Applicable□ Not applicable
Expenses incurred during the research phase of the internal research and development
projects are included in the current profit or loss. Expenses in the development phase
are recognized as intangible assets when all of the following conditions are satisfied:
(1) It is technically feasible to complete the intangible assets so that it will be
available for use or sale; (2) there is an intention to complete the intangible assets
for use or sale; (3) the intangible assets can produce economic benefits, including there
is evidence that the products produced using the intangible assets has a market or the
intangible assets itself has a market; if the intangible assets is for internal use, there
is evidence that there exists usage for the intangible assets; (4) there is sufficient
support in terms of technology, financial resources and other resources in order to
complete the development of the intangible assets, and there is capability to use or sell
the intangible assets; (5) the expenses attributable to the development phase of the
intangible assets can be measured reliably.
30. Impairment of long-term assets
√ Applicable□ Not applicable
For such long-term assets as long-term equity investment, investment real estate
measured by the cost model, fixed assets, construction in progress and intangible assets
with limited useful life, in case that there are signs indicating impairment on the balance
sheet date, the recoverable amount shall be estimated. Whether there is a sign of
impairment or not, the goodwill acquired in the enterprise merger and intangible assets
with indefinite useful life is tested for impairment each year. The impairment test on
goodwill is carried out in combination with its related asset group or asset group
portfolio.
In case the recoverable amount of the above long-term assets is less
than its carrying value, the provision for asset impairment is recognized
according to its differences and included into current profit or loss.
31. Long-term prepaid expenses
√ Applicable□ Not applicable
The long-term prepaid expenses involve all expenses already paid with amortization
period of more than 1 year (excluding 1 year). Long-term prepaid expenses are entered
in an account at the actual amounts, and are amortized by even amortization within the
benefit period or prescribed amortization period. If the long-term deferred expenses
190 / 323
2020 ANNUAL REPORT
cannot provide benefit to the future accounting period, then all of the amortized value
of the unamortized long-term deferred expenses are transferred into the current profit
or loss.
32. Contract liabilities
(1).Recognition method of contract liabilities
√ Applicable□ Not applicable
The Company recognizes the obligation to transfer goods to customers
for the consideration received or receivable from the customers as contract
liabilities.
33. Employee remuneration
(1).Accounting treatment for short-term remuneration
√ Applicable□ Not applicable
During the accounting period when employees provide service for the company, the
short-term remuneration actually incurred will be recognized as liabilities, and will
be included in the current profit or loss or the costs of the related assets.
(2).Accounting treatment for post-employment benefits
√ Applicable□ Not applicable
Post-employment benefits are divided into the defined contribution plan and defined
benefit plan.
(1) During the accounting period when employees provide service for the Company, the
amounted to be deposited as calculated according to the defined contribution plan shall
be recognized as liabilities, and will be included in the current profit or loss or the
costs of the related assets.
(2) The accounting treatment for the defined benefit plan generally comprises the
following steps:
1) According to the expected cumulative benefit unit method, the demographic
variables, financial variables, etc. shall be estimated through unbiased and mutually
consistent actuarial assumption, so as to measure the obligations arising from the defined
benefit plan and determine the period of relevant obligations. In addition, the obligation
generated from the defined benefit plan shall be discounted, so as to determine the present
value of defined benefit plan obligation and current service cost;
2) In case of assets in the defined benefit plan, the deficit or surplus generated
from the present value of obligations of the defined benefit plan minus the fair value
of the assets of defined benefit plan is recognized as net liabilities or net assets in
191 / 323
2020 ANNUAL REPORT
the defined benefit plan. When the defined benefit plan has surplus, the net assets of
the defined benefit plan are measured at the lower of the surplus of defined benefit plan
and the upper limit of the assets;
3) At the end of the period, the employee remuneration costs generated by the defined
benefit plan are recognized as three parts, i.e., service costs, net interest of the net
liabilities or net assets of the defined benefit plan, and the changes generated by
re-measurement of the net liabilities or net assets of the defined benefit plan, in which
the service costs and the net interest of the net liabilities or net assets of the defined
benefit plan are included in current profit or loss or the costs of the related assets,
and the changes generated by re-measurement of the net liabilities or net assets of the
defined benefit plan are included in other comprehensive income, and cannot be reversed
to profit or loss in the subsequent accounting period. However, the amount recognized
in other comprehensive income can be transferred within the equity scope.
(3).Accounting treatment methods of termination benefits
√ Applicable□ Not applicable
If termination benefits are provided to employees, the employee remuneration
liabilities arising from the termination benefits are recognized on the earlier date of
the following and included in the current profit or loss: (1) when the Company cannot
unilaterally withdraw the termination benefits provided due to termination of labor
relation plan or layoff proposal; (2) when the Company recognizes the cost or expenses
related to the restructuring involving payment of termination benefits.
(4).Accounting treatment for other long-term employees’ benefits
√ Applicable□ Not applicable
Other long-term employee benefits satisfying the conditions in the defined
contribution plan are treated in accounting as stipulated in the defined contribution
plan; and other long-term benefits beyond that are treated in accounting as stipulated
in the defined benefit plan. In order to simplify related accounting treatment, the
generated employee remuneration costs are recognized as the service cost. The total net
amount of item composed of the net interest of net liabilities or net assets of other
long-term employee benefits and the changes generated from re-measuring net liabilities
or net assets of other long-term employee benefits is included in the current profit or
loss or the costs of the related assets.
192 / 323
2020 ANNUAL REPORT
34. Lease liabilities
□ Applicable√ Not applicable
35. Estimated liabilities
√ Applicable□ Not applicable
1. The obligations imposed by contingencies, such as providing external guarantee,
lawsuits, product quality assurance and onerous contract, become the current obligations
assumed by the Company, which are determined by the Company as estimated liabilities when
their performance is very likely to result in economic benefit outflow from the Company
and their amount can be measured reliably.
2. The estimated liabilities are initially measured by the Company based on the
optimal estimate to be paid for performing relevant current obligations and their carrying
value are reviewed on the balance sheet date.
36. Share-based payments
√ Applicable□ Not applicable
1. Types of share-based payments
There are equity-settled and cash-settled share-based payments.
2. Relevant accounting treatment of implementing, modifying and terminating the
share-based payment schedule
(1) Equity-settled share-based payments
These equity-settled share-based payments vested immediately after the grant date
and exchanged for employee services shall be included in relevant costs or expenses as
per the fair value of the equity instruments on the grant date, and the capital reserve
shall be adjusted accordingly. For the equity-settled share-based payments that are
vested only after the services within the waiting period are completed or the specified
performance conditions are satisfied and that are exchanged for employee services, the
services acquired in the current period are included in relevant costs or expenses as
per the fair value of the equity instruments on the grant date based on the optimal estimate
of the number of vesting equity instruments on each balance sheet date within the waiting
period, and the capital reserve is adjusted accordingly.
The equity-settled share-based payments exchanged for services of other parties are
measured as per the fair value of the services of other parties on the date of acquiring
if its reliable measurement is possible, and as per the fair value of the equity
instruments on the date of acquiring the services if the reliable measurement of the fair
value of the services of other parties is impossible, but that of the equity instruments
193 / 323
2020 ANNUAL REPORT
is possible, they are included in relevant costs or expenses, and the owner’s equity
is increased accordingly.
(2) Cash-settled share-based payments
These cash-settled share-based payments vested immediately after the grant date and
exchanged for employee services shall be included in relevant costs or expenses as per
the fair value of the liabilities assumed by the Company on the grant date, and the
liabilities shall be increased accordingly. For these cash-settled share-based payments
that are vested only after the services within the waiting period are completed or the
specified performance conditions are satisfied and that are exchanged for employee
services, the services acquired in the current period shall be included in relevant costs
or expenses and corresponding liabilities as per the fair value of the liabilities assumed
by the Company based on the optimal estimate of the vesting conditions on each balance
sheet date within the waiting period.
(3) Modifying and terminating the share-based payment schedule
If the fair value of the granted equity instruments is increased, the Company
recognizes the increase of the acquired services according to the fair value of the equity
instruments. If the number of the granted equity instruments is increased, the Company
recognizes the increased fair value of the equity instruments as the increase of the
acquired services accordingly. If the Company modifies the vesting conditions in a way
favorable to employees, the Company considers the modified vesting conditions when
dealing with the vesting conditions.
If the fair value of the granted equity instruments is decreased, the Company
continues to recognize the amount of the acquired services according to the fair value
of the equity instruments on the grant date, without taking into account the decrease
of the fair value of the equity instruments. If the number of the granted equity
instruments is decreased, the Company treats the decreased part as cancellation of the
granted equity instruments. If the Company modifies the vesting conditions in a way
unfavorable to employees, the Company will not consider the modified vesting conditions
when dealing with the vesting conditions.
If the Company cancels or settles the granted equity instruments within the waiting
period (other than the cancellation arising from failure to meet the vesting conditions),
the cancellation or settlement is regarded as accelerated vesting treatment to
immediately recognize the amount that should be recognized within the remaining waiting
period.
194 / 323
2020 ANNUAL REPORT
37. Preferred shares, perpetual bonds and other financial instruments
□ Applicable√ Not applicable
38. Revenue
(1).Accounting policy applied for revenue recognition and measurement
√ Applicable□ Not applicable
1. Revenue recognition principle
The Company shall, on the commencement date of the contract, evaluate the contract,
identify the individual performance obligations provided in the contract and determine
whether to perform them within a period or at a time point.
The performance obligations shall be deemed to perform within a period if one of the
following conditions is satisfied, otherwise, at a time point: (1) The customer acquires
and consumes the economic benefits brought by the Company’s performance while the Company
is performing its obligations; (2) the customer is capable to control the commodities
under creation during the Company’s performance; (3) the commodities produced during
the Company’s performance have irreplaceable purpose and the Company has the right to
collect the amounts for the performance part already completed to date within the whole
contract term.
For the obligations performed within a period, the Company shall recognize the revenue
according to the performance progress in that period. If the performance progress cannot
be determined in a reasonable way, but the incurred costs are expected to be reimbursed,
the revenue shall be recognized according to the incurred amount of costs until the
performance progress can be determined in a reasonable way. For the obligations performed
at a time point, the revenue shall be recognized at the time of the customer’s acquiring
the control of related commodities or services. The Company shall take into account the
following when judging whether the customer has acquired the commodity control: (1) The
Company has the current right for collection, namely the customer has the current
obligation for payment with respect to the commodity; (2) the Company has transferred
the legal title of the commodity to the customer, namely the customer has acquired the
same; (3) the Company has transferred the physical commodity to the customer, namely the
customer has physical possession of the commodity; (4) the Company has passed the main
risks and return on the commodity’s title to the customer, namely the customer has
acquired the same; (5) the customer has accepted the commodity; and (6) there are other
signs indicating that the customer has acquired the commodity control.
195 / 323
2020 ANNUAL REPORT
2. Revenue measurement principle
(1) The Company shall measure the revenue according to the transaction price
apportioned to the individual performance obligations. The transaction price refers to
the consideration amount of which the Company is expected to have right for collection
due to transfer of commodities or services to the customer, excluding the amounts charged
on behalf of the third party and expected to refund to the customer.
(2) In case of variable consideration in the contract, the Company shall determine
the optimal estimate of the variable consideration according to the expected value or
the amount most likely to incur, while the transaction price including the variable
consideration shall not exceed the amount under the circumstance where the accumulatively
recognized revenue will not be highly likely to suffer major reversal when relevant
uncertainties are eliminated.
(3) In case of major financing composition in the contract, the Company shall
determine the transaction price according to the payable amount assumed to be paid by
the customer in cash immediately after he acquires the control of the commodities or
services. The difference between the transaction price and the contract consideration
shall be amortized by the effective interest method within the contract term. If the
Company expects, on the commencement date of the contract, that the interval between the
customer’s acquisition of the control of the commodities or services and its payment
is not more than one year, the major financing composition in the contract shall not be
taken into account.
(4) In case of two or more performance obligations in the contract, the Company shall,
on the commencement date of the contract, apportion the transaction price to the
individual performance obligations according to the relative proportion of the individual
sales price of the commodities undertaken as per the individual performance obligations.
(2).Difference in accounting policy for revenue recognition resulting from different
business models for similar businesses
√ Applicable□ Not applicable
The Company sells cosmetics. It has different sales models classified as distribution,
direct selling and sales on commission.
(1) Distribution
The sales revenue shall be recognized after the Company delivers the products to the
buyer according to the provisions of the contract and the buyer accepts the same.
(2) Direct selling
196 / 323
2020 ANNUAL REPORT
The sales revenue shall be recognized after the Company delivers the commodities to
the consumer, and the consumer confirms receipt and makes payment.
(3) Sales on commission
The sales revenue shall be recognized after the Company delivers the products to the
commissioned party according to the provisions of the contract and the commissioned party
provides the list of sales on commission to the Company upon selling the products to
others.
39. Contract cost
√ Applicable□ Not applicable
The assets associated with the contract cost include the contract acquisition cost
and contract performance cost.
The incremental cost incurred by the Company for acquiring the contract that is
expected to be recoverable, as the contract acquisition cost, shall be recognized as an
asset. If the amortization period of the contract acquisition cost is no more than one
year, it shall be directly included in the current profit or loss at the time of incurrence.
The cost incurred by the Company for performing the contract that falls out of the
standard scope of relevant criteria for stock, fixed assets or intangible assets and that
satisfies the following conditions, as the contract performance cost, shall be recognized
as an asset:
1. The cost is directly related to one contract acquired currently or as expected,
including direct labor, direct materials and manufacturing expenses (or similar), costs
expressly borne by the customer and other costs incurred solely in connection with the
contract;
2. The cost increases the resources for the Company to perform its obligations in
the future;
3. The cost is expected to be recoverable.
The Company shall amortize the assets related to the contract cost on the same basis
as for recognizing the revenue of the commodities or services in connection with the assets
and include the same in the current profit or loss.
If the carrying value of the assets related to the contract cost is more than the
surplus consideration expected to be acquired for transferring the commodities or
services in connection with the assets minus the cost expected to incur, the Company shall
make the provision for impairment against the exceeding part and recognize it as the assets
impairment loss. If any changes in the factors for impairment in previous periods make
197 / 323
2020 ANNUAL REPORT
the surplus consideration expected to be acquired for transferring the commodities or
services in connection with the assets minus the cost expected to incur higher than the
carrying value of the assets, the provision for assets impairment made originally shall
be reversed and included in the current profit or loss, provided that the reversed carrying
value of the assets is no more than that on the reversal date without making the provision
for impairment.
40. Government grant
√ Applicable□ Not applicable
1. Government grants are recognized when all of the following conditions are satisfied:
(1) The Company is able to meet the conditions attached to the government grants; (2)
the Company is able to receive the government grants. In case of government grants as
monetary assets, they shall be measured as per the amount received or receivable. In case
of government grants as non-monetary assets, they shall be measured as per the fair value;
in case that the fair value cannot be acquired in a reliable way, they shall be measured
as per the nominal amount.
2. Basis of determination and accounting treatment method for government grants
related to assets
These government grants that are used for purchasing and constructing or otherwise
forming long-term assets as specified in government documents are classified as
government grants related to assets. In case of no provision in government documents,
the government grants shall be determined on the basis of the essential condition required
for obtaining the grants, and shall be considered as related to assets if the essential
condition is purchasing and constructing or otherwise forming long-term assets. The
government grants related to assets shall offset the carrying value of relevant assets
or be recognized as deferred income. If the government grants related to assets are
recognized as deferred income, they shall be included in the profit and loss in a
reasonable and systematic way within the useful life of relevant assets. The government
grants measured as per the nominal amount shall be directly included in the current profit
or loss. If related assets are sold, transferred, scrapped or damaged before the end of
their useful life, related deferred income balance unallocated shall be transferred into
the profit and loss in the current period of assets disposal.
3. Basis of determination and accounting treatment method for government grants
related to income
The government grants other than those related to assets are classified as government
198 / 323
2020 ANNUAL REPORT
grants related to income. If it is difficult to distinguish whether the government grants
containing both the part related to assets and the part related to income are related
to assets or income, they shall be entirely classified as the government grants related
to income. The government grants related to income that are used for compensation for
relevant costs or losses in subsequent periods shall be recognized as deferred income,
and included in the current profit or loss or offset relevant costs in the period in which
relevant costs or losses are recognized; those used for compensation for relevant costs
or losses that have incurred shall be directly included in the current profit or loss
or offset relevant costs.
4. The government grants related to daily business activities of the Company shall
be included in other incomes or offset relevant costs according to the nature of the
economic business. The government grants unrelated to the daily activities of the Company
shall be included in non-operating income and expenses.
41. Deferred income tax assets/liabilities
√ Applicable□ Not applicable
1. According to the difference between the carrying value of the assets and
liabilities and their tax basis (if the tax basis of the items recognized not as assets
and liabilities can be determined according to the provisions of the tax law, the
difference between that tax basis and their physical count quantity), the deferred income
tax assets or liabilities shall be calculated and recognized according to the tax rate
applicable in the period where it is expected to recover the assets or liquidate the
liabilities.
2. Deferred income tax assets are recognized to the extent that it is very likely
to obtain the taxable income to deduct the deductible temporary differences. If on the
balance sheet date, there are conclusive evidences proving that it is very likely to obtain
sufficient taxable income in future periods to deduct the deductible temporary
differences, the deferred income tax assets not recognized yet in previous accounting
periods shall be recognized.
3. If the carrying value of the deferred income tax assets is reviewed on the balance
sheet date and it is very likely to not obtain sufficient taxable income in future periods
to deduct their benefits, the carrying value of the deferred income tax assets shall be
written down. When it is very likely to obtain sufficient taxable income, the amount
written down shall be reversed.
4. The current income tax and deferred income tax of the Company are included in the
199 / 323
2020 ANNUAL REPORT
current profit or loss as the income tax expense or income, except for the income tax
arising from the following circumstances: (1) Business merger; (2) transaction or matters
recognized directly in the owner’s equity.
42. Lease
(1).Accounting treatment method of operating lease
√ Applicable□ Not applicable
If the Company is the lessee, the rent is included in relevant asset cost or recognized
as the current profit or loss according to the straight-line method during each period
of the lease term, and the initial direct expenses incurred are directly included in the
current profit or loss. The contingent rent is included in the current profit or loss
at the time of actually incurring.
If the Company is the lessor, the rent is recognized as the current profit or loss
according to the straight-line method during each period of the lease term, and the initial
direct expenses incurred are directly included in the current profit or loss, except for
the large amount which is capitalized and included in the profit and loss in stages. The
contingent rent is included in the current profit or loss at the time of actually
incurring.
(2).Accounting treatment method of financing lease
□ Applicable√ Not applicable
(3).Determination method and accounting treatment method of lease under new lease
standards
□ Applicable√ Not applicable
43. Other significant accounting policies and accounting estimates
□ Applicable√ Not applicable
44. Changes in significant accounting policies and accounting estimates
(1).Changes in significant accounting policies
√ Applicable□ Not applicable
Contents and reasons of Remarks (name and amount of
Review and approval
changes in accounting report items affected
procedure
policies materially)
th
The Company has implemented For Resolutions at the 12 In accordance with the
the revised Accounting meeting of the Second Session link-up rules for relevant
Standards for Business of the Board of Directors in new and old standards, the
Enterprises No. 14 - Revenue 2020, refer to Company Notice information in the
of the Ministry of Finance No.: 2020-012 comparable periods shall not
(hereinafter referred to as be adjusted, and the
200 / 323
2020 ANNUAL REPORT
“new revenue standards”) cumulative effects of
since 1 January 2020. implementing the new
standards on the first
implementation date shall be
used for retroactive
adjustment of the retained
earnings at the beginning of
the Reporting Period as well
as the amount of other
related items in the
financial statements. See
“other particulars” below
for details.
Other particulars
1. The major impact of the implementation of new revenue standards on the
Company's financial statements on 1 January 2020 is as follows:
Balance sheet
31 December 2019 Impact from 1 January 2020
Item
adjustment of new
revenue standards
Other current 11,723,268.59 7,122,566.88
18,845,835.47
assets
Accounts received 40,913,490.55 -40,913,490.55
in advance
Contract 50,216,613.89 50,216,613.89
liabilities
Other current 1,948,803.22 1,948,803.22
liabilities
Estimated 10,102,532.74 7,122,566.88 17,225,099.62
liabilities
Deferred income 19,743,036.56 -11,251,926.56 8,491,110.00
2. The Company has implemented the Interpretation No. 13 of the Accounting Standards
for Business Enterprises issued by the Ministry of Finance in 2019 since 1 January 2020,
and prospective application was adopted for this accounting policy change.
(2).Changes in significant accounting estimates
□ Applicable√ Not applicable
201 / 323
2020 ANNUAL REPORT
(3).Particulars on adjustment to the financial statements at the beginning of the year for the first
implementation of new standards for revenues and new standards for lease from 2020
√ Applicable□ Not applicable
Combined Balance Sheet
Unit: Yuan Currency: RMB
Item 31 December 2019 1 January 2020 Adjusted amount
Current assets:
Cash and equivalents 1,246,901,218.99 1,246,901,218.99
Transaction settlement
funds
Lending funds
Held-for-trading financial 71,450,000.00 71,450,000.00
assets
Derivative financial assets
Bills receivable
Accounts receivable 198,409,249.19 198,409,249.19
Receivables financing 2,150,000.00 2,150,000.00
Prepayment 53,313,963.76 53,313,963.76
Premium receivable
Reinsurance premium
receivable
Reserves for reinsurance
contract receivable
Other receivables 15,269,949.97 15,269,949.97
Where: Interest receivable
Dividend receivable
Financial assets purchased
under agreements to resell
Inventories 313,649,003.07 313,649,003.07
Contract assets
Held for sale assets
Non-current assets due
within one year
Other current assets 11,723,268.59 18,845,835.47 7,122,566.88
Total current assets 1,912,866,653.57 1,919,989,220.45 7,122,566.88
Non-current assets:
Loans and advances to
customers
Debt investment
Other debt investment
Long-term receivables
Long-term equity 14,728,003.68 14,728,003.68
investments
Investments in other equity
instruments
Other non-current financial
assets
Investment real estate 71,622,083.18 71,622,083.18
202 / 323
2020 ANNUAL REPORT
Fixed assets 550,329,145.07 550,329,145.07
Construction in progress 31,894,658.49 31,894,658.49
Productive biological
assets
Oil and gas assets
Right-of-use assets
Intangible assets 328,564,563.33 328,564,563.33
Development expenses
Goodwill
Long-term prepaid expenses 26,378,564.50 26,378,564.50
Deferred income tax assets 27,975,258.51 27,975,258.51
Other non-current assets 15,006,146.49 15,006,146.49
Total non-current assets 1,066,498,423.25 1,066,498,423.25
Total assets 2,979,365,076.82 2,986,487,643.7 7,122,566.88
Current liabilities:
Short-term borrowings 129,047,396.51 129,047,396.51
Borrowings from central
bank
Placements from banks and
other financial institutions
Held-for-trading financial
liabilities
Derivative financial
liabilities
Bills payable 41,830,948.53 41,830,948.53
Accounts payable 347,316,843.39 347,316,843.39
Accounts received in 40,913,490.55 -40,913,490.55
advance
Contract liabilities 50,216,613.89 50,216,613.89
Financial assets sold under
repurchase agreements
Deposits from customers and
other banks
Brokerage for trading
securities
Brokerage for underwriting
securities
Employee benefits payable 66,684,151.98 66,684,151.98
Taxes payable 71,833,700.61 71,833,700.61
Other payables 91,444,673.31 91,444,673.31
Where: Interest payable
Dividend payable
Fees and commissions
payable
Reinsured accounts payable
Held-for-sale liabilities
Non-current liabilities due 85,258,247.69 85,258,247.69
within one year
Other current liabilities 1,948,803.22 1,948,803.22
203 / 323
2020 ANNUAL REPORT
Total current liabilities 874,329,452.57 885,581,379.13 11,251,926.56
Non-current liabilities:
Reserves for insurance
contracts
Long-term borrowings
Bonds payable
Where: Preference shares
Perpetual bonds
Lease liabilities
Long-term payables
Long-term employee benefits
payable
Estimated liabilities 10,102,532.74 17,225,099.62 7,122,566.88
Deferred income 19,743,036.56 8,491,110.00 -11,251,926.56
Deferred income tax 5,132,011.38 5,132,011.38
liabilities
Other non-current
liabilities
Total non-current 34,977,580.68 30,848,221.00 -4,129,359.68
liabilities
Total liabilities 909,307,033.25 916,429,600.13 7,122,566.88
Owner’s equity (or shareholders’ equity):
Share capital 201,269,560.00 201,269,560.00
Other equity instruments
Where: Preference shares
Perpetual bonds
Capital reserve 835,353,615.48 835,353,615.48
Less: Treasury shares 15,769,051.20 15,769,051.20
Other comprehensive income -212,628.22 -212,628.22
Special reserve
Surplus reserve 100,634,780.00 100,634,780.00
General risk provision
Undistributed profit 908,411,607.62 908,411,607.62
Total equity attributable 2,029,687,883.68 2,029,687,883.68
to the owners of the parent
company
Minority equity 40,370,159.89 40,370,159.89
Total owners’ equity (or 2,070,058,043.57 2,070,058,043.57
shareholders’ equity)
Total liabilities and 2,979,365,076.82 2,986,487,643.70 7,122,566.88
owner's equity (or
shareholders’ equity)
Description on adjustment to relevant items:
□ Applicable√ Not applicable
Balance Sheet of Parent Company
Unit: Yuan Currency: RMB
Item 31 December 2019 1 January 2020 Adjusted amount
204 / 323
2020 ANNUAL REPORT
Current assets:
Cash and equivalents 403,072,398.35 403,072,398.35
Held-for-trading 70,000,000.00 70,000,000.00
financial assets
Derivative financial
assets
Bills receivable
Accounts receivable 614,081,454.90 614,081,454.90
Receivables financing
Prepayment 13,257,712.52 13,257,712.52
Other receivables 31,800,093.90 31,800,093.90
Where: Interest receivable
Dividend receivable
Inventories 157,614,679.78 157,614,679.78
Contract assets
Held for sale assets
Non-current assets due
within one year
Other current assets
Total current assets 1,289,826,339.45 1,289,826,339.45
Non-current assets:
Debt investment
Other debt investment
Long-term receivables
Long-term equity 159,882,467.38 159,882,467.38
investments
Investments in other
equity instruments
Other non-current
financial assets
Investment real estate 336,462,349.68 336,462,349.68
Fixed assets 283,156,520.47 283,156,520.47
Construction in progress 31,877,256.59 31,877,256.59
Productive biological
assets
Oil and gas assets
Right-of-use assets
Intangible assets 318,477,880.56 318,477,880.56
Development expenses
Goodwill
Long-term prepaid expenses 1,177,831.47 1,177,831.47
Deferred income tax assets 18,414,499.56 18,414,499.56
Other non-current assets 15,006,146.49 15,006,146.49
Total non-current assets 1,164,454,952.20 1,164,454,952.20
Total assets 2,454,281,291.65 2,454,281,291.65
Current liabilities:
Short-term borrowings
Held-for-trading
financial liabilities
205 / 323
2020 ANNUAL REPORT
Derivative financial
liabilities
Bills payable 41,830,948.53 41,830,948.53
Accounts payable 300,820,130.33 300,820,130.33
Accounts received in 13,628,235.50 -13,628,235.50
advance
Contract liabilities 12,060,385.40 12,060,385.40
Employee benefits payable 23,436,531.67 23,436,531.67
Taxes payable 49,102,562.13 49,102,562.13
Other payables 27,706,157.37 27,706,157.37
Where: Interest payable
Dividend payable
Held-for-sale liabilities
Non-current liabilities 85,258,247.69 85,258,247.69
due within one year
Other current liabilities 1,567,850.10 1,567,850.10
Total current 541,782,813.22
541,782,813.22
liabilities
Non-current liabilities:
Long-term borrowings
Bonds payable
Where: Preference shares
Perpetual bonds
Lease liabilities
Long-term payables
Long-term employee
benefits payable
Estimated liabilities
Deferred income 8,491,110.00 8,491,110.00
Deferred income tax 4,986,605.71 4,986,605.71
liabilities
Other non-current
liabilities
Total non-current 13,477,715.71 13,477,715.71
liabilities
Total liabilities 555,260,528.93 555,260,528.93
Owner’s equity (or shareholders’ equity):
Share capital 201,269,560.00 201,269,560.00
Other equity instruments
Where: Preference shares
Perpetual bonds
Capital reserve 834,592,133.74 834,592,133.74
Less: Treasury shares 15,769,051.20 15,769,051.20
Other comprehensive income
Special reserve
Surplus reserve 100,634,780.00 100,634,780.00
Undistributed profit 778,293,340.18 778,293,340.18
Total owners’ equity 1,899,020,762.72 1,899,020,762.72
(or shareholders’ equity)
206 / 323
2020 ANNUAL REPORT
Total liabilities and 2,454,281,291.65 2,454,281,291.65
owner's equity (or
shareholders’ equity)
Description on adjustment to relevant items:
□ Applicable√ Not applicable
(4).Description on retrospective adjustment to previous comparative data for the first
implementation of new standards for revenues and new standards for lease from 2020
□ Applicable√ Not applicable
45. Others
□ Applicable√ Not applicable
VI Taxes
1. Major tax types and tax rates
Particulars on major tax types and tax rates
√ Applicable□ Not applicable
Tax type Taxing basis Tax rate
Value added tax (“VAT”) The output tax is calculated 13%, 9%, 6%
on the basis of the income
from sales of products and
taxable income from rendering
of services calculated
according to the provisions
of the tax law. The difference
between the output tax and the
amount after deducting the
input tax which is allowed to
be deductible in the current
period is the payable VAT.
Consumption tax Taxable sales (volume) 15%
Business tax
Urban maintenance and Actual turnover tax paid 7%, 5%
construction tax
Enterprise income tax Taxable income [Note]
Property tax In case of ad valorem 12%, 1.2%
taxation, it is calculated
and paid as per 1.2% of the
remaining value after 30% of
the original value of the
property is deducted in a lump
sum; in case of taxation
according to lease, it is
calculated and paid as per 12%
of the rental income
Education surcharge Actual turnover tax paid 3%
Local education surcharge Actual turnover tax paid 2%
[Note]: Descriptions on tax payers with different enterprise income tax rates
207 / 323
2020 ANNUAL REPORT
If there are taxpayers with different enterprise income tax rates, the disclosure will
be made for description
√ Applicable□ Not applicable
Name of taxpayer Income tax rate (%)
The Company 15%
Huzhou Niuke Technology Co., Ltd. 20%
Relevant taxes are calculated and paid
Korea Younimi Cosmetics Co., Ltd. according to local tax regulations in South
Korea
Relevant taxes are calculated and paid
Hanna Cosmetics Co., Ltd. according to local tax regulations in South
Korea
Relevant taxes are calculated and paid
Hapsode Co., Ltd. according to local tax regulations in South
Korea
Relevant taxes are calculated and paid
HONGKONG KESHI TRADING LIMITED according to local tax regulations in Hong
Kong, China
Relevant taxes are calculated and paid
Hong Kong Xinghuo Industry Limited according to local tax regulations in Hong
Kong, China
Relevant taxes are calculated and paid
Hong Kong Wanyan Electronic Commerce Co.,
according to local tax regulations in Hong
Limited
Kong, China
Relevant taxes are calculated and paid
Hong Kong Zhongwen Electronic Commerce Co.,
according to local tax regulations in Hong
Limited
Kong, China
Relevant taxes are calculated and paid
Hong Kong Xuchen Trading Limited according to local tax regulations in Hong
Kong, China
Relevant taxes are calculated and paid
BOYA (Hong Kong) Investment Management Co.,
according to local tax regulations in Hong
Limited
Kong, China
Relevant taxes are calculated and paid
Proya Europe SARL according to local tax regulations in
Luxembourg
Relevant taxes are calculated and paid
P.R.O CO., LTD.
according to local tax regulations in Japan
Tax payers other than the above 25%
2. Tax preference
√ Applicable□ Not applicable
The Company was reviewed as the high-tech enterprise on 1 December 2020 and obtained
the high-tech enterprise certificate, with the validity of certification of 3 years and
the grace period for enterprise income tax in 2020-2022. The Company was subject to the
enterprise income tax at the preferential rate of 15% in 2020.
According to the Notice of the Ministry of Finance and the State Taxation
208 / 323
2020 ANNUAL REPORT
Administration on the Implementation of Inclusive Tax Relief Policy for Small and Micro
Enterprises (CS [2019] No.13) and the Announcement of the State Taxation Administration
on Relevant Issues on the Implementation of Inclusive Tax Relief Policy for Small and
Micro Enterprises (Announcement No. 2 of the State Taxation Administration in 2019),
Huzhou Niuke Technology Co., Ltd. complies with the criteria for tax payment of small
and micro enterprises and would pay the enterprise income tax as per the tax rate of 20%
in 2020.
In accordance with the provisions of the Announcement on Clarifying Policies for
Accrual and Deduction of Value-Added Tax for Life Service Industry jointly issued by the
Ministry of Finance and the State Taxation Administration (Announcement No. 87 of the
Ministry of Finance and the State Taxation Administration in 2019), Hangzhou Proya
Commercial Management Co., Ltd., a subsidiary of the Company, complies with the conditions
for general tax payers engaged in production and consumer-oriented service industries,
and the input tax deductible in the current period plus 15% would be used for deducting
the tax payable from 1 October 2019 to 31 December 2021.
3. Others
□ Applicable√ Not applicable
VII Notes to the Items in Consolidated Financial Statements
1 Cash and equivalents
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Cash on hand 26,853.58 42,499.65
Cash at bank 1,368,800,012.77 1,230,772,238.87
Other cash and 47,827,774.58 16,086,480.47
equivalents
Total 1,416,654,640.93 1,246,901,218.99
Where: Total cash 83,771,568.02 27,200,237.51
deposited outside
China
Other particulars
At the end of the period, the scope of restricted use covered the margin for fixed-term
deposits of transformer of RMB 293,481.72 in bank deposits, as well as the land
construction deposit of RMB 7,036,404.33, L/C deposit of RMB 7,000,000.00, ETC vehicle
deposit of RMB 69,000.00, and Tmall and Alipay deposits of RMB 405,000.00 in other monetary
capitals.
At the beginning of the period, the scope of restricted use covered the structured
209 / 323
2020 ANNUAL REPORT
deposits of RMB 140,000,000.00 and margin for fixed-term deposits of transformer of RMB
293,481.72 in bank deposits, as well as the land construction deposit of RMB 6,909,952.20
and Tmall and Alipay deposits of RMB 605,000.00 in other monetary capitals.
2 Held-for-trading financial assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Financial assets at fair value 71,450,000.00
through current profit or loss
Where:
Wealth management products 71,450,000.00
Financial asset designated as at
fair value through profit or loss
Where:
Total 71,450,000.00
Other particulars:
□ Applicable√ Not applicable
3 Derivative financial assets
□ Applicable√ Not applicable
4 Notes receivable
(1). Notes receivable presented by category
□ Applicable√ Not applicable
(2). Notes receivable pledged by the Company at the end of the period
□ Applicable√ Not applicable
(3). Notes receivable endorsed or discounted by the Company at the end of the period
but not due yet at the balance sheet date
□ Applicable√ Not applicable
(4). Notes transferred by the Company into accounts receivable at the end of the period
due to the note issuer’s failure of performance
□ Applicable√ Not applicable
(5). Disclosure by accruing method for bad debt provisions
□ Applicable√ Not applicable
Bad debt provisions accrued separately:
□ Applicable√ Not applicable
Bad debt provisions accrued according to the combination:
□ Applicable√ Not applicable
If bad debt provisions are accrued according to the general model of expected credit losses,
please refer to the disclosure on other receivables:
□ Applicable√ Not applicable
210 / 323
2020 ANNUAL REPORT
(6). Particulars on bad debt provisions
□ Applicable√ Not applicable
(7). Particulars on notes receivable actually written-off in the current period
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
5 Accounts receivable
(1).Disclosure by account age
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Account age Carrying balance at the end of the period
Within 1 year
Where: Subitems within 1 year
Sub-total within 1 year 298,778,494.35
1-2 years 14,593,734.48
2-3 years 4,710,807.60
Above 3 years 1,840,662.14
3-4 years
4-5 years
Above 5 years
Total 319,923,698.57
(2).Disclosure by accruing method for bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Carrying Bad debt Carrying Bad debt
balance provisions balance provisions
Accr Accr
Categ Carryi Carryi
Perc uing Perc uing
ory ng ng
enta perc enta perc
Amount Amount value Amount Amount value
ge enta ge enta
(%) ge (%) ge
(%) (%)
Bad 16,916 5.29 16,916 100. 130,18 0.06 130,18 100.
debt ,210.8 ,210.8 00 7.88 7.88 00
provi 8 8
sions
accru
ed
separ
ately
Where:
211 / 323
2020 ANNUAL REPORT
Bad 303,00 94.7 18,129 5.98 284,87 212,01 99.9 13,609 6.42 198,40
debt 7,487. 1 ,068.1 8,419. 9,218. 4 ,969.2 9,249.
provi 69 1 58 48 9 19
sions
accru
ed
accor
ding
to
the
combi
natio
n
Where:
319,92 / 35,045 / 284,87 212,14 / 13,740 / 198,40
Total 3,698. ,278.9 8,419. 9,406. ,157.1 9,249.
57 9 58 36 7 19
Bad debt provisions accrued separately:
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance
Name Carrying Bad debt Accruing
Accruing reason
balance provisions percentage (%)
Bad debt 16,916,210.88 16,916,210.88 100.00 Not expected to
provisions accrued be recovered
separately
Total 16,916,210.88 16,916,210.88 100.00 /
Description on bad debt provisions accrued separately:
□ Applicable√ Not applicable
Bad debt provisions accrued according to the combination:
√ Applicable□ Not applicable
Items of portfolio provision: Account age combination
Unit: Yuan Currency: RMB
Closing balance
Name Accruing percentage
Accounts receivable Bad debt provisions
(%)
Account age 303,007,487.69 18,129,068.11 5.98
combination
Total 303,007,487.69 18,129,068.11 5.98
Recognition standards and descriptions on bad debts in portfolio provision:
√ Applicable□ Not applicable
In the account age combination, accounts receivable with bad debt provisions were
withdrawn according to the comparison of account age loss rate
Account age Closing balance
212 / 323
2020 ANNUAL REPORT
Carrying balance Bad debt provisions Accruing percentage (%)
Within 1 year 297,087,692.51 14,854,383.70 5.00
1-2 years 2,702,251.55 810,675.46 30.00
2-3 years 1,507,069.37 753,534.69 50.00
Above 3 years 1,710,474.26 1,710,474.26 100.00
Subtotal 303,007,487.69 18,129,068.11 5.98
If bad debt provisions are accrued according to the general model of expected credit losses,
please refer to the disclosure on other receivables:
□ Applicable√ Not applicable
(3).Particulars on bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period
Recover
Opening Resold or Closing
Category ed or Other
balance Accrued written-of balance
reverse changes
f
d
Bad debt 130,187.88 16,786,023. 16,916,210.
provision 00 88
s accrued
separatel
y
Bad debt 13,609,969. 7,506,093.3 3,593,624. 606,629. 18,129,068.
provision 29 8 01 45 11
s accrued
according
to the
combinati
on
Total 13,740,157. 24,292,116. 3,593,624. 606,629. 35,045,278.
17 38 01 45 99
Significant bad debt provision amounts recovered or reversed in the current period:
□ Applicable√ Not applicable
(4).Particulars on accounts receivable actually written-off in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Written-off amount
Accounts receivable actually written-off 3,593,624.01
Writing-off of significant accounts receivable
□ Applicable√ Not applicable
Description on writing-off of accounts receivable:
213 / 323
2020 ANNUAL REPORT
□ Applicable√ Not applicable
(5).Particulars on top 5 accounts receivable in terms of the balance at the end of the
period based on debtors
√ Applicable□ Not applicable
Proportion (%) of
the balance of Bad debt
Company name Carrying balance
accounts provisions
receivable
Beijing Jingdong Century Trading
66,863,696.90 20.90 3,343,184.85
Co., Ltd.
Zhejiang Youcaihua Network
35,000,003.20 10.94 1,750,000.16
Technology Co., Ltd.
Quzhou Mingbo Century Trading Co.,
24,108,668.27 7.54 1,205,433.41
Ltd. [Note]
Vipshop (China) Co., Ltd. 18,795,189.86 5.87 939,759.49
Shandong Chengtian Trading Co.,
13,339,122.10 4.17 666,956.11
Ltd.
Subtotal 158,106,680.33 49.42 7,905,334.02
[Note] The amount of Quzhou Mingbo Century Trading Co., Ltd. refers to the
consolidated amount of Quzhou Mingbo Century Trading Co., Ltd., Quzhou Jiaomei Trading
Co., Ltd., Quzhou Yumei Trading Co., Ltd. and Quzhou Ruoxi Cosmetics Co., Ltd. under the
control of the same person.
(6).Accounts receivable derecognized due to the transfer of financial assets
□ Applicable√ Not applicable
(7).Amount of assets and liabilities formed due to the transfer and continuous
involvement of accounts receivable
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
6 Receivables financing
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Bills receivable 5,531,997.32 2,150,000.00
Total 5,531,997.32 2,150,000.00
214 / 323
2020 ANNUAL REPORT
Changes in receivables financing during the current period and changes in fair value:
□ Applicable√ Not applicable
If bad debt provisions are accrued according to the general model of expected credit losses,
please refer to the disclosure on other receivables:
□ Applicable√ Not applicable
Other particulars:
√ Applicable□ Not applicable
Notes receivable endorsed or discounted by the Company at the end of the period and
unexpired at the balance sheet date
Amount derecognized
Item at the end of the
period
Bank acceptance 2,750,000.00
Subtotal 2,750,000.00
The acceptor of bank acceptance is the commercial bank. Due to higher credit of
commercial bank, the possibility of nonpayment when the banker acceptance is expired is
low. Therefore, the Company has terminated the recognition for the endorsed or discounted
bank acceptance. However, in case of nonpayment when such bank acceptance is expired,
as stipulated in the Law of Negotiable Instruments, the Company will still bear the joint
liability for the bearer.
7 Advance payment
(1).Advance payment presented by account age
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Account age
Amount Percentage (%) Amount Percentage (%)
Within 1 81,149,897.32 98.07 52,483,348.55 98.44
year
1-2 years 802,393.47 0.97 830,615.21 1.56
2-3 years 790,525.13 0.96
Above 3
years
Total 82,742,815.92 100.00 53,313,963.76 100.00
Description on the reasons for failure to settle the advance payment with an account age
over one year and a significant amount:
None
215 / 323
2020 ANNUAL REPORT
(2).Particulars on top 5 advance payments in terms of the balance at the end of the period
according to the concentration of parties to which the advance payments are made
√ Applicable□ Not applicable
Percentage (%) in the
Company name Carrying balance balance of
prepayment
Zhuhai Healthlong Biotechnology Co., Ltd. 21,432,452.28 25.90
Beauty Hi-tech Innovation Co., Ltd. 9,196,896.04 11.12
Alipay (China) Network Technology Co.,
6,201,918.15 7.50
Ltd.
Shanghai Mamamiya Mutual Entertainment
4,443,396.10 5.36
Network Technology Co., Ltd.
Shanghai Xunmeng Information Technology
3,490,744.72 4.22
Co., Ltd.
Subtotal 44,765,407.29 54.10
Other particulars
□ Applicable√ Not applicable
8 Other receivables
Presented by item
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Interest receivable
Dividend receivable
Other receivables 48,733,527.35 15,269,949.97
Total 48,733,527.35 15,269,949.97
Other particulars:
□ Applicable√ Not applicable
Interest receivable
(1).Classification of interest receivable
□ Applicable√ Not applicable
(2).Important overdue interest
□ Applicable√ Not applicable
(3).Particulars on accruing of bad debt provisions
□ Applicable√ Not applicable
Other particulars:
216 / 323
2020 ANNUAL REPORT
□ Applicable√ Not applicable
Dividend receivable
(1).Dividend receivable
□ Applicable√ Not applicable
(2).Important dividend receivable with the account age over one year
□ Applicable√ Not applicable
(3).Particulars on accruing of bad debt provisions
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
Other receivables
(1).Disclosure by account age
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Account age Carrying balance at the end of the period
Within 1 year
Where: Subitems within 1 year
Sub-total within 1 year 42,822,248.80
1-2 years 10,571,067.64
2-3 years 1,305,284.32
Above 3 years 1,009,369.58
3-4 years
4-5 years
Above 5 years
Total 55,707,970.34
(2).Particulars on classification by amount nature
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Carrying balance at the end Carrying balance at the
Amount nature
of the period beginning of the period
Deposit and margin 15,177,436.77 10,024,373.00
Provisional receivables 39,073,769.81 6,892,173.88
Petty cash 712,751.90 539,361.62
Others 744,011.86 27,000.00
Total 55,707,970.34 17,482,908.50
(3).Particulars on accruing of bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Bad debt Phase 1 Phase 2 Phase 3
Total
provisions Expected Expected credit Expected credit
217 / 323
2020 ANNUAL REPORT
credit losses loss for the loss for the
in the next 12 entire duration entire duration
months (no credit (credit
impairment impairment
occurred) occurred)
Balance as at 1 716,693.59 514,051.50 982,213.44 2,212,958.53
January 2020
Balance as at 1
January 2020 in
the current
period
-- Transferred -528,553.38 528,553.38
into Phase 2
-- Transferred -391,585.29 391,585.29
into Phase 3
-- Reversed into
Phase 2
-- Reversed into
Phase 1
Accrued in the -376,997.57 -25,638.37 19,241.95 -383,393.99
current period
Reserved in the
current period
Resold in the
current period
Written-off in 56,484.22 56,484.22
the current
period
Other changes 2,329,968.32 2,545,939.07 325,455.28 5,201,362.67
Balance as at 31 2,141,110.96 3,171,320.29 1,662,011.74 6,974,442.99
December 2020
Particulars on the significant changes in the carrying balance of other receivables in which changes in
loss provisions occurred in the current period:
□ Applicable√ Not applicable
The basis for adopting the amount of bad debt provisions accrued for the current period
and the assessment on whether the credit risk of financial instruments increased
significantly:
□ Applicable√ Not applicable
(4).Particulars on bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period
Opening Recovere Resold or Closing
Category Other
balance Accrued d or written-of balance
changes
reversed f
Account 2,212,958. -383,393.9 56,484.22 5,201,362. 6,974,442.
age 53 9 67 99
218 / 323
2020 ANNUAL REPORT
combinatio
n
Total 2,212,958. -383,393.9 56,484.22 5,201,362. 6,974,442.
53 9 67 99
Significant bad debt provision amounts reversed or recovered in the current period:
□ Applicable√ Not applicable
(5).Particulars on other receivables actually written-off in the current period
□ Applicable√ Not applicable
(6).Particulars on top 5 other receivables in terms of the balance at the end of the
period based on debtors
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Percentage (%)
in the total
Bad debt
balance at the
Company Amount Closing Account provisions
end of the
name nature balance age Closing
period of
balance
other
receivables
EURL Provisional 24,167,639.75 Within 1 43.38 1,208,381.99
PHARMATICA receivables year
[Note 1]
SIKEROM Provisional 8,204,225.54 Within 1 14.73 410,211.28
EUROPE GMBH receivables year
Hangzhou Deposit and 4,708,614.72 1-2 years 8.45 1,412,584.42
Property margin
Maintenance
Fund
Management
Center
Shanghai Provisional 1,500,000.00 [Note 2] 2.69 443,955.00
Zhicheng receivables
Heli
Network
Media
Development
Co., Ltd.
Zhejiang Provisional 1,412,036.00 Within 1 2.53 70,601.80
ZTO Jixiang receivables year
Express
Service
Co., Ltd.
Total / 39,992,516.01 / 71.78 3,545,734.49
[Note 1] The amount of EURL PHARMATICA refers to the consolidated amount of EURL
PHARMATICA, PARISEZHAN HK LIMITED, SARL ORTUS and S.A.S AREDIS under the control of the
219 / 323
2020 ANNUAL REPORT
same person.
[Note 2] Within 1 year: RMB 24,180.00; 1-2 years: RMB 1,475,820.00.
(7).Receivables involving government grants
□ Applicable√ Not applicable
(8).Other receivables derecognized due to the transfer of financial assets
□ Applicable√ Not applicable
(9).Amount of assets and liabilities formed due to the transfer and continuous
involvement of other receivables
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
9 Inventories
(1).Classification of inventories
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Inventory
Inventory
falling
depreciation
price
provisions/im
reserves/imp
Item Carrying pairment Carrying Carrying Carrying
airment
balance provisions for value balance value
provisions
contract
for contract
performance
performance
cost
cost
Raw 25,023,19 790,191.51 24,233,00 16,474,64 801,848.85 15,672,79
materials 8.10 6.59 4.08 5.23
Work-in-p 19,699,80 333,215.45 19,366,59 8,767,643 1,331,381.19 7,436,261
rocess 9.41 3.96 .14 .95
Finished 402,419,0 21,221,419.14 381,197,6 280,160,0 16,867,854.4 263,292,2
products 36.40 17.26 75.99 6 21.53
Revolving
materials
Expendabl
e
biologica
l assets
Contract
performan
ce cost
Packaging 32,988,46 1,383,453.99 31,605,01 18,042,22 1,623,844.55 16,418,38
materials 9.32 5.33 8.43 3.88
220 / 323
2020 ANNUAL REPORT
Low-value 2,643,028 268,617.88 2,374,410 1,918,233 95,937.86 1,822,295
consumabl .64 .76 .68 .82
es
Purchased 11,494,42 1,630,055.73 9,864,373 12,946,64 3,939,600.16
gift 9.58 .85 4.82 9,007,044
.66
Total 494,267,9 25,626,953.70 468,641,0 338,309,4 24,660,467.0 313,649,0
71.45 17.75 70.14 7 03.07
(2).Inventory falling price reserves and impairment provisions for contract performance
cost
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase amount of the Decrease amount of the
Opening current period current period Closing
Item
balance Reversed balance
Accrued Others Others
or resold
Raw materials 801,848.8 695,497.9 166.09 707,321.3 790,191.5
5 6 9 1
Work-in-process 1,331,381 182,647.5 1,180,813 333,215.4
.19 7 .31 5
Finished 16,867,85 24,751,87 378,553.9 20,776,85 21,221,41
products 4.46 0.03 7 9.32 9.14
Revolving
materials
Expendable
biological
assets
Contract
performance cost
Packaging 1,623,844 1,057,784 1,298,174 1,383,453
materials .55 .09 .65 .99
Low-value 95,937.86 178,070.3 17,532.14 22,922.43 268,617.8
consumables 1 8
Purchased gift 3,939,600 1,368,735 3,678,279 1,630,055
.16 .54 .97 .73
Total 24,660,46 28,234,60 396,252.2 27,664,37 25,626,95
7.07 5.50 0 1.07 3.70
Other increase of RMB 396,252.20 of inventory falling price reserve in the current
period came from the equity of Shanghai Healthlong Biochemical Technology Co., Ltd., and
its inventory falling price reserve was transferred in correspondingly.
At the end of the current period, the net realizable value of some products was lower
than the corresponding cost, so the inventory falling price reserve shall be withdrawn
in accordance with the difference between the cost and the net realizable value.
221 / 323
2020 ANNUAL REPORT
(3).Description on the capitalization amount of the borrowing expenses included in the
balance of inventories at the end of the period
□ Applicable√ Not applicable
(4).Description of amortization amount of the contract performance cost in the current
period
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
10 Contract assets
(1).Contract assets
□ Applicable√ Not applicable
(2).Amount of and reasons for material changes in the carrying value in the Reporting
Period
□ Applicable√ Not applicable
(3).Impairment provisions accrued from the contract assets in the current period
□ Applicable√ Not applicable
If bad debt provisions are accrued according to the general model of expected credit
losses, please refer to the disclosure on other receivables:
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
11 Held-for-sale assets
□ Applicable√ Not applicable
12 Non-current assets due within one year
□ Applicable√ Not applicable
Important debt investment and other debt investment at the end of the period:
□ Applicable√ Not applicable
Other particulars
None
13 Other current assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Contract acquisition cost
Return cost receivable 4,434,684.01 7,122,566.88
VAT input tax to be deducted 24,162,220.64 7,126,880.88
Advance payment of taxes 6,638,906.62 4,596,387.71
Total 35,235,811.27 18,845,835.47
222 / 323
2020 ANNUAL REPORT
Other particulars
Refer to the particulars of V.44 in “Section XI Financial Report” of this report for
the difference between the opening balance and closing balance of prior period (31
December 2019).
14 Debt investment
(1).Particulars on debt investment
□ Applicable√ Not applicable
(2).Important debt investment at the end of the period
□ Applicable√ Not applicable
(3).Particulars on accruing of impairment provisions
□ Applicable√ Not applicable
The basis for adopting the amount of impairment provisions accrued for the current period and the
assessment on whether the credit risk of financial instruments increased significantly:
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
15 Other debt investments
(1).Particulars on other debt investments
□ Applicable√ Not applicable
(2).Other important debt investments at the end of the period
□ Applicable√ Not applicable
(3).Particulars on accruing of impairment provisions
□ Applicable√ Not applicable
The basis for adopting the amount of impairment provisions accrued for the current period and the
assessment on whether the credit risk of financial instruments increased significantly:
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
16 Long-term receivables
(1).Long-term receivables
□ Applicable√ Not applicable
(2).Particulars on accruing of bad debt provisions
□ Applicable√ Not applicable
The basis for adopting the amount of bad debt provisions accrued for the current period and the
assessment on whether the credit risk of financial instruments increased significantly:
□ Applicable√ Not applicable
223 / 323
2020 ANNUAL REPORT
(3).Long-term receivables derecognized due to the transfer of financial assets
□ Applicable√ Not applicable
(4).Amount of assets and liabilities formed due to the transfer and continuous
involvement of long-term receivables
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
17 Long-term equity investment
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period
Inves Balan
tment Decla ce of
Adju
gains ratio impai
stme
and n on rment
nt to Accru
With losse Othe distr provi
Inves Openi othe ing Closi
Addit draw s r ibuti sions
ted ng r of ng
ional n recog equi on of Other at
compa balan comp impai balan
inves inve nized ty cash s the
ny ce rehe rment ce
tment stme under chan divid end
nsiv provi
nt the ges ends of
e sions
equit or the
inco
y profi perio
me
metho ts d
d
I. Joint venture
Huzho 3,314 -7,85 3,306
u ,489. 9.00 ,630.
Panru 57 57
i
Indus
trial
Inves
tment
Partn
ershi
p
(Limi
ted
Partn
ershi
p)
Sub-t 3,314 -7,85 3,306
otal ,489. 9.00 ,630.
224 / 323
2020 ANNUAL REPORT
57 57
II. Associate
Xiong 2,999 -14,4 2,985
ke ,955. 44.47 ,511.
Cultu 82 35
re
Media
(Hang
zhou)
Co.,
Ltd.
Beiji
ng
Mitan
gpai
Cosme
tics
Co.,
Ltd.
[Note
1]
Ningb 2,574 1,86 -713,
o Segu ,740. 1,32 411.9
Brand 38 8.48 0
Manag
ement
Co.,
Ltd.
[Note
2]
Metis 5,838 465,6 6,304
Info ,817. 12.87 ,430.
Tech 91 78
(Guan
gzhou
) Co.,
LTD.
Jiaxi 46,00 -376, 45,62
ng 0,000 513.1 3,486
Woyon .00 0 .90
g
Inves
tment
Partn
ershi
p
(Limi
ted
Partn
ershi
225 / 323
2020 ANNUAL REPORT
p)
Sub-t 11,41 46,00 1,86 -638, 54,91
otal 3,514 0,000 1,32 756.6 3,429
.11 .00 8.48 0 .03
14,72 46,00 1,86 -646, 58,22
Total 8,003 0,000 1,32 615.6 0,059
.68 .00 8.48 0 .60
Other particulars
[Note 1] The original investment, by the Company, on Beijing Mitangpai Cosmetics Co.,
Ltd. was RMB 5,638,295.00, the investment gains and losses recognized under the equity
method was RMB -1,561,584.17, and the accruing of impairment provisions amounted to RMB
4,076,710.83. This company was canceled in August 2020.
[Note 2] The Company transferred 35% equity of Ningbo Segu Brand Management Co., Ltd.
to Liu Wei at a consideration of RMB 1.75 million in November 2020, and the investment
income of RMB -111,328.48 was recognized.
18 Investments in other equity instruments
(1).Particulars on other equity instrument investments
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Hangzhou Regenovo Biotechnology., 20,580,000.00
Ltd.
Total 20,580,000.00
(2).Particulars on non-trading equity instrument investment
□ Applicable√ Not applicable
Other particulars:
√ Applicable□ Not applicable
Based on the strategic investment purpose, the Company made foreign equity investment,
and the investee will obtain the investment of the Company as equity instrument. Therefore,
this part of equity instrument investment was designated, by the Company, as financial
assets measured at fair value through other comprehensive income.
19 Other non-current financial assets
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
20 Investment real estate
Measurement model of investment real estate
226 / 323
2020 ANNUAL REPORT
(1).Investment real estate applying cost measurement model
Unit: Yuan Currency: RMB
Buildings and Land use Construction
Item Total
constructions rights in progress
I. Original carrying value
1. Balance at the 73,788,298.77 73,788,298.77
beginning of the period
2. Increase amount of 3,071,733.33 3,071,733.33
the current period
(1) Acquisition
(2) Transfer in of 3,071,733.33 3,071,733.33
inventories\fixed
assets\projects under
construction
(3) Increase for
business combination
3. Decrease amount of
the current period
(1) Disposal
(2) Other transfer out
4. Balance at the end 76,860,032.10 76,860,032.10
of the period
II. Accumulated
depreciation and
accumulated amortization
1. Balance at the 2,166,215.59 2,166,215.59
beginning of the period
2. Increase amount of 2,456,206.41 2,456,206.41
the current period
(1) Accrual or 2,456,206.41 2,456,206.41
amortization
3. Decrease amount of
the current period
(1) Disposal
(2) Other transfer out
4. Balance at the end 4,622,422.00 4,622,422.00
of the period
III. Impairment
provisions
1. Balance at the
beginning of the period
2. Increase amount of
the current period
(1) Accruing
3. Decreased amount in
the current period
(1) Disposal
(2) Other transfer out
4. Balance at the end
227 / 323
2020 ANNUAL REPORT
of the period
IV. Carrying value
1. Carrying value at 72,237,610.10 72,237,610.10
the end of the period
2. Carrying value at 71,622,083.18 71,622,083.18
the beginning of the
period
(2).Investment real estate with the property ownership certificate unsettled
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
21 Fixed assets
Presented by item
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Fixed assets 565,864,152.62 550,329,145.07
Disposal of fixed assets
Total 565,864,152.62 550,329,145.07
Other particulars:
□ Applicable√ Not applicable
Fixed assets
(1).Particulars on fixed assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Means of
Property and Machinery and General
Item transportati Total
buildings equipment equipment
on
I. Original
carrying
value:
1.
Balance at
the 512,551,045. 154,267,432. 17,017,117.5 55,344,021. 739,179,616.
beginning 14 04 8 49 25
of the
period
2.
Increase
21,138,093.2 23,392,008.6 7,242,158.1 56,391,544.5
amount of 4,619,284.66
0 0 0 6
the current
period
(1) 3,928,467.6 15,285,639.1
7,666,292.13 3,690,879.37
Acquisitio 9 9
228 / 323
2020 ANNUAL REPORT
n
(2)
Transfer-i
n from 21,138,093.2 15,725,716.4 1,617,977.3 38,481,787.0
constructi 0 7 4 1
on in
progress
(3)
Increase
for 1,695,713.0
928,405.29 2,624,118.36
business 7
combinatio
n
3.
Decrease
amount of 6,837.61 411,428.99 335,243.75 753,510.35
the current
period
(1)
Disposal or 6,837.61 411,428.99 335,243.75 753,510.35
scraping
4.
Balance at 533,689,138. 177,652,603. 21,224,973.2 62,250,935. 794,817,650.
the end of 34 03 5 84 46
the period
II.
Accumulati
ve
depreciati
on
1.
Balance at
the 72,724,807.3 87,465,399.0 10,683,650.7 17,976,614. 188,850,471.
beginning 5 2 4 07 18
of the
period
2.
Increase
16,496,264.7 14,109,195.8 8,000,920.4 40,815,777.6
amount of 2,209,396.57
4 9 3 3
the current
period
(1) 16,496,264.7 14,109,195.8 6,963,029.5 39,489,836.6
1,921,346.50
Accruing 4 9 6 9
Othe 288,050.07 1,037,890.8 1,325,940.94
r 7
transfer-i
n [Note]
3.
Decrease 6,170.94 387,106.96 319,473.07 712,750.97
amount of
229 / 323
2020 ANNUAL REPORT
the current
period
(1)
Disposal or 6,170.94 387,106.96 319,473.07 712,750.97
scraping
4.
Balance at 89,221,072.0 101,568,423. 12,505,940.3 25,658,061. 228,953,497.
the end of 9 97 5 43 84
the period
III.
Impairment
provisions
1.
Balance at
the
beginning
of the
period
2.
Increase
amount of
the current
period
(1)
Accruing
3.
Decrease
amount of
the current
period
(1)
Disposal or
scraping
4.
Balance at
the end of
the period
IV.
Carrying
value
1.
Carrying
444,468,066. 76,084,179.0 36,592,874. 565,864,152.
value at 8,719,032.90
25 6 41 62
the end of
the period
2.
Carrying
439,826,237. 66,802,033.0 37,367,407. 550,329,145.
value at 6,333,466.84
79 2 42 07
the
beginning
230 / 323
2020 ANNUAL REPORT
of the
period
[Note] Other transfer-in of original value of fixed assets of RMB 2,624,118.36 and other
transfer-in of accumulated depreciation of RMB 1,325,940.94 came from the equity of
Shanghai Healthlong Biochemical Technology Co., Ltd., and its original value of fixed
assets and accumulated depreciation were transferred in correspondingly.
(2).Particulars on temporary idle fixed assets
□ Applicable√ Not applicable
(3).Particulars on fixed assets leased in under financing leases
□ Applicable√ Not applicable
(4).Fixed assets leased out under operating leases
□ Applicable√ Not applicable
(5).Particulars on fixed assets with the property ownership certificate unsettled
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
Disposal of fixed assets
□ Applicable√ Not applicable
22 Construction in progress
Presented by item
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Construction in progress 47,324,523.36 31,894,658.49
Engineering materials
Total 47,324,523.36 31,894,658.49
Other particulars:
□ Applicable√ Not applicable
Construction in progress
(1).Particulars on projects under construction
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Impairme Carrying Impairme
Item Carrying nt Carrying nt Carrying
balanc
balance provision value provision value
s e s
231 / 323
2020 ANNUAL REPORT
Decoration 1,725,308. 1,725,308. 10,299,774 10,299,774
works 02 02 .68 .68
Make-up 28,236,822 28,236,822 9,919,160. 9,919,160.
factory .35 .35 47 47
Proya
Building
Other 17,362,392 17,362,392 11,675,723 11,675,723
miscellane .99 .99 .34 .34
ous works
47,324,523 47,324,523 31,894,658 31,894,658
Total
.36 .36 .49 .49
(2).Changes in important projects under construction in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Pro
por
Amou tio
Where
nt n of
: Inter
of Othe cum
Amoun est
Incr fixe r ula Accum
t of capit
ease d decr tiv ulate
inter aliza
Ope amou asse ease e Pro d
est tion
nin nt ts amou Clos inv gre amoun Sour
It capit rate
Bud g of tran nts ing est ss t of ce
em aliza (%)
get bal the sfer in bala men of inter of
s tion in
anc curr red the nce t in wor est fund
in the
e ent in curr the ks capit
the curre
peri the ent pro aliza
curre nt
od curr peri jec tion
nt perio
ent od t to
perio d
peri the
d
od bud
get
(%)
Pr RMB 23,9 23,9 82. 100 9,206 Self
oy 458 27,3 27,3 22 .00 ,186. -rai
a ,93 48.6 48.6 % 05 sed
Bu 6,3 5 5
il 00
di
ng
Ma 9,91 36,9 5,27 13,3 28,2 89. 96. Self
ke 9,16 37,7 1,73 48,3 36,8 92 47% -rai
-u 0.47 89.5 0.94 96.6 22.3 sed
p 0 8 5
fa
ct
or
y
232 / 323
2020 ANNUAL REPORT
RMB 9,91 60,8 29,1 13,3 28,2 / / 9,206 / /
To 458 9,16 65,1 99,0 48,3 36,8 ,186.
ta ,93 0.47 38.1 79.5 96.6 22.3 05
l 6,3 5 9 8 5
00
[Note] Other decreases in the current period were transferred long-term prepaid expenses.
(3).Particulars on impairment provisions accrued for projects under construction in the
current period
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
Engineering materials
(1).Particulars on engineering materials
□ Applicable√ Not applicable
23 Productive biological assets
(1).Productive biological assets applying cost measurement model
□ Applicable√ Not applicable
(2).Productive biological assets applying fair value measurement model
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
24 Oil and gas assets
□ Applicable√ Not applicable
25 Right-of-use assets
□ Applicable√ Not applicable
26 Intangible assets
(1).Particulars on intangible assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Unpaten
Tradema
Land use Patent ted Customer
Item Software rk Total
rights right technol resources
right
ogy
I.
Original
carrying
value
1. 376,212,92 18,390,99 420,000 532,600 12,833,68 120,640 408,510,85
Balance 8.47 8.71 .00 .00 4.00 .00 1.18
at the
beginnin
233 / 323
2020 ANNUAL REPORT
g of the
period
2. 1,168,132 126,900 16,491. 1,311,523.
Increase .13 .00 75 88
amount of
the
current
period
(1 740,165.5 16,491. 756,657.27
) 2 75
Acquisit
ion
(2
) R&D
(3 427,966.6 126,900 554,866.61
) 1 .00
Increase
for
business
combinat
ion
3.
Decrease
amount of
the
current
period
(1
)
Disposal
4. 376,212,92 19,559,13 420,000 659,500 12,833,68 137,131 409,822,37
Balance 8.47 0.84 .00 .00 4.00 .75 5.06
at the
end of
the
period
2.
Cumulati
ve
amortiza
tion
1. 59,724,558 16,060,00 420,000 525,265 3,208,421 8,042.3 79,946,287
Balance .17 1.34 .00 .00 .00 4 .85
at the
beginnin
g of the
period
2. 9,230,473. 1,704,823 3,260.0 4,277,894 16,311. 15,232,763
Increase 82 .03 0 .67 72 .24
amount of
234 / 323
2020 ANNUAL REPORT
the
current
period
(1 9,230,473. 1,454,410 3,260.0 4,277,894 16,311. 14,982,350
) 82 .50 0 .67 72 .71
Accruing
22 250,412.5 250,412.53
) Other 3
transfer
-in
[Note]
3.
Decrease
amount of
the
current
period
(1)
Disposal
4. 68,955,031 17,764,82 420,000 528,525 7,486,315 24,354. 95,179,051
Balance .99 4.37 .00 .00 .67 06 .09
at the
end of
the
period
III.
Impairme
nt
provisio
ns
1.
Balance
at the
beginnin
g of the
period
2.
Increase
amount of
the
current
period
(1
)
Accruing
3.
Decrease
amount of
235 / 323
2020 ANNUAL REPORT
the
current
period
(1
)
Disposal
4.
Balance
at the
end of
the
period
IV.
Carrying
value
1. 307,257,89 1,794,306 130,975 5,347,368 112,777 314,643,32
Carrying 6.48 .47 .00 .33 .69 3.97
value at
the end
of the
period
2. 316,488,37 2,330,997 7,335.0 9,625,263 112,597 328,564,56
Carrying 0.30 .37 0 .00 .66 3.33
value at
the
beginnin
g of the
period
[Note] Other transfer-in of original value of intangible assets of RMB 554,866.61
and other transfer-in of accumulated amortization of RMB 250,412.53 came from the equity
of Shanghai Healthlong Biochemical Technology Co., Ltd., and its original value of
intangible assets and accumulated amortization were transferred in correspondingly.
The proportion of intangible assets formed by the Company's internal R&D at the end of
the current period in the balance of intangible assets was 0
(2).Particulars on land use rights with the property ownership certificate unsettled
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
27 Development expenses
□ Applicable√ Not applicable
236 / 323
2020 ANNUAL REPORT
28 Goodwill
(1).Original carrying value of goodwill
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of the Decrease of the
current period current period
Name of invested Formed
Opening Closing
company or event due to
balance balance
forming goodwill business Disposal
combinati
on
Shanghai 31,034,16 31,034,1
Healthlong 1.20 61.20
Biochemical
Technology Co.,
Ltd.
31,034,16 31,034,1
Total
1.20 61.20
(2).Impairment provisions of goodwill
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Name of invested Increase of the Decrease of the
Opening Closing
company or event current period current period
balance balance
forming goodwill Accrued Disposal
Shanghai
Healthlong
Biochemical
Technology Co.,
Ltd.
Total
(3).Information regarding the asset group or the combination of asset groups to which
goodwill belongs
√ Applicable□ Not applicable
Composition of asset group or Operating assets and liabilities of Shanghai Healthlong
combination of asset groups Biochemical Technology Co., Ltd.
Carrying value of the asset group
146,178,528.82
or the combination of asset groups
Carrying value and apportionment The Company held 52% equity of Shanghai Healthlong
method of goodwill apportioned to Biochemical Technology Co., Ltd., and the goodwill
the asset group or the combination value apportioned to its asset group was RMB
of asset groups 59,681,079.23
Carrying value of the asset group
or the combination of asset groups 205,859,608.05
including goodwill
237 / 323
2020 ANNUAL REPORT
Whether the asset group or the
combination of asset groups is
consistent with that determined in Yes
goodwill impairment test on the
acquisition date and in previous years
(4).Describe the goodwill impairment test process, key parameters (such as growth rate
in the forecast period, growth rate in the stable period, profit margin, discount
rate, forecast period, etc. when estimating the present value of the estimated future
cash flow, if applicable) and the recognition method for impairment losses of
goodwill
√ Applicable□ Not applicable
The recoverable amount of goodwill is calculated at the present value of the expected
future cash flow. The expected cash flow is based on the 2021 cash flow forecast approved
by the Company, with the discount rate of 17.77% for cash flow forecast. The cash flow
after the forecast period is calculated by the growth rate of 0%.
Other key data used in impairment test include: estimated selling price, sales volume,
production cost and other related expenses.
The Company determines the above key data according to the historical experience and the
market development forecast. The discount rate adopted by the Company is the pre-tax rate
reflecting the time value of money in current market and special risks of relevant asset
groups.
The forecast on the above recoverable amount indicates no impairment loss in goodwill.
(5).Effect of goodwill impairment test
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
29 Long-term prepaid expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Opening Increase Amortization Other Closing
balance amount of the amount of the decrease balance
current current amounts
period period
Decoration 25,303,734.19 23,795,756.26 15,887,393.25 33,212,097.20
and rental
fee
Endorsement 488,145.15 31,132,074.61 14,757,013.06 16,863,206.70
fee
238 / 323
2020 ANNUAL REPORT
Garage use 578,850.40 192,949.92 385,900.48
fee
Mould 7,834.76 7,834.76
Software 134,423.63 18,834.48 115,589.15
service fee
Total 26,378,564.50 55,062,254.50 30,864,025.47 50,576,793.53
Other particulars:
In the current period, the decoration and rental fee increased by RMB 640,613.07,
and the software service fee increased by RMB 134,423.63, which came from the equity of
Shanghai Healthlong Biochemical Technology Co., Ltd.; its long-term prepaid expenses were
transferred in correspondingly.
30 Deferred income tax assets/liabilities
(1).Non-offset deferred income tax assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Deductible Deferred Deductible Deferred
Item
temporary income tax temporary income tax
differences Assets differences assets
Impairment
provisions of assets
Unrealized profits 28,021,116.50 7,005,279.12 34,435,895.93 8,608,973.98
from internal
transactions
Deductible losses 14,342,610.24 3,585,652.56
Bad debt provisions 27,188,715.77 6,796,972.50 8,107,969.05 2,025,703.32
for accounts
receivable
Devaluation 15,796,150.28 2,634,264.73 14,868,791.08 2,571,107.32
provisions of
inventories
Impact from 103,953,760.07 22,803,327.25 61,640,988.02 9,246,148.20
share-based payment
Government grants 8,495,353.33 1,274,303.00 8,491,110.00 1,273,666.50
related to assets
Unredeemed member 4,487,591.14 1,121,897.79 6,896,104.00 1,724,026.00
points
Expected return loss 5,755,415.21 1,438,853.81 10,102,532.74 2,525,633.19
Total 208,040,712.54 46,660,550.76 144,543,390.82 27,975,258.51
(2).Non-offset deferred income tax liabilities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
239 / 323
2020 ANNUAL REPORT
Taxable Deferred Taxable Deferred
temporary income tax temporary income tax
differences liabilities differences liabilities
Assets appreciation
for business
combination not under
the common control
Changes in fair value
of other debt
investments
Changes in fair value
of other equity
instrument
investments
One-time deduction of 44,252,231.66 6,874,105.45 33,825,660.75 5,132,011.38
depreciation of fixed
assets
Total 44,252,231.66 6,874,105.45 33,825,660.75 5,132,011.38
(3).Deferred income tax assets or liabilities presented on a net basis after offsetting
□ Applicable√ Not applicable
(4).Details of unrecognized deferred income tax assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Deductible temporary 25,362,258.78 23,305,078.22
differences
Deductible losses 379,300,493.32 275,181,937.40
Total 404,662,752.10 298,487,015.62
(5).The deductible losses of unrecognized deferred income tax assets will expire in the
following years
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount at the
Amount at the end of
Year beginning of the Note
the period
period
2021 48,812,246.22 48,812,246.22
2022 62,924,802.76 63,135,622.67
2023 63,485,783.30 63,485,783.30
2024 99,748,285.21 99,748,285.21
2025 104,329,375.83
Total 379,300,493.32 275,181,937.40 /
Other particulars:
□ Applicable√ Not applicable
240 / 323
2020 ANNUAL REPORT
31 Other non-current assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Carrying Impairme Carrying Impairme
Item balance nt Carrying balance nt Carrying
provisio value provisio value
ns ns
Contract
acquisiti
on cost
Contract
performan
ce cost
Return
cost
receivabl
e
Contract
assets
Prepaymen 83,203,303. 83,203,303. 15,006,146. 15,006,146.
t for 76 76 49 49
purchase
of
long-term
assets
Other 4,119,476.2 4,119,476.2
long-term 7 7
assets
87,322,780. 87,322,780. 15,006,146. 15,006,146.
Total
03 03 49 49
Other particulars:
RMB 81.6 million was used for land purchase in Longwu. As at 31 December 2020, the
corresponding land delivery procedure has not been completed.
32 Short-term borrowings
(1).Classification of short-term borrowings
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Pledged borrowings
Mortgaged borrowings
Guaranteed borrowings 99,116,462.50
Credit borrowings 200,163,972.59
Pledged and guaranteed 129,047,396.51
borrowings
Total 299,280,435.09 129,047,396.51
241 / 323
2020 ANNUAL REPORT
Description on classification of short-term borrowings:
None
(2).Particulars on overdue but outstanding short-term borrowings
□ Applicable√ Not applicable
Particulars of important overdue but yet unrepaid short-term borrowings:
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
33 Held-for-trading financial liabilities
□ Applicable√ Not applicable
34 Derivative financial liabilities
□ Applicable√ Not applicable
35 Notes payable
(1).Presentation of notes payable
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Type Closing balance Opening balance
Trade acceptance
Bank acceptance 64,580,000.00 41,830,948.53
Total 64,580,000.00 41,830,948.53
The total amount of notes payable due but outstanding at the end of the current period
was RMB 0.
36 Accounts payable
(1).Presentation of accounts payable
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Payment for goods 428,697,891.17 277,377,279.70
Expenses payable 69,493,675.06 44,347,651.15
Payment for engineering 17,640,465.04 25,591,912.54
equipment
Total 515,832,031.27 347,316,843.39
(2).Significant accounts payable with the account age over one year
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
242 / 323
2020 ANNUAL REPORT
37 Prepayment received
(1). Presentation of advance received from customers
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Payment for goods
Total
(2). Significant prepayment received with the account age over one year
□ Applicable√ Not applicable
Other particulars
√ Applicable□ Not applicable
Refer to the particulars of V.44 in “Section XI Financial Report” herein for the
difference between the opening balance and closing balance of prior year (31 December
2019).
38 Contract liabilities
(1).Contract liabilities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Advances on sales 25,430,738.70 38,964,687.33
Unredeemed member points 5,188,040.29 11,251,926.56
Total 30,618,778.99 50,216,613.89
(2).Amount of and reasons for material changes in the carrying value in the Reporting
Period
□ Applicable√ Not applicable
Other particulars:
√ Applicable□ Not applicable
Refer to the particulars of V.44 in “Section XI Financial Report” herein for the
difference between the opening balance and closing balance of prior year (31 December
2019).
39 Employee benefits payable
(1).Presentation of employee benefits payable
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of Decrease of
Opening Closing
Item the current the current
balance balance
period period
I. Short-term benefits 65,565,250.54 375,017,339.6 370,327,967.4 70,254,622.82
8
II. Post-employment 1,118,901.44 5,863,903.93 6,409,188.49 573,616.88
243 / 323
2020 ANNUAL REPORT
benefits - Defined
contribution plans
III. Dismissal benefits 201,571.73 201,571.73
IV. Other benefits due
within one year
66,684,151.98 381,082,815.3 376,938,727.6 70,828,239.70
Total
4 2
(2).Presentation of short-term benefits
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of Decrease of
Opening Closing
Item the current the current
balance balance
period period
I. Salary, bonus, 63,909,902.04 334,251,903.2 329,517,966.7 68,643,838.60
allowance and subsidy 8 2
II. Employee benefits 14,327,349.36 14,320,533.80 6,815.56
III. Social insurance 938,499.38 12,849,186.25 12,905,457.63 882,228.00
Where: Medical 789,484.39 12,246,181.23 12,259,474.67 776,190.95
insurance premiums
Work-related 62,603.91 167,745.13 172,489.71 57,859.33
injury insurance
Maternity 86,411.08 435,259.89 473,493.25 48,177.72
insurance
IV. Housing provident 716,771.52 11,587,769.58 11,582,800.44 721,740.66
fund
V. Labor union and 77.6 2,001,131.21 2,001,208.81
employee education
funds
VI. Short-term
compensated absences
VII. Short-term profit
sharing plan
65,565,250.54 375,017,339.6 370,327,967.4 70,254,622.82
Total
8 0
(3).Presentation of defined contribution plans
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of Decrease of
Opening Closing
Item the current the current
balance balance
period period
1. Basic pension 1,078,408.97 5,605,689.66 6,137,980.91 546,117.72
2. Unemployment 40,492.47 258,214.27 271,207.58 27,499.16
insurance
3. Enterprise annuity
payment
244 / 323
2020 ANNUAL REPORT
Total 1,118,901.44 5,863,903.93 6,409,188.49 573,616.88
Other particulars:
□ Applicable√ Not applicable
40 Taxes payable
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Value added tax (“VAT”) 25,557,167.53 25,197,722.01
Consumption tax 359.31 4,103.80
Business tax
Enterprise income tax 32,994,016.76 35,920,176.92
Personnel income tax 1,193,830.42 1,145,293.78
Urban maintenance and 2,971,080.02 1,711,912.59
construction tax
Property tax 5,822,344.89 6,188,353.46
Education surcharge 1,469,430.26 900,330.64
Local education surcharge 979,620.14 600,220.42
Stamp duty 330,703.60 154,729.52
Disabled security fund 16,737.84 10,857.47
Total 71,335,290.77 71,833,700.61
Other particulars:
None
41 Other payables
Presented by item
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Interest payable
Dividend payable
Other payables 75,546,323.32 91,444,673.31
Total 75,546,323.32 91,444,673.31
Other particulars:
□ Applicable√ Not applicable
Interest payable
(1).Presentation by category
□ Applicable√ Not applicable
Dividends payable
(1).Presentation by category
□ Applicable√ Not applicable
245 / 323
2020 ANNUAL REPORT
Other payables
(1). Other payables presented by amount nature
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Deposit and margin 54,289,062.52 66,903,407.44
Repurchase obligation of 12,653,905.25 15,769,051.20
restricted shares
Others 8,603,355.55 8,772,214.67
Total 75,546,323.32 91,444,673.31
(2). Other payables with the account age over one year
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Reasons for outstanding
Item Closing balance
amount or carry-over
Repurchase obligation of 12,653,905.25 The repurchase obligation of
restricted shares restricted shares has not
been fulfilled yet
Total 12,653,905.25 /
Other particulars:
□ Applicable√ Not applicable
42 Held-for-sale liabilities
□ Applicable√ Not applicable
43 Non-current liabilities due within one year
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Long-term borrowings due 85,258,247.69
within one year
Bonds payable due within
one year
Long-term payables due
within one year
Lease liabilities due
within one year
Total 85,258,247.69
Other particulars:
None
44 Other current liabilities
Particulars on other current liabilities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
246 / 323
2020 ANNUAL REPORT
Short-term bonds payable
Return refunds payable
Output taxes to be 1,439,262.02 1,948,803.22
transferred
Total 1,439,262.02 1,948,803.22
Changes in short-term bonds payable:
□ Applicable√ Not applicable
Other particulars:
√ Applicable□ Not applicable
Refer to the particulars of V.44 in “Section XI Financial Report” herein for the
difference between the opening balance and closing balance of prior year (31 December
2019).
45 Long-term borrowings
(1). Classification of long-term borrowings
□ Applicable√ Not applicable
Other particulars, including interest rate ranges:
□ Applicable√ Not applicable
46 Bonds payable
(1).Bonds payable
□ Applicable√ Not applicable
(2).Increase or decrease of bonds payable: (excluding other financial instruments such
as preferred shares and perpetual bonds classified as financial liabilities)
□ Applicable√ Not applicable
(3).Description on the conversion conditions and conversion time of convertible
corporate bonds
□ Applicable√ Not applicable
(4).Description on other financial instruments classified as financial liabilities
Basic information on other financial instruments such as outstanding preferred shares
and perpetual bonds at the end of the period
□ Applicable√ Not applicable
Form of changes in financial instruments such as outstanding preferred shares and
perpetual bonds at the end of the period
□ Applicable√ Not applicable
Description of the basis for other financial instruments classified as financial
liabilities:
□ Applicable√ Not applicable
247 / 323
2020 ANNUAL REPORT
Other particulars:
□ Applicable√ Not applicable
47 Lease liabilities
□ Applicable√ Not applicable
48 Long-term payables
Presented by item
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
Long-term payables
(1).Long-term payables presented by amount nature
□ Applicable√ Not applicable
Special payables
(1).Special payables presented by amount nature
□ Applicable√ Not applicable
49 Long-term employee remuneration payable
□ Applicable√ Not applicable
50 Estimated liabilities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Opening balance Closing balance Cause of formation
External guarantee
Pending actions
Product quality
assurance
Restructuring
obligation
Onerous contract to
be executed
17,225,099.62 10,190,099.22 Estimate the
Return refunds
possible return
payable
loss in the future
Others
Total 17,225,099.62 10,190,099.22 /
Other particulars, including descriptions on relevant important assumptions and
estimates of significant estimated liabilities:
248 / 323
2020 ANNUAL REPORT
Refer to the particulars of V.44 in “Section XI Financial Report” herein for the
difference between the opening balance and closing balance of prior period (31 December
2019).
51 Deferred income
Particulars on deferred income
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of Decrease of
Opening Closing Cause of
Item the current the current
balance balance formation
period period
Government 8,491,110.00 2,000,000.00 1,995,756.67 8,495,353.33 Government
grant allocations
Total 8,491,110.00 2,000,000.00 1,995,756.67 8,495,353.33 /
Refer to the particulars of V.44 in “Section XI Financial Report” of the report for the
difference between the opening balance and closing balance of prior period (31 December
2019).
Items involving government subsidies:
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount Amount
included included
Subsidy
in in other
amount Pertinent
non-opera income of Other
Liability Opening increase Closing to
ting the chang
items balance d in the balance assets/in
income of current es
current come
the period
period
current
period
Subsidy 8,491,11 2,000,00 1,995,75 8,495,35 Pertinent
for 0.00 0.00 6.67 3.33 to assets
technologi
cal
transforma
tion of
cosmetics
Other particulars:
√ Applicable□ Not applicable
Refer to the particulars of “VII. 84 Government grant” in “Section XI Financial
Report” herein for the amount of government grant included in current profit or loss
in the current period.
249 / 323
2020 ANNUAL REPORT
52 Other non-current liabilities
□ Applicable√ Not applicable
53 Share capital
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase or decrease (+ or -) due to this change
Provident
Opening Issue Closing
Bonus funds
balance New Others Sub-total balance
shares Transferred
shares
shares
Total 201,269,560 -152,635 -152,635 201,116,925
shares
Other particulars:
th th
According to the resolution at the 15 and 16 meetings of the Second Session of the
rd
Board of Directors in 2020, the 3 extraordinary general shareholders’ meeting in 2020
and the amended articles of association, the Company applied for repurchasing 152,635
restricted RMB ordinary shares (A-shares) that are authorized but not yet unlocked by
cash, and the share repurchase payment totaled RMB 2,584,110.55, in which the share
capital decreased by RMB 152,635.00 and the capital reserve (share premium) decreased
by RMB 2,431,475.55. Pan-China Certified Public Accountants LLP has audited and verified
the above matters, and issued the Capital Verification Report (TJY [2020] No. 496).
Statement of equity pledge
As at 31 December 2020, the breakdown for the shares of major shareholders of the
Company was as follows:
Name of shareholder Total number of Number of frozen Freezing type
shares held shares (share)
(share)
Fang Yuyou 46,830,632 23,120,000 Pledge
Subtotal 46,830,632 23,120,000
54 Other equity instruments
(1).Basic information on other financial instruments such as preferred shares and
perpetual bonds outstanding at the end of the period
□ Applicable√ Not applicable
(2).Changes in financial instruments such as preferred shares and perpetual bonds
outstanding at the end of the period
□ Applicable√ Not applicable
250 / 323
2020 ANNUAL REPORT
Changes in other equity instruments of the current period, reasons for changes, and basis
for relevant accounting treatment:
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
55 Capital reserve
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of the Decrease of the
Item Opening balance Closing balance
current period current period
Capital 803,404,232.49 11,225,993.69 20,344,266.98 794,285,959.20
premium (Share
premium)
Other capital 31,949,382.99 21,994,190.14 11,194,695.64 42,748,877.49
reserve
Total 835,353,615.48 33,220,183.83 31,538,962.62 837,034,836.69
Other particulars, including descriptions on changes of the current period and reasons
for changes:
1) Increase or decrease of capital premium
The capital premium (share premium) increased by RMB 11,225,993.69 in the current
period, due to the followings: ① the increase of RMB 11,194,695.64 was because that other
capital reserve recognized in the waiting period of the unlocked part of restricted shares
issued by equity incentive plan had been transferred to the share premium; the increase
of RMB 31,298.05 was because that the minority shareholder increased the capital of
Zhejiang Biyouti Cosmetics Co., Ltd. (hereinafter referred to as “Biyouti”) by 5%, and
because of the difference between the share in carrying net asset of Biyouti calculated
according to the shareholding ratio of the Company after the capital increase and that
before the capital increase.
The capital premium (share premium) decreased by RMB 20,344,266.98 in the current
period, due to the followings: ① decreased by RMB 2,431,475.55; see the particulars of
“VII.53 share capital” in “Section XI Financial Report” of this report for details; ②
the decrease of RMB 3,065,227.01 was due to the purchase of minority shareholder equity
of subsidiary - Huzhou UZERO Trading Co., Ltd., as well as the difference between the
payment and the share of net identifiable assets of the subsidiary according to the new
shareholding ratio; ③ the decrease of RMB 1,088,996.78 was due to the purchase of minority
shareholder equity of subsidiary - Shanghai Zhongwen Electronic Commerce Co., Ltd., as
well as the difference between the payment and the share of net identifiable assets of
251 / 323
2020 ANNUAL REPORT
the subsidiary according to the new shareholding ratio; ④ the decrease of RMB 110,459.96
was due to the purchase of minority shareholder equity of Hong Kong Zhongwen Electronic
Commerce Co., Limited, as well as the difference between the payment and the share of
net identifiable assets of the subsidiary according to the new shareholding ratio; ⑤
the decrease of RMB 13,648,107.68 was due to the purchase of minority shareholder equity
of subsidiary - Ningbo TIMAGE Cosmetics Co., Ltd., as well as the difference between the
payment and the share of net identifiable assets of the subsidiary according to the new
shareholding ratio.
2) Increase and decrease of other capital reserve
The capital reserve increased by RMB 21,994,190.14 in the current period, due to the
followings: ① the increase of RMB 19,832,803.09 was because that, according to the equity
incentive plan of the Company, restricted shares incentive expense of RMB 4,193,320.87
was recognized in 2020 and included in other capital reserve; meanwhile, deferred income
tax assets of RMB 15,639,482.22 were withdrawn and included in other capital reserve for
the deductible amount before tax in the future that exceeded the recognized incentive
expense of restricted shares; ② the increase of RMB 2,161,387.05 was due to the adjustment
of capital reserve based on the difference between the actual deductible amount before
tax of the unlocked part and the amount recognized in previous years.
The decrease of other capital reserve of RMB 11,194,695.64 in the current period was
because that other capital reserve recognized in the waiting period of the unlocked part
of restricted shares issued by equity incentive plan had been transferred to the share
premium.
56 Treasury shares
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Increase of the Decrease of the
Item Opening balance Closing balance
current period current period
Restricted 15,769,051.20 3,115,145.95 12,653,905.25
shares with
repurchase
obligation
Total 15,769,051.20 3,115,145.95 12,653,905.25
Other particulars, including descriptions on changes of the current period and reasons
for changes:
Main reasons for the decrease of RMB 3,115,145.95 in the current period: 1) the
decrease of RMB 2,584,110.55 in the current period was due to the repurchase of 152,635
252 / 323
2020 ANNUAL REPORT
restricted RMB ordinary shares (A-shares) that are authorized but not yet unlocked by
cash; 2) the decrease of RMB 531,035.40 in the current period was due to the offset of
treasury shares for dividend distributed for 747,425 unlocked restricted shares and
152,635 restricted shares repurchased in the current period and corresponding adjustment
of other payables.
57 Other comprehensive incomes
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in the current period
Less: Less:
Included Included
in other in other
Amount comprehe comprehe
incurr nsive nsive
Attribu
At the ed incomes incomes Attribu
table to At the
beginni before in the in the Less: table to
minorit end of
ng of income prior previous Incom the
Item y the
the tax period period e tax parent
shareho period
period for and and expen company
lders Balance
Balance the transfer transfer ses after
after
curren red to red to the tax
the tax
t profit retained
period and loss earnings
in the in the
current current
period period
I. Other
comprehens
ive income
not to be
reclassifi
ed into
profit or
loss
Where:
Re-measure
ment of the
changes in
the
defined
benefit
plan
Other
comprehens
ive income
that may
253 / 323
2020 ANNUAL REPORT
not be
reclassifi
ed to
profit or
loss under
equity
method
Changes
in fair
value of
other
equity
instrument
investment
s
Change
in fair
value of
enterprise
's own
credit
risk
II. Other -212,62 -56,43 -56,437 -269,06
comprehens 8.22 7.91 .91 6.13
ive income
to be
reclassifi
ed into
profit or
loss
Where:
Other
comprehens
ive
incomes to
be
reclassifi
ed to
profits
and losses
via equity
method
Changes
in fair
value of
other debt
investment
s
Amount
included
254 / 323
2020 ANNUAL REPORT
in other
comprehens
ive income
on
reclassifi
cation of
financial
assets
Credit
impairment
provisions
of other
debt
investment
s
Cash
flow
hedging
reserve
Exchange -212,62 -56,43 -56,437 -269,06
difference 8.22 7.91 .91 6.13
s from
translatio
n of
financial
statements
Total -212,62 -56,43 -56,437 -269,06
other 8.22 7.91 .91 6.13
comprehens
ive income
Other particulars, including the adjustment of the effective portion of cash flow hedging
profit or loss transferred to the initial recognition amount of the hedged item:
None
58 Special reserve
□ Applicable√ Not applicable
59 Surplus reserve
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Opening balance Increase of the Decrease of the Closing balance
current period current period
Statutory 100,634,780.00 100,634,780.00
surplus reserve
Arbitrary
surplus reserve
Reserve fund
Enterprise
255 / 323
2020 ANNUAL REPORT
development
fund
Others
Total 100,634,780.00 100,634,780.00
Descriptions on surplus reserve, including descriptions on changes of the current period
and reasons for changes:
In accordance with the Company Law, where the Company’s accumulated amount of legal
reserve exceeds 50% of the Company’s registered capital, it can be no longer withdrawn.
60 Undistributed profit
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Current period Previous period
Pre-adjustment undistributed 908,411,607.62 634,448,228.13
profits at the end of the previous
period
Total adjustment amount of 908,411,607.62 634,448,228.13
undistributed profits at the
beginning of the period (“+”
refers to increase by adjustment
and “-” refers to decrease by
adjustment)
Post-adjustment amount of
undistributed profits at the
beginning of the period
Add: Net profit attributable to 476,009,298.41 392,681,976.58
shareholders of the parent
company in the current period
Less: Withdrawal of statutory 32,165,703.09
surplus reserves
Arbitrary surplus reserve
accrued
Withdrawal of general risk
provision
Dividends on common shares 118,749,040.40 86,552,894.00
payable
Dividends on common shares
converted to stock capital
Undistributed profit at the end 1,265,671,865.63 908,411,607.62
of the period
According to the resolution at the 2019 annual general meeting of the Company, the
Company distributed cash dividend of RMB 5.90 (tax inclusive) per 10 shares to all
shareholders based on the total share capital of 201,269,560 shares registered on the
registration date of dividend-paying equity, totaling RMB 118,749,040.40 (tax
256 / 323
2020 ANNUAL REPORT
inclusive).
Details on adjustment of undistributed profits at the beginning of the period:
1. Due to the retrospective adjustment based on the Accounting Standards for Business
Enterprises and their related new regulations, the affected undistributed profit at the
beginning of the period was RMB 0.
2. Due to changes in accounting policies, the affected undistributed profit at the
beginning of the period was RMB0.
3. Due to correction of major accounting errors, the affected undistributed profit at
the beginning of the period was RMB 0.
4. Due to changes in the scope of the consolidated financial statements caused by the
business combination under common control, the affected undistributed profit at the
beginning of the period was RMB 0.
5. Due to other adjustments, the affected undistributed profit at the beginning of the
period was RMB 0.
61 Operating revenues and operating costs
(1).Particulars on operating revenues and operating costs
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in the current Amount accounted for in the previous
Item period period
Revenue Costs Revenue Costs
Main 3,747,924,600.60 1,363,486,774.26 3,116,453,641.63 1,120,308,887.81
operations
Other 4,462,248.42 4,075,175.52 7,066,570.14 5,264,338.42
operations
Total 3,752,386,849.02 1,367,561,949.78 3,123,520,211.77 1,125,573,226.23
(2).Particulars on revenues from contracts
□ Applicable√ Not applicable
Description on revenues from contracts:
□ Applicable√ Not applicable
(3).Description on performance obligations
□ Applicable√ Not applicable
(4).Description on apportionment to remaining performance obligations
□ Applicable√ Not applicable
Other particulars:
None
62 Taxes and surcharges
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in the
257 / 323
2020 ANNUAL REPORT
current period previous period
Consumption tax 66,493.56 155,946.77
Business tax
Urban maintenance and 13,634,530.33 10,717,040.55
construction tax
Education surcharge 6,988,508.15 5,651,261.92
Resource tax -527,984.00
Property tax 5,822,344.89 6,189,563.61
Land use tax -527,984.00
Vehicle usage tax 15,600.00 356,788.50
Stamp duty 1,758,703.64 1,537,784.18
Local education surcharge 4,659,005.42 3,758,763.75
Total 32,945,185.99 27,839,165.28
Other particulars:
The land use tax was negative in the prior period, because the land use tax of RMB
527,984.00 in 2018 was exempted in accordance with the Notice on Tax Matters of Huzhou
Wuxing District Taxation Bureau, State Taxation Administration.
63 Selling expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in the Amount accounted for in the
Item
current period previous period
Image promotion expense 1,226,430,935.32 839,023,707.19
Employee remuneration 216,021,800.31 233,027,016.74
Freight 76,246,332.91
Office expense 22,228,325.98 25,640,510.49
Travel expense 15,220,908.88 22,754,602.59
Conference fee 6,610,405.20 15,008,494.06
Research and consulting fee 7,764,271.67 9,052,048.12
Others 2,782,295.98 2,279,111.97
Total 1,497,058,943.34 1,223,031,824.07
Other particulars:
Due to the implementation of new revenue standards, the freight of RMB 117,852,735.96
was presented in the principal business cost in the current period.
64 Administrative expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in Amount accounted for
the current period in the previous period
Employee remuneration and service fee 99,248,945.51 79,481,331.22
Office expense and business 33,851,704.91 37,535,967.80
entertainment expense
Expenses for depreciation, 40,809,336.86 29,130,823.88
amortization and lease
258 / 323
2020 ANNUAL REPORT
Equity incentive expense for 4,193,320.87 16,864,155.99
restricted shares
Consulting and intermediary expenses 17,799,433.91 12,403,364.64
Travel expense and conference fee 3,368,329.40 10,784,663.99
Others 5,008,307.22 9,059,619.50
Total 204,279,378.68 195,259,927.02
Other particulars:
None
65 R&D expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in Amount accounted for
the current period in the previous period
Labor charge 42,457,484.59 33,218,856.20
Outsourced R&D expense 22,198,043.50 28,528,937.23
Direct input expense 2,232,870.29 8,553,749.86
Expenses for depreciation, 3,976,173.74 3,179,228.45
amortization and lease
Others 1,335,456.65 1,121,834.81
Total 72,200,028.77 74,602,606.55
Other particulars:
None
66 Financial expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in Amount accounted for
the current period in the previous period
Interest expenses 9,190,674.26 8,565,736.81
Interest income -20,740,463.77 -18,108,947.26
Handling fee 963,155.58 542,976.58
Exchange gains and losses -3,020,481.60 -494,578.43
Total -13,607,115.53 -9,494,812.30
Other particulars:
None
67 Other incomes
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in the
current period previous period
Government grants related to 1,995,756.67 1,879,090.00
assets [Note]
Government grants related to 10,202,653.51 6,042,824.03
income [Note]
Return of handling fee for 684,529.89 236,203.39
withholding individual
259 / 323
2020 ANNUAL REPORT
income tax
Additional deduction of VAT 608,569.65 257,340.26
input tax
Total 13,491,509.72 8,415,457.68
Other particulars:
[Note] Refer to the particulars of “VII. 84 Government grant” in “Section XI
Financial Report” herein for the amount of government grant included in other income
in the current period.
68 Investment income
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in Amount accounted for in
Item
the current period the previous period
Long-term equity investment income -646,615.60 -2,530,337.96
accounted for under the equity
method
Investment income from disposal of 149,705.73
long-term equity investment
Investment income from
held-for-trading financial assets
during the holding period
Dividend income from other equity
instrument investments during the
holding period
Interest income from debt
investment during the holding
period
Interest income from other debt
investments during the holding
period
Investment income from disposal of
held-for-trading financial assets
Investment income from disposal of
other equity instrument
investments
Investment income from disposal of
debt investment
Investment income from disposal of
other debt investments
Income from wealth management 2,266,301.37 4,653,362.83
products
Total 1,769,391.50 2,123,024.87
Other particulars:
None
260 / 323
2020 ANNUAL REPORT
69 Net exposure hedging income
□ Applicable√ Not applicable
70 Income from changes in fair value
□ Applicable√ Not applicable
71 Credit impairment losses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in Amount accounted for in
Item
the current period the previous period
Bad debt losses of notes receivable
Bad debt losses of accounts -24,292,116.38 -8,203,372.40
receivable
Bad debt losses of other 383,393.99 -339,166.76
receivables
Impairment losses of debt
investment
Impairment losses of other debt
investments
Bad debt losses of long-term
receivables
Impairment losses of contract
assets
Total -23,908,722.39 -8,542,539.16
Other particulars:
None
72 Asset impairment losses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in Amount accounted for in the
Item
the current period previous period
1. Bad debt losses
II. Inventory falling price loss -28,234,605.50 -23,062,698.05
and impairment losses of
contract performance cost
III. Impairment losses of -4,076,710.83
long-term equity investment
IV. Impairment losses of
investment real estate
V. Impairment losses of fixed
assets
VI. Impairment losses of
261 / 323
2020 ANNUAL REPORT
engineering materials
VII. Impairment loss of projects
under construction
VIII. Impairment losses of
productive biological assets
IX. Impairment losses of oil and
gas assets
X. Impairment losses of
intangible assets
XI. Impairment losses of
goodwill
XII. Others
Total -28,234,605.50 -27,139,408.88
Other particulars:
None
73 Income from disposal of assets
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in the
current period previous period
Income from disposal of 854.57 43,245.67
fixed assets
Total 854.57 43,245.67
Other particulars:
None
74 Non-operating income
Non-operating profits
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount included in
Amount accounted for
Amount accounted for the current
Item in the previous
in the current period non-recurring gains
period
and losses
Total gains from
disposal of
non-current assets
Where: Gains from
disposal of fixed
assets
Gains from
disposal of
intangible assets
Gains from
restructuring of
debts
Gains from exchange
of non-currency
262 / 323
2020 ANNUAL REPORT
assets
Acceptance of
donations
Government grant
Income from 1,438,505.28 576,749.36 1,438,505.28
forfeiture and
liquidated damages
Others 104,088.97 202,228.79 104,088.97
Total 1,542,594.25 778,978.15 1,542,594.25
Government subsidies included in current profit and loss
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
75 Non-operating expenditure
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount included in
Amount accounted for
Amount accounted for the current
Item in the previous
in the current period non-recurring gains
period
and losses
Total losses from
disposal of
non-current
assets
Where: Losses from
disposal of fixed
assets
Losses from
disposal of
intangible assets
Losses from
restructuring of
debts
Losses from
exchange of
non-currency
assets
Offering of 8,419,034.02 4,950,639.40 8,419,034.02
donations
Compensation 304,032.01
expenditure
Losses from 4,113.95 4,831.73 4,113.95
retirement of
non-current
assets
263 / 323
2020 ANNUAL REPORT
Others 614,781.74 884,573.70 614,781.74
Total 9,037,929.71 6,144,076.84 9,037,929.71
Other particulars:
None
76 Income tax expenses
(1).Table of income tax expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in the Amount accounted for in the
Item
current period previous period
Current income tax expenses 97,265,732.16 87,534,077.32
Deferred income tax expenses -1,303,715.96 2,340,679.62
Total 95,962,016.20 89,874,756.94
(2).Adjustment process of accounting profits and income tax expenses
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the current period
Total profits 547,571,570.43
Income tax expenses calculated at 136,892,892.61
statutory/applicable tax rate
Effect of applying different tax rates to -59,108,336.59
subsidiaries
Effect of adjusting income taxes of the 918,095.21
previous periods
Effect of non-taxable income
Effect of non-deductible costs, expenses 224,499.02
and losses
Effect of deductible losses of deferred -367,935.75
income tax assets not recognized in the
previous period
Effect of deductible temporary 24,833,284.65
differences or deductible losses of
deferred income tax assets not recognized
in the current period
Additional deduction of R&D expense -7,430,482.95
Income tax expenses 95,962,016.20
Other particulars:
□ Applicable√ Not applicable
77 Other comprehensive incomes
√ Applicable□ Not applicable
Refer to V.57 in “Section XI Financial Report” of this report for details.
264 / 323
2020 ANNUAL REPORT
78 Items of the cash flow statement
(1).Other cash received relating to operating activities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in Amount accounted for in
the current period the previous period
Bank interest income 20,755,011.64 17,945,462.87
Government grant 12,198,410.18 6,034,656.66
Others related to operating 3,459,621.48
activities 48,786,531.20
Total 81,739,953.02 27,439,741.01
Descriptions on other cash received from operating activities:
None
(2).Other cash paid relating to operating activities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in Amount accounted for in
the current period the previous period
Image promotion expense 1,146,440,191.10 712,065,545.72
Other cash expenses 241,438,672.23 216,134,626.98
Others related to operating 35,086,174.43 11,246,654.35
activities
Total 1,422,965,037.76 939,446,827.05
Descriptions on cash paid for other operating activities:
None
(3).Other cash received relating to investing activities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in
current period the previous period
Net cash received from
subsidiaries 66,052,759.40
Recovery of working capital 2,500,000.00
provided to associates
Total 66,052,759.40 2,500,000.00
Description on other cash received relating to investing activities
None
(4).Other cash paid relating to investing activities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in
current period the previous period
Net cash paid for disposal of 1,035,148.02
265 / 323
2020 ANNUAL REPORT
subsidiaries
Working capital provided to 2,500,000.00
associates
Total 1,035,148.02 2,500,000.00
Description on other cash paid relating to investing activities
None
(5).Other cash received relating to financing activities
□ Applicable√ Not applicable
(6).Other cash paid relating to financing activities
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount accounted for in the Amount accounted for in
current period the previous period
Payment for share repurchase 2,584,110.55 1,657,699.80
Amount for acquisition of
minority shareholder equity 100,000.00
Total 2,684,110.55 1,657,699.80
Descriptions on other cash paid for financing-related activities:
None
79 Supplementary information for the cash flow statement
(1).Supplementary information for the cash flow statement
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount in the current
Supplementary information Amount in the last period
period
1. Operating cash flow adjusted
from net profits:
Net profit 451,609,554.23 366,368,199.47
Add: Impairment provisions of 23,908,722.39 8,542,539.16
assets
Credit impairment losses 28,234,605.50 27,139,408.88
Depreciation of fixed assets, oil 41,946,043.10 35,243,126.99
and gas assets, and productive
biological assets
Amortization of right-of-use
assets
Amortization of intangible 14,982,350.71 14,015,243.08
assets
Amortization of long-term 30,864,025.47 25,913,102.37
prepaid expenses
Losses from disposal of fixed -854.57 -43,245.67
assets, intangible assets and
other long-term assets (“-”
refers to gains)
266 / 323
2020 ANNUAL REPORT
Losses from retirement of fixed 4,113.95 4,831.73
assets (“-” refers to gains)
Losses from changes in fair value
(“-” refers to gains)
Financial expenses (“-” refers 9,190,674.26 8,538,736.81
to income)
Investment losses (“-” refers -1,769,391.50 -2,123,024.87
to gains)
Decrease in deferred income tax -3,045,810.03 -5,115,103.48
assets (“-” refers to increase)
Increase in deferred income tax 1,742,094.07 2,216,088.09
liabilities (“-” refers to
decrease)
Decrease in inventories (“-” -174,795,286.43 -103,933,904.36
refers to increase)
Decrease in operating -145,846,608.97 -163,773,517.84
receivables (“-” refers to
increase)
Increase in operating payables 48,171,169.04 864,996.98
(“-” refers to decrease)
Others 6,354,707.92 22,103,851.00
Net cash flow generated from 331,550,109.14 235,961,328.34
operating activities
2. Major investment and
financing activities involving
no cash deposit and withdrawal:
Debts converted to capital
Convertible company bonds due
within one year
Fixed assets acquired under
financing leases
3. Net change in cash and cash
equivalents:
Closing balance of cash 1,401,850,754.88 1,099,092,785.07
Less: Opening balance of cash 1,099,092,785.07 1,126,866,649.39
Add: Closing balance of cash
equivalents
Less: Opening balance of cash
equivalents
Net increase in cash and cash 302,757,969.81 -27,773,864.32
equivalents
(2).Net cash amount paid for the acquisition of subsidiaries in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount
Cash or cash equivalents paid for the business combination
of the current period in the current period
Less: Cash and cash equivalents held by the subsidiaries 66,052,759.40
267 / 323
2020 ANNUAL REPORT
on the acquisition date
Where: Shanghai Healthlong Biochemical Technology Co., 66,052,759.40
Ltd.
Add: Cash or cash equivalents paid in the current period
for the consolidation in the previous periods
Net cash paid for acquiring subsidiaries -66,052,759.40
Other particulars:
In the current period, the capital increase of RMB 110,500,000 was made, by the Company,
to Shanghai Healthlong Biochemical Technology Co., Ltd. to acquire its 52% equity, and
the cash and cash equivalents held by Shanghai Healthlong Biochemical Technology Co.,
Ltd. on the acquisition date were listed in “other cash received relating to investing
activities”.
(3).Net cash amount received from the disposal of subsidiaries in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount
Cash or cash equivalents received in the current period 2,445,612.19
from the disposal of subsidiaries in the current period
Where: Huzhou Tizhi Cosmetics Co., Ltd. 2,445,612.19
Less: Cash and cash equivalents held by the subsidiaries 3,480,760.21
on the date of losing the control
Where: Huzhou Tizhi Cosmetics Co., Ltd. 3,480,760.21
Add: Cash or cash equivalents received in the current
period from the disposal of subsidiaries in the previous
periods
Net cash received from disposal of subsidiaries -1,035,148.02
Other particulars:
The net cash was listed in “other cash paid relating to investing activities”.
(4).Composition of cash and cash equivalents
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
I. Cash 1,401,850,754.88 1,099,092,785.07
Where: Cash on hand 26,853.58 42,499.65
Bank deposits readily 1,368,515,531.05 1,090,478,757.15
available for payment
Other cash and equivalents 33,308,370.25 8,571,528.27
readily available for payment at
any time
Due from central bank
available for payment
Due from placements with
banks and other financial
institutions
Call loan to banks and other
financial institutions
268 / 323
2020 ANNUAL REPORT
II. Cash equivalents
Where: Bond investment due in 3
months
III. Closing balance of cash and 1,401,850,754.88 1,099,092,785.07
cash equivalents
Where: Cash and cash equivalents
the use of which by the parent
company or any subsidiary of the
Group is limited
The amount of trade bills transferred by endorsement, involving no cash payment and
expenses
Item Amount in the Balance in last
current period period
Amount of trade bills transferred by 12,176,952.00
58,796,965.82
endorsement
Where: Payment of goods 12,176,952.00 58,796,965.82
Other particulars:
√ Applicable□ Not applicable
Supplementary information of cash flow statement
Time Balance of monetary Cash and cash Amount difference Causes of difference
capital equivalents
The margin for fixed-term
deposits of transformer was
RMB 293,481.72, the ETC
vehicle deposit was RMB
69,000.00, the land
31 December 2020 1,416,654,640.93 1,401,850,754.88 14,803,886.05 construction deposit was
RMB 7,036,404.33, the L/C
deposit was RMB
7,000,000.00, and Tmall and
Alipay deposits were RMB
405,000.00.
The margin for fixed-term
deposits of transformer was
RMB 293,481.72, the land
construction deposit was
31 December 2019 1,246,901,218.99 1,099,092,785.07 147,808,433.92 RMB 6,909,952.20, Tmall and
Alipay deposits were RMB
605,000.00, and the
structured deposit was RMB
140,000,000.00.
269 / 323
2020 ANNUAL REPORT
80 Notes to items of the Statements of Changes in Owners’ Equity
Description on “other” item name and adjustment amount adjusted for balance at the end
of the previous year:
□ Applicable√ Not applicable
81 Assets with restricted ownership or use rights
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Carrying value at the end of Reason for restriction
the period
Cash and equivalents 14,803,886.05 Land construction
deposit, transformer
deposit, L/C deposit,
Tmall deposit, Alipay
deposit, etc.
Bills receivable
Inventories
Fixed assets
Intangible assets
Total 14,803,886.05 /
Other particulars:
None
82 Foreign currency monetary items
(1).Foreign currency monetary items
√ Applicable□ Not applicable
Unit: Yuan
RMB translated at
Foreign currency Translation
the end of the
Item balance at the end foreign exchange
period
of the period rate
Balance
Cash and equivalents - - 84,925,396.80
Where: USD 910,161.83 6.5249 5,938,714.92
EUR 9,089,403.05 8.0250 72,942,459.48
HKD 4,707,222.42 0.84164 3,961,786.68
Japanese Yen 2,080.00 0.063236 131.53
Korean Won 318,899,153.00 0.005997 1,912,438.22
Swiss franc 22,953.00 7.4006 169,865.97
Accounts receivable - - 2,872,452.48
Where: USD
EUR 331,984.86 8.0250 2,664,178.50
HKD 19,218.52 0.84164 16,175.08
Korean Won 32,032,500.00 0.005997 192,098.90
Long-term borrowings - -
Where: USD
EUR
HKD
270 / 323
2020 ANNUAL REPORT
Accounts payable - - 7,486,451.74
Where: USD 6,813.05 6.5249 44,454.47
EUR 897,119.52 8.0250 7,199,384.15
HKD 288,262.35 0.84164 242,613.12
Other receivables - - 29,027,874.26
Where: USD 29,565.13 6.5249 192,909.52
EUR 3,485,128.23 8.0250 27,968,154.05
HKD 737,060.97 0.84164 620,339.99
Korean Won 41,099,000.00 0.005997 246,470.70
Other payables - - 751,958.71
Where: Korean Won 99,667,602.97 0.005997 597,706.62
EUR 16,933.33 8.0250 135,889.97
HKD 21,817.07 0.84164 18,362.12
Other particulars:
None
(2).Descriptions on overseas operating entities, including, for important overseas
business entities, their main overseas business locations, accounting currency and
selection basis shall be disclosed; in case of any change in the accounting currency,
the reasons for such change shall be also disclosed
√ Applicable□ Not applicable
Hapsode Co., Ltd., Hanna Cosmetics Co., Ltd. and Korea Younimi Cosmetics Co., Ltd.
are located in South Korea, with business income and expenditure dominated by Korean Won,
which is used as the accounting currency; Hong Kong Xinghuo Industry Limited, Hong Kong
Zhongwen Electronic Commerce Co., Limited, Hong Kong Xuchen Trading Limited, HONGKONG
KESHI TRADING LIMITED, BOYA (Hong Kong) Investment Management Co., Limited and Hong Kong
Wanyan Electronic Commerce Co., Limited are located in Hong Kong, with RMB as the
accounting currency; P.R.O CO., LTD. is located in Japan, with business income and
expenditure dominated by Japanese Yen, which is used as the accounting currency.
83 Hedging
□ Applicable√ Not applicable
84 Government grant
(1).Basic information on government grant
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount included in
Type Amount Presentation item current profit and
loss
Government grants 1,995,756.67 Other income 1,995,756.67
related to assets
Government grants 10,202,653.51 Other income 10,202,653.51
271 / 323
2020 ANNUAL REPORT
related to income
(2).Return of government grant
□ Applicable√ Not applicable
Other particulars:
1) Government grants related to assets
Amount of
Deferred Amortization Deferred Amortization
subsidies
income at the of the income at the items in the the
Item increased in
beginning of current end of the current situation
the current
the period period period period
period
Subsidy for
technological 2,000,000.00
8,491,110.00 1,995,756.67 8,495,353.33 Other income
transformation
of cosmetics
Subtotal 8,491,110.00 2,000,000.00 1,995,756.67 8,495,353.33
According to the Notice on the Award for Technical Transformation of Proya Cosmetics
Co., Ltd. Huzhou Branch issued by the People's Government of Daixi Town, Huzhou, the
Company received technical transformation subsidy of RMB 14,561,400.00 from the
Government of Daixi Town in 2014, relevant assets were allocated equally within the
service life, and RMB 1,456,140.00 was included in the other income in the current period.
According to the Notice on Issuing Construction and Development Fund (First Batch)
for Powerful Industrial City in 2015 (HCQ [2015] No. 150) issued by Huzhou Finance and
Huzhou Economy and Information Bureau, the technical transformation subsidy of RMB
2,350,000.00 was appropriated by Huzhou Finance in 2015, relevant assets were allocated
equally within the service life, and RMB 235,000.00 was included in the other income in
the current period.
According to the Notice on Issuing Special Funds (Second Batch) for “Machine
Substitution for Humans” Project in 2014 (WFG [2015] No. 18) issued by Development and
Reform Commission of Wuxing District, Huzhou and Finance Bureau of Wuxing District, the
technical transformation subsidy of RMB 500,000.00 was appropriated by Finance Bureau
of Wuxing District, Huzhou in 2015, relevant assets were allocated equally within the
service life, and RMB 50,000.00 was included in the other income in the current period.
According to the Notice on Issuing Special Funds (Second Batch) for Industrial
Development in Huzhou in 2018 (HCQ [2018] No. 319) issued by Huzhou Finance and Huzhou
Economy and Information Bureau, the technical transformation subsidy of RMB 1,379,500.00
was appropriated by Huzhou Finance in December 2018, relevant assets were allocated
equally within the service life, and RMB 137,950.00 was included in the other income in
272 / 323
2020 ANNUAL REPORT
the current period.
According to the Notice on Appropriating Special Subsidy Fund for Demonstration
Intelligent Workshop in Wuxing District in 2019 (WCQH [2020] No. 145) issued by Huzhou
Finance and Development, Reform and Economic Information Technology Commission of Wuxing
District, the technical transformation subsidy of RMB 2,000,000.00 was appropriated by
Finance Bureau of Wuxing District, Huzhou in May 2020, relevant assets were allocated
equally within the service life, and RMB 116,666.67 was included in the other income in
the current period.
2) Government grants related to income, used to cover the accrued relevant costs or
losses
Presenta
Item Amount the situation
tion item
According to the Supporting Opinions on
Promoting the Financial Innovation and
Utilization of municipal Other Development of “Internet Plus” (XFG [2016]
support funds for 3,915,000.00 No. 1), it was appropriated by Xixi
income
capital market in 2019 Sub-district Office and Liuxia Sub-district
Office of the People's Government of Xihu
District, Hangzhou
According to the Notice on Declaration for
Scale Award of Large Enterprises and Groups
Enterprise scale award Other under "Kunpeng Plan" in 2019 issued by Hangzhou
for municipal “Kunpeng 1,000,000.00 Municipal Bureau of Economy and Information
income
Plan” Technology (HJXYX [2020] No. 98), it was
appropriated by Hangzhou Municipal Bureau of
Economy and Information Technology
According to the Opinions of CPC Zhejiang
Provincial Committee and Zhejiang Provincial
People's Government on Fight against COVID-19
as well as Stable Enterprises, Stable Economy
and Stable Development, Notice of Zhejiang
Province Human Resources and Social Security
Other
530,528.03 Department and Zhejiang Provincial Department
Post stability subsidies
income of Finance on Implementation of the Policy for
Steady Work and Refund with Unemployment
Insurance in 2020, Notice on Further
Implementation of the Work for Steady Work with
Unemployment Insurance (ZWF [2020] No. 4, ZRSF
[2020] No. 10), it was appropriated by Hangzhou
Employment Service Center
Special subsidy for Appropriated by Liuxia Sub-district Office of
Other
municipal Industry and 4,757,125.48 the People's Government of Xihu District,
information technology, income Hangzhou, Huzhou Finance, Hangzhou Finance
invention patent Bureau, Finance Bureau of Qingpu District,
273 / 323
2020 ANNUAL REPORT
subsidy, special subsidy Shanghai, Finance Bureau of Wuxing District,
for e-commerce, Huzhou, Human Resources and Social Security
financial support fund Bureau of Wuxing District, Huzhou, Market
from Qingpu Finance Supervision Administration of Xihu, Hangzhou,
Bureau, district subsidy etc.
for provincial leading
innovation team, special
subsidy for service
industry, two-direct
subsidy, etc.
Subtotal 10,202,653.51
(2) The government grant included in the current profit or loss was RMB 12,198,410.18
in the current period.
85 Others
□ Applicable√ Not applicable
VIII Change in Consolidation Scope
1 Consolidation not under common control
√ Applicable□ Not applicable
(1).Consolidation not under common control occurring in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Net
Income of profit
Basis
acquiree of
Equity for
from the acquiree
Equity acquis determ
Name of Equity Equity Date of acquisit from the
acquis ition ining
acquir acquisit acquisit acquis ion date acquisit
ition percen the
ee ion cost ion type ition to the ion date
time tage acquis
end of to the
(%) ition
the end of
date
period the
period
Shangh Octobe 110,500, 52.00 Consolid Octobe Comple 181,257, -6,640,3
ai r 2020 000.00 ation r 2020 tion of 879.50 91.94
Health not proper
long under ty
Bioche common right
mical control transf
Techno er and
logy obtain
Co., ing of
Ltd. contro
l
Other particulars:
None
274 / 323
2020 ANNUAL REPORT
(2).Consolidation cost and goodwill
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Combination cost Shanghai Healthlong Biochemical
Technology Co., Ltd.
--Cash 110,500,000.00
--Fair value of non-cash assets
--Fair value of the debts issued or assumed
--Fair value of the equity securities issued
--Fair value of contingent consideration
--Acquisition-date fair value of the equity
held before the acquisition date
--Others
Total combination cost 110,500,000.00
Less: Fair value share of the identifiable 79,465,838.80
net assets acquired
Goodwill/Amount of the combination cost 31,034,161.20
below fair value share of the identifiable
net assets acquired
Description on determination method for fair value of combination cost, contingent
consideration and its change:
None
Main reason for the formation of large-amount goodwill:
None
Other particulars:
The fair value share of the net identifiable assets acquired includes RMB 57.46
million entitled by the Company as per the shareholding ratio in the capital increase
of RMB 110.5 million of the Company.
(3).Identifiable assets and liabilities of the acquiree on the acquisition date
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Shanghai Healthlong Biochemical Technology Co., Ltd.
Fair value on the acquisition date Carrying value on the acquisition
Assets: 171,243,990.12 date 171,243,990.12
Cash and 66,052,759.40 66,052,759.40
equivalents
Receivables 5,746,539.14 5,746,539.14
Inventories 8,431,333.75 8,431,333.75
Fixed assets 1,298,177.42 1,298,177.42
Intangible 304,454.08 304,454.08
assets
Long-term 775,036.70 775,036.70
prepaid
275 / 323
2020 ANNUAL REPORT
expenses
Prepayment 38,318,670.27 38,318,670.27
Other 50,317,019.36 50,317,019.36
receivables
Liabilities: 128,925,069.36 128,925,069.36
Borrowings
Payables 78,525,109.34 78,525,109.34
Deferred
income tax
liabilities
Accounts 20,272,794.03 20,272,794.03
received in
advance
Other 16,504,326.42 16,504,326.42
payables
Employee 1,224,371.90 1,224,371.90
benefits
payable
Taxes 12,398,467.67 12,398,467.67
payable
Net assets 42,318,920.76 42,318,920.76
Less:
Minority
equity
Net assets 42,318,920.76 42,318,920.76
acquired
Determination method for fair value of identifiable assets and liabilities:
None
Contingent liabilities of acquiree assumed in the business combination:
None
Other particulars:
None
(4).Gains or losses arising from the re-measurement of the equity held before the
acquisition date as per the fair value
Whether there is a transaction where a business combination is achieved stepwise through
multiple transactions and the control is obtained within the Reporting Period
□ Applicable√ Not applicable
(5).Descriptions on the situation that it is unable to reasonably determine the
consolidation consideration or the fair value of identifiable assets and liabilities
of the acquiree on the acquisition date or at the end of the current consolidation
period
□ Applicable√ Not applicable
276 / 323
2020 ANNUAL REPORT
(6).Other particulars
□ Applicable√ Not applicable
2 Consolidation under common control
□ Applicable√ Not applicable
3 Reverse acquisition
□ Applicable√ Not applicable
277 / 323
2020 ANNUAL REPORT
4 Disposal of subsidiaries
Whether there is a loss of control upon a single disposal of investment to subsidiaries
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Balance of
net assets
Determinati
shares of Carrying Fair
Proportion method an
subsidiaries value of value of Gains or losses
of the main
Time Basis of corresponded the the arising from
remaining assumption
Equity point determination by disposal remaining remaining re-measurement
Equity Equity equities of the fai
Name of disposal of of the time of price and equities equities of the
disposal disposal on the day value of t
subsidiaries ratio losing point of disposal of on the on the remaining
price method of losing remaining
(%) the losing the investment date of date of equities
the equities o
control control at the level losing losing pursuant to the
control the date o
of the the fair value
(%) losing th
consolidated control control
control
financial
statements
Huzhou Tizhi 4,106,289.39 51.00 Sales April Control loss 261,034.21
Cosmetics 2020 upon
Co., Ltd. completion of
property
right
transfer
Other particulars:
□ Applicable√ Not applicable
278 / 323
2020 ANNUAL REPORT
5 Change in consolidation scope due to other reasons
Descriptions on changes in the scope of consolidated financial statements for other reasons (e.g., establishing subsidiaries, clearing
subsidiaries, etc.) and their related circumstances:
√ Applicable□ Not applicable
1. Increase of consolidation scope
Company Name Equity Equity
Amount of Contribution
acquisition acquisition
contribution ratio (%)
type time
New
Hong Kong Xuchen March 2020 0.00 100.00
Trading Limited subsidiaries
BOYA (Hong New
Kong) Investment March 2020 0.00 100.00
Management Co., subsidiaries
Limited
New
Proya Europe SARL April 2020 90,685.20 100.00
subsidiaries
Zhejiang Qingya New
Culture Art May 2020 550,000.00 55.00
Communication subsidiaries
Co., Ltd.
Hangzhou Weiluoke New
Cosmetics Co., Ltd. July 2020 3,907,664.00 100.00
[Note] subsidiaries
Hangzhou Yizhuo New
Culture Media Co., July 2020 1,000,000.00 100.00
Ltd. subsidiaries
New
P.R.O CO., LTD. August 2020 0.00 95.00
subsidiaries
279 / 323
2020 ANNUAL REPORT
Hangzhou
Tiedingxian New
Catering August 2020 2,000,000.00 80.00
Management Co., subsidiaries
Ltd.
Hangzhou Tielexin New
Aini Catering August 2020 500,000.00 100.00
Management Co., subsidiaries
Ltd.
Hangzhou Xiake New
Bar Catering August 2020 2,500,000.00 100.00
Management Co., subsidiaries
Ltd.
Hangzhou Proya New
Snail Fitness Co., August 2020 1,000,000.00 100.00
Ltd. subsidiaries
New
Hangzhou Qingyan August 2020 0.00 51.00
Cosmetics Co., Ltd. subsidiaries
New
Hangzhou Oumisi August 2020 2,000,000.00 100.00
Trading Co., Ltd. subsidiaries
Huzhou Poyun New September
Electronic 1,200,000.00 60.00
Commerce Co., Ltd. subsidiaries 2020
Guangzhou Qianxi New
Network October 2020 1,000,000.00 100.00
Technology Co., subsidiaries
Ltd.
[Note] Hangzhou Weiluoke Cosmetics Co., Ltd. is jointly contributed by the Company and Hong Kong Xinghuo Industry Limited, with the total amount of
RMB 3,907,664.00.
280 / 323
2020 ANNUAL REPORT
2. Decrease of consolidation scope
Net profit from
Time point of
Company Name Equity disposal disposal of
Net assets on the beginning of
method disposal date the period to the
equity
disposal date
Hangzhou
Qingyan Cancellation December 2020 993,316.79 -6,683.21
Cosmetics Co.,
Ltd.
6 Others
□ Applicable√ Not applicable
281 / 323
2020 ANNUAL REPORT
IX Equity in Other Entities
1 Equity in subsidiaries
(1).Composition of the enterprise group
√ Applicable□ Not applicable
Main Nature of Shareholding ratio
Name of Registered Mode of
place of the (%)
subsidiaries address acquisition
business business Direct Indirect
Hangzhou Hangzhou Hangzhou Wholesale 100.00 Establishment
Proya Trade and
Co., Ltd. retail
business
Zhejiang Hangzhou Hangzhou Wholesale 100.00 Establishment
Meiligu and
Electronic retail
Commerce business
Co., Ltd.
Huzhou Huzhou Huzhou Wholesale 100.00 Establishment
Chuangdai and
E-commerce retail
Co., Ltd. business
Hapsode Hangzhou Hangzhou Wholesale 100.00 Establishment
(Hangzhou) and
Cosmetics retail
Co., Ltd. business
Huzhou UZERO Huzhou Huzhou Wholesale 100.00 Establishment
Trading Co., and
Ltd. retail
business
Hong Kong Hong Kong Hong Kong Wholesale 100.00 Establishment
Xinghuo and
Industry retail
Limited business
HONGKONG Hong Kong Hong Kong Wholesale 52.00 Establishment
KESHI and
TRADING retail
LIMITED business
Ningbo Keshi Ningbo Ningbo Wholesale 52.00 Establishment
Trading and
Limited retail
business
Ningbo Ningbo Ningbo Wholesale 61.36 Establishment
TIMAGE and
Cosmetics retail
Co., Ltd. business
Shanghai Shanghai Shanghai Wholesale 52.00 Consolidation
Healthlong and not under
Biochemical retail common
Technology business control
Co., Ltd.
282 / 323
2020 ANNUAL REPORT
Descriptions on the situation that the shareholding ratio in the subsidiary is different
from the share of the voting rights:
None
Basis for holding half or less of the voting rights of the investee but still controlling
the investee and holding more than half of the voting rights but not controlling the
investee:
None
Basis for controlling important structured entities included in the scope of consolidated
financial statements:
None
Basis for determining whether the Company is an agent or a principal:
None
Other particulars:
None
(2).Important non-wholly-owned subsidiaries
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Profits and Dividends
losses declared and
Shareholding Minority equity
attributable to distributed to
Name of ratio of balance at the
minority minority
subsidiaries minority end of the
shareholders in shareholders in
shareholders period
the current the current
period period
HONGKONG 48.00% -5,981,584.30 17,365,581.26
KESHI TRADING
LIMITED
Ningbo Keshi 48.00% -3,917,661.02 -5,614,155.64
Trading
Limited
Ningbo TIMAGE 38.64% -5,345,955.31 -8,636,628.03
Cosmetics
Co., Ltd.
Shanghai 48.00% -3,187,388.13 70,165,693.83
Healthlong
Biochemical
Technology
Co., Ltd.
Descriptions on the situation that the shareholding ratio of minority shareholders in
the subsidiary is different from that of the voting rights:
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
283 / 323
2020 ANNUAL REPORT
(3).Major financial information of important non-wholly-owned subsidiaries
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Name Non- Non-
Non-c Curr Tota Non- Curre
of Curre curr Curre curr Total
urren Total ent l curr Total nt
subs nt ent nt ent liabi
t asset liab liab ent asset liabi
idia asset liab asset liab litie
asset s ilit ilit asse s litie
ries s ilit s ilit s
s ies ies ts s
ies ies
HONG 81,65 81,65 50,8 50,8 155,4 155,4 116,4 116,4
KONG 5,123 5,123 24,1 24,1 19,17 19,17 04,50 04,50
KESH .48 .48 97.5 97.5 4.42 4.42 9.18 9.18
I 4 4
TRAD
ING
LIMI
TED
Ning 10,51 10,51 22,2 22,2 4,866 45, 4,911 8,445 8,445
bo 8,765 8,765 14,9 14,9 ,629. 000 ,629. ,992. ,992.
Kesh .49 .49 23.0 23.0 16 .00 16 96 96
i 8 8
Trad
ing
Limi
ted
Ning 42,47 85,0 42,56 64,3 64,3 4,383 4,383 7,454 7,454
bo 7,967 10.0 2,977 00,8 00,8 ,228. ,228. ,712. ,712.
TIMA .12 7 .19 99.0 99.0 97 97 50 50
GE 0 0
Cosm
etic
s
Co.,
Ltd.
Shan 163,0 3,94 166,9 20,7 20,7
ghai 08,51 5,88 54,40 75,8 75,8
Heal 8.70 5.57 4.27 75.4 75.4
thlo 5 5
ng
Bioc
hemi
cal
Tech
nolo
gy
Co.,
Ltd.
Name of Amount accounted for in the current Amount accounted for in the previous
284 / 323
2020 ANNUAL REPORT
subsid period period
iaries Cash Cash
flow flow
Total Total
from from
Net compreh Net compreh
Revenue operati Revenue operati
profit ensive profit ensive
ng ng
income income
activit activit
ies ies
HONGKO 115,636 -8,183, -8,183, 3,713,5 135,818 4,278,1 4,278,1 -13,269
NG ,625.15 739.30 739.30 47.69 ,021.02 74.24 74.24 ,802.15
KESHI
TRADIN
G
LIMITE
D
Ningbo 11,342, -8,161, -8,161, -3,229, 738,107 -4,534, -4,534, -235,67
Keshi 789.14 793.79 793.79 770.29 .69 363.80 363.80 0.94
Tradin
g
Limite
d
Ningbo 176,461 -18,666 -18,666 4,907,6 -3,685, -3,685, 794,443
TIMAGE ,811.57 ,438.28 ,438.28 11.95 083.53 083.53 .17
Cosmet
ics
Co.,
Ltd.
Shangh 181,257 -6,640, -6,640, -72,438
ai ,879.50 391.94 391.94 ,611.71
Health
long
Bioche
mical
Techno
logy
Co.,
Ltd.
Other particulars:
None
(4).Significant restrictions on the use of corporate group assets and the liquidation
of corporate group debts
□ Applicable√ Not applicable
285 / 323
2020 ANNUAL REPORT
(5).Financial support or other supports provided to structured entities included in the
scope of consolidated financial statements
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
2 Transaction resulting in change of owner’s equity proportion in subsidiaries but
still in control of the subsidiaries
√ Applicable□ Not applicable
(1).Description on change of owner’s equity proportion in subsidiaries
√ Applicable□ Not applicable
Shareholding Shareholding
Name of subsidiaries Change date ratio before ratio after
change change
Huzhou UZERO Trading Co., March 2020 95.00% 100.00%
Ltd.
Zhejiang Biyouti Cosmetics May 2020 100.00% 95.00%
Co., Ltd.
Shanghai Zhongwen Electronic September 2020 53.00% 83.00%
Commerce Co., Limited
Hong Kong Zhongwen Electronic September 2020 53.00% 83.00%
Commerce Co., Limited
Ningbo TIMAGE Cosmetics Co., November 2020 55.22% 61.36%
Ltd.
(2).Influence of transactions on minority shareholders’ equity and equity attributable
to shareholders of the parent company
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Huzhou UZERO Shanghai Hong Kong Ningbo TIMAGE
Trading Co., Ltd. Zhongwen Zhongwen Cosmetics
Electronic Electronic Co., Ltd.
Commerce Co., Commerce
Limited Co.,
Limited
Purchase 100,000.00 15,350,000.00
cost/disposal
consideration
--Cash 100,000.00 15,350,000.00
--Fair value of
non-cash assets
Total purchase 100,000.00 15,350,000.00
cost/disposal
consideration
Less: Net assets of -3,065,227.01 -988,996.78 -110,459.96 1,701,892.32
286 / 323
2020 ANNUAL REPORT
subsidiaries
calculated as per the
equity ratio of
acquisition/disposal
Difference 3,065,227.01 1,088,996.78 110,459.96 13,648,107.68
Where: Adjusted 3,065,227.01 1,088,996.78 110,459.96 13,648,107.68
capital reserve
Adjusted
surplus reserve
Adjusted
undistributed
profits
Other particulars
√ Applicable□ Not applicable
On 26 May 2020, the Resolution of Shareholders Meeting of Zhejiang Biyouti Cosmetics
Co., Ltd. approved the registered capital increase of RMB 526,300 and the contribution
of RMB 1.50 million by TEOH YONG WOOI, including RMB 526,300 as the paid-up capital and
RMB 973,700 as the capital reserve. The difference between the share in carrying net asset
of Biyouti calculated according to the shareholding ratio of the Company after the capital
increase and that before the capital increase was RMB 31,298.05 and included in the capital
reserve.
3 Equity in joint ventures or associates
√ Applicable□ Not applicable
(1).Important joint ventures or associates
□ Applicable√ Not applicable
(2).Major financial information of important joint ventures
□ Applicable√ Not applicable
(3).Major financial information of important associates
□ Applicable√ Not applicable
(4).Summary financial information of unimportant joint ventures and associates
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Balance at the end of the Balance at the beginning of
period/Amount accounted for the period/Amount accounted
in the current period for in the previous period
Joint ventures:
Total carrying value of 3,306,630.57 3,314,489.57
investments
Total of the following items calculated according to the shareholding ratio
287 / 323
2020 ANNUAL REPORT
--Net profits -7,859.00 -882,267.90
--Other comprehensive
income
--Total comprehensive -7,859.00 -882,267.90
income
Associates:
Total carrying value of 54,913,429.03 11,413,514.11
investments
Total of the following items calculated according to the shareholding ratio
--Net profits -638,756.60 -1,648,070.06
--Other comprehensive
income
--Total comprehensive -638,756.60 -1,648,070.06
income
Other particulars
None
(5).Descriptions on significant limitation of the ability of a joint venture or associate
to transfer funds to the Company
□ Applicable√ Not applicable
(6).Excess losses incurred by a joint venture or associate
□ Applicable√ Not applicable
(7).Unrecognized commitments related to joint venture investment
□ Applicable√ Not applicable
(8).Contingent liabilities related to joint venture or associate investment
□ Applicable√ Not applicable
4 Important joint operations
□ Applicable√ Not applicable
5 Equity in structured entities not included in the consolidated financial statements
Descriptions on structured entities not included in the consolidated financial
statements:
□ Applicable√ Not applicable
6 Others
□ Applicable√ Not applicable
X Risks Associated with Financial Instruments
√ Applicable□ Not applicable
288 / 323
2020 ANNUAL REPORT
The Company's risk management objective is to achieve balance between risks and
returns and minimize the negative impact of risks on our results of operations, so as
to maximize interests of shareholders and other equity investors. Based on this risk
management objective, the basic strategy of the Company's risk management is to identify
and analyze the risks faced by the Company, establish appropriate baseline risk tolerance
and carry out risk management, and monitor various risks in a timely and reliable manner,
so as to control the risks within a limited range.
The Company is faced with different risks related to financial instruments during
daily activities, mainly including credit risk, liquidity risk and market risk. The
Company’s management has examined and approved policies for managing these risks, which
can be summarized as follows.
(I) Credit risk
Credit risk refers to the risk that may bring financial loss to one party of the
financial instrument caused by the other party’s failure to perform its obligations in
the contract.
1. Practice of credit risk management
(1) Assessment method of credit risk
The Company, on each balance sheet date, assesses whether the credit risk of relevant
financial instruments has increased significantly since initial recognition. In
determining whether the credit risk has increased significantly since initial recognition,
the Company takes into account the reasonable and well-founded information available
without unnecessary additional costs or efforts, including qualitative and quantitative
analysis based on historical data, external credit risk rating and forward-looking
information. The Company determines the changes that may result in default risk of
financial instruments within their expected duration by comparing the default risk of
the financial instruments on the balance sheet date and the initial recognition date based
on an individual financial instrument or the combined financial instruments with similar
credit risk characteristics.
The Company deems that the credit risk of the financial instruments has increased
significantly if any one or more of the following quantitative and qualitative standards
are triggered:
1) The main quantitative standard is that the probability of default within the
remaining duration on the balance sheet date has increased by more than certain proportion
compared with that at the initial recognition;
289 / 323
2020 ANNUAL REPORT
2) The main qualitative standard is that there are material adverse changes occurring
to the business or financial conditions of the debtor and changes in the exiting or
anticipated technology, market, economic or legal environment which have a material
adverse effect on the debtor’s ability to make repayment to the Company.
(2) Definitions of default and assets with credit impairment
If the financial instruments meet any one or more of the following conditions, the
Company defines the financial assets as in default, with its standard consistent with
the definition of credit impairment:
1) The debtor faces major financial difficulties;
2) The debtor breaches the governing provisions for it in the contract;
3) The debtor is very likely to become bankrupt or undergo other financial
restructuring proceedings;
4) The creditor makes a concession to the debtor which it will not make under any
other circumstances for the economic or contractual considerations in connection with
the debtor’s financial difficulties;
2. Measurement of expected credit loss
The key parameters for measurement of expected credit loss include the probability
of default, loss given default and default risk exposure. The Company builds the model
of probability of default, loss given default and default risk exposure considering the
quantitative analysis of historical statistical data (such as counterparty rating,
guarantee type, category of collateral and pledge, repayment method) and forward-looking
information.
3. Refer to the particulars of VII.5, VII.6 and VII.8 in “Section XI Financial Report”
herein for the opening balance and closing balance reconciliation sheet of financial
instrument loss provisions.
4. Credit risk exposure and credit risk concentration
The credit risk of the Company is mainly from the monetary capital and receivables.
To control the above related risk, the Company has respectively taken the following
measures.
(1) Monetary capital
The bank deposit and other monetary capitals of the Company were deposited at
financial institutions with high credit rating; therefore, the credit risk was low.
(2) Receivables
The Company continuously carries out credit assessment on customers who trade in
290 / 323
2020 ANNUAL REPORT
credit. According to the result of credit assessment, the Company deals with the approved
customers with good credit, and monitors the balance of its receivables, so as to prevent
a significant risk of bad debt.
No guarantee is required as the Company only transacts with recognized and reputable
third parties. Credit risk concentration is managed as per customers. As of 31 December
2020, there was certain credit risk concentration in the Company and 49.42% (31 December
2019: 56.80%) of the accounts receivable of the Company was from the customers with a
balance ranking top 5. The Company had no guarantee or other credit enhancements on the
balance of the accounts receivable.
The maximum credit risk exposure of the Company is the carrying value of the financial
assets in the balance sheet.
(II) Liquidity risk
Liquidity risk refers to the risk of a shortage of funds of the Company when the Company
is performing its obligation to settle in the form of delivery of cash or other financial
assets. Liquidity risk may be from the inability to sell financial assets at fair value
as soon as possible, the other party’ inability to pay off its contractual debt, the
debt due in advance or the inability to generate anticipated cash flow.
To control such risk, the Company applies various financing methods, such as clearing
and bank loans, in appropriate combination of long and short-term financing ways to
optimize the financing structure and keep the balance between financing sustainability
and flexibility. The Company has obtained line of credit from several commercial banks
to meet the working capital demand and capital expenditure.
Financial liabilities classified as per the remaining due date
Closing balance
Item 1-3 Above 3
Carrying value Undiscounted Within 1 year
contract value years years
Bank loans 299,280,435.09 306,965,009.72 306,965,009.72
Bills
64,580,000.00 64,580,000.00 64,580,000.00
payable
Accounts
515,832,031.27 515,832,031.27 515,832,031.27
payable
Other
75,546,323.32 75,546,323.32 75,546,323.32
payables
291 / 323
2020 ANNUAL REPORT
Subtotal 955,238,789.68 962,923,364.31 962,923,364.31
(Continued)
Year-end balance of last year
Item 1-3 Above 3
Carrying value Undiscounted Within 1 year
contract value years years
Bank loans 214,305,644.20 217,020,041.44 217,020,041.44
Bills
41,830,948.53 41,830,948.53 41,830,948.53
payable
Accounts
347,316,843.39 347,316,843.39 347,316,843.39
payable
Other
91,444,673.31 91,444,673.31 91,444,673.31
payables
Subtotal 694,898,109.43 697,612,506.67 697,612,506.67
(III) Market risk
Market risk refers to the risk of fluctuating fair value of the financial instruments
or future cash flow due to the change of the market price. Market risk mainly includes
interest rate risk and foreign exchange risk.
1. Interest rate risk
Interest rate risk refers to the risk of fluctuating fair value of the financial
instruments or future cash flow due to the change of the market interest rate. The
interest-bearing financial instruments with a fixed interest rate put the Company at the
interest rate risk of fair value and those with a floating interest rate put the Company
at the interest rate risk of cash flow. The Company determines the proportion of financial
instruments with a fixed interest rate and floating interest rate according to the market
environment, and maintains an appropriate combination of financial instruments through
regular review and monitoring.
2. Foreign exchange risk
Foreign exchange risk refers to the risk of fluctuating fair value of the financial
instruments or future cash flow due to the change of foreign exchange rate. The risk of
foreign exchange rate changes faced by the Company is mainly related to the Company's
foreign currency assets and liabilities. The Company carries out business in the Chinese
mainland, with the main activities valuated in RMB. Therefore, the market risk of foreign
exchange changes faced by the Company is not material.
See VII.82 in “Section XI Financial Report” of this report for particulars on the
292 / 323
2020 ANNUAL REPORT
foreign currency assets and liabilities of the Company at the end of the period.
XI Disclosure of Fair Value
1 Closing fair value of assets and liabilities measured at fair value
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing fair value
Level-1 fair Level-2 fair Level-3 fair
Item
value value value Total
measurement measurement measurement
I. Continuous fair
value measurement
(I) Held-for-trading
financial assets
1. Financial assets at
fair value through
profit or loss
(1) Debt instrument
investment
(2) Equity instrument
investment
(3) Derivative
financial assets
2. Financial asset
designated as at fair
value through profit
or loss
(1) Debt instrument
investment
(2) Equity instrument
investment
(II) Other debt
investments
(III) Other equity
instrument
investments
(IV) Investment real
estate
1. Land use rights used
for rent
2. Rental buildings
3. Land use rights held
and ready to be
transferred after
appreciation
(V) Biological assets
1. Consumable
biological assets
2. Productive
293 / 323
2020 ANNUAL REPORT
biological assets
(VI) Receivables 5,531,997.32 5,531,997.32
financing
Total assets 5,531,997.32 5,531,997.32
continuously measured
at fair value
(VI) Held-for-trading
financial liabilities
1. Financial
liabilities at fair
value through profit
or loss
Where: Tradable bonds
issued
Derivative
financial liabilities
Others
2. Financial
liabilities
designated to be
measured as per fair
value, with their
changes included in
the current profit or
loss
Total liabilities
continuously measured
at fair value
II. Non-continuous
fair value
measurement
(I) Assets held for
sale
Total assets not
continuously measured
at fair value
Total liabilities not
continuously measured
at fair value
2 Basis for determining market prices of items continuously and not continuously
measured at the first-level fair value
□ Applicable√ Not applicable
3 Qualitative and quantitative information on valuation techniques and important
parameters adopted by items continuously and not continuously measured at the
second-level fair value
□ Applicable√ Not applicable
294 / 323
2020 ANNUAL REPORT
4 Qualitative and quantitative information on valuation techniques and important
parameters adopted by items continuously and not continuously measured at the
third-level fair value
√ Applicable□ Not applicable
The fair value of the notes receivable held is determined by their nominal amount.
5 Information on reconciliation between the beginning carrying value and the closing carrying
value of items continuously measured at the third-level fair value and sensitivity analysis on
unobservable parameters
□ Applicable√ Not applicable
6 For items continuously measured at fair value, in case of any conversion between various levels
in the current period, reasons for the conversion and policies to determine the conversion time
should be provided
□ Applicable√ Not applicable
7 Changes in valuation techniques and reasons for changes in the current period
□ Applicable√ Not applicable
8 Particulars on fair value of financial assets and liabilities which are not measured at fair value
□ Applicable√ Not applicable
9 Others
□ Applicable√ Not applicable
XII Related Parties and Related-party Transactions
1 Particulars on the parent company of the Company
□ Applicable√ Not applicable
2 Particulars on subsidiaries of the Company
Particulars on subsidiaries of the Company are shown in the relevant notes
√ Applicable□ Not applicable
See Note IX in Section XI of this Report for the particulars on subsidiaries of the Company.
3 Particulars on joint ventures and associates of the Company
For important joint ventures and associates of the Company, see the Notes for details
□ Applicable√ Not applicable
Particulars on other joint ventures and associates which have related-party transactions
with the Company in the current period or had related-party transactions with the Company
in the previous period and form balances are as follows
□ Applicable√ Not applicable
Other particulars
□ Applicable√ Not applicable
4 Particulars on other related parties
√ Applicable□ Not applicable
Name of other related parties Relationship between other related parties and
295 / 323
2020 ANNUAL REPORT
the Company
Chu Xiuqi Others
Zhejiang Yueqing Rural Commercial Others
Bank Company Limited
Huzhou Meizhuang Town Science and Others
Technology Incubation Park Co., Ltd.
Raohe Ussuri River Rice Industry Co., Others
Ltd.
China Commerce Association for Others
General Merchandise
Xiongke Culture Media (Hangzhou) Co., Others
Ltd.
Beijing Mitangpai Cosmetics Co., Ltd. Others
[Note]
Metis Info Tech (Guangzhou) Co., LTD. Others
Hangzhou Regenovo Biotechnology., Others
Ltd.
Zhuhai Healthlong Biotechnology Co., Others
Ltd.
Shaoxing Keqiao Qingteng Culture Others
Investment Co., Ltd.
PARISEZHAN HK LIMITED Others
EURL PHARMATICA Others
SARL ORTUS Others
S.A.S AREDIS Others
Korea Youke Co., Ltd. Others
Shanghai Youke Brand Management Co., Others
Ltd.
Pan Xiang Others
Other particulars
[Note] Beijing Mitangpai Cosmetics Co., Ltd. was cancelled in August 2020.
5 Particulars on related-party transactions
(1).Related-party transactions for the purchase and sales of goods and the rendering
and receipt of services
Table of information on the purchase of goods/the receipt of services
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Amount accounted Amount accounted
Related-party
Related party for in the current for in the previous
transaction content
period period
Zhuhai Healthlong Procurement of 2,914.13
Biotechnology Co., goods
Ltd.
EURL PHARMATICA [Note] Procurement of 2,908.10 3,023.88
goods
296 / 323
2020 ANNUAL REPORT
SARL ORTUS [Note] Procurement of 959.72 962.16
goods
Metis Info Tech Advertising and 203.88 1,262.47
(Guangzhou) Co., LTD. communication
service fees
Hangzhou Regenovo R&D and design fees 120.00
Biotechnology., Ltd.
S.A.S AREDIS [Note] Procurement of 117.16 274.11
goods
Shaoxing Keqiao Procurement of 54.08
Qingteng Culture goods
Investment Co., Ltd.
Beijing Mitangpai Procurement of 10.00
Cosmetics Co., Ltd. goods
Xiongke Culture Media Consulting fees, 0.53 164.18
(Hangzhou) Co., Ltd. video production
services
China Commerce Membership fee 0.50 0.50
Association for
General Merchandise
PARISEZHAN HK LIMITED Procurement of 8,198.96
[Note] goods
Korea Youke Co., Ltd. Procurement of 744.54
goods
Raohe Ussuri River Purchase of rice 7.49
Rice Industry Co.,
Ltd.
[Note] The Company and PARISEZHAN HK LIMITED entered into the Investment Cooperation
Contract and a Supplementary Agreement (hereinafter collectively referred to as
“Investment Agreement”) in 2019. According to the Investment Agreement, the Parties
will jointly found HONGKONG KESHI TRADING LIMITED, to which PARISEZHAN HK LIMITED and
its shareholders agree to transfer its brand agency services (including Boiron and
Puressentiel), cross-border e-commerce business, online Tmall International Store, etc.
After founding HONGKONG KESHI TRADING LIMITED, the Parties completed the business
handover and transferred the online store to HONGKONG KESHI TRADING LIMITED for operation.
Before completion of the change of registration information of the store, HONGKONG KESHI
TRADING LIMITED carries out sales through the online store, with the payment for goods
and promotion expenses collected and paid by PARISEZHAN HK LIMITED. PARISEZHAN HK LIMITED
has collected the sales volume of RMB 10,296,200 through the online store and paid the
store promotion expenses of RMB 675,300 in the current period.
Meanwhile, pursuant to the investment agreement, PARISEZHAN HK LIMITED agreed that
the business of EURL PHARMATICA, SARL ORTUS and S.A.S AREDIS controlled by PARISEZHAN
297 / 323
2020 ANNUAL REPORT
HK LIMITED and its shareholders would be transferred into HONGKONG KESHI TRADING LIMITED
within 12 months from the date of officially becoming a shareholder of HONGKONG KESHI
TRADING LIMITED (subject to the industrial and commercial registration), and EURL
PHARMATICA, SARL ORTUS and SARL ORTUS would no longer engage in business competing with
the Company and HONGKONG KESHI TRADING LIMITED. As at 31 December 2020, EURL PHARMATICA,
SARL ORTUS and S.A.S AREDIS have not transferred related business to HONGKONG KESHI
TRADING LIMITED due to overseas COVID-19 pandemic situation, business direction
adjustment of the Company, etc.
Table of information on the sale of goods/the rendering of services
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Amount accounted for Amount accounted for
Related-party
Related party in the current in the previous
transaction content
period period
Shanghai Youke Brand Sales of goods 5,672.40
Management Co., Ltd.
Korea Youke Co., Ltd. Sales of goods 630.03 813.22
Beijing Mitangpai Sales of goods, 224.53 139.44
Cosmetics Co., Ltd. agent operation
services
Shaoxing Keqiao Sales of goods 0.71
Qingteng Culture
Investment Co., Ltd.
PARISEZHAN HK LIMITED Sales of goods 248.09
Particulars on related-party transactions for the purchase and sales of goods and the
rendering and receipt of services
□ Applicable√ Not applicable
(2).Particulars on related-party entrusted management/contracting and entrusting
management/outsourcing
Table of information on the Company's entrusted management/contracting:
□ Applicable√ Not applicable
Particulars on related-party entrusting/contracting
□ Applicable√ Not applicable
Table of information on the Company's entrusting management/outsourcing
□ Applicable√ Not applicable
Particulars on related-party management/outsourcing
□ Applicable√ Not applicable
(3).Particulars on related-party leases
The Company as the lessor:
□ Applicable√ Not applicable
298 / 323
2020 ANNUAL REPORT
The Company as the lessee:
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Types of leased Rental fee recognized Rental fee recognized in
Name of lessor
assets in the current period the previous period
Huzhou Plant 65.26 42.64
Meizhuang Town
Science and
Technology
Incubation Park
Co., Ltd.
Descriptions on related-party leases
□ Applicable√ Not applicable
(4).Particulars on related-party guarantees
The Company as a guarantor
□ Applicable√ Not applicable
The Company as a guaranteed party
□ Applicable√ Not applicable
Descriptions on related-party guarantees
□ Applicable√ Not applicable
(5).Related-party fund lending
□ Applicable√ Not applicable
(6).Particulars on related-party asset transfer and debt restructuring
□ Applicable√ Not applicable
(7).Compensation of key management personnel
√ Applicable□ Not applicable
Unit: RMB 0’000 Currency: RMB
Amount accounted for in the Amount accounted for in
Item
current period the previous period
Compensation of key management 734.87 731.15
personnel
(8).Other related-party transactions
√ Applicable□ Not applicable
The Company and its subsidiaries have opened bank accounts in Zhejiang Yueqing Rural
Commercial Bank Company Limited and collected the interest on deposit according to the market
interest rate.
(1) Deposit in related-party bank
Unit: RMB 0’000
Related-party
Related party Closing Opening
transaction
balance balance
content
299 / 323
2020 ANNUAL REPORT
Zhejiang Yueqing Rural Commercial Bank
Cash at bank 14,390.77 12,149.26
Company Limited
(2) Interest collection from related party
Unit: RMB 0’000
Related-party Amount in the
Related party Balance in
transaction current
last period
content period
Zhejiang Yueqing Rural Commercial Bank
Interest income 593.97 513.91
Company Limited
6 Receivables from and payables to related parties
(1).Receivables
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Items Related party Carrying Bad debt Carrying Bad debt
balance provisions balance provisions
Accounts
receivable
Beijing 1,436,213.74 71,810.69
Mitangpai
Cosmetics
Co., Ltd.
Subtotal 1,436,213.74 71,810.69
Prepayment
Zhuhai 21,432,452.28
Healthlong
Biotechnology
Co., Ltd.
Huzhou 44,000.00 1,000.00
Meizhuang
Town Science
and
Technology
Incubation
Park Co., Ltd.
Shanghai 39,150.95
Youke Brand
Management
Co., Ltd.
EURL 16,860,085.06
PHARMATICA
[Note]
Xiongke 5,300.00
Culture Media
300 / 323
2020 ANNUAL REPORT
(Hangzhou)
Co., Ltd.
Subtotal 21,515,603.23 16,866,385.06
Other
receivables
EURL 24,167,639.75 1,208,381.99 5,004,666.01 250,233.30
PHARMATICA
[Note]
Huzhou 132,568.20 61,770.46 132,568.20 34,128.41
Meizhuang
Town Science
and
Technology
Incubation
Park Co., Ltd.
Pan Xiang 75,000.00 22,500.00 75,000.00 3,750.00
Beijing 27,000.00 1,350.00
Mitangpai
Cosmetics
Co., Ltd.
Subtotal 24,375,207.95 1,292,652.45 5,239,234.21 289,461.71
[Note] The item EURL PHARMATICA refers to the consolidated statistics of EURL
PHARMATICA, PARISEZHAN HK LIMITED, SARL ORTUS and S.A.S AREDIS under the control of the
same person.
(2).Payables
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Items Related party Carrying balance Carrying balance at the
at the end of the beginning of the period
period
Accounts payable
Metis Info Tech 99,718.88
(Guangzhou) Co.,
LTD.
S.A.S AREDIS 263,358.19
Huzhou Meizhuang 126,303.38
Town Science and
Technology
Incubation Park
Co., Ltd.
Subtotal 363,077.07 126,303.38
Contract
liabilities
Shanghai Youke 34,200.00
Brand Management
Co., Ltd.
301 / 323
2020 ANNUAL REPORT
Subtotal 34,200.00
7 Related-party commitments
□ Applicable√ Not applicable
8 Others
□ Applicable√ Not applicable
XIII Share-based payments
1 Overall situation of share-based payment
√ Applicable□ Not applicable
Unit: Share Currency: RMB
Total amount of equity instruments granted by Not applicable
the Company in the current period
Total amount of equity instruments exercised
by the Company in the current period
Total amount of equity instruments invalid in 152,635
the Company in the current period
Range of the exercise price for outstanding Not applicable
share options of the Company at the end of the
period, and the remaining contract term
Range of the exercise price for other The grant price of the granted restricted
outstanding equity instruments of the shares is RMB 17.95/share, with the term
Company at the end of the period, and the of 60 months from the grant date.
remaining contract term
Other particulars
On 12 July 2018, according to the Proposal on the Restricted Share Incentive Plan
of the Company in 2018 (Draft) and Its Summary reviewed and adopted at the First
Extraordinary General Meeting of the Company in 2018 and to the Incentive Plan, the Company
proposed to grant no more than 1.4672 million restricted shares to incentive objects,
where 1.2011 million stocks would be initially granted and 266,100 stocks would be
reserved. The initial grant date of the restricted shares is 12 July 2018, the incentive
objects include senior management, middle management and backbone employees working for
the Company (excluding the independent directors and supervisors, the shareholder or
actual controller severally or jointly holding more than 5% shares in the Company and
its spouse, parents and children), with 32 persons in total, and the grant price is RMB
17.95/share. The subject shares involved in this Incentive Plan is from the Class A
ordinary shares of the Company introduced to the incentive objects by the Company. The
validity period of this Incentive Plan is from the date when the registration of the grant
of restricted shares was completed to the date when all the restricted shares granted
to the incentive objects are exempt from restricted sales or repurchased and cancelled,
302 / 323
2020 ANNUAL REPORT
with the maximum period no more than 60 months. The granted restricted shares will be
exempt from restricted sales within 36 months in three phases after 12 months of initial
grant of the restricted shares, with the proportion in three phases respectively as 30%,
30% and 40%. The performance condition for exempting from restricted sales in phase 1
is that: On the basis of the operating revenue and net profit in 2017, the growth rate
of operating revenue and net profit in 2018 was respectively no less than 30.8% and 30.1%.
The performance condition for exempting from restricted sales in phase 2 is that: On the
basis of the operating revenue and net profit in 2017, the growth rate of operating revenue
and net profit in 2019 was respectively no less than 74.24% and 71.21%. The performance
condition for exempting from restricted sales in phase 3 is that: On the basis of the
operating revenue and net profit in 2017, the growth rate of operating revenue and net
profit in 2020 was respectively no less than 132.61% and 131.99%.
On 12 July 2018, the Proposal on Initial Grant of Restricted Shares to Incentive
Objects was reviewed and adopted at the 22th meeting of the First Session of the Board
of Directors of the Company to determine 12 July 2018 as the initial grant date. Some
incentive objects voluntarily waived the subscription in practice and the number of
restricted shares actually granted by the Company was 1.0962 million.
On 12 December 2018, the Proposal on Grant of Reserved Restricted Shares to Incentive
Objects was reviewed and adopted at the 3rd meeting of the Second Session of the Board
of Directors of the Company to determine 12 December 2018 as the grant date of the reserved
restricted shares. The incentive objects completed the subscription in practice and the
number of restricted shares actually granted by the Company was 266,100.
On 30 December 2019, the Proposal on Achievement Conditions for Exempting from
Restricted Sales in Phase 1 of Initial Grant and Reserved Grant in the Restricted Share
Incentive Plan in 2018 was reviewed and adopted at the 10th meeting of the Second Session
of the Board of Directors of the Company to lift 369,500 restricted shares held by the
incentive objects meeting the conditions for exempting from the restricted sales in phase
1, with the circulation date as 6 January 2020.
According to the Proposal on Repurchase and Cancellation of the Restricted Shares
Granted to the Incentive Objects No Longer Meeting the Incentive Conditions But Not Exempt
from Restricted Sales reviewed and adopted at the 4th meeting of the Second Session of
the Board of Directors in 2019 and the First Extraordinary General Meeting in 2019, and
the Proposal on Repurchase and Cancellation of Some Equity Incentive Restricted Shares
th
reviewed and adopted at the 8 meeting of the Second Session of the Board of Directors
303 / 323
2020 ANNUAL REPORT
in 2019, 92,740 restricted shares were repurchased and cancelled and the repurchase cost
of RMB 1,657,699.80 was paid because some incentive objects quitted the job or their
performance assessment failed to meet the conditions for exempting from restricted sales
of restricted shares in the current period.
On 6 July 2020, according to the Proposal on Adjusting the Performance Assessment
Indexes at Company Level in 2020 in the Restricted Share Incentive Plan in 2018 and
Relevant Documents reviewed and adopted at the Second Extraordinary General Meeting of
the Company in 2020, the Company adjusted the performance assessment target in phase 3
of exempting from restricted sales in the original incentive plan to that: on the basis
of the operating revenue and net profit in 2017, the growth rate of the operating revenue
and net profit in 2020 is respectively no less than 110.22% and 131.99%.
The equity instruments invalid in the current period were, in accordance with the
th th
resolutions at the 15 and 16 meetings of the Second Session of the Board of Directors
in 2020 and the Proposal on Repurchase and Cancellation of Some Equity Incentive
Restricted Shares reviewed and adopted at the Third Extraordinary General Meeting in 2020,
to repurchase and cancel 152,635 restricted shares and pay the repurchase cost of RMB
2,584,110.55 because some incentive objects resigned or their performance assessment
failed to meet the conditions for exempting from restricted sales of restricted shares
in the current period.
2 Particulars on equity-settled share-based payment
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Determination method for the fair value of Determined as per the stock price on the
equity instruments on the grant date grant date and the grant price of
restricted shares
Basis for determining the number of Determined according to the estimated
exercisable equity instruments performance conditions in the lifting
period
Reasons for significant differences between Not applicable
the estimates in the current period and the
previous period
Accumulative amount of equity-settled 53,943,573.13
share-based payments included in the capital
reserve
Total expenses recognized by equity-settled 4,193,320.87
share-based payments in the current period
Other particulars
None
304 / 323
2020 ANNUAL REPORT
3 Particulars on cash-settled share-based payment
□ Applicable√ Not applicable
4 Particulars on modification and termination of share-based payment
□ Applicable√ Not applicable
5 Others
□ Applicable√ Not applicable
XIV Commitments and Contingencies
1 Important commitments
√ Applicable□ Not applicable
Important external commitments, nature, and amount existing on the balance sheet date
In 18 October 2020, as approved by the 3rd extraordinary general shareholders’ meeting in 2020,
the Company was proposed to apply for public offering of A-share convertible bonds of not exceeding
RMB 803,500,000, and the net amount of the funds raised for issuing of convertible bonds, net of issue
expenses, will be used for the following items:
Items Total investment Raised fund to be
(00’000) invested
Huzhou Production Base Expansion
48,687.11 33,850.00
Project
Longwu R&D Center Construction Project 21,774.45 19,450.00
Information System Upgrade Project 11,239.50 9,050.00
Additional working capital 18,000.00 18,000.00
Total 99,701.06 80,350.00
2 Contingencies
(1).Important contingencies on the balance sheet date
□ Applicable√ Not applicable
(2).If the Company has no important contingencies that need to be disclosed, explanation
shall also be provided:
□ Applicable√ Not applicable
3 Others
□ Applicable√ Not applicable
XV Events after the Balance Sheet Date
1 Important non-adjusting events
□ Applicable√ Not applicable
305 / 323
2020 ANNUAL REPORT
2 Profit distribution
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Profits or dividends proposed to be 144,804,186.00
distributed
Profits or dividends reviewed and 144,804,186.00
approved to be declared for
distribution
3 Sales return
□ Applicable√ Not applicable
4 Description on other events after the balance sheet date
□ Applicable√ Not applicable
XVI Other Important Events
1 Correction of accounting errors in previous period
(1).Retrospective restatement method
□ Applicable√ Not applicable
(2).Future application method
□ Applicable√ Not applicable
2 Debt restructuring
□ Applicable√ Not applicable
3 Assets replacement
(1).Non-monetary assets exchange
□ Applicable√ Not applicable
(2).Other assets replacement
□ Applicable√ Not applicable
4 Annuity plan
□ Applicable√ Not applicable
5 Discontinued operations
□ Applicable√ Not applicable
6 Segment information
(1).Basis for determining reporting segments and accounting policies
√ Applicable□ Not applicable
306 / 323
2020 ANNUAL REPORT
The Company has no diversified operations or trans-regional operations, so no
segmental reporting is made. The breakdown of principal business income and principal
business cost of the Company, by brand, was as follows:
2020
Brand Income from main Cost of principal Gross profit
operations business
Proya 2,985,608,479.56 986,945,516.11 1,998,662,963.45
Other brands 762,316,121.04 376,541,258.15 385,774,862.89
Subtotal 3,747,924,600.60 1,363,486,774.26 2,384,437,826.34
2019
Brand Income from main Cost of principal Gross profit
operations business
Proya 2,655,623,315.78 862,688,977.18 1,792,934,338.60
Other brands 460,830,325.85 257,619,910.63 203,210,415.22
Subtotal 3,116,453,641.63 1,120,308,887.81 1,996,144,753.82
(2).Financial information of reporting segments
□ Applicable√ Not applicable
(3).If the Company does not have a reporting segment, or if it cannot disclose the total
assets and total liabilities of each reporting segment, the reasons shall be
explained
□ Applicable√ Not applicable
(4).Other particulars
□ Applicable√ Not applicable
7 Other important transactions and events that have an impact on investors’ decisions
□ Applicable√ Not applicable
8 Others
□ Applicable√ Not applicable
XVII Notes to the main items of the parent company’s financial statements
1 Accounts receivable
(1).Disclosure by account age
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Account age Carrying balance at the end of the period
Within 1 year
307 / 323
2020 ANNUAL REPORT
Where: Subitems within 1 year
Sub-total within 1 year 539,730,234.31
1-2 years 67,108,742.67
2-3 years 10,635,137.38
Above 3 years
3-4 years
4-5 years
Above 5 years
Total 617,474,114.36
(2).Disclosure by accruing method for bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Closing balance Opening balance
Carrying Bad debt Carrying Bad debt
balance provisions balance provisions
Accr Accr
Categ Carryi Carryi
Perc uing Perc uing
ory ng ng
enta perc enta perc
Amount Amount value Amount Amount value
ge enta ge enta
(%) ge (%) ge
(%) (%)
Bad
debt
provi
sions
accru
ed
separ
ately
Where:
Bad 617,47 100. 52,436 8.49 565,03 655,25 100. 41,170 6.28 614,08
debt 4,114. 00 ,703.2 7,411. 1,782. 00 ,327.8 1,454.
provi 36 1 15 77 7 90
sions
accru
ed
accor
ding
to
the
combi
natio
n
Where:
617,47 / 52,436 / 565,03 655,25 / 41,170 / 614,08
Total 4,114. ,703.2 7,411. 1,782. ,327.8 1,454.
36 1 15 77 7 90
308 / 323
2020 ANNUAL REPORT
Bad debt provisions accrued separately:
□ Applicable√ Not applicable
Bad debt provisions accrued according to the combination:
√ Applicable□ Not applicable
Items of portfolio provision: Account age combination
Unit: Yuan Currency: RMB
Closing balance
Name Accruing percentage
Accounts receivable Bad debt provisions
(%)
Account age 617,474,114.36 52,436,703.21 8.49
combination
Total 617,474,114.36 52,436,703.21 8.49
Recognition standards and descriptions on bad debts in portfolio provision:
□ Applicable√ Not applicable
If bad debt provisions are accrued according to the general model of expected credit losses,
please refer to the disclosure on other receivables:
□ Applicable√ Not applicable
(3).Particulars on bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period
Opening Recovere Resold or Other Closing
Category
balance Accrued d or written-of change balance
reversed f s
Bad debt 41,170,327.8 11,477,535.5 211,160.22 52,436,703.2
provisions 7 6 1
accrued
according
to the
combinatio
n
Total 41,170,327.8 11,477,535.5 211,160.22 52,436,703.2
7 6 1
Significant bad debt provision amounts recovered or reversed in the current period:
□ Applicable√ Not applicable
(4).Particulars on accounts receivable actually written-off in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Written-off amount
Accounts receivable actually written-off 211,160.22
309 / 323
2020 ANNUAL REPORT
Writing-off of significant accounts receivable
□ Applicable√ Not applicable
(5).Particulars on top 5 accounts receivable in terms of the balance at the end of the
period based on debtors
√ Applicable□ Not applicable
Proportion (%) of
the balance of Bad debt
Company name Carrying balance
accounts provisions
receivable
Zhejiang Meiligu Electronic
194,757,806.35 31.54 9,737,890.32
Commerce Co., Ltd.
Hangzhou Proya Trade Co., Ltd. 164,236,582.96 26.60 8,211,829.15
Huzhou UZERO Trading Co., Ltd. 105,627,945.58 17.11 18,370,228.37
Huzhou Chuangdai E-commerce Co.,
57,196,907.32 9.26 2,859,845.37
Ltd.
Hangzhou Proya Commercial
44,351,306.05 7.18 4,435,130.61
Management Co., Ltd.
Subtotal 566,170,548.26 91.69 43,614,923.82
(6).Accounts receivable derecognized due to the transfer of financial assets
□ Applicable√ Not applicable
(7).Amount of assets and liabilities formed due to the transfer and continuous
involvement of accounts receivable
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
2 Other receivables
Presented by item
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
Interest receivable
Dividend receivable
Other receivables 236,585,409.48 31,800,093.90
Total 236,585,409.48 31,800,093.90
Other particulars:
□ Applicable√ Not applicable
310 / 323
2020 ANNUAL REPORT
Interest receivable
(1).Classification of interest receivable
□ Applicable√ Not applicable
(2).Important overdue interest
□ Applicable√ Not applicable
(3).Particulars on accruing of bad debt provisions
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
Dividend receivable
(1).Dividend receivable
□ Applicable√ Not applicable
(2).Important dividend receivable with the account age over one year
□ Applicable√ Not applicable
(3).Particulars on accruing of bad debt provisions
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
Other receivables
(1). Disclosure by account age
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Account age Carrying balance at the end of the period
Within 1 year
Where: Subitems within 1 year
Sub-total within 1 year 225,714,864.15
1-2 years 23,059,702.19
2-3 years 35,780,461.67
Above 3 years 123,488,831.25
3-4 years
4-5 years
Above 5 years
Total 408,043,859.26
(2). Particulars on classification by amount nature
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount nature Carrying balance at the end Carrying balance at the
311 / 323
2020 ANNUAL REPORT
of the period beginning of the period
Borrowing/lending cost 402,005,709.08 179,090,840.39
Deposit and margin 5,100,314.72 4,838,414.72
Petty cash 932,910.70 300,000.00
Others 4,924.76 421,215.83
Total 408,043,859.26 184,650,470.94
(3). Particulars on accruing of bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Phase 1 Phase 2 Phase 3
Expected credit Expected credit
Expected loss for the loss for the
Bad debt Total
credit losses entire duration entire duration
provisions
in the next 12 (no credit (credit
months impairment impairment
occurred) occurred)
Balance as at 1 579,944.52 14,700.00 152,255,732.52 152,850,377.04
January 2020
Balance as at 1
January 2020 in
the current
period
-- Transferred -465,370.74 465,370.74
into Phase 2
-- Transferred -14,700.00 14,700.00
into Phase 3
-- Reversed into
Phase 2
-- Reversed into
Phase 1
Accrued in the 7,890,983.06 2,326,853.68 8,390,236.00 18,608,072.74
current period
Reserved in the
current period
Resold in the
current period
Written-off in
the current
period
Other changes
Balance as at 31 8,005,556.84 2,792,224.42 160,660,668.52 171,458,449.78
December 2020
Particulars on the significant changes in the carrying balance of other receivables in which changes in
loss provisions occurred in the current period:
□ Applicable√ Not applicable
312 / 323
2020 ANNUAL REPORT
The basis for adopting the amount of bad debt provisions accrued for the current period
and the assessment on whether the credit risk of financial instruments increased
significantly:
□ Applicable√ Not applicable
(4). Particulars on bad debt provisions
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period
Opening Recovere Resold or Other Closing
Category
balance Accrued d or written-o change balance
reversed ff s
Bad debt 152,209,232. 8,363,936.0 160,573,168.
provision 52 0 52
s accrued
separatel
y
Bad debt 641,144.52 10,244,136. 10,885,281.2
provision 74 6
s accrued
according
to the
combinati
on
Total 152,850,377. 18,608,072. 171,458,449.
04 74 78
Significant bad debt provision amounts reversed or recovered in the current period:
□ Applicable√ Not applicable
(5). Particulars on other receivables actually written-off in the current period
□ Applicable√ Not applicable
(6). Particulars on top 5 other receivables in terms of the balance at the end of the
period based on debtors
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Percentage
(%) in the
total Balance of bad
balance at debt
Company Closing Accoun
Amount nature the end of provisions at
name balance t age
the period the end of the
of other period
receivable
s
313 / 323
2020 ANNUAL REPORT
Hapsode Borrowing/lendin 237,448,782.7 [Note 58.19 159,856,503.4
(Hangzhou) g cost 0 1] 9
Cosmetics
Co., Ltd.
Hong Kong Borrowing/lendin 143,782,379.1 Within 35.24 7,189,118.96
Xinghuo g cost 9 1 year
Industry
Limited
Ningbo Borrowing/lendin 15,849,466.68 [Note 3.88 1,942,173.33
TIMAGE g cost 2]
Cosmetics
Co., Ltd.
Hangzhou Deposit and 4,708,614.72 1-2 1.15 1,412,584.42
Property margin years
Maintenanc
e Fund
Management
Center
Ningbo Borrowing/lendin 3,031,666.68 Within 0.74 151,583.33
Keshi g cost 1 year
Trading
Limited
Total / 404,820,909.9 / 99.20 170,551,963.5
7 3
[Note 1] Within 1 year: RMB 65,559,502.30; 1-2 years: RMB 12,731,987.48; 2-3 years:
RMB 35,731,461.67; more than 3 years: RMB 123,425,831.25.
[Note 2] Within 1 year: RMB 11,250,666.68; 1-2 years: RMB 4,598,800.00.
(7). Receivables involving government grants
□ Applicable√ Not applicable
(8). Other receivables derecognized due to the transfer of financial assets
□ Applicable√ Not applicable
(9). Amount of assets and liabilities formed due to the transfer and continuous
involvement of other receivables
□ Applicable√ Not applicable
Other particulars:
□ Applicable√ Not applicable
3 Long-term equity investment
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Closing balance Opening balance
314 / 323
2020 ANNUAL REPORT
Impairmen Impairmen
Carrying t Carrying Carrying t Carrying
balance provision value balance provision value
s s
Investmen 337,957,32 42,500,00 295,457,32 193,493,28 42,500,00 150,993,28
t to 7.24 0.00 7.24 1.61 0.00 1.61
subsidiar
ies
Investmen 51,915,628 51,915,628 12,965,896 4,076,710 8,889,185.
ts to .82 .82 .60 .83 77
associate
s and
joint
ventures
389,872,95 42,500,00 347,372,95 206,459,17 46,576,71 159,882,46
Total
6.06 0.00 6.06 8.21 0.83 7.38
(1). Investment to subsidiaries
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Impairme
nt Balance of
Decrease provisio impairment
Increase of
Invested Opening of the Closing ns provisions
the current
company balance current balance accrued at the end
period
period in the of the
current period
period
Hangzhou 30,000,000. 875,097.64 30,875,097.
Proya Trade 00 64
Co., Ltd.
Hanna 2,094,048.0 2,094,048.0
Cosmetics 0 0
Co., Ltd.
Zhejiang 10,000,000. 6,383,777.5 16,383,777.
Meiligu 00 1 51
Electronic
Commerce
Co., Ltd.
Yueqing 1,000,000.0 1,000,000.0
Laiya 0 0
Trading
Co., Ltd.
Hapsode 42,500,000. 42,500,000. 42,500,000
(Hangzhou) 00 00 .00
Cosmetics
Co., Ltd.
Mijing Siyu 18,000,000. 18,000,000.
(Hangzhou) 00 00
Cosmetics
315 / 323
2020 ANNUAL REPORT
Co., Ltd.
Huzhou 4,750,000.0 818,795.63 5,568,795.6
UZERO 0 3
Trading
Co., Ltd.
Huzhou 3,500,000.0 3,500,000.0
Niuke 0 0
Technology
Co., Ltd.
Hangzhou 5,000,000.0 5,000,000.0
Proya 0 0
Commercial
Management
Co., Ltd.
Huzhou 20,308,163. 20,308,163.
Younimi 00 00
Cosmetics
Co., Ltd.
Shanghai 5,300,000.0 100,000.00 5,400,000.0
Zhongwen 0 0
Electronic
Commerce
Co.,
Limited
Korea 5,046,455.6 5,046,455.6
Younimi 1 1
Cosmetics
Co., Ltd.
HONGKONG 24,736,491. 24,736,491.
KESHI 00 00
TRADING
LIMITED
Hong Kong 10,185,924. 10,185,924.
Xinghuo 00 00
Industry
Limited
Ningbo 552,200.00 15,350,000. 15,902,200.
TIMAGE 00 00
Cosmetics
Co., Ltd.
Ningbo 520,000.00 520,000.00
Keshi
Trading
Limited
Zhejiang 10,000,000. 10,000,000.
Biyouti 00 00
Cosmetics
Co., Ltd.
Ningbo 4,186,374.8 4,186,374.8
Proya 5 5
316 / 323
2020 ANNUAL REPORT
Enterprise
Consulting
Management
Co., Ltd.
Hangzhou 1,000,000.0 1,000,000.0
Yizhuo 0 0
Culture
Media Co.,
Ltd.
Hangzhou 2,000,000.0 2,000,000.0
Oumisi 0 0
Trading
Co., Ltd.
Guangzhou 1,000,000.0 1,000,000.0
Qianxi 0 0
Network
Technology
Co., Ltd.
Zhejiang 550,000.00 550,000.00
Qingya
Culture Art
Communicat
ion Co.,
Ltd.
Hangzhou 510,000.00 510,000.
Qingyan 00
Cosmetics
Co., Ltd.
Huzhou 1,200,000.0 1,200,000.0
Poyun 0 0
Electronic
Commerce
Co., Ltd.
Shanghai 110,500,000 110,500,000
Healthlong .00 .00
Biochemica
l
Technology
Co., Ltd.
Hangzhou 500,000.00 500,000.00
Weiluoke
Cosmetics
Co., Ltd.
BOYA (Hong
Kong)
Investment
Management
Co.,
Limited
Total 193,493,281 144,974,045 510,000. 337,957,327 42,500,000
317 / 323
2020 ANNUAL REPORT
.61 .63 00 .24 .00
(2). Investments to associates and joint ventures
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Change of the current period Bala
Inves nce
tment Decla of
Adju
gains ratio impa
stme
and n on irme
nt to Accru
With losse Othe distr nt
Openi othe ing Closi
Addit draw s r ibuti prov
Inves ng r of ng
ional n recog equi on of Other isio
tor balan comp impai balan
inves inve nized ty cash s ns at
ce rehe rment ce
tment stme under chan divid the
nsiv provi
nt the ges ends end
e sions
equit or of
inco
y profi the
me
metho ts peri
d od
I. Joint venture
Huzho 3,314 -7,85 3,306
u ,489. 9.00 ,630.
Panru 57 57
i
Indus
trial
Inves
tment
Partn
ershi
p
(Limi
ted
Partn
ershi
p)
Sub-t 3,314 -7,85 3,306
otal ,489. 9.00 ,630.
57 57
II. Associate
Xiong 2,999 -14,4 2,985
ke ,955. 44.47 ,511.
Cultu 82 35
re
Media
(Hang
zhou)
Co.,
Ltd.
318 / 323
2020 ANNUAL REPORT
Beiji
ng
Mitan
gpai
Cosme
tics
Co.,
Ltd.
Ningb 2,574 1,86 -713,
o Segu ,740. 1,32 411.9
Brand 38 8.48 0
Manag
ement
Co.,
Ltd.
Jiaxi 46,00 -376, 45,62
ng 0,000 513.1 3,486
Woyon .00 0 .90
g
Inves
tment
Partn
ershi
p
(Limi
ted
Partn
ershi
p)
Sub-t 5,574 46,00 1,86 -1,10 48,60
otal ,696. 0,000 1,32 4,369 8,998
20 .00 8.48 .47 .25
8,889 46,00 1,86 -1,11 51,91
Total ,185. 0,000 1,32 2,228 5,628
77 .00 8.48 .47 .82
Other particulars:
None
4 Operating revenues and operating costs
(1). Particulars on operating revenues and operating costs
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in the Amount accounted for in the
Item current period previous period
Revenue Costs Revenue Costs
Main operations 1,877,388,044.31 906,212,295.56 1,733,852,516.29 859,925,094.37
Other operations 73,581,174.62 12,405,049.40 36,943,357.45 10,485,667.66
Total 1,950,969,218.93 918,617,344.96 1,770,795,873.74 870,410,762.03
319 / 323
2020 ANNUAL REPORT
(2). Particulars on revenues from contracts
□ Applicable√ Not applicable
(3). Description on performance obligations
□ Applicable√ Not applicable
(4). Description on apportionment to remaining performance obligations
□ Applicable√ Not applicable
Other particulars:
None
5 Investment income
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Amount accounted for in Amount accounted for in
Item
the current period the previous period
Long-term equity investment income
calculated by cost method
Long-term equity investment income -1,112,228.47 -2,869,155.87
accounted for under the equity
method
Investment income from disposal of -114,873.70
long-term equity investment
Investment income from
held-for-trading financial assets
during the holding period
Dividend income from other equity
instrument investments during the
holding period
Interest income from debt
investment during the holding
period
Interest income from other debt
investments during the holding
period
Investment income from disposal of
held-for-trading financial assets
Investment income from disposal of
other equity instrument
investments
Investment income from disposal of
debt investment
Investment income from disposal of
other debt investments
Income from wealth management 2,266,301.37 4,653,362.83
products
320 / 323
2020 ANNUAL REPORT
Total 1,039,199.20 1,784,206.96
Other particulars:
None
6 Others
□ Applicable√ Not applicable
XVIII Supplementary Information
I Statement of non-recurring profit and loss in the current period
√ Applicable□ Not applicable
Unit: Yuan Currency: RMB
Item Amount the situation
Gains or losses on disposal of 150,560.30
non-current assets
Tax returns and exemption with approval
exceeding one's authority or without
formal approval document
Government subsidies included in the 12,198,410.18
profits and losses of the current
period (except those closely related to
the Company's business and of fixed
amount or fixed quantity granted in
accordance with national uniform
standards)
Fund possession cost from
non-financial business included in
current profit or loss
Gains arising from investment costs for
acquisition of subsidiaries,
associates and joint ventures less than
the fair values of attributable
identifiable net assets of the invested
entity at the time of acquisition
Profit and loss from exchange of
non-currency assets
Gains or losses on entrusted investment
or asset management
Provision for asset impairment due to
force majeure factors, such as natural
disaster
Profit and loss from restructuring of
debts
Enterprise restructuring charge, such
as expenditure on staffing,
integration cost
Profit and loss of the part exceeding
fair value generated from transaction
321 / 323
2020 ANNUAL REPORT
with unreasonable transaction price
Net current profit and loss of
subsidiary generated from enterprise
merger under common control from the
beginning of the period to the date of
merger
Profit and loss generated from
contingencies unrelated to normal
business of company
Investment income arising from changes 2,266,301.37 Investment income from
in fair values held-for-trading disposal of financial
financial assets, derivative financial asset designated as at
assets, held-for-trading financial fair value through
liabilities and derivative financial profit or loss
liabilities, and investment gains on
the disposal of held-for-trading
financial assets, derivative financial
assets, held-for-trading financial
liabilities, derivative financial
liabilities and other debt investment,
except the Company normal operations
related to effective hedging business
Reversal of provision for impairment of
receivables and contract assets which
are individually tested for impairment
Profit and loss obtained from entrusted
loans
Profit and loss generated from fair
value change of investment real estate
whose subsequent measurement is
conducted with fair value model
Influences on current profit and loss
of one-time adjustment to current
profit or loss pursuant to the laws and
regulations on tax and accounting
Trustee fee income obtained from
entrusted operation
Other net non-operating income and -6,810,805.57
expenses, other than the above items
Other profit and loss items conforming
to the definition of non-recurring
gains and losses
Effect of income tax -1,042,102.64
Effect of minority equity -688,969.45
Total 6,073,394.19
For non-recurring profit and loss items defined by the Company according to the
Explanatory Announcement of Information Disclosure by Companies Offering Securities to
322 / 323
2020 ANNUAL REPORT
the Public No. 1 - Non-recurring Gains and Losses, and non-recurring profit and loss items
listed in the Explanatory Announcement of Information Disclosure by Companies Offering
Securities to the Public No. 1 - Non-recurring Gains and Losses defined as recurring profit
and loss items，the reasons shall be explained.
□ Applicable√ Not applicable
II Return on net assets and income per share
√ Applicable□ Not applicable
Earnings per share
Profits during the Weighted
Basic earnings per Diluted earnings
Reporting Period average ROE (%)
share per share
Net profit attributable to 21.82 2.37 2.37
ordinary shareholders of
the company
Net profit attributable to 21.54 2.34 2.34
ordinary shareholders of
the company after deducting
non-recurring gains and
losses
III Accounting data difference between PRC GAAP and Overseas Accounting Standards
□ Applicable√ Not applicable
IV Others
□ Applicable√ Not applicable
Section XII Directory of Documents for Future Reference
Financial statements signed and sealed by the Legal Representative, CFO
References
of the Company, and the Head of the public accountant
Original of the audit report with the seal of the accounting firm and the
References
signature and seal of the certified public accountant
Originals of all company documents and announcements publicly disclosed
References
on the designated newspapers by CSRC in the Reporting Period
Chairman: Hou Juncheng
Date of submission approved by the Board of Directors:21 April 2021
Revision information
□ Applicable√ Not applicable
323 / 323
